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ABSTRACT 
  
 RNA polymerase (RNAP) is an essential enzyme which catalyses transcription; a highly 
regulated process. Bacteriophage are viruses which infect bacteria and as a result have evolved a 
diverse range of mechanisms to regulate the bacterial RNAP to serve the needs of the virus. T7 Gp2 
and Xp10 P7 are two bacteriophage-encoded transcription factors that inhibit the activity of the 
bacterial RNAP. The aim of this study is to investigate the molecular mechanisms of action of Gp2 
and P7. 
 Fluorescence anisotropy experiments proved Gp2 to bind to RNAP, independently of the σ-
factor, with a 1:1 stoichiometry and a low nanomolar affinity. In vitro transcription assays 
demonstrated that a negatively charged strip in Gp2 is the major determinant for its inhibitory 
activity. Furthermore, it was shown that efficient Gp2-mediated inhibition of RNAP also depends 
upon the highly negatively charged and flexible σ70 specific domain, R1.1. Gp2 and R1.1 both bind in 
the downstream-DNA binding channel and exert long-range antagonistic effects on RNAP-promoter 
DNA interactions around the transcription start site. 
 A systematic mutagenesis screen was used to identify residues in P7 necessary for binding to 
the RNAP; results were interpreted in the context of a newly resolved NMR structure of P7. 
Electrophoretic mobility shift assays revealed that P7 ‘traps’ a RNAP-promoter DNA complex en 
route to the transcriptionally-competent complex. Preliminary results from a fluorescence based 
RNAP-DNA interaction assay suggest that P7 may target RNAP interactions with the -35 promoter 
element and the ‘discriminator region’. 
 This study has contributed to our understanding of how non-bacterial transcriptional factors 
can influence bacterial gene expression by modulating RNAP activity. This study has also uncovered 
vulnerabilities in RNAP, which have the potential to be exploited therapeutically. To this end, these 
structure-function studies of Gp2 and P7 have provided the basis for the rational design of novel 
anti-bacterial compounds. 
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1.1. Bacterial transcription 
 
1.1.1. Bacterial transcription overview 
 In bacteria, RNAP is the key enzyme that catalyses transcription, the first and most highly 
regulated step of gene expression. RNAP facilitates the process of transcription by which DNA is used 
as a template for the de novo synthesis of messenger RNA (mRNA), ribosomal RNA (rRNA) and 
transfer RNA (tRNA) from nucleoside triphosphate (NTP) substrates. A mRNA transcript can then be 
subsequently translated into a polypeptide chain. Transcription can be divided into three distinct but 
successive stages; initiation, elongation and termination. To initiate transcription the RNAP 
associates with a σ-factor to form a complex, which is able to specifically interact with the promoter, 
a region upstream of the gene. The initial engagement of RNAP-σ with the promoter DNA is referred 
to as the RNAP-promoter DNA closed complex (RPc), in reference to the conformation of the DNA.  
The RNAP then unwinds a section of the DNA to form the ‘transcription bubble’ and positions the 
transcription start site near the catalytic centre. This transcriptionally competent state is referred to 
as the RNAP-promoter DNA open complex (RPo). The separation of the DNA strands forms a region 
of single-stranded DNA that serves as a template for RNA synthesis. The incoming NTPs are then able 
to base pair to their now exposed deoxyribonucleotide counterparts. In the RNAP catalytic centre, 
two Mg2+ions are required for coordinating the formation of the phosphodiester bond and 
consequently the release of a pyrophosphate side product. One Mg2+ ion is permanently chelated to 
three absolutely conserved aspartic acid residues within a NADFDGD motif (Zaychikov et al., 1996) of 
the RNAP, whereas the other is associated with the β and  phosphates of the entering NTP and is 
recruited for each act of catalysis. The arrangement of these ions facilitates the nucleophilic attack 
of the entering NTP α-phosphate by the 3’ hydroxyl at the terminus of the nascent RNA chain and 
stabilises the pentavalent transition state of the target phosphate (Sosunov et al., 2003;Sosunov et 
al., 2005).  
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Figure 1.1.1 Phosphodiester bond formation during nucleotidyl transfer. 
A schematic showing the nucleophilic attack of the -phosphate of the incoming NTP by the 3’ hydroxyl at the 
terminus of the nascent RNA chain. The pentavalent transition state of the -phosphate is coordinated by two 
Mg
2+ 
ions (yellow circles). One of the Mg
2+
 ions is associated with the β and -phosphates of the incoming NTP. 
Phosphodiester bond formation results in the release of a pyrophosphate product (blue). Inspired by (Zhang et 
al., 2010). 
 
 Initially, as the substrate NTPs bind to the growing DNA/RNA hybrid, the template DNA is 
pulled into the main channel of the RNAP. Meanwhile the promoter region of the DNA remains 
bound to the σ-factor. The outcome of these counterintuitive events is ‘DNA scrunching’. This results 
in an accumulation of free energy, which initially causes cycles of the premature breaking of the 
DNA/RNA hybrid and release of short abortive products. It has been hypothesised that these short 
RNA transcripts may serve to prime initiation and therefore regulate gene expression (Goldman et 
al., 2009). Once the RNA chain reaches more than 8-11 nucleotides the free energy exceeds that of 
promoter DNA binding, allowing the RNAP to dissociate from the σ-factor and clear the promoter 
(Borukhov and Nudler, 2008). Promoter clearance triggers the dissociation of the σ-factor from the 
RNAP to form a stable transcription elongation complex (TEC). However, in some cases the 
dissociation of the σ-factor from the RNAP is not compulsory; the σ-factor can remain bound 
throughout the transcription cycle (Bar-Nahum and Nudler, 2001). In the TEC, the ‘transcription 
bubble’ and DNA/RNA hybrid are maintained as the RNAP productively transverses the DNA from 5’ 
– 3’ (with respect to the non-template strand) at an average rate of 30-100 nt/s in vivo (Mooney et 
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al., 1998). The conservation of these nucleic acid structures means that the RNAP translocates the 
DNA template one nucleotide at a time to match the incorporation of individual substrate NTPs with 
the displacement of one nucleotide of the nascent RNA from the DNA/RNA hybrid. The growth of 
the RNA chain occurs in parallel with the re-annealing of the upstream duplex DNA and the DNA 
strand separation at the downstream edge of the ‘transcription bubble’ (Vassylyev et al., 2007). 
Transcription can be terminated by two different mechanisms, which are both dependent on RNAP 
pausing followed by destabilisation of the TEC. Intrinsic termination occurs when the newly 
synthesised RNA forms a hairpin loop caused by intramolecular base pairing of a G-C rich region, this 
is subsequently followed by a poly-U tract. These structures cause the melting of the DNA/RNA 
hybrid and collapse of the ‘transcription bubble’ (Gusarov and Nudler, 1999). Alternatively, 
termination can also be induced by the mono-hexameric helicase protein , which threads the 
nascent RNA through the centre of its ring and translocates towards the RNAP to unwind the 
DNA/RNA hybrid (Ciampi, 2006). After the release of the nascent RNA and the DNA template, the 
RNAP becomes available for σ-factor binding and new cycle of transcription. 
 
1.2. Structure-function of bacterial RNAP 
 
1.2.1. Bacterial RNAP structures 
 RNAP is a large, multi-subunit enzyme which is evolutionary conserved across all three 
kingdoms of life. Eukaryotic organisms possess at least three distinct nuclear RNAPs; RNA Pol I, RNA 
Pol II and RNA Pol III for synthesising rRNA, mRNA and tRNA respectively. Conversely, all prokaryotic 
(bacterial and archaeal) transcription is performed by a single RNAP, analogous to the eukaryotic 
RNA Polymerase II. The study of prokaryotic transcription, particularly in the bacterial model 
organism Escherichia coli has provided fundamental information on the structure and function of all 
RNAPs. Due to the large size (390 kDa) and multi-subunit composition of bacterial RNAP a 
combination of biochemical, biophysical, structural and genetic approaches is needed to fully 
understand the mechanism and regulation of transcription. Although the E. coli RNAP is the best 
studied enzyme of its type to date, the only high resolution, x-ray crystallography structures of the 
RNAP belong to the thermophilic bacterium Thermus thermophilus (2.6 Å and 2.5 Å) (Vassylyev et al., 
2002;Vassylyev et al., 2007) and Thermus aquaticus (3.3 Å and 4 Å) (Zhang et al., 1999;Murakami et 
al., 2002b) enzymes.  However the bacterial RNAP proteins are functionally similar and share a high 
level of sequence homology. Furthermore, the overall shape and size of a low resolution (19 Å) 
 19 
 
structure of the E. coli RNAP (Darst et al., 1998) obtained by cryo-electron microscopy is reminiscent 
of the high resolution structures of T. thermophilus and T. aquaticus RNAP.  
 
1.2.2. Architecture and channels of RNAP 
 The bacterial RNAP is a large enzyme, comprising of 150 Å (long), 115 Å (tall) and 110 Å 
(wide) dimensions (Zhang et al., 1999). RNAP has an overall negative charge but with an asymmetric 
charge distribution; the exterior is uniformly negative, whereas the surfaces that contact the nucleic 
acids are predominantly positive (Murakami et al., 2002b). The architecture of the RNAP, like the 
eukaryotic (Darst et al., 1991;Gnatt et al., 2001) enzyme reveals a characteristic crab-claw like shape 
(Figure 1.2.1), in which the major catalytic subunits comprise the smaller and larger ‘pincers’ 
respectively.  
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2.1 Structure of RNAP. 
A structure of T. aquaticus RNAP (Zhang et al., 1999) shown in the ribbon representation. The overall 
architecture of the multi-subunit RNAP resembles that of a ‘crab claw’. 
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 The ‘pincers’ of the claw form a positively charged (27 Å wide) channel referred to as the 
main channel or cleft which is often subdivided into two sections: the active site channel where 
catalysis occurs and the DNA/RNA hybrid resides and the downstream-DNA binding channel (dw-
DBC) which holds the duplex DNA, still to be transcribed, downstream of the active site. The main 
channel branches at the upstream of the RNAP into the RNA exit channel and forms a path through 
which the nascent RNA transcript can exit the complex. A secondary channel (10-12 Å wide) at the 
downstream face of the enzyme leads to the catalytic centre and is responsible for the delivery of 
substrate NTPs as well as providing access for specific transcriptional regulators (Zhang et al., 1999). 
The arrangement of the RNAP channels is summarised in Figure 1.2.2. 
 
 
 
Figure 1.2.2 RNAP channels. 
A schematic representation of the RNAP channels and their accommodation of nucleic acids during 
transcription. The RNA substrates (red dashed line) enter the active site via the secondary channel. The 
downstream duplex DNA is held in the downstream-DNA binding channel (non-template strand in yellow, 
template strand in green), catalysis of nucleotidyl transfer occurs in the active site channel and the nascent 
RNA (red line) exits the RNAP through the RNA exit channel. Inspired by (Nudler, 2009). 
 
 
1.2.3. Subunits of E. coli RNAP 
  The E. coli RNAP core consists of five subunits; two α (36.5 kDa), β (150.6 kDa), β’ (155.2 
kDa) and ω (10.2 kDa) which are collectively referred to as E. The α-subunits consist of two domains 
connected by an unstructured flexible linker (Blatter et al., 1994). The N-terminal domains (α-NTD) 
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of the αI and αII subunits contact the β and β’ subunits respectively (Zhang et al., 1999).  The α-NTDs 
are responsible for RNAP subunit assembly, during which the two α subunits dimerise before 
association with the β, β’ and ω subunits sequentially (Wang et al., 1997;Ishihama, 1981). The C-
terminal (α-CTD) domains are connected to the rest of the RNAP via the linkers which permit the 
differential positioning of the α-CTDs at different promoters. The α-CTDs form sequence specific 
interactions with regions of DNA or with DNA-bound transcriptional regulatory factors to influence 
transcriptional activation, repression, termination and anti-termination (Liu et al., 1996;Browning 
and Busby, 2004). In addition, the length of the linkers  has also been shown to effect transcription 
in a promoter-dependent manner (Meng et al., 2000).  
 The ω-subunit is unique to bacteria and is also proposed to have a structural role in enzyme 
assembly, specifically acting as a chaperone to the β’-subunit and in the recruitment of the σ-factor 
(Mathew and Chatterji, 2006). More recently it has also been suggested that ω may influence 
promoter specificity by altering the affinities of the σ-factor for the RNAP (Geertz et al., 2011). 
However its precise function during RNAP transcription remains unclear.  
 The larger β and β’ subunits comprise the major catalytic components of the enzyme which 
form the ‘pincers’. The β and β’ subunits were historically subdivided into evolutionary conserved 
regions from prokaryotic, archaeal and eukaryotic sequences, classified A-I for β (Sweetser et al., 
1987;Zhang et al., 1999) and A-H for β’ (Jokerst et al., 1989;Zhang et al., 1999). More recently the 
conserved sequence regions have been updated and redefined; amongst bacterial RNAP, 16 shared 
regions for the β subunit and 20 for the β’ subunit have been identified (Lane and Darst, 2010) 
(Figure 1.2.3). This comparison revealed that the highly conserved regions are also interspersed with 
species specific additions referred to as insertion elements.  
 Relative to E. coli the Thermus enzymes contain two insertions; βi12 (Opalka et al., 2010)  
and β’i2 (β’ non-conserved domain) (Chlenov et al., 2005). Compared to the Thermus enzymes, E. 
coli RNAP contains four sequence insertion elements; βi4 (dispensable region I), βi9 (dispensable 
region II), β’i6 (G non-conserved domain) (Chlenov et al., 2005) and βi11 (Lane and Darst, 2010) 
(Figure 1.2.3). These E. coli insertion elements have been structurally resolved and the Thermus 
specific regions removed to present a complete structural model of the E. coli RNAP (Opalka et al., 
2010). 
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Figure 1.2.3 RNAP β and β’ sequence insertion elements. 
Representation of the evolutionary conserved regions of the bacterial β and β’ subunits. The white boxes 
indicate conserved regions between all bacteria, whereas the coloured boxes indicate lineage-specific 
insertion elements of E. coli and the Thermus RNAPs. Adapted from (Opalka et al., 2010). 
 
1.2.4. RNAP ‘mobile modules’ 
 A more useful and descriptive nomenclature is more commonly used to subdivide the β and 
β’ catalytic domains into structurally conserved and highly flexible regions referred to as ‘mobile 
modules’. These ‘mobile modules’ possess varied roles in RNAP-σ assembly, nucleic acid 
interactions, enzyme movement (translocation), catalytic activity and transcription regulation. The β 
flap, β’ Zn-binding element, β’ zipper, β’ lid and β’ coiled-coil are located at the upstream face of the 
RNAP and primarily form the RNA exit channel. The β’ rudder, β’ bridge-helix and the β’ trigger-loop 
are located in the active site channel and the β dw-lobe, β’ clamp and the β’ jaw form the dw-DBC 
(Figure 1.2.4). 
 The most substantial conformational changes of the RNAP are a result of the flexibility of the 
‘pincers’ which enclose the main channel. The β’ pincer is formed predominantly by the β’ clamp 
(Thermus 3-619) (which also encompasses the β’ zipper, β’ Zn-binding element, β’ lid, β’ coiled-coil 
and β’ rudder). Swinging motions of the β’ clamp and the β clamp (Thermus 1058-1116) around a 
hinge referred to as the switch region, can alter the width of the main channel by nearly 25 Å (Darst 
et al., 2002). The ‘pincers’ can exist in three conformational states; an open clamp state with a 
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channel width of 20 Å which is sufficient for the accommodation of double stranded (ds)-DNA, a 
closed state of 12 Å which can accommodate only single stranded (ss)-DNA and a collapsed state 
with a width of 8 Å which is insufficient for even ss-DNA. The width of the main channel in the open 
state allows for DNA loading and strand-separation, whereas clamp closure stabilises the RPo and 
elongation complexes (Chakraborty et al., 2012). 
 The downstream portion of the β’ clamp together with the β dw-lobe (Thermus 142-330),  β’ 
jaw (E. coli 1149-1190) and β’i6 (E. coli 944-1129) contribute to the dw-DBC which accommodates 
the duplex DNA. The dw-DBC interactions with the dw-DNA can be subdivided into active site 
proximal and active site distal contacts. Active site proximal contacts with the +5 to +8 DNA is made 
by the β’ clamp and β’ dw-lobe. Whereas active site distal, +10 to +20 DNA, is also contacted by the 
β’ clamp as well as the β’ jaw and β’i6. The β’ jaw domain contributes to all three stages of 
transcription by increasing the longevity of the RPo and facilitating pausing during elongation and 
termination (Ederth et al., 2002a). In particular, the β’ jaw stabilises DNA strand-separation together 
with the β’ clamp and β dw-lobe (Nechaev et al., 2000;Wigneshweraraj et al., 2002;Wigneshweraraj 
et al., 2003;Wigneshweraraj et al., 2005;Wigneshweraraj et al., 2006). In addition, β’i6 also plays a 
role in E. coli RNAP pausing and termination (Artsimovitch et al., 2003), most likely because the 
sequence of this insertion element intercepts a critical mobile module known as the β’ trigger loop 
(Opalka et al., 2010).  
 The highly conserved β’ trigger loop (Thermus 1238-1250) and β’ bridge helix (Thermus 
1067-1102) are both situated in the active centre and are positioned to separate the main channel 
from the secondary channel as well as marking the boundary between the active site channel and 
the dw-DBC (Zhang et al., 1999;Vassylyev et al., 2002;Cramer et al., 2001). The flexible β’ trigger loop 
together with the β’ bridge helix function in concert to catalyse nucleotidyl transfer. The β‘ trigger 
loop, in its folded conformation is proposed to be directly responsible for the coupling of substrate 
NTP recognition with the catalysis of phosphodiester bond formation (Wang et al., 2006). In addition 
the β’ trigger loop may also influence the conformation of the β’ bridge helix. The state of the β’ 
bridge helix seems to differ in the available structures, consequently it is proposed to adopt at least 
two conformations, straight and kinked (Vassylyev et al., 2002;Gnatt et al., 2001). These 
conformations interchange depending on the stage of catalysis and correlate with the translocation 
of the DNA and RNA through the RNAP (Epshtein et al., 2002;Bar-Nahum et al., 2005).  
 Several mobile modules are required for the stability of the DNA/RNA hybrid and the 
processivity of the nascent RNA chain. The β flap (Thermus 703-830), β’ zipper (Thermus 26-47), β’ 
Zn-binding element (Thermus 51-83), and β’ lid (Thermus 525-538), β’ rudder (Thermus 584-602) and 
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β’ coiled-coil (Thermus 540-581) all comprise or are located in close proximity to the RNA exit 
channel.  The β’ flap is a major component of the RNA exit channel, acting as a cover for the nascent 
RNA (Zhang et al., 1999). The β’ flap contributes to σ-factor binding and (-35) promoter element 
recognition and is likely to be required for σ-release during promoter escape (Vassylyev et al., 
2002;Kuznedelov et al., 2002b). The flap is also responsible for the recognition and stabilisation of 
hairpin structures in the nascent RNA (Toulokhonov and Landick, 2003) together with the β’ zipper 
and β’ Zn-binding element (Epshtein et al., 2007a;King et al., 2004).  
 The β’ Zn-binding element comprises 4 conserved cysteine residues which may play a critical 
role in β’ folding (Zhang et al., 1999). The positioning of the β’ Zn-binding element suggests that in 
addition to termination it may also be involved in recognition of (-35) promoter DNA elements 
(Murakami et al., 2002b;Vassylyev et al., 2002). The β’ zipper is involved in forming interactions with  
the promoter DNA (spacer region) to form a stable RPc and at some promoters it also facilitates RPo 
formation (Yuzenkova et al., 2011).  
 The β’ lid forms contacts with the σ-factor (linker region) as is required for efficient 
transcription initiation (Toulokhonov and Landick, 2006). The β’ lid stacks onto the upstream edge of 
the DNA/RNA hybrid, thus mimicking the base-stacking interactions within the nucleic acid duplex 
and sterically blocking its extension (Vassylyev et al., 2007). Therefore, the β’ lid is also well 
positioned to facilitate the dissociation of the RNA chain from the DNA template strand of the 
DNA/RNA hybrid (Naryshkina et al., 2006;Toulokhonov and Landick, 2006). 
 The primary contact site of the σ-factor with RNAP is with the ’ coiled-coil which extends 
out from the main channel (Murakami et al., 2002b). The ’ coiled-coil induces the σ-factor (R 2.2) to 
recognise the DNA non-template strand (-10 promoter element) (Young et al., 2001). The ’ coiled-
coil also supports another loop-like structure called the ’ rudder (Zhang et al., 1999). The ’rudder 
stabilises the RNA at the upstream edge of the DNA/RNA hybrid in the initiation and elongation 
complexes (Kuznedelov et al., 2002a). 
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Figure 1.2.4 RNAP mobile modules. 
Top: schematic of RNAP with the mobile modules highlighted. Inspired by (Nudler, 2009). Bottom: structural 
model of E. coli RNAP with mobile modules highlighted as above (Opalka et al., 2010).  
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1.2.5. σ-factors 
 The core RNAP (E) is catalytically proficient but is unable to initiate promoter specific 
transcription. E forms extensive contacts with a dissociable sixth subunit, σ, to form a fully functional 
holoenzyme (Eσ). Upon formation of the holoenzyme and only then, the σ-factor is able to recognise 
and interact with specific promoter elements, which contain conserved hexameric motifs. The 
number of σ-factors encoded in a bacterial genome varies considerably from 1 in Mycoplasma 
genitalium to 63 in Streptomyces coelicolor, and generally differs in accordance with the lifestyle of 
the species (Gruber and Gross, 2003). In response to environmental cues, bacterial cells are able to 
select from their repertoire of σ-factors in order to direct gene expression towards various adaptive 
responses. Each of these σ-factors accumulate in response to different stress cues and compete for 
binding to the free E, enabling transcription from a specific subset of promoters therefore altering 
the global pattern of gene expression. 
 E. coli has seven different species of σ-factor;  σ70 (rpoD), σ54 (rpoN), σ38 (rpoS), σ32 (rpoH), σ28 
(rpoF), σ24 (rpoE) and σ19 (fecI), named according to their respective molecular weights. Even though 
the σ-factors contact E in a similar manner they all confer differential regulatory properties upon the 
holoenzyme. The principal and prototypical E. coli σ-factor, σ70 is responsible for expression of 
housekeeping genes predominantly during exponential growth. Five of the other E. coli σ-factors 
(σ38, σ32, σ28, σ24 and σ19) are closely related to σ70 in sequence and structure and therefore belong to 
the σ70-like family. σ-factors of this type recognise and initiate transcription from promoters 
containing the non-template consensus -35 (-35TTGACA-30) and -10 (-12TATAAT-7) sequences (Lisser 
and Margalit, 1993) (Figure 1.2.5). The length of the spacer region between the -10 and -35 
promoter elements is optimally 17 bps (Harley and Reynolds, 1987) and is important for Eσ-
promoter DNA interactions and promoter activity (Mulligan et al., 1985). σ70-like factors can also 
recognise a TG motif just upstream of the -10 element referred to as the extended -10 promoter 
element which is present in a subset of promoters that often lack the -35 element (Barne et al., 
1997) as well as residues in the discriminator region located between the -10 element and the 
transcription start site (+1) (Haugen et al., 2006). 
 
 
 
Figure 1.2.5 σ
70
 consensus promoter sequences. 
Sequence and position of the non-template consensus promoter elements and regions recognised by σ
70
. 
 27 
 
The σ70-like factors can be broadly divided into four phylogenetic groups (Gruber and Gross, 
2003;Paget and Helmann, 2003). Group 1 includes the primary housekeeping σ-factor represented 
by E. coli σ70. Group 2 σ-factors are closely related to group 1 but differ in the fact that they are 
dispensable for growth. E. coli σ38 is a group 2 σ-factor which drives the transcription of genes 
required during the stationary phase, making it the master regulator of the general stress response 
(Hengge-Aronis, 2002).  Group 3 σ-factors are more distantly related and also tend to initiate 
transcription from specific promoters in response to more precise cues. For instance E. coli σ32 
responds to aberrant protein folding usually as a result of heat shock (Arsene et al., 2000) whereas 
σ28 is responsible for the transcription of late genes in flagellum assembly required for rapid motility 
(Chilcott and Hughes, 2000). Group 4 includes the most numerous and diverse σ-factors which are 
also termed ECF σ-factors due to their role in responding to signals from the extracytoplasmic 
environment. σ24 responds to accumulation of aberrant proteins in the cell envelope in order to 
restore the integrity of the cell membrane (Alba and Gross, 2004), whereas  σ19 directs transcription 
of the operon responsible for iron uptake (Visca et al., 2002). 
Although most strains of bacteria have multiple σ70-like representatives they tend to have 
only one major alternative type of σ-factor. The σ54 class of σ-factors are associated with the 
transcription of genes required for specific adaptive changes such as growth under nitrogen limiting 
conditions and changes to membrane integrity. σ54 is the single E. coli representative of the σ54 class 
of σ-factors. Unlike σ70, σ54 characteristically directs E to promoters with conserved regions at -12 
(GC) and -24 (GG) (Barrios et al., 1999). Furthermore, Eσ54 requires an enhancer protein (AAA+ 
ATPase) to initiate this energy (ATP hydrolysis) dependent form of transcription (Wigneshweraraj et 
al., 2008;Buck et al., 2000).  
 
1.2.6. Organisation and function of σ70-like factor domains  
 σ70 type factors consist of up to four domains; 1.1, 2, 3 and 4 joined by flexible linkers 
(Campbell et al., 2002). These domains contain the highly conserved regions (R) 1.1, 1.2-2.4, 3.0-3.1 
and 4.1-4.2 as well as a large non-conserved region (σNCR) between regions 1.2 and 2.1. The 
interdomain distances in free σ are short, resulting in an overall compact structure (Mekler et al., 
2002;Schwartz et al., 2008;Callaci et al., 1999). In the holoenzyme each of the σ-domains and the 
linkers makes extensive contacts with the upstream face of E, (Murakami et al., 2002b;Vassylyev et 
al., 2002) whilst the crucial promoter binding elements, σ domains 2 and 4, are solvent exposed to 
engage with the DNA (Figure 1.2.6).  
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Figure 1.2.6 The RNAP holoenzyme 
Top: schematic of RNAP holoenzyme in the RPo formation with the σ-factor coloured red. Inspired by (Nudler, 
2009). Bottom: structural model of T. aquaticus RPo with the σ-factor highlighted in red (Opalka et al., 2010).  
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 R1.1 is limited to only group 1 σ70-like factors, and although its sequence is poorly conserved 
its high negativity is always preserved. To date, there is limited structural information available for 
R1.1 in either the free σ or holoenzyme, with only the full length version of σA from Thermotoga 
maritime resolved (Schwartz et al., 2008). Thus far, R1.1 has been assigned with two major 
functions.  In the free σ, R1.1 is believed to function as an auto-inhibitory domain by positioning 
itself to putatively interact with R4.2 and mask the promoter binding elements (Dombroski et al., 
1993a;Dombroski et al., 1993b;Camarero et al., 2002;Schwartz et al., 2008). Binding to the RNAP 
core induces large scale conformational changes in σ including the movement of R1.1 which relieves 
the masking and allows for spatial rearrangements of the promoter DNA binding elements to a 
distance which is compatible for engagement with the -10 and -35 sequences (Callaci et al., 1999). 
Consequently, most functions of the σ70-like factors are only able to manifest themselves in the 
context of the holoenzyme. With respect to the holoenzyme, it was proposed that because R1.1 is 
highly flexible its positioning may alter during the transition between RPc to RPo (Murakami et al., 
2002b;Nagai and Shimamoto, 1997). In fact, in the holoenzyme the negative nature of R1.1 allows it 
to bind deep within the dw-DBC (which may sufficiently widen the channel to facilitate the entry of 
ds-DNA). However, upon RPo formation R1.1 is displaced from the inside of the channel and is re-
positioned to interact with the tip of the β dw-lobe. Therefore R.1.1 also acts to promote 
transcription by serving as a molecular placeholder for the dw-DNA (Mekler et al., 2002). 
 σ domain 2 is comprised of five conserved regions. R1.2 directly contacts the discriminator 
region (Haugen et al., 2006). Regions 2.1 and 2.2 are important for forming interactions with the 
RNAP core, predominantly with the β’ rudder, β lobes (Sharp et al., 1999) and the β’ coiled-coil 
(Murakami et al., 2002b). Regions 2.3 and 2.4 have specific roles in promoter binding and DNA 
strand-separation; R2.4 contains the promoter recognition elements for interaction with the -10 
promoter element (Siegele et al., 1989) whereas residues in region 2.3 are responsible for the 
nucleation of DNA strand-separation by the flipping of a highly conserved adenine at position -11 of 
the non-template strand (Lim et al., 2001;Tomsic et al., 2001;deHaseth and Helmann, 1995).  
 σ domain 3 consists of regions 3.0 (Campbell et al., 2002) (originally known as 2.5) and 3.1. 
R3.0 recognises the extended -10 promoter element (Barne et al., 1997;Campbell et al., 2002) 
whereas R3.1 serves as another RNAP core binding interface (Sharp et al., 1999;Murakami et al., 
2002b).  
 The linker region between σ domains 3 and 4 constitutes R3.2. The linker contains nine 
negatively charged residues which are highly conserved in group 1 σ-factors (Gruber and Bryant, 
1997) suggesting it has an important function. It seems that part of the linker forms a loop that 
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protrudes into the active site channel between the β’ lid and β’ rudder, whereas the rest of the 
linker is located within the RNA exit channel and therefore occupies the same space as the nascent 
RNA (Murakami et al., 2002b;Vassylyev et al., 2002). Since part of the loop is negatively charged it 
may function to serve as a molecular mimic or placeholder for RNA (Murakami et al., 2002b). 
Consequently it has been hypothesised that the linker region must be displaced upon synthesis of an 
RNA product ≥ 9–11 nt, thus extension of the RNA chain during abortive initiation displaces the 
linker and triggers σ-release and consequently promoter escape (Murakami et al., 2002b;Mekler et 
al., 2002).   
  The σ4 domain, consisting of R4.1 and R4.2, forms RNAP core interactions with the β flap.  
R4.2 specifically, determines interactions with the -35 promoter element (Gardella et al., 1989), and 
induces DNA bending to facilitate interactions between the -CTDs and specific upstream DNA 
sequences (UP-elements) (Campbell et al., 2002;Ross et al., 1993). However, the presence of the 
extended -10 promoters makes region 4.2 dispensable for promoter binding (Kumar et al., 1993). 
 
 
 
 
Figure 1.2.7 Conserved domains and functions of σ
70
 type factors.  
The conserved regions and non-conserved region (NCR) of the σ
70
 type factors are labelled. Arrows point to the 
regions of contact between the σ-factor and the discriminator region, -10, extended -10 and -35 promoter 
elements. Regions 1.1 and 2.3 are required for inhibitory activity and initiation of DNA strand-separation 
respectively. Adapted from (Gruber and Gross, 2003). 
 
 
1.3. The isomerisation from RPc to RPo 
 
 In addition to the RNAP core and holoenzyme, structures of the T. aquaticus and T. 
thermophilius holoenzyme bound to nucleic acids have also been resolved (Murakami et al., 
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2002a;Vassylyev et al., 2007). These structures, together with extensive biochemical and biophysical 
data have provided valuable insights into the extent of the holoenzyme-promoter DNA interactions 
and the dynamics of the conformational changes, which occur during transcription initiation and 
elongation. The most intricate stage of transcription initiation is the conversion of the RPc to the RPo 
to generate the ‘transcription bubble’, a structure, which remains throughout elongation. The 
transition between the RPc and RPo is a multi-step and reversible process, which involves the 
isomerisation of the DNA in conjunction with large scale conformational changes within the 
holoenzyme (Figure 1.3.1). 
 At most σ70 promoters, the RPc is typically formed by the initial engagement of the -10 and -
35 promoter DNA elements with σ R2.4 and 4.2 of the holoenzyme. In the RPc the promoter DNA 
remains characteristically double stranded and resides outside of the main channel. The DNA in this 
complex demonstrates only upstream protection between  -55 to -20  which primarily results from 
the contacts with the -CTDs and σ R4.2 (Sclavi et al., 2005). The lack of downstream-DNA contacts 
renders the RPc sensitive to competitors such as heparin and salt.  
 DNA strand-separation is facilitated by the motion of ‘DNA breathing’ which can be 
influenced by a variety of factors, including DNA sequence, supercoiling and wrapping (deHaseth and 
Helmann, 1995) as well as the chemical environment and the temperature. The nucleation of DNA 
strand-separation is triggered by aromatic residues in σ R2.3 which are responsible for the flipping of 
the highly conserved adenine at position -11 of the non-template strand (Heyduk et al., 2006). 
Propagation of DNA strand-separation then occurs sequentially from the -10 promoter element. As 
the DNA strands separate the distance between the -10 base pair and the downstream edge of the 
bubble actually decreases. This implies that the DNA may adopt a scrunched conformation in the 
active site channel, not unlike the scrunching that occurs during abortive initiation (Chen et al., 
2010). The final ‘transcription bubble’ comprises  12 separated base pairs typically between the -10 
to +3 sites. The single-stranded non-template DNA is positioned in a groove between the β lobes and 
interacts with conserved aromatic residues of σ R2.3. Whereas the single-stranded template DNA is 
enclosed in a tunnel formed from σ domains 2, 3, the β’ lid and β’ rudder,  which position the +1 site 
next to the Mg2+ ions in the catalytic centre (Murakami et al., 2002a).  
 The DNA at the downstream edge of the ‘transcription bubble’ bends or kinks sharply by 90 
to position the duplex dw-DNA in line with the dw-DBC (Vassylyev et al., 2007). The entry of the 22 Å 
ds-DNA in the 10-19 Å wide dw-DBC (Murakami et al., 2002b;Vassylyev et al., 2002) is facilitated by 
the opening of the clamp domains of the β and β’ pincers (Chakraborty et al., 2012) and appears to 
coincide with the displacement of σ R1.1 (Mekler et al., 2002). The protection of the dw-DNA to +20, 
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arises from potential interactions with the β’ jaw (Wigneshweraraj et al., 2005), β’ i6 (Artsimovitch et 
al., 2003) and β clamp (Wigneshweraraj et al., 2006) which are likely to contribute to the tight 
binding of the duplex dw-DNA (Kontur et al., 2010), resulting in a stable, transcriptionally competent 
and competitor resistant RPo.  
 
 
 
 
 
Figure 1.3.1 Transition between RPc and RPo. 
A schematic illustrating the characteristic differences between the RPc and RPo. In the RPc the DNA remains in 
its duplex conformation outside of the main channel of the RNAP. In the RPo the DNA strands are locally 
separated and the dw-DNA is held by the β’ jaw (green rectangle) and β’ clamp (blue rectangle). Inspired by 
(Saecker et al., 2011). 
 
 These sequences of events that lead to the formation of the RPo take place through 
relatively short-lived intermediates which are too transient to capture for structural analysis. 
However intermediate complexes at the lacUV5, T7A1 and PR promoters have been characterised 
using time-resolved footprinting methods (Buc and McClure, 1985;Sclavi et al., 2005;Saecker et al., 
2011). The precise order and kinetics of events governing RPo formation are debatable and are likely 
to differ from promoter to promoter. The major conflicting hypothesis in RPo formation is centred 
around whether DNA bending and entry of the dw-DNA into the dw-DBC occurs before strand-
separation as described by footprinting experiments using the PR promoter (Gries et al., 
2010;Kontur et al., 2010), or whether DNA strand-separation facilitates DNA bending and dw-DNA 
loading as suggested from structural analysis and footprinting experiments on the T7A1 promoter 
(Chen et al., 2010;Rogozina et al., 2009).  
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1.4. Regulation of transcription initiation 
 
 Within a bacterial cell the supply of available RNAP is limited, therefore it is beneficial for the 
cell to function economically by controlling when and how much of each gene is expressed. The 
majority of RNAP is utilised for the transcription of genes required for translation and other 
housekeeping tasks, consequently, bacteria employ a range of methods to fine tune gene expression 
in response to environmental cues and stresses. The general distribution of RNAP can be affected by 
various mechanisms including the architecture of the DNA, the strength of promoter DNA sequences 
and the availability of specific σ-factors or nucleotides. Transcription initiation is also tightly 
controlled by a network of proteins known as transcription factors (TFs) which function to modify 
the activity of the holoenzyme at specific promoters. TFs can either up-regulate (activate) or down-
regulate (repress/inhibit) transcription from specific or subsets of genes.  
 Many TFs are DNA binding proteins; in E. coli 50% of regulated genes are controlled by seven 
‘global’ protein DNA binding TFs: CRP, FNR, IHF, Fis, ArcA, NarL and Lrp, conversely 60 TFs can only 
regulate transcription from one promoter (Martinez-Antonio and Collado-Vides, 2003). DNA binding 
TFs regulate transcription initiation by binding to specific sites adjacent to promoters, and also often 
interact with the -CTDs or σ domain 4. The location and sequence of transcription factor binding 
sites (TFBSs) typically determines whether a TF acts to repress or activate transcription of a certain 
gene. TFBSs are usually 12-30 bps in length and contain palinodromic sequences or direct repeats as 
most TFs function as homodimers (van Hijum et al., 2009). Activators increase the affinity of the 
RNAP for promoter DNA; three mechanisms have been described for simple activation. Class I 
activators target subunits of the RNAP. The cyclic AMP receptor protein (CRP) is a class I (and class II) 
activator which responds to elevated cAMP levels by binding to a position upstream of the lac 
promoter. CRP induces a bend in the DNA enabling it to make contact with the α-CTD of RNAP which 
is favourable for RPc formation, and with the α-NTD which facilitates isomerisation to the RPo 
(Busby and Ebright, 1999). The bacteriophage λ CI protein is an example of a class II activator which 
binds close to the -35 (bacteriophage λ PRM) promoter and makes contacts with domain 4 of σ70 
(Nickels et al., 2002). Class III activators such as members of the MerR family bind in the spacer 
region and twist the DNA, re-orientating the -10 and -35 promoters to an arrangement more optimal 
for RNAP binding (Browning and Busby, 2004). In addition, activators can also function to negatively 
modulate repressors of transcription (van Hijum et al., 2009). 
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Figure 1.4.1 Mechanisms of simple activation. 
Schematics illustrating the organisation of Eσ
70
 and activators (cyan) during simple activation. A) Class I 
activation. The activator is bound to an upstream site and contacts the -CTD of RNAP, recruiting it to the 
promoter. B) Class II activation. The activator binds adjacent to the -35 promoter element and contacts σ
70
 
domain 4. C) Class III activation. The activator binds at or near to the -10 and -35 promoter elements and 
realigns them for optimal Eσ
70
 binding. Adapted from (Browning and Busby, 2004). 
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 There are also four major modes by which TFs modulate transcription by simple repression. 
Class I repression can occur by steric hindrance either by directly binding to, or close to the promoter 
elements such as the as the lac repressor at the lac operon. Class II repression is brought about by 
the interaction of TFs such as GalR which bind upstream and downstream of the gal promoter to 
form a DNA loop, thereby preventing access to this region of DNA (Choy and Adhya, 1992). Class III 
repressors function as anti-activators. For instance CytR inhibits transcription initiation by contacting 
the promoter DNA bound CRP dimer and sterically blocking its interactions with the α-CTDs of the 
RNAP (Busby and Ebright, 1999).  
 
A 
 
 
 
 
 
 
 
B 
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Figure 1.4.2 Mechanisms of simple repression. 
Schematics illustrating the organisation of Eσ
70
, activators (cyan) and repressors (orange) during simple 
repression. A) Class I repression. The repressors blocks recognition of core promoter elements by Eσ
70
. B) Class 
II repression. Repressors bind to distal sites and interact to facilitate DNA looping. C) Class III repression. The 
repressors bind to activators to prevent them from functioning. Adapted from (Browning and Busby, 2004). 
 
 Furthermore, transcription is also subject to regulation by non-DNA binding factors (either 
proteins or nucleotides) that bind directly to subunits of the holoenzyme, irrespective of the 
promoter, to modulate the enzymes activity. For instance, alarmones are small modified nucleotides 
which can be synthesised and degraded quickly in response to the environment. The best studied 
alarmones are guanine tetraphosphate (ppGpp) and guanine pentaphosphate (pppGpp) which 
accumulate rapidly in amino acid starved E. coli cells in a process known as the stringent response. 
During amino acid starvation the binding of uncharged tRNAs to the ribosome stalls protein 
synthesis. This event triggers the synthesis of (p)ppGpp from GTP/GDP by the RelA protein. Other 
stress conditions such as depletion of phosphorus, carbon and iron also trigger the synthesis of 
(p)ppGpp, catalysed by SpoT or RelA homologs (Srivatsan and Wang, 2008). (p)ppGpp functions 
alongside its protein cofactor, DskA. (p)ppGpp is proposed to bind near to the RNAP active centre 
(Artsimovitch et al., 2004) whereas DskA is structurally similar to the TFs GreA/B and therefore is 
likely to bind in the secondary channel (Symersky et al., 2006). Together, their effects specifically 
alter gene expression from the rRNA and amino acid biosynthesis promoters. The rRNA promoters 
have a GC-rich discriminator region which is suboptimal for interacting with σ R1.2 (Haugen et al., 
2006). Therefore RPos from these promoters are intrinsically unstable (p)ppGpp and DskA act to 
lower the stability of these RPos even further, effectively preventing transcription initiation (Paul et 
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al., 2004). In contrast (p)ppGpp and DskA activate transcription from the amino acid biosynthesis 
promoters (which have AT-rich discriminator sequences) by increasing the rate of RPc to RPo 
isomerisation (Paul et al., 2005). In addition (p)ppGpp and DskA have a global effect on gene 
expression by releasing RNAP from σ70 dependent genes, shifting the equilibrium towards the use of 
alternative σ-factors (Durfee et al., 2008). 
 An alternative method by which bacterial transcription can be regulated is by non-native 
transcription factors which are produced by viruses that infect bacteria. To successfully propagate, 
the bacterial viruses synthesise low-MW, often non-DNA binding proteins, which specifically interact 
with and modulate the activity of the bacterial RNAP in favour of the limited transcription of host 
genes required for phage development and/or the efficient transcription of phage genes. 
 
1.5. Bacteriophage 
 
 Bacterial viruses referred to as bacteriophages or simply phages are probably the most 
ubiquitous entities on the planet. Phage were first identified by Felix d’Herelle and Frederick Twort 
independently as bacterial lytic agents in the early 20th century (D'Herelle, 2007;Twort, 1936). 
Phages typically adopt one of two types of life cycles; lytic or lysogenic. Lytic phage cause immediate 
lysis of the bacterial host cell to release the phage progeny. Lysogenic or temperate phage integrate 
their phage DNA into the bacterial host genome to generate a prophage which multiplies upon host 
cell division. The prophage remains dormant until host cell conditions deteriorate which stimulates 
excision from the bacterial genome and then initiates the process of lysis. Thus both lytic and 
lysogenic phage are dependent on their bacterial hosts for proliferation and consequently have 
developed a variety of mechanisms to modify cellular components of the host to benefit the survival 
of the phage. 
 Regulation of the phage life cycle is achieved by sequential expression of the phage early 
middle and late genes. In view of the fact that the bacterial RNAP is a key target for regulation, it is 
not surprising that phages have evolved mechanisms to ‘hijack’ the host RNAP for expression of at 
least their early genes if not all of their genes. Thus the host RNAP may be prevented from 
transcribing its own genes as well as directed to the correct phage genes during the appropriate time 
during infection.    
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1.6. Phage-encoded transcription factors of bacterial RNAP 
 
 Phages employ two methods of host RNAP modulation: covalent modifications such as ADP-
ribosylation or phosphorylation and regulation by non-DNA binding, low-MW proteins which bind 
directly to the host RNAP to control and/or direct its transcriptional activity (Nechaev and Severinov, 
2003). The E. coli infecting, ds-DNA, lytic phage, T4, is a good example of how both types of 
modification can be utilised to divert transcription by the bacterial Eσ70 away from the host genes 
and towards the phage early and middle genes.  
 The T4 enzymes Alt and Mod covalently modify the bacterial RNAP early in infection via ADP-
ribosylation. Alt acts with low efficiency to ADP-ribosylate the Arg265 residue of the -CTD of only 
one of the -subunits as well as other sites on , β, β’, and σ70. Whereas Mod specifically ADP-
ribosylates the Arg256 residue of both α-subunits (Goff, 1984). ADP-ribosylated Eσ70 is unable to 
transcribe from UP-element-dependent and CRP-dependent promoters. As UP-element-dependent 
transcription from rRNA promoters accounts for a large proportion of RNA synthesis during E. coli 
exponential growth, it is thought that this covalent modification functions to increase the number of 
available RNAP for transcription of T4 genes (Nechaev and Severinov, 2003).  
 A product of T4 middle-stage expression is AsiA, a low-MW protein (Orsini et al., 1993). AsiA 
exists as a homodimer which dissociates to bind to σ70 as a heterodimer with a 1:1 stoichiometry 
(Adelman et al., 1997). AsiA specifically interacts with σ R4.2 and prevents its interaction with the -
35 promoter element which thereby inhibits transcription from E. coli -10/-35 promoters and early 
phage promoters (Colland et al., 1998;Minakhin et al., 2001;Severinova et al., 1998). In support of 
this view, extended -10 promoters and pre-formed RPos are not inhibited by AsiA (Adelman et al., 
1997). AsiA also cooperates with MotA, an early-stage T4 protein, to activate transcription of E. coli 
Eσ70 dependent middle-stage T4 genes which are predominantly under the control of the extended -
10 class of promoters (Ouhammouch et al., 1995). These middle-stage genes also contain a MotA 
binding site (Guild et al., 1988) which is positioned to allow MotA to bind to σ70 R4.2 and therefore 
induce AsiA to interact with an identical sequence of amino acids at σ70 R4.1 (Minakhin et al., 2003). 
The interaction of AsiA with σ70 R4.1 stimulates transcription by increasing the efficiency of RPc 
formation and promoter escape (Adelman et al., 1998). Thus AsiA functions as a switch for the 
transition between T4 early-stage and middle-stage transcription; AsiA inhibits transcription from 
host and early T4 genes but together with MotA, activates transcription from T4 middle genes. T4 
late gene expression also requires the host bacterial RNAP but σ70 is replaced by the phage encoded 
promoter specificity factors Gp55 and the activator Gp45 (Nechaev and Severinov, 2003). 
 39 
 
 
Table 1.6.1 Known phage-encoded proteins that bind to and modulate bacterial RNAP. 
Protein Size  
(a.a.) 
Phage Host Targets which stage(s) of 
transcription? 
Effect on transcription  
Alc 167 T4 Escherichia coli Elongation/termination Proposed to bind to the N-terminal of the β’ subunit and inhibit transcription of 
unmodified cytosine-containing DNA. 
AsiA 90 T4 Escherichia coli Initiation Interacts with σ R4.2 and prevents its interaction with the -35 promoter. 
E3 237 SPO1 Bacillus subtilis UNK Proposed to bind to the N-terminal of the β’ subunit to inhibit transcription. 
Gp2 64 T7 Escherichia coli Initiation Binds to the β’ jaw domain and antagonises RPo formation at -10/-35 promoters. 
Gp24 131 Dp-1 Streptococcus 
pneumoniae 
Initiation Putative σ-factor which may direct host RNAP to phage genes. 
Gp28 225 SPO1 Bacillus subtilis Initiation σ-like factor which binds to host RNAP core and directs it to middle promoters. 
Gp36 214 PhiEco32 Escherichia coli Initiation σ-like factor which binds to host RNAP core, likely to direct transcription to middle or 
late phage genes. 
Gp39 147 P23-45 Thermus 
thermophilus 
Initiation, elongation, 
termination 
Binds to the β flap and inhibits transcription from -10/-35 promoters as well as 
decreasing pausing during elongation and preventing termination. 
Gp55 185 T4 Escherichia coli Initiation σ-like factor which binds to host RNAP core to transcribe late phage genes. 
Gp69 204 Dp-1 Streptococcus 
pneumoniae 
Initiation Putative σ-factor which may direct host RNAP to phage genes. 
Gp76 53 P23-45 Thermus 
thermophilus 
Initiation Inhibits transcription from -10/-35 promoters. 
MotA 211 T4 Escherichia coli Initiation Binds to an upstream DNA site and σ R4.2 which induces AsiA to interact with σ R4.1, 
stimulating RPc formation and promoter escape. 
N  107  Escherichia coli Elongation/termination RNA binding protein that interacts with elongating RNAP to prevent termination at nut 
sites. 
Nun  114 HK022 Escherichia coli Termination Interacts with RNA nut site and RNAP to abolish N-dependent anti-termination. 
ORF67 198 G1 Staphylococcus 
aureus 
Initiation Binds to σ domain 4 to prevent DNA binding. 
P7 73 Xp10 Xanthomonas 
oryzae 
Initiation, termination Binds to the N-terminal of the β’ subunit to inhibit RPo formation at -10/-35 promoters 
and prevent termination. 
Q protein 144  Escherichia coli Elongation, termination Binds between the -10/-35 promoter elements and RNAP core to suppress promoter-
proximal pausing and prevent termination. 
ss-DNA binding 
(SSB) 
265 N4 Escherichia coli Initiation Proposed to bind to the C-terminal of the β’ subunit and activate Eσ
70
 transcription 
from late phage promoters. 
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 The T4 proteins MotA and AsiA are representatives of a novel group of non-bacterial TFs 
which bind to and modulate the bacterial RNAP. To date, over 5000 different phages have been 
isolated, of which 750 have had their complete genomes sequenced (Hatfull and Hendrix, 2011). 
Considering the abundance and genetic diversity of the phage, only a very small proportion of the 
phage-encoded TFs have been studied, from a limited number of hosts. A list of the known and 
partly characterised phage-encoded proteins which bind to and modulate the bacterial RNAP during 
different stages of transcription is detailed in Table 1.6.1. This study aims to further contribute to the 
understanding of the regulation of bacterial RNAP during transcription initiation by investigating the 
molecular mechanisms of action of two phage-encoded proteins; T7 Gp2 and Xp10 P7. 
 
1.7. T7 phage-encoded Gp2 
 
 T7 is also a ds-DNA lytic phage which is dependent on the E. coli host RNAP as well as its own 
RNAP for gene expression. T7 phage relies upon the host RNAP to transcribe early genes including 
gene 1 which encodes the T7 single subunit RNAP (Studier, 1972). T7 RNAP is then responsible for 
the transcription of middle and late genes which are required for host transcription ‘shut-off’ and 
the production of viral progeny. Therefore the host transcription ‘shut-off’ regulates the switch from 
early to late phage gene expression. Host transcription ‘shut-off’ by T7 is implicated by two phage 
proteins, Gp0.7 an early gene product and Gp2 a middle gene product.  
 Gp0.7 is a serine/threonine protein kinase which acts to phosphorylate various host proteins 
including RNAP, the endonucleases RNase III and RNase E and the translational components 
initiation factor 1 (IF1), IF2, IF3, elongation factor G, ribosomal proteins S1 and S6, in addition to 
itself. Gp0.7 phosphorylation of RNAP occurs specifically at the amino acid residue T1068 of β’i6 and 
causes -dependent transcription termination. Gp0.7 is dispensable for T7 growth under normal 
laboratory conditions but it becomes essential when Gp2 function is attenuated. This suggests that 
the functional roles of Gp0.7 and Gp2 in host transcription ‘shut-off’ may be overlapping (Severinova 
and Severinov, 2006).   
 Gp2 was first assigned a role in the host transcription ‘shut-off’ because it was discovered 
bound to the inactive bacterial RNAP isolated from T7 infected cells. Moreover, removal of Gp2 from 
RNAP with high salt levels, recovered transcription activity (Hesselbach and Nakada, 
1977a;Hesselbach and Nakada, 1975). Additionally, T7 phage that are defective in gene protein 2, 
which encodes Gp2, can be rescued by the addition of rifampicin (the only clinically used antibiotic 
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that targets RNAP), further suggesting the involvement of Gp2 as an inhibitor of RNA synthesis 
(Hesselbach and Nakada, 1975;LeClerc and Richardson, 1979a). It seems that the precise role of Gp2 
in the switch from early-late phage gene expression is to prevent anti-terminated transcription from 
the A3 promoter by the bacterial RNAP, into areas of the phage genome normally transcribed by the 
T7 RNAP (Savalia et al., 2010). The bacterial RNAP translocates the DNA much slower than the T7 
RNAP, which results in a roadblock and causes the later to pause. The paused T7 RNAP may then 
recruit DNA packaging machinery which introduces a premature break in the DNA resulting in the 
formation of short concatamers. Thus, Gp2 deficient T7 phage are able to infect and lyse the host 
cell efficiently, but do not produce viable progeny (Chamberlin, 1974;Center, 1975;LeClerc and 
Richardson, 1979b;DeWyngaert and Hinkle, 1979;DeWyngaert and Hinkle, 1980;Qimron et al., 
2008). 
 An initial investigation into the interaction between RNAP and Gp2 was based on the E. coli 
strains tsnB, BR3, and Y49. These strains were selected as they are non-permissive for T7 growth 
because Gp2 is no longer able to bind to and therefore inhibit the bacterial RNAP (Chamberlin, 
1974;Studier, 1973;DeWyngaert and Hinkle, 1979;DeWyngaert and Hinkle, 1980;Shanblatt and 
Nakada, 1982). Sequencing of tsnB, BR3 and Y49, identified two individual charge reversal mutations 
in the β’ jaw of RNAP; E1158K and E1188K, suggesting that these amino acid residues are important 
determinants for Gp2 binding to the RNAP (Nechaev and Severinov, 1999).  
 Early work from this laboratory also focused on studying the interaction between Gp2 and 
RNAP. A comprehensive alanine mutagenesis screen of Gp2 revealed that two amino acid residues, 
R56 and R58, which are highly conserved in Gp2, seem to be important for inhibitory activity (Figure 
1.7.1). Native-PAGE assays showed that the R56A and R58A mutants of Gp2 were significantly 
impaired in binding to Eσ70. Moreover, the contribution of the charge of Gp2 amino acid residues 56 
and 58 was assessed in vivo: charge reversal substitutions (R to E) significantly reduced the efficiency 
of T7 plating more than charge conservation (R to K) or charge removal (R to A). In view of the fact 
that Gp2-RNAP binding can be disrupted with high salt levels and that the charge reversal mutations, 
E1158K and E1188K in the β’ jaw also abolish Gp2 binding, it would appear that the interaction 
between Gp2 and the β’ jaw is likely to include a significant electrostatic component (Camara et al., 
2010). Although the major amino acid residues responsible for the Gp2-RNAP binding have been 
established, the affinity of the interaction between Gp2 and RNAP remains unknown. Therefore the 
first objective of this study was to develop and apply a solution based assay to quantitatively 
measure the affinity between Gp2 and RNAP. 
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Figure 1.7.1 Alanine mutagenesis screen of Gp2. 
A graph showing the effect of single alanine substitutions in Gp2. The inhibitory activity of each single alanine 
mutant version of Gp2 was assessed using an in vitro transcription assay: The ability of Eσ
70
 to synthesise the 
ApApUpU RNA transcript from the lacUV5 promoter template in the presence of each Gp2 single-alanine 
mutant was normalised to a reaction conducted in the absence of Gp2 (first bar). Gp2 and Eσ
70
 were present at 
equimolar amounts. The dotted line indicates the cut-off for Eσ
70
 activity, below which a Gp2 mutant was 
considered to have a WT level of inhibitory activity. 
 
 Work from this laboratory also led to the determination of a high resolution 3-D, NMR 
structure of Gp2, which showed Gp2 to adopt a compact β1β2α1β3 topology. The structure was 
initially used to further consider the results of the alanine mutagenesis screen. The structure of Gp2 
revealed that the R56 and R58 amino acid residues were surface exposed at the C-terminal of the 
protein and positioned to project outwards to form an interaction with the β’ jaw, whereas the 
majority of the remaining amino acid residues important for function (at residues F16, I31, G51, F52, 
V54 and V57) were located in positions proposed to stabilise the hydrophobic core of the protein or 
necessary for correct protein folding. Furthermore, a notable feature of the Gp2 structure is the 
separation of charges created by the R56 and R58 amino acid residues located at in the β3 strand and 
a surface exposed strip of aspartic and glutamic acid residues (E34, D37, E38, E41, E44, E53 and E21) 
which run down the length of the α-helix to the β1β2 loop (Figure 1.7.2). The role of this negatively 
charged strip (NCS) of amino acid residues in Gp2 inhibition of RNAP is unknown. The second 
objective of this study is to investigate the role of the NCS in the Gp2-mediated inhibition of Eσ70. 
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Figure 1.7.2 Charge separation of Gp2 structure. 
Ribbon representation of the NMR structure of Gp2 with the positively charged binding determinants, R56 and 
R58 coloured blue and the aspartic and glutamic acid residues of the NCS (E34, D37, E38, E41, E44, E53 and 
E21) coloured red.  
 
 Gp2 inhibits the stage of transcription initiation, but can only exert its effects prior to the 
formation of the RPo, meaning that Gp2 has no effect on promoter escape or elongation 
(Hesselbach and Nakada, 1977b;Nechaev and Severinov, 1999). Gp2-mediated inhibition of 
transcription initiation appears to be both σ-factor and promoter specific; Gp2 is a potent inhibitor 
of Eσ70 transcription at -10/-35 promoters such as lacUV5 and T7A1 but has significantly less effect at 
extended -10 promoters such as galP1 (Nechaev and Severinov, 1999). Furthermore, transcription 
from promoters recognised by the activator and ATP-hydrolysis dependent Eσ54 is also resistant to 
Gp2 inhibition (Wigneshweraraj et al., 2004). It was originally proposed that Gp2 inhibited 
transcription initiation by preventing RPc formation as judged by a reduction in promoter DNA 
binding (Hesselbach and Nakada, 1977b;Nechaev and Severinov, 1999). However, recently the 
mechanism of inhibition of transcription by Gp2 has been studied in more detail by this laboratory. 
Results from in vitro transcription assays showed that Gp2 does not affect RPc formation but a stage 
afterwards, leading to the RPo; Gp2 can successfully inhibit transcription initiation from homoduplex 
DNA templates but has markedly less effect on heteroduplex DNA templates (containing mismatches 
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between the -10/+3) which mimic the ‘transcription bubble’ in the RPo. Further in vitro transcription 
assays were conducted with different heteroduplex DNA templates to determine the length and 
position and of the mismatched segment required to overcome Gp2 inhibition. Results showed that 
inhibition was attenuated from DNA templates containing +1 proximal heteroduplex segments and 
that Gp2 is displaced upon Eσ70-promoter DNA complex formation. This suggests that Gp2 affects a 
late stage en route to RPo formation associated with DNA strand-separation around the +1 site 
(Camara et al., 2010). The third objective of this study is to further unravel the overall mechanism of 
inhibition of Eσ70 by Gp2. Since, σ R1.1, like Gp2 is highly negatively charged, also resides in the dw-
DBC and has been proposed to play an important role in the progression to RPo formation, the third 
objective will focus on the potential contribution of σ R1.1 in the Gp2-mediated inhibition of Eσ70.  
  
1.8. Xp10 phage-encoded P7 
 
 Xp10 is a ds-DNA lytic phage which infects the phytopathogenic bacterium Xanthomonas 
oryzae a major cause of rice blight. The genome organisation of Xp10 is different to T7 phage and 
more reminiscent of temperate phages related to . The Xp10 genome is split into two groups of 
genes which are expressed divergently. The leftward genes are involved in genome replication and 
expression and are expressed early in infection by the host RNAP, whereas rightward genes are 
required for the formation of phage progeny and host cell lysis and are transcribed by the phage 
RNAP in addition to the host RNAP (Yuzenkova et al., 2003).  
 Xp10 was originally reported to employ an anti-σ activity to ‘shut-off’ host transcription as 
only the bacterial RNAP core was isolated from Xp10 infected X. oryzae cells compared to the 
isolation of the holoenzyme from un-infected X. oryzae cells (Liao and Kuo, 1986). However, later 
research proved this finding to be untrue. Instead it was shown that a low-MW phage protein 
referred to as P7 binds to the X. oryzae holoenzyme and is responsible for its inactivity in promoter-
dependent transcription. Electrophoretic mobility shift assays (EMSAs) and in vitro transcription 
assays demonstrated that P7 prevents RPo formation as well as displaying characteristics of an anti-
terminator. Additionally, like AsiA and Gp2, pre-formed RPos and transcription initiation from 
extended -10 promoters seems to be resistant to P7 inhibition (Nechaev et al., 2002). Therefore it 
was proposed that P7 may play a dual role in Xp10 development; inhibiting transcription initiation of 
host RNAP to induce a switch between early and late phage genes and also ensuring that promoter-
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distal phage genes (predominantly of the extended -10 type) are expressed, perhaps utilising an anti-
termination mechanism (Yuzenkova et al., 2003). 
 It was hypothesised that P7 may prevent RPo formation by interfering with conformational 
changes in the σ required for Eσ-promoter complex formation. In support of this view, luminescence 
resonance energy transfer (LRET) experiments demonstrated that in the presence of P7 the 
interdomain distances between σ R2.4 and 4.2 were reduced to resemble that of free σ. Since the σ 
R2.4 and R4.2 are required for interaction with the -10 and -35 promoter elements, this result 
suggests that P7 may act to prevent RPc formation (Nechaev et al., 2002). The precise mechanism of 
inhibition of transcription initiation by P7 remains unknown.  
 P7 appears to have no effect on transcription by E. coli Eσ70 suggesting that P7 binds to an 
evolutionary variable region of the RNAP. The site of P7 binding to the X. oryzae RNAP was 
determined by co-purification, far-Western blotting and bacterial two-hybrid based interaction 
analyses. The results indicated that the precise site of P7 binding mapped to the N6L7F8N9 amino acid 
residues of the β’ subunit, located at the upstream face of RNAP (Yuzenkova et al., 2008). The fourth 
and fifth objectives of this study are to further characterise P7 activity by determining which of its 
amino acid residues are necessary for binding to the RNAP and to investigate the mechanism by 
which P7 inhibits transcription initiation.  
 
1.9. Research objectives 
 
 T7 Gp2 and Xp10 P7 inhibit transcription initiation by RNAP at a stage(s) en route to RPo 
formation (Figure 1.9.1). This thesis concerns a detailed investigation into the molecular mechanism 
of action of Gp2 and also a preliminary characterisation of P7 with the following objectives: 
 Establish and apply a quantitative assay for measuring the binding affinity between Gp2 and 
RNAP and variant versions thereof. 
 Explore the role of the NCS of Gp2 in the inhibition of Eσ70. 
 Investigate the contribution of σ R1.1 in the overall molecular mechanism of inhibition of Eσ70 by 
Gp2. 
 Determine the amino acid residues in P7 important for binding to RNAP. 
 Investigate the mechanism by which P7 inhibits transcription initiation. 
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Figure 1.9.1 Gp2 and P7 inhibit RPo formation. 
A cartoon depicting the major conformational changes between the RPc and RPo of Eσ
70
 (E is grey, σ
70
 is 
purple). The active site is represented by a yellow dot whereas the DNA template strand is shown in orange 
and the non-template strand in dark blue. Gp2 and P7 inhibit a stage(s) en route to RPo formation.   
 
 
1.10. Why is this research important? 
 
 Transcription is a fundamental process in all living organisms. Bacterial transcription is 
catalysed by the multi-subunit enzyme RNAP. The regulation of bacterial transcription 
predominantly occurs at the initiation step where the activity of RNAP is controlled by a plethora of 
transcription regulatory factors which predominantly exert their effects by binding to the promoter 
DNA. This study focuses on furthering our current understanding of two, non-DNA binding 
transcription regulatory factors; the phage-encoded proteins, T7 Gp2 and Xp10 P7. These non-
bacterial proteins specifically bind to RNAP to inhibit its activity and therefore represent a novel 
group of regulators of bacterial transcription initiation which are relatively poorly studied compared 
to their bacterial counterparts. Here, the regulation of RNAP by Gp2 and P7 has been investigated 
from a detailed biochemical and structural perspective to provide insights into their molecular 
mechanisms of inhibition. Investigating how such proteins inhibit bacterial RNAP activity is integral 
to furthering our understanding of the essential process of transcription and the complexity of its 
regulation.  
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 The overuse and misuse of antibiotics has accelerated the evolution of drug-resistant 
bacteria, this effect has been exacerbated by the under development of new anti-bacterials. Thus, 
there is a significant, currently un-met need for the development of novel anti-bacterials. Bacterial 
RNAP is an essential enzyme and also a proven antibiotic target. Many of the available anti-bacterial 
compounds were originally isolated from other bacteria. However bacteriophage provide an 
alternative approach as they have evolved specific mechanisms to inhibit its hosts activity. The study 
of Gp2 and P7 not only uncovers novel vulnerabilities in the bacterial RNAP which can be exploited 
therapeutically but also provides a framework for the rational design of anti-bacterial compounds.  
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CHAPTER 2 
MATERIALS AND METHODS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.  
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2.1. Solutions and buffers 
 
Lysogeny broth (LB)     10 g peptone, 5 g yeast extract, 10 g NaCl, dH2O to   
(Merck)      1L. 
 
Lysogeny agar (LA)    10 g peptone, 5 g yeast extract, 10 g NaCl, 20 g agar,  
(Merck)      dH2O to 1L. 
SOB 20 g tryptone, 5 g yeast extract, 0.5 g NaCl, 2.4 g 
(BD) MgSO4, 0.186 g KCl. 
 
SOC      SOB + 20 mM glucose. 
 
DNA loading dye (6x) 10 mM Tris-HCl (pH 7.6), 0.03% (w/v) bromophenol  
(Fermentas) blue, 0.03% (w/v) xylene, 60% (v/v) glycerol, 60 mM 
EDTA. 
   
Nickel buffer A 25mM NaH2PO4 (pH 7.0), 0.5 M NaCl, 5% (v/v) 
glycerol. 
 
Lysis buffer   100 ml nickel buffer A + 1 protease inhibitor tablet 
(Roche). 
 
Nickel buffer B     Nickel buffer A + 1 M imidazole. 
 
Heparin dialysis buffer 10 mM Tris-HCl (pH 8.0), 50 mM NaCl, 5% (v/v) 
glycerol, 0.1 mM EDTA, 1 mM DTT. 
 
Heparin buffer A   Heparin dialysis buffer + 10 mM MgCl2. 
 
Heparin buffer B   Heparin buffer A + 1 M NaCl. 
 
High-glycerol storage buffer 10 mM Tris-HCl (pH 8.0), 50 mM NaCl, 50% (v/v) 
glycerol, 0.1 mM EDTA, 1 mM DTT. 
 
High-throughput nickel buffer A Nickel buffer A + 50 mM imidazole, 0.05% (v/v) 
Triton X-100. 
 
High-throughput nickel buffer B Nickel buffer A + 1 M imidazole, 0.05% (v/v) Triton 
X-100. 
 
Conjugation buffer 10 mM Tris-HCl (pH 7.0), 300 mM NaCl, 0.1 mM 
EDTA, 5% (v/v) glycerol, 0.5mM TCEP. 
 
Low -glycerol storage buffer 10 mM Tris-HCl (pH 8.0), 50 mM NaCl, 0.1 mM 
EDTA, 1 mM DTT, 50% (v/v) glycerol. 
 
Acrylamide proto gel (30%) (solution I) 30% (w/v) acrylamide, 0.8 % (w/v) methylene bis- 
(National Diagnostics) acrylamide. 
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Acrylamide solution II    1.5 M Tris-HCl, pH 8.8, 0.3% (w/v) SDS. 
 
Acrylamide solution III    0.5 M Tris-HCl, pH 6.8, 0.4% (w/v) SDS. 
 
Laemmli buffer  (2x)  4% (w/v) SDS, 20% (v/v) glycerol, 10% (v/v) 2-              
(Sigma-Aldrich) mercaptoethanol, 0.004% (w/v) bromophenol blue, 
0.125 M Tris-HCl, pH 6.8. 
 
Tris glycine SDS (TGS) (10x)   0.25 M Tris, 1.92 M glycine, 1% (w/v) SDS. 
(National Diagnostics) 
 
Phosphate buffered saline (PBS) 8 g NaCl, 0.2 g KCl, 1.44 g Na2HPO4, 0.24 g KH2PO4, 
dH2O to 1 L, final pH 7.4. 
 
Transblot buffer (20x)    24.2 g Tris, 150 g glycine, dH2O to 1 L. 
 
Transblot buffer (1x) 20 ml 20x transblot buffer, 40 ml methanol, dH2O to 
400 ml. 
 
Tris buffered saline (TBS) (10x) 24.2 g Tris, 80 g NaCl, dH2O to 1 L, final pH 7.6. 
 
Tris buffered saline Tween 20 (TBSTT)  1x TBS, 0.1% (v/v) Tween 20. 
 
Z-buffer 16.1 g Na2HPO4, 5.5 g NaH2PO4, 0.75 g KCl, 0.246 g 
MgSO4, 2.7 ml 2-mercaptoethanol, dH2O to 1 L, final 
pH 7.0. 
 
TM buffer (10x)     10 mM Tris-HCl (pH 8.0), 10 mM MgCl2. 
 
PKA buffer (2x) 80 mM Tris-HCl (pH 6.4), 400 mM NaCl, 50 mM 
MgCl2, 4 mM DTT, 50% (v/v) glycerol. 
 
Reaction buffer  (5x)            200 mM Tris-HCl (pH 8.0), 500 mM NaCl, 50 mM  
MgCl2, 5 mM DTT. 
 
Footprinting reaction buffer (5x) 200 mM Tris-HCl (pH 8.0), 200 mM NaCl, 50 mM 
MgCl2. 
 
Native loading dye (6x) 40 mM Tris-HCl, (pH 8.0), 100 mM NaCl, 10 mM 
MgCl2, 1 mM DTT, 50% (v/v) glycerol, 0.03% (w/v) 
bromophenol blue. 
 
Transcription stop buffer (3x) 0.03% (w/v) bromophenol blue, 0.03% (w/v) xylene, 
20 mM EDTA in deionized formamide. 
 
Tris glycine (TG) (10x)    0.25 M Tris, 1.92 M glycine. 
(National Diagnostics) 
 
Acrylamide concentrate 237.5 g acrylamide, 12.5 g methylene bis- 
(National Diagnostics) acrylamide, 7.5 M urea, dH2O to 1 L. 
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Acrylamide diluent    7.5 M urea. 
(National Diagnostics) 
 
Tris borate EDTA (TBE) (10x) 0.89 M Tris borate, 0.02 M EDTA, final pH 8.3. 
(Lonza)  
 
Fluorescence reaction buffer 40 mM Tris-HCl (pH 8.0), 50 mM NaCl, 10 mM 
MgCl2, 5% (v/v) glycerol, 0.02% (v/v) Tween 20. 
 
 
 
2.2. Bacterial strains and culture conditions 
 
2.2.1. Media preparation 
 All media for bacterial growth were autoclaved at 121C and 2 bars for 15 min or filter 
sterilised through a 0.2 μM cellulose acetate syringe filter (VWR). Where necessary, media were 
supplemented with antibiotics to select for only bacterial strains or plasmids conferring this 
resistance (Table 2.2.1). Cells grown in liquid culture were incubated in a water bath at 37C, shaking 
at 145 rpm unless otherwise stated. The optical density of liquid cultures was measured using a 
Biochrom Libra S11 spectrophotometer at 600. 
 
 
Antibiotic Abbreviation 
Stock 
concentration 
Final 
concentration 
Storage 
Ampicillin Amp 
100 mg/ml in 
ethanol 
100 μg/ml -20C 
Kanamycin Kan 
50 mg/ml in  
ddH2O 
50 μg/ml -20C 
Chloramphenicol Cm 
25 mg/ml in 
ethanol 
25 μg/ml -20C 
 
Table 2.2.1 Antibiotics used in this study. 
 
The bacterial strains and plasmids used in this study are detailed in Table 2.2.2 and Table 2.2.3. 
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2.2.2. Bacterial strains 
Strain Description Genotype 
Antibiotic 
resistance 
References 
E. coli MG1655 A laboratory wild-type strain of E. coli K-12 with minimal genetic manipulations. 
F
-
 λ
-
 ilvG- rfb-50 
rph-1 
 
(Blattner et al., 
1997) 
E. coli DH5 
An E. coli K-12 derived transformable strain. This strain does not produce 
endonuclease I therefore avoids non-specific digestion resulting in high quality 
plasmid DNA. DH5α also lacks the alpha portion of the lacZ gene and thus is 
suitable for blue-white screening. 
F
-
 endA1 glnV44 
thi-1 recA1 relA1 
gyrA96 deoR nupG 
Φ80dlacZΔM15 
Δ(lacZYA-
argF)U169, 
hsdR17(rK
-
 mK
+
), λ– 
 Life technologies 
E. coli BL21 (DE3) 
BL21 (DE3) competent cells allow high-efficiency protein expression of target 
genes under the control of a T7 promoter. BL21 (DE3) is lysogenic for λ-DE3 
which encodes the T7 RNA polymerase under the control of the lacUV5 
promoter inducible by IPTG.  
F
–
 ompT gal dcm 
lon hsdSB(rB
-
 mB
-
) 
λ(DE3 *lacI lacUV5-
T7 gene 1 ind1 
sam7 nin5]) 
 
(Studier and 
Moffatt, 1986) 
E. coli NovaBlue 
(DE3) 
A K-12 strain ideally suited as a cloning host due to its high transformation 
efficiency and recA, endA mutations, which result in high yields of unaltered 
plasmid DNA. This DE3 lysogen is useful for stringent expression due to the 
presence of the lacI
q
 repressor. 
endA1 hsdR17 (rK12
–
 mK12
+
) supE44 thi-1 
recA1 gyrA96 relA1 
lac F′*proA
+
B
+
 lacI
q
Z
ΔM15::Tn10] (Tet
R
)  
Tet Novagen 
E. coli 397c 
E. coli 397c contains a 16 bp deletion, resulting in a frameshift that leads to 
truncation of the β' subunit at the carboxyl terminus. This strain is temperature 
sensitive for growth at 43.5C and unable to plate bacteriophage P2 at 33C. 
 
P90A5 cI857h80 St68 
dlac
+
 
rpoC Δ 4065-4080 
 
 
 (Christie et al., 
1996) 
E. coli JE1134 (DE3) 
MG1655 strain of E. coli lacking the 1149-1190 residues of the RNAP β’ subunit, 
conferring resistance to Gp2. These cells are also lysogenic for λ-DE3. 
MG1655 rpoC Δ 
1149-1190 
 
 
(Ederth et al., 
2002c) 
E. coli KS1 
MC1000 derivative containing a lac promoter bearing a single  operator 
centred 62bp upstream of the transcription start site. Used for -CI activated 
transcription measurable in β-galactosidase assays. 
MC1000 F’lacI
q
 
placOR2-62 
Kan (Dove et al., 1997) 
Table 2.2.2 Bacterial strains used in this study. 
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2.2.3. Bacterial plasmids 
 
Plasmid Description Antibiotic Resistance Reference 
pET28b
+
 
Cloning and expression of recombinant proteins with an N-terminal 
His6-tag and optional C-terminal His6-tag. Expression of target genes is 
under the control of the T7 promoter. 
Kan Novagen 
pET33b
+
 
Derived from pET28b
+
 but carries an additional 15 bp sequence 
encoding the protein kinase A (PKA) site RRASV for 
32/33
P--ATP 
labelling. 
Kan Novagen 
pBAD18 
Expression of target genes is tightly controlled by the L-arabinose 
operon. Protein expression is positively and negatively regulated with 
the addition of arabinose or glucose respectively. 
Amp 
(Guzman et 
al., 1995) 
pVS10 
Expression of E. coli RNAP under the control of the T7 gene 10 
promoter. RNAP contains a His6-tag at the C-terminal of the β subunit. 
Amp 
 
(Belogurov et 
al., 2007) 
pRL663 
Expression of E. coli RNAP β’ subunit with C-terminal His6-tag under 
the control of the trc promoter. 
Amp 
(Wang et al., 
1995) 
pBR 
‘Prey’ plasmid encodes the - NTD which can be used to generate a 
fusion protein under the control of the tandem lpp and lacUV5 
promoters for two-hybrid protein-protein experiments. 
Amp 
(Dove and 
Hochschild, 
2004) 
pACCI 
‘Bait’ plasmid encodes CI which can be used to generate a fusion 
protein under the control of the lacUV5 promoter for two-hybrid 
protein-protein experiments. 
Cm 
(Dove and 
Hochschild, 
2004) 
  
Table 2.2.3 Bacterial plasmids used in this study. 
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2.3. Molecular cloning 
 
2.3.1. CaCl2 competent cell preparation 
 The E. coli strain of interest was streaked out onto an LA plate and incubated at 37C 
overnight. A seed culture was prepared by inoculating 5 ml of LB with a single bacterial colony and 
incubating at 37C overnight. 200 ml of LB was inoculated with 200 μl of seed culture and cells were 
grown at 37C until mid exponential phase, OD600 = 0.4-0.45. The culture was then centrifuged at 
3200 x g for 10 min at 4C. The cell pellet was resuspended in 40 ml of pre-chilled 100 mM CaCl2 and 
15% (v/v) glycerol solution. Cells were then incubated on ice, in a 4C room overnight or for 2 hours. 
The cells were centrifuged again at 3200 x g for 10 min at 4C. The pellet was then resuspended in 6 
ml of pre-chilled 100 mM CaCl2 and 15% (v/v) glycerol solution. Cells were either used immediately 
or aliquoted into 50 μl volumes, snap frozen in liquid nitrogen and stored at -80C. 
Note: E. coli  397c cells are temperature sensitive therefore need to be cultured at 30C.  
2.3.2. Transformation by heat shock 
 50 μl aliquots of competent cells (refer to section 2.3.1) were thawed on ice for 10 min. 
Approximately 100 ng of plasmid DNA was added to the cells and then incubated on ice for 30 min. 
The cells were heat shocked in a 42C water bath for 1 min before immediately returning to ice for 2 
min. Cells were recovered by the addition of 1 ml pre-warmed SOC media and incubation at 37C, 
shaking for 1-2 hours. Cells were then centrifuged at 17,000 x g for 2 min and resuspended in 50 μl 
of the original SOC media. The cell solution was then plated onto an appropriate LA plate and 
incubated at 37C overnight.  
2.3.3. Purification of plasmid DNA 
 A 5 ml overnight culture of cells harbouring the desired plasmid was centrifuged at 3200 x g 
for 10 min and the supernatant discarded. The plasmid DNA was then purified from the cells using 
the QIAprep spin mini-prep kit (Qiagen) as per the manufacturer’s instructions. The DNA 
concentration was measured using a NanoVue Plus spectrophotometer (GE Healthcare). 
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2.3.4. Polymerase chain reaction (PCR) 
Reactions were conducted in 0.2 ml thin-walled PCR tubes. 
Reaction component μl per reaction 
ddH2O 40.5 
10x PFU buffer (Stratagene) 5.0 
25 mM dNTP (Sigma) mix 1.0 
DNA template (100 ng/μl) 1.0 
Forward Primer (10 µM) 1.0 
Reverse Primer (10 µM) 1.0 
PfuUltra II Fusion HS DNA Polymerase (Stratagene) 0.5 
Total   50.0 
 
94C – 5 min   
94C – 30 s denaturing  
53C – 30 s annealing* 30 cycles 
72C – 15 s per 1 kb extension  
72C – 5 min   
10C –  hold  
* The annealing temperature was at least 5C less than the lowest Tm of the primers. 
PCR products were purified using a QIAquick PCR purification kit (Qiagen) as per the manufacturer’s 
instructions. DNA concentration was measured using a NanoVue Plus spectrophotometer. 
2.3.5. Restriction digest 
 Digestion reactions were performed using NEB enzymes and buffers. A suitable buffer for 
both enzymes was first selected or the reactions were performed sequentially following a DNA 
purification step.  A typical reaction included 1 μl of 10x NEB buffer (1/2/3/4), 1 μl of each restriction 
enzyme, 10 μg/ml BSA if required and ddH2O to 10 μl. Reactions were incubated at 37C for 2 hours 
and then heat inactivated at 65C for 20 min. To prevent re-ligation, the plasmid DNA was de-
phosphorylated at its 5’ ends by adding 2.5 μl of shrimp alkaline phosphatase (SAP) and 2.5 μl of SAP 
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10x buffer (Promega) and incubating at 37 C for 30 min. The enzyme was then heat inactivated by 
incubating at 75C for 15 min. The digestions were purified using the QIAquick PCR purification kit as 
per the manufacturer’s instructions. DNA concentration was measured using a NanoVue Plus 
spectrophotometer. 
2.3.6. Agarose gel electrophoresis 
 Typically gels were prepared at either 1% (w/v) agarose (DNA > 200bp) or 2% (w/v) agarose 
(DNA < 200bp) by heating in 1x TBE. SYBR Safe DNA gel stain (Invitrogen) was added to the agarose 
solution at a 1:10,000 dilution and then poured into a level casting tray with an appropriate gel 
comb and allowed to set. 6x DNA loading dye (Fermentas) was added to the samples before loading 
into the gel alongside an O’Generuler 1 kb or 100 bp DNA marker (Fermentas). The gel was run at 
100 V in 1x TBE for approximately 30-60 min before being removed and visualised using a Safe 
Imager Blue Light Transilluminator (Invitrogen). Gel images were captured using a Bio-rad GelDoc EZ 
imager. 
2.3.7. Gel extraction and purification 
 DNA was resolved using an appropriate percentage agarose gel (refer to section 2.3.6) until 
the desired band(s) was distinguishable from any other DNA bands. The gel was transferred onto a 
clear glass plate and placed onto a blue light transilluminator safe imager. The band of interest was 
then excised from the gel using a scalpel and placed on a petri dish before freezing at -80C. Once 
frozen, the gel slice was then cut into thin slices and transferred into a microcentrifuge tube. 
Sufficient ddH2O was added to just cover the slices which were then vortexed until the agarose had 
dissolved.  The DNA was purified from the agarose using the QIAquick PCR purification kit as per the 
manufacturer’s instructions or by phenol-chloroform and ethanol precipitation (refer to section 
2.3.8). The DNA concentration was measured using a NanoVue Plus spectrophotometer. 
2.3.8. Phenol-chloroform extraction and ethanol precipitation 
 An equal volume of phenol-chloroform was added to the DNA containing solution, vortexed 
and centrifuged at 17,000 x g for 2 min. The upper-phase was then extracted being careful not to 
disrupt the interface, and transferred to a fresh microcentrifuge tube. 2.5 volumes of 100% ethanol 
and 0.25 volumes of 3M NaOAc pH 5.2 were added to the solution.  The DNA was then precipitated 
by either incubating at -80C for 1 hour or by freezing in liquid nitrogen. The solution was then 
centrifuged at 17,000 x g for 10 min and the supernatant discarded. The pellet was washed with 70% 
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pre-chilled ethanol and left to air dry. The DNA pellet was then resuspended in ddH2O or appropriate 
buffer. 
2.3.9. Ligation 
 Reactions were conducted using the purified digested plasmid DNA and insert DNA (refer to 
section 2.3.5) at a 3:1 ratio (refer to equation below). For example, 100 ng of plasmid DNA was 
combined with 33 ng of insert DNA, 0.5 µl of T4 ligase (5 U/μl) (Fermentas), 1 µl of 10x T4 ligase 
buffer (Fermentas) and ddH2O to total 20 µl. The ligation reactions were incubated at 22C for 10-60 
min. 5 μl of ligation reaction was used per transformation (refer to section 2.3.2).  
ng of vector x kb size of insert
kb size of vector
 x molar ra o of
insert
vector
 ng of insert 
2.3.10. Colony PCR 
 Primers were either designed to anneal to regions closely flanking the multiple cloning site 
(MCS) or alternatively one primer was complementary to the inserted gene and the second primer 
to a region within the plasmid. 
Reactions were conducted in 0.2 ml thin-walled PCR tubes. 
Reaction component μl per reaction 
ddH2O 38.25 
10x Taq buffer (NEB) 5.00      
25 mM dNTP mix 1.25 
Forward Primer (10 µM)  2.50 
Reverse Primer (10 µM)              2.50 
Taq DNA Polymerase (5 U/μl) (NEB) 0.50  
Total 50.00 
Each PCR reaction was inoculated with a single colony using a pipette tip. This tip was then dabbed 
onto a marked LA plate and incubated overnight at 37C as a reference. 
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94C – 5 min   
94C – 30 s denaturing  
53C – 30 s annealing* 30 cycles 
72C – 15 s per 1 kb extension  
72C – 5 min   
10C –  hold  
* The annealing temperature was at least 5C less than the lowest Tm of the primers. 
 Positive clones were identified by resolving 5 µl of PCR product on a 1% (DNA > 200bp) or 2% 
(DNA < 200bp) (w/v) agarose gel (refer to section 2.3.6). Clones of the correct insert size were then 
sequenced using the appropriate primers (refer to section 2.3.12). 
2.3.11. Site directed mutagenesis (SDM) 
 Primers were designed to anneal to the same sequence on opposite strands of the plasmid 
and with the desired mutation approximately in the middle of each primer.  
Reactions were conducted in 0.2 ml thin-walled PCR tubes. 
Reaction component μl per reaction 
ddH2O 40.5 
10x PFU buffer (Stratagene) 5.0 
25 mM dNTP mix 1.0 
DNA template (100 ng/μl) 1.0 
Forward Primer (10 µM)  1.0 
Reverse Primer (10 µM)              1.0 
PfuUltra II Fusion HS DNA Polymerase (Stratagene) 0.5  
Total 50.0 
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95C – 30 s   
95C – 30 s denaturing  
55C – 1 min annealing* 15 cycles 
68C – 15 s per 1 kb extension  
10C –  hold  
* The annealing temperature was at least 5C less than the lowest Tm of the primers and often 
required optimisation for SDM. 
 The template DNA was digested by adding 6 µl buffer 4 (NEB), 3 µl ddH2O, 1 µl DpnI (20 
U/μl) (NEB) to the PCR reaction and incubating at 37C for 1 hour before spiking with 1 µl DpnI and 
incubating for a further hour. The DNA was then purified using a QIAgen PCR purification kit as per 
the manufacturer’s instructions. The plasmid was transformed into an E. coli cloning strain and 
incubated overnight at 37C (refer to section 2.3.2). A single colony was then used to inoculate 5 ml 
of LB, which was incubated overnight, shaking at 37C. The plasmid DNA was then purified from this 
culture using a QIAgen mini-prep kit as per the manufacturer’s instructions. DNA concentration was 
measured using a NanoVue Plus spectrophotometer and plasmids were then sequenced using 
appropriate primers (refer to section 2.3.12). 
2.3.12. Sequencing 
DNA sequences were determined using the Imperial College Core Sequencing Service at the 
MRC genomics laboratory. Sequencing reactions contained 3.2 pmoles of primer, 150 - 300 ng of 
plasmid DNA per 3 kb or 500 - 600 ng for > 3kb plasmid DNA in 10 μl total ddH2O. Samples were 
cycle sequenced using BigDye v 3.1 (Applied Biosystems) as follows:  
94C – 1 min  
94C – 10 s  
55C – 15 s 30 cycles 
60C – 4 min  
4C –   
Products were then purified by EDTA-ethanol precipitation, resuspended in highly deionised 
formamide and run on 3730xl DNA Analyser (Applied Biosystems). All sequences were then analysed 
using Chromas and Clone Manager. 
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2.4. Protein expression and purification 
 
2.4.1. pET system of expression 
 Expression plasmids containing genes under the control of the T7 promoter were 
transformed (refer to section 2.3.2) into DE3 E. coli strains of cells, plated onto LA and incubated at 
37C overnight. 1 L of LB was inoculated with half of the transformants and grown, shaking at 37C. 
When the ODλ600 reached 0.4-0.5 the culture was temperature shifted to 25C for 30 min. Expression 
was then induced with the addition of a final concentration of 1 mM isopropyl-β-D-1-
thiogalactopyranoside (IPTG). The cultures were grown for a further 3 hours, shaking at 25C. 1 ml 
samples were taken before and after induction. These were centrifuged at 17,000 x g and the pellet 
was resuspended in 100 µl of ddH2O for future SDS-PAGE analysis (refer to section 2.4.3). Cells were 
harvested by centrifugation at 2700 x g, 4C and the pellet frozen at -20C overnight.  
2.4.2. Temperature sensitive system of expression 
 E. coli 397c cells were transformed with pRL663:rpoCWT/NLFN, plated onto LA and incubated at 
30C overnight. 1 L of pre-warmed (42.5C) LB was inoculated with half of the transformants 
together with 0.5 mM IPTG and grown shaking at 42.5C for 8 hours. Cells were harvested by 
centrifugation at 2700 x g, 4C and the pellet frozen at -20C overnight. 
2.4.3. SDS-Polyacrylamide gel electrophoresis (SDS-PAGE) 
 SDS-PAGE gels were prepared at an appropriate percentage according to the molecular 
weight of the protein of interest (the percentage acrylamide is inversely proportional to protein 
size). Solutions were prepared as described in Table 2.4.1 with the addition of APS and TEMED 
immediately prior to pouring. The separating solution was quickly poured into 1 mm thick Mini-
PROTEAN glass plates (Bio-Rad) to 1 cm below the well level or half this amount if making a split 
percentage gel. 100 μl of isopropanol was pipetted on top to level the gel solution. Once the gel was 
set, the isopropanol was decanted and the top of the gel was washed with ddH2O. Residual ddH2O 
was removed by absorption with Whatman paper. The stacking gel was then prepared and poured 
on top of the separating gel and either a 10 or 15 well comb inserted. Once set, the gels could either 
be used immediately or for future use; wrapped in wet paper towel, then clingfilm and stored at 4C.  
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 Separating Stacking 
 10% 12.5% 15% 20%  
Acrylamide (30%) 3.25ml 4.1ml 5.0ml 6.7ml 0.6ml 
Acrylamide Solution II 2.5ml 2.5ml 2.5ml 2.5ml - 
Acrylamide Solution III - - - - 1ml 
ddH2O 4.2ml 3.4ml 2.5ml 0.8ml 2.4ml 
10% (w/v) APS 100μl 100μl 100μl 100μl 40μl 
TEMED 10μl 10μl 10μl 10μl 4μl 
 
Table 2.4.1 Composition of SDS polyacrylamide gels. 
 
 The gels were assembled in a Mini-PROTEAN Tetra Electrophoresis gel tank (Bio-Rad) with 1x 
TGS buffer and pre-warmed by running at  200 V. Samples were prepared by mixing 10 μl of protein 
sample with 2x Laemmli buffer (Sigma), incubated at 95oC for 5 min and then briefly centrifuged. 
The samples were then loaded into the pre-warmed gel alongside 5 μl of PageRuler Prestained 
protein ladder (Fermentas) and the gel run at 200 V for approximately 50 min or until the dye front 
reached the bottom of the gel. The gel was then removed from the glass plates, washed three times 
in dH2O and then stained with 20 ml of Bio-safe Coomassie stain (Bio-rad) for 30-60 min. The gel was 
then destained by rinsing twice in dH2O. The gel was viewed on a light box and an image captured 
using the Biorad GelDoc EZ imager. 
2.4.4. Nickel affinity purification (FPLC) 
 Recombinant His6-tagged proteins were purified using nickel affinity chromatography. Cells 
were harvested as per section 2.4.1 and 2.4.2 then thawed and resuspended in 25 ml of pre-chilled 
lysis buffer and 25 mg of lysozyme. The cell solution was then transferred to a high-speed centrifuge 
tube and placed in a beaker of ice cold water. The cells were lysed by sonicating for 10 min (10 
second pulses) with 40% amplitude using a Sonics Vibra-Cell sonicator or by passing through a 
French press twice until the cell lysate was transparent. The cell lysate was then centrifuged at 
31400 x g for 30 min at 4C. The supernatant (soluble fraction) was decanted into a pre-chilled 
universal tube and the pellet (insoluble fraction) roughly resuspended in an equivalent amount of 
nickel buffer A to the soluble fraction. A HisTrap column (GE Healthcare) was prepared by washing 
with 5 x column volumes of nickel buffer A,  0.1 M EDTA, nickel buffer A, ddH2O, 0.1 M NiCl2 (1.5 
column volumes), ddH2O, nickel buffer A, nickel buffer B, nickel buffer A. The supernatant of the cell 
lysate was then loaded into a glass super loop and injected into the AKTA prime (GE Healthcare) via 
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the HisTrap column. Typically a 3-7% nickel buffer B wash was performed before a 40 ml elution 
gradient. Fractions of washes and peaks were collected. 10 µl samples of each collected fraction 
were resolved by SDS-PAGE. Pure fractions were dialysed into storage buffer overnight at 4C using 
dialysis membrane (Spectrum laboratories) with either 3500 or 6-8000 molecular weight (MW) cut 
off. 
2.4.5. High-throughput nickel affinity purification  
 For small scale preparations of recombinant His6-tagged proteins a high-throughput method 
of expression and purification was used. Expression plasmids containing genes under the control of 
the T7 promoter were transformed into E. coli DE3 cells. These transformants were used to inoculate 
3 ml of LB in a 24 deep-well plate. The cultures were grown, shaking at 37C, overnight. 100 µl of Cell 
lysis reagent (Sigma) and 2 µl of Lysonase (Novagen) was added to each well and incubated, shaking 
at RT for 15 min. 20 µl of Magne-His bead suspension (Promega) was added to each well before a 
further incubation, shaking at room temperature (RT) for 30 min. Using a 24-point magnetic block 
the lysates were washed three times with wash buffer. The proteins were then eluted from the 
magne-his beads with 200 µl of elution buffer. The eluate was then dialysed into suitable storage 
buffer using mini-dialysis units (Thermo Scientific) with a 3500 MW cut off. 
2.4.6. Heparin affinity purification (FPLC) 
 Heparin is a highly negatively charged glycosaminoglycan with similar properties to RNA and 
DNA, therefore it can be immobilised for the affinity purification of nucleic acid binding proteins. 
RNAP and σ-factor containing eluate fractions that still contained contaminants after nickel column 
purification were pooled and dialysed into heparin dialysis buffer at 4C overnight. A HiTrap column 
(GE Healthcare) was prepared by passing through 5 x column volumes of ddH2O, 1 M NaCl, ddH2O, 
heparin buffer A, heparin buffer B, heparin buffer A. 10 mM MgCl2 was then added to the protein 
sample before loading into a glass super loop and injected into the HiTrap column attached to an 
AKTA prime (GE Healthcare). Typically a 20 ml elution gradient was performed. Fractions of washes 
and peaks were collected and 10 µl samples of each collected fraction were resolved by SDS-PAGE. 
Pure fractions were dialysed into storage buffer overnight at 4C using dialysis membrane with a 6-
8000 MW cut off. 
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2.4.7. Polyethyleneimine and ammonium sulphate precipitation 
 RNAP expressed from the E. coli 397c cells was first purified by polyethyleneimine (PEI) and 
ammonium sulphate precipitation followed by nickel affinity purification. PEI is used to precipitate 
nucleic acids and their bound proteins, whereas ammonium sulphate is used to precipitate proteins 
by ‘salting out’. After protein expression (refer to section 2.4.2) the cells were harvested by 
centrifugation at 2700 x g for 30 min at 4C. The cell pellets were then resuspended in 100 ml of 
RNAP lysis buffer A before re-centrifugation and storage of the cell pellet -20oC overnight. The cell 
pellet was thawed on ice and resuspended in 50 ml of RNAP lysis buffer B and 50 mg of lysozyme. 
The cells were then lysed by sonicating for 10 min (10 second pulses) with 40% amplitude using a 
Sonics Vibra-Cell sonicator. The cell lysates were centrifuged at 31,400 x g for 30 min at 4C and the 
supernatant collected. All further steps were carried out at 4oC where possible. The nucleic acids and 
RNAP were precipitated by the gradual addition and mixing of 0.6% (v/v) PEI (Sigma) from a 10% 
stock (pH 7.9 using HCl), over a 15 min period before a further 30 min of mixing. The PEI precipitate 
was pelleted in a high speed centrifuge tube at 31,400 x g for 20 min and the pellet thoroughly 
resuspended in 10 ml RNAP wash buffer. The solution was re-centrifuged at 31,400 x g for 20 min 
and resuspended in 10 ml RNAP elution buffer, before further centrifugation at 31,400 x g for 20 
min. The supernatant was collected and gently mixed with 0.4 g (NH4)SO4 (Sigma)/ ml supernatant, 
gradually added over 15 min, followed by a further 30 min of mixing. The precipitate was pelleted at 
31,400 x g for 10 min, resuspended in nickel buffer A and dialysed into nickel buffer A overnight at 
4C. 
2.4.8. Bradford assay 
 The Bradford assay was used to determine the concentrations of purified protein 
preparations. The absorbance of the bound form of the Coomassie Brilliant Blue G-250 dye is 
proportional to the concentration of protein in the sample. A protein standard curve was prepared 
by pipetting 5 μl of bovine serum albumin (BSA) (NEB) into individual wells of a clear, flat-bottomed 
96 well microtiter plate. Typically the standard curve consisted of a serial dilution of 2.0, 1.75, 1.5, 
1.25, 1.0, 0.5, 0.25, 0.125, 0.05 mg/ml BSA in ddH2O and also a ddH2O blank. 5 μl of the protein of 
interest was also pipetted, in triplicate into the plate.  250 μl of Quickstart Bradford dye reagent 
(Bio-Rad) was added to every protein containing well and then absorbance at 595 nm was measured 
in a BMG labtech POLARstar Omega plate reader. 
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2.4.9. Activator dependent transcriptional bacterial two-hybrid β-galactosidase 
assay. 
 Bacterial two-hybrid assays were conducted as described in (Dove and Hochschild, 2004); 
pBR and pACCI or derivatives were transformed into KS-1 cells and plated onto LA containing Kan, 
Amp and Cm antibiotics and incubated at 37C overnight. A single colony of each transformation was 
used to inoculate 3 ml of LB containing antibiotics and 20 μM IPTG, these were cultured for 16 hours 
at 30C. 0.5 ml of the overnight cultures was diluted in 2 ml of LB containing antibiotics and IPTG. 1 
ml of diluted culture was used to take an absorbance reading at 600 nm. The cells in the remaining 
diluted cultures were lysed by addition of 20 μl choloform and 20 μl of 0.1% SDS followed by 
vortexing for 10 s and shaking at 37C for 40 min. 10 μl of the lysed cell solutions were mixed in 990 
μl of Z-buffer and then 10 μl was transferred to a 96 well plate. The plate was incubated at 30C for 
5 min before the addition of 25 μl of pre-warmed 4 mg/ml ONPG. The plate was incubated for a 
further 30 min at 30C and then the reactions stopped with 50 μl of 1 M Na2CO3. The OD at 600, 420 
and 550 was then measured. The enzymatic activity in miller units (MU) was calculated as follows: 
 
                                               
 
OD600 = cell density. 
OD550 = scatter from cell debris, multiplication by 1.75 approximates for scatter at 420 nm. 
OD420 = absorbance of o-nitrophenol. 
t = time of reaction in min 
v = volume of cells in ml 
 
 
2.5. Immunoblotting 
 
2.5.1. Polyclonal antibody production  
 Peptide sequences were designed by Eurogentec for rabbit immunisation. Immunisation was 
conducted using two different peptide sequences per rabbit. Bleeds were taken pre-immunisation, 
21 days after immunisation and after termination (final bleed). Anti-peptide ELISA analysis was 
conducted for the final bleed prior to shipping. 
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2.5.2. Affinity purification of antibody serum 
 50 μg of the protein of interest was resolved by SDS-PAGE and transferred to PVDF 
membrane as per the Western blotting protocol (refer to section 2.5.4). The membrane was then 
stained with Ponceau S for 5 min and rinsed with dH2O to visualise the protein. The protein 
containing sections of the membrane were excised and placed in a 50 ml tube. The membrane was 
blocked with 25 ml of 5% fat-free milk powder (in PBS) for 1 hour and then incubated with 25 ml 5% 
fat-free milk powder + 5 ml final bleed antibody serum at 4C overnight. The membrane was rinsed 
twice in PBS for a few seconds each time and then the antibody was eluted with 4 ml 100 mM 
glycine pH 2.7 for exactly 2 min. The eluate was transferred into a 15 ml tube containing 300 μl 1.5 
M Tris-HCl pH 8.8 to neutralise the acid. The eluate was then dialysed against 500 ml PBS twice over 
8 hrs. The antibody was then aliquoted and frozen at -20C. 
2.5.3. Antibody purification against cell background 
 To remove cross-reactivity and non-specific background the antibodies were purified against 
the relevant cell extract. An overnight 200 ml culture of cell strain without the protein of interest 
was centrifuged at 3200 x g and resuspended in 2 ml of PBS. Cells were lysed by sonication as 
described in section 2.4.4. 100 μl of antibody was then added to 1 ml of cell extract and incubated at 
37C for 1 hour. The cell extract solution was then centrifuged at 31,400 x g for 30 min at 4C. The 
supernatant was then transferred to the second 1 ml of cell extract and the incubation and 
centrifugation step was repeated. The antibody containing supernatant was stored at 4C or in 
aliquots at -20C. 
2.5.4. Western blotting 
 Protein samples were resolved using the appropriate percentage SDS-PAGE (refer to section 
2.4.3).  The gel was then blotted in 1x transblot buffer for 10 min. A gel-sized sheet of PVDF 
membrane was soaked in methanol for 10 s, in water for 5 min and then equilibrated in 1x transblot 
buffer for 10 min. Meanwhile, eight gel-sized sheets of Whatman paper were soaked in 1x transblot 
buffer. The blot was assembled onto a Bio-rad trans-blot semi-dry transfer cell; with the gel on top 
of the membrane and 4 pieces of Whatman paper either side. Any bubbles were then removed by 
rolling over the blot with a stripette. The blot was transferred to the membrane by running at 10 V 
for 1 hour. The membrane was then blocked in 5% fat-free milk powder (in TBS) for 1 hour at RT or 
overnight at 4C. The membrane was washed twice for 10 min each in TBSTT and for a further 10 
min in TBS. The membrane was then incubated for 1 hour with the primary antibody, diluted in 5% 
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fat-free milk powder. After incubation the membrane was washed five times for 10 min each in 
TBSTT. On parafilm, Supersignal west femto/pico ECL solution (Pierce) was prepared as per the 
manufacturer’s instructions. The blot was then placed face down into the ECL mixture for 30 s 
(femto) or 5 min (pico). The membrane was then lightly dried on blue towel, covered with clingfilm 
and placed into a cassette. The image was either visualised using an LAS-3000 Fuji Imager. 
 
2.6. In vitro biochemical assays  
 
2.6.1. 32P-labelling of DNA probes 
 Oligonucleotides were custom made and PAGE purified (Sigma-Aldrich). Either the non-
template (NT) or template (T) strand was labelled with 32P by incubating 20 pmoles of 
oligonucleotide, 2 μl of 10x polynucleotide (PNK) buffer A, 3 μl of 32P--ATP (250 Ci/mmol) (Perkin 
Elmer) and 1 μl polynucleotide kinase (PNK) (10 U/μl) (Fermentas) in a total volume of 20 μl of 
ddH2O at 37C for 30 min. The enzyme was inactivated by incubating the reaction at 75C for 10 min. 
40 pmoles of the complementary oligonucleotide was added to the reaction along with 4 μl of 10x 
TM buffer and made up to 40 μl with ddH2O. The oligonucleotides were denatured at 95C for 5 min 
and then allowed to anneal by slowly cooling to RT. The final concentration of labelled duplexed 
DNA was estimated to be 500 nM.  
2.6.2. Electrophoretic mobility shift assay (EMSA) 
 Typically, EMSAs were conducted in 10 µl reactions; 100 nM RNAP was reconstituted with 
400 nM  σ-factor in 2 μl 5x reaction buffer and ddH2O for 5 min. RNAP-promoter complexes were 
formed by adding 20 nM 32P-labelled promoter DNA followed by a further 5 min incubation. 
Reactions were either conducted at 4 or 37C to maximise the percentage of either closed or open 
complexes. In some instances, transcription factors such a Gp2 or P7 were added in varying molar 
ratios at different stages of the reaction. Additionally, the stability of RNAP-DNA complexes was 
assessed by further incubation with 100 g/ml heparin. 2 μl of native loading dye was added to 
reactions before loading onto a 4.5% native polyacrylamide gel (Table 2.6.1) run at 100 V in TG 
buffer at either 4C/RT/37C for 30-90 min depending on temperature and length of DNA. Gels were 
transferred to Whatman paper, dried and visualised using a FLA-5000 Fujilfilm phosphorimager. 
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Table 2.6.1 Composition of a native 4.5% polyacrylamide gel. 
 
2.6.3. 32P-labelling of proteins 
 Recombinant proteins were 32P-labelled at the serine residue within the RRASV sequence. 
Proteins were labelled in reactions containing, 50 μl 2x protein kinase A (PKA) reaction buffer, 500 
ng of protein, 1 μl of 32P--ATP (250 Ci/mmol-Perkin Elmer) and 5 U of PKA made up to 100 μl  with 
ddH2O. Reactions were incubated at 37C for 30 min.  
2.6.4. Protein-protein native gel binding assay 
 Protein-protein native gel binding experiments were conducted at 37C in 10 µl reactions. 
Typically, increasing concentrations of RNAP were reconstituted with σ-factor using a 1:4 molar ratio 
and incubated with 2 μl 5x reaction buffer, 1 μg -lactalbumin and ddH2O for 5 min. RNAP-Gp2 
complexes were formed by adding 50 nM 32P-Gp2 (refer to section 2.6.3) followed by a further 5 min 
incubation. 2 μl of native loading dye was added to reactions before loading onto a 4.5% native 
polyacrylamide gel (Table 2.6.1) run at 100 V in TG buffer for 80 min at 37C. Gels were transferred 
to Whatman paper, dried and visualised using a FLA-5000 Fujilfilm phosphorimager. 
2.6.5. Abortive transcription assay 
 Transcription reactions were performed in 10 μl volumes at 37C.  Typically 100 nM RNAP 
was reconstituted with 400 nM σ-factor and incubated for 5 min. 20 nM DNA promoter template 
was added and incubated for a further 5 min. Then, an elongation mixture contained 0.25 mM ApA 
dinucleotide primer, 0.05 mM UTP, 0.2 μl of 32P--UTP (250 Ci/mmol) and 100 μg/ml heparin was 
added and the reaction allowed to proceed for 5 min. Reactions were stopped with 4 μl of stop dye 
and the samples were resolved on a 20% urea denaturing acrylamide gel (Table 2.6.2) for 45 min at 
Native PAGE (4.5%)  
Acrylamide (30%) 3 ml 
10x TG buffer 2 ml 
ddH2O 15 ml 
10% (w/v) APS 200 μl 
TEMED 20 μl 
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100 V. The gels were exposed to an imaging plate and visualised by FLA-5000 Fujilfilm 
phosphorimager. 
 
Urea-denaturing polyacrylamide gel (20%) 
Acrylamide concentrate 20 ml 
Acrylamide diluents 2.5 ml 
10x TBE buffer 2.5 ml 
10% (w/v) APS 150 μl 
TEMED 20 μl 
 
Table 2.6.2 Composition of a urea-denaturing 20% polyacrylamide gel. 
 
 
2.7. Fluorescent binding assays 
 
2.7.1. Alexa-488 labelling of Gp2  
 Gp2 and derivatives were purified by nickel affinity chromatography, dialysed into 
conjugation buffer and then the protein concentration was determined by Bradford assay (refer to 
sections 2.4.4, 2.4.5 and 2.4.8). A stock solution of 10 mM Alexa-488 (Invitrogen) was prepared by 
reconstitution in dimethylformamide (DMF). Gp2 was combined with 5 times excess Alexa-488 and 
incubated at RT for 2 hours. The reaction was quenched with 10 mM 2-mercaptoethanol. The 
conjugated protein was then dialysed into nickel buffer A at 4C overnight. The labelled protein was 
re-purified from excess Alexa-488 by nickel affinity chromatography. The peak fractions were 
dialysed (3500 MW cut off ) at 4C, overnight into low-glycerol storage buffer and the concentration 
of labelled protein was measured via the Bradford assay. Labelled protein was snap frozen in liquid 
nitrogen and stored at -80C. The conjugation efficiency was calculated using [Alexa-488]/[protein]. 
This equation assumes that all Alexa-488 is bound to the protein with a 1:1 ratio. 
2.7.2. Fluorescence anisotropy 
 50 nM Gp2Alexa488 was diluted in 400 µl of low-glycerol storage buffer within a 5 mm glass 
cuvette. The degree of polarisation was measured using a Fluoromax-3 spectrofluorometer (Horiba 
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Scientific) fitted with automated polarisation filters. Measurements were recorded using an 
excitation and emission wavelengths of 495 nm and 519 nm respectively with a G-factor of 0.63 and 
slit size of 0.5 nm. Binding curves were generated at 37C by titrating in RNAP or reconstituted 
holoenzyme (E:σ at a 1:4 molar ratio) and measuring the anisotropy 5 times in immediate 
succession. Data were fitted using the tight binding equation in Grafit 5 (Erithacus Software) as show 
below. 
A = AD + (ADE – AD) × ({(Kd + [E]0 + [Gp2]T) – √ – Kd – [E]0 – [Gp2]T2 – 4[E]0[Gp2]T)}/(2[Gp2]T)) 
Where A is the observed anisotropy, AD is the anisotropy of free Gp2
Alexa488, ADE is the anisotropy of 
RNAP-bound Gp2Alexa488, Kd is the equilibrium dissociation constant, [Gp2]T is the total concentration 
of Gp2Alexa488 and [E]0 is the RNAP concentration. 
2.7.3. TMR labelling of σ70 
 Single cysteine σ70 and derivatives were labelled at position 211 as described in (Mekler et 
al., 2002). Labelling reactions were conducted in 1 ml volumes and contained 20 μM single cys σ70 
subjected to solid-phase reduction on Reduce-Imm (Pierce) as per the manufacturer’s instructions,  
200 μM tetramethylrhodamine-5-maleimide (TMR) (Molecular Probes), 100 mM sodium phosphate 
(pH 8.0) and 1 mM EDTA. Following a 1 hr incubation at 0C, products were purified by gel-filtration 
chromatography on Bio-Gel P6DG (Bio-Rad) and stored in high-glycerol storage buffer at -20C.  
2.7.4. RNAP beacon assay 
 Fluoresence measurements were performed using a QuantaMaster QM4 
spectrofluorometer with an excitation wavelength of 550 nm and an emission of 578 nm. Reactions 
were performed at 25C in a plastic cuvette with a total volume of 800 μl fluorescence reaction 
buffer. Reactions typically contained 1 nM labelled Eσ70, DNA probes at various concentrations 
(according to their binding affinities) and inhibitors were added at various stages of the reaction. 
Time dependent changes in fluorescence intensity were measured after a manual mixing time of 15 
s.
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CHAPTER 3 
ESTABLISHING A SOLUTION-BASED ASSAY TO 
DETECT THE BINDING OF GP2 TO E. COLI RNAP 
 
 
 
 
 
 
 
 
 
 
 
 
3.  
 
 71 
 
3.1. Introduction 
 
 There are a wide variety of methods to detect and analyse protein-protein interactions. The 
choice of method ultimately depends on the circumstance of the interaction and the extent of 
characterisation required. Biochemical techniques such as co-immunoprecipitation, crosslinking, 
electrophoretic mobility shift assays (EMSAs) as well as phage display and bacterial/yeast two-hybrid 
assays are typically used for the screening of protein-protein interactions but are limited in terms of 
specificity, therefore proposed interactions often require further confirmation and a more a detailed 
analysis. Biophysical techniques such as fluorescence anisotropy, fluorescence resonance energy 
transfer, surface plasmon resonance, dual polarisation interferometry and isothermal titration 
calorimetry are able to accurately measure binding affinities and kinetics of interactions as well as 
informing on stoichiometry and conformational changes. However, some of these techniques 
require more elaborate and specialised equipment which is perhaps beyond the scope of many 
biological demands. 
 Previous work in this laboratory has used conventional gel-based methods such as EMSAs to 
assess the binding between wild-type (WT) and variant versions of Gp2 and E. coli RNAP (Camara et 
al., 2010). However such techniques are neither quantitative nor sensitive enough to accurately 
measure binding affinities, determine stoichiometries nor to detect subtle differences in binding. In 
addition, the experimental conditions used in gel-based assays are somewhat artificial, thus often 
disrupt the binding equilibrium of the reaction which is particularly biased against transient 
interactions. The nature of solution-based assays is not only more native but also allows for the easy 
manipulation of pH and/or salt concentration in order to investigate the type of the interaction. This 
study aims to establish a reliable, solution based method which can be used to accurately detect the 
binding and measure the affinity of Gp2 to RNAP and variants thereof. 
 Fluorescent anisotropy (FA) is a solution based technique that is frequently used to measure 
the binding constants and kinetics of reactions, as it only requires limited modification to one of the 
binding partners and a spectrofluorometer for obtaining measurements. This technique depends on 
a significant size difference between the two interacting molecules of which the smaller molecule is 
fluorescently labelled. When the fluorescently-labelled molecule is in solution it rotates freely, which 
upon excitation with polarized light has a scrambling effect, generating a depolarized emission 
(Figure 3.1.1, left panel). The ratio of polarized light relative to the total light intensity of the 
emission is expressed in terms of anisotropy. The anisotropy measurements describe the average 
angular displacement of the fluorophore that occurs between the absorption and subsequent 
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emission of a photon. This angular displacement of the fluorescent molecule is dependent upon the 
rate and extent of rotation and consequently upon the size and shape of the rotating molecule as 
well as the viscosity of the solution and local environment of the fluorophore (Joseph R.Lakowicz, 
2012). In general, the smaller the molecule the more rapidly it rotates and the more the emitted 
light is depolarized, resulting in lower anisotropy. Therefore upon binding to a larger molecule a 
more stable complex is formed which rotates slower in the solution and therefore reduces the 
degree of scrambling, producing a more polarized emission and higher anisotropy (Figure 3.1.1, right 
panel). An increase in the concentration of the larger molecule will result in an increase in anisotropy 
until a state of saturation is reached.  
 
 
 
Figure 3.1.1 Schematic of the relationship between binding and anisotropy. 
Left panel: upon excitation with polarized light a small (green), fluorescently labelled molecule (light blue) 
which does not bind to other available molecules (purple) produces a depolarized emission referred to as low 
anisotropy. Right panel: by binding to another molecule (dark blue) and forming a significantly larger complex, 
the light emitted after excitation remains comparatively polarized, referred to as high anisotropy. 
 
 
  To obtain measurements during a binding experiment a sample is excited with vertically 
polarized light, orientated parallel to the z-axis. The intensity of the emission is then detected via 
polarizers on two different planes. Iv describes the intensity of the emission orientated parallel to 
the direction of the polarized excitation (z-axis). Ih denotes the intensity of the emission 
perpendicular to the excitation (x-axis) (Figure 3.1.2). These values are used in the following 
equation to calculate the anisotropy (r). 
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Figure 3.1.2 A diagram displaying the orientation of the emitted and excited polarized light.  
To obtain FA measurements the sample is excited with polarized light orientated parallel to the z-axis. Light 
emitted from the sample is detected parallel to the z-axis (Iv) and perpendicular to the z-axis (Ih). 
 
 When measuring the interaction between two molecules a binding curve can be generated 
by maintaining the concentration of the smaller, fluorescently labelled molecule and titrating in the 
larger binding partner until maximal binding has been reached. The resulting curve can then be used 
to calculate the strength of the interaction in terms of binding affinity such as the association or 
dissociation constants, Ka and Kd respectively. The dissociation constant (Kd) is commonly used to 
describe the affinity between two molecules and in the case of FA is a reference to the 
concentration of the fluorescently labelled molecule, expressed in units of moles. Kd defines the 
equilibrium between bound and unbound states with respect to the reverse reaction i.e. the 
separation of the molecules. The smaller the Kd the stronger the binding, for instance the antibiotic 
rifampicin binds to E. coli  RNAP with a very high affinity; Kd = 130 nM (Xu et al., 2005). The 
measurement of the Kd provides a valuable reference for the comparison of similar interactions. 
Similarly to rifampicin, Gp2 is also a potent inhibitor of E. coli RNAP; however the affinity of Gp2 to 
RNAP has never been quantitatively assessed. Therefore this chapter aims to establish an FA assay to 
accurately measure the strength of binding between Gp2 and RNAP as well as inform on the 
stoichiometry of the interaction.  Furthermore, this FA assay and the resulting Kd value can then be 
used to compare the binding of variant and mutant forms of the two proteins in future studies.  
 In early attempts to understand T7 infection and identify the processes which involve host-
phage component interactions three E. coli mutant strains (TsnB, BR3 and Y49) were discovered that 
were non-permissive for T7 intracellular growth (Shanblatt and Nakada, 1982;Chamberlin, 
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1974;Studier, 1973). When RNAP was isolated from these strains it was found to be specifically 
resistant to T7 Gp2 inhibition, attributed to a lack of interaction (DeWyngaert and Hinkle, 
1979;Shanblatt and Nakada, 1982). Complementation assays localised these mutations and 
therefore the proposed site of Gp2 binding to the C-terminus of the largest subunit of RNAP, now 
known as the β’ jaw domain (residues 1149-1190) (Buchstein and Hinkle, 1982). These mutant rpoC 
genes were then sequenced, revealing that the resistant strains possess the charge reversal point 
mutations, E1158K (BR3 and Y49) and E1188K (TsnB) (Nechaev and Severinov, 1999), suggesting that 
E1158 and E1188 amino acid residues are necessary determinants for Gp2 to bind to RNAP. In fact, 
recent structural analysis has confirmed that the E1158 and E1188 amino acid residues reside within 
the interface of a complex formed between Gp2 and a fragment of the β’ jaw (James et al., 2012) 
(refer to section 4.8).  
  Previous work from this laboratory included a functional alanine mutagenesis screen of 
Gp2, which identified two closely located and surface exposed amino acid residues, R56 and R58 as 
being important for Gp2 inhibition (Camara et al., 2010). In addition, sequence alignments revealed 
that R56 is conserved in all known Gp2 orthologs, whereas R58 is conserved in all but one case, 
where it is substituted for the also positively charged lysine (Figure 3.1.3). 
 
Figure 3.1.3 Sequence alignment of Gp2 orthologs. 
Alignment of the amino acid sequences of all known Gp2 orthologs in the single-letter amino acid codon. The 
length of the proteins is noted at the C-terminus in terms of amino acid residues. A * represents an absolutely 
conserved amino acid residue, : indicates conservation between groups of strongly similar properties and . 
indicates conservation between groups of weakly similar properties. The highly conserved R56 and R58 
residues are highlighted in blue.  
 
  EMSAs confirmed that the function of these two residues could be attributed to the binding 
to RNAP. Considering the nature of these arginines and the glutamic acid mutations in the β’ jaw,  in 
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vivo experiments were conducted to evaluate the contribution of the charge of the R56 and R58 
residues in RNAP binding.  Results revealed that charge reversal mutations (R to E) attenuated Gp2 
function significantly more than charge removal (R to A) or charge conservation (R to K) (Camara et 
al., 2010). This data implied that the Gp2-RNAP interaction involves, in part, an electrostatic 
component, likely to involve the E1158 and E1188 residues in the β’ jaw. Consistent with this view, 
the interaction between Gp2 and RNAP has previously been shown to be salt sensitive (Hesselbach 
and Nakada, 1975). 
 In this study the point, charge reversal mutations in the RNAP β’ subunit (E1158K and 
E1188K) and in Gp2 (R56E and R58E) were used as reciprocal negative controls in the FA assay as 
well as in downstream biochemical experiments.  
 
3.2. Objectives 
 
 This chapter aims to establish an FA assay from which the binding affinity and the 
stoichiometry of the interaction between Gp2 and RNAP can be determined.  The large size 
difference between Gp2 (7 kDa) and RNAP core (390 kDa) maximises the difference in signal 
between the unbound (depolarized light) and bound (polarized light) which is ideal for distinguishing 
between subtle variations of different interactions. Thus, this assay will also serve as a reliable 
method for assessing the binding between mutant forms of Gp2 and RNAP core, hereafter referred 
to as E, as well as alternative versions of the RNAP holoenzyme (Eσ). The charge reversal mutations 
at β’ subunit E1188K and Gp2 R56E will serve as negative controls for the setup of this assay and 
future experiments described in the following chapters.  
 The overall objective for this study was to establish a quantitative assay from which the 
binding affinity of E-Gp2 and variants thereof can be determined. This included the following aims: 
 Over-express and purify the essential core components necessary for initial binding experiments 
including; recombinant E. coli EWT, EE1188K, σ70, σ54, Gp2WT and Gp2R56E. 
 Fluorescently label Gp2WT and Gp2R56E. 
 Establish assay conditions for conducting titration curves. 
 Determine the binding affinity and the stoichiometry of the interaction between Gp2WT and EWT, 
Eσ70 and Eσ54. 
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3.3. Over-expression and purification of recombinant proteins 
 
 To apply this technique to the study of Gp2 and E/Eσ binding the relevant proteins first 
needed to be over-expressed and purified; these included recombinant E. coli EWT, EE1188K, σ70, σ54, 
Gp2WT and Gp2R56E. Preliminary findings had suggested that only a single mutation at either 
E1158/E1188 of the RNAP ’ subunit or R56/R58 of Gp2 was required to entirely disrupt the 
interaction, therefore it was only necessary to construct one mutant version of each protein. The σ-
factors and Gp2 proteins were expressed using the pET system which allows for the controlled, over-
expression of recombinant proteins (refer to section 2.4.1). The pET28b+ and pET33b+ plasmids 
encode proteins fused to an N-terminal His6-tag. In addition, the pET33b
+ plasmid also includes the 
RRASV sequence upstream of the His6-tag which enables 
32P-labelling by protein kinase A. Gp2WT and 
variants were specifically encoded under the pET33b+ plasmid so the proteins could be 32P-labelled 
and used as probes in gel-based protein-protein interaction experiments as well as the FA assay. The 
expression of the encoded proteins from these two plasmids is under the control of the T7 promoter 
and lac operator. The BL21/JE1134 (DE3) host cell strains harbour a single chromosomal copy of the 
T7 gene 1 which encodes T7 RNAP under the control of the lac promoter and lac operator. Addition 
of IPTG results in the displacement of the LacI repressor from both the lac promoter on the 
chromosome and the T7 promoter on the pET plasmid. Only then is the E. coli RNAP able to 
transcribe the T7 gene 1 from the chromosome which in turn can express the target gene encoded 
on the pET plasmid. The pVS10 plasmid encodes all five subunits of E. coli E with a C-terminal His6-
tag on the β’ subunit under the control of a single T7 gene 10 promoter. Expression of E and mutant 
versions was performed using the Novablue (DE3) cell strain which also harbours the T7 gene 1 and 
is inducible with IPTG. 
 His6-tags allow for the purification of the recombinant proteins by immobilised metal affinity 
chromatography (IMAC). The amino acid histidine (His) possesses an imidazole ring side-chain with a 
lone pair of electrons, therefore the His6-tag binds strongly to divalent metal ions such as Ni
2+ which 
can be immobilised on an agarose column. The recombinant protein can be eluted using an 
imidazole gradient which competes for the binding to Ni2+. A further purification step was used to 
separate E from its associated σ-factors. Heparin is a highly negatively charged glycosaminoglycan 
with a similar structure to DNA and RNA. These properties mean it can be exploited for the specific 
purification of nucleic acid-binding proteins. Therefore E and σ-factor proteins were expressed and 
purified using a two step fast protein liquid chromatography (FPLC); nickel (Figure 3.3.1 and Figure 
3.3.3) and heparin affinity chromatography (Figure 3.3.2 and Figure 3.3.4) (refer to sections 2.4.4 
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and 2.4.6). Whereas Gp2 was purified using only nickel affinity chromatography (Figure 3.3.5). In 
some cases where multiple variants of Gp2 were required in the same set of assays the high-
throughput method for expression and purification was used (refer to section 2.4.5).  Examples of 
the SDS-PAGE analysis of the expression and purification of the recombinant proteins are shown in 
Figure 3.3.1 to Figure 3.3.5. 
 
 
Figure 3.3.1 Nickel affinity chromatography of E
WT
. 
Image of a 10% (w/v) SDS-PAGE gel from the nickel affinity purification of recombinant E. coli E
WT
. M = Marker, 
- = without IPTG induction, + = with IPTG induction, S = soluble fraction, I = insoluble fraction, FT = flow-
through and W = low imidazole wash. The molecular weight of the protein markers is shown in kDa and the 
migratory positions of the subunits of E, β’, β, , and ω are indicated with arrows. 
 
 
 
Figure 3.3.2 Heparin affinity chromatography of E
WT
. 
Image of a 10% SDS-PAGE gel from the heparin affinity purification of recombinant E. coli E
WT
. M = Marker and 
L = load. The molecular weight of the protein markers is shown in kDa and the migratory positions of the 
subunits of E, β’, β, , and ω are indicated with arrows. 
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Figure 3.3.3 Nickel affinity chromatography of σ
70
. 
Image of a 12.5% (w/v) SDS-PAGE gel from the nickel affinity purification of recombinant E. coli σ
70
. M = 
Marker, - = without IPTG induction, + = with IPTG induction, S = soluble fraction, I = insoluble fraction, FT = 
flow-through and W = low imidazole wash. The molecular weight of the protein markers is shown in kDa and 
the migratory position of σ
70
 is indicated with an arrow. Note, E. coli σ
70
 has an apparent MW of 87 kDa. 
 
 
 
 
Figure 3.3.4 Heparin affinity chromatography of σ
70
. 
Image of a 12.5% (w/v) SDS-PAGE gel from the heparin affinity purification of recombinant E. coli σ
70
. M = 
Marker, L = load. The molecular weight of the protein markers is shown in kDa and the migratory position of 
σ
70
 is indicated with an arrow. Note, E. coli σ
70
 has an apparent MW of 87 kDa.  
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Figure 3.3.5 Nickel affinity chromatography of Gp2. 
Image of a 12.5% + 15% (w/v) SDS-PAGE gel from the nickel affinity purification of recombinant T7 Gp2. M = 
Marker, - = without IPTG induction, + = with IPTG induction, S = soluble fraction, I = insoluble fraction, FT = 
flow-through, W = low imidazole wash. The molecular weight of the protein markers is shown in kDa and the 
migratory position of Gp2 is indicated with an arrow. 
 
 Eluate fractions containing proteins of >90% homogeneity as judged by densitometry (Figure 
3.3.6) were dialysed into low-glycerol storage buffer. The protein concentration was then 
determined using the Bradford assay (refer to section 2.4.8). 
 
 
 
Figure 3.3.6 Lane profile of an SDS-PAGE gel from the nickel affinity chromatography of Gp2. 
Graph showing the profile of lane 11 from the SDS-PAGE gel in Figure 3.3.5. Each peak represents a band in the 
gel, with the corresponding percentage of densitometry shown above. 
 
3.4. Fluorescent labelling of Gp2 
 
 To fluorescently label Gp2 a suitable fluorophore needed to be selected. Alexa-488 is only 
700 daltons in size, has strong absorption, excellent photostability, is pH insensitive between pH 4 
and 10 and has an exceptional fluorescence output per protein conjugate (Panchuk-Voloshina et al., 
1999). As a result of these qualities it is frequently used in the study of protein-protein interactions 
by FA. Alexa-488 is a thiol or sulphydryl reactive probe and therefore labels proteins at their cysteine 
 80 
 
residues. Fortunately Gp2 only contains one native cysteine at position 60 which is surface exposed 
at the C-terminus. Alanine mutagenesis at C60 showed this residue to be relatively unimportant for 
function (Camara et al., 2010), making it an ideal position for modification. Gp2 was conjugated with 
Alexa-488 as described in section 2.7.1 and re-purified by nickel affinity chromatography to remove 
excess un-conjugated fluorophore. Gp2 and Gp2Alexa488 were then 32P-labelled and used in native gel 
binding assays to establish whether the modification affects the ability of Gp2 to bind to Eσ70 relative 
to an unlabelled version; compare Figure 3.4.1 lanes 2, 3 and 4 to lanes 6, 7 and 8. The Alexa-488 
modified version of 32P-Gp2 bound Eσ70 as well as the non-fluorescently modified 32P-Gp2, as judged 
by the relative proportions of complex formation. Therefore, the Alexa-488 modification of Gp2 does 
not detectably affect its ability to bind to Eσ70.  
 
 
 
 
Figure 3.4.1 Native gel binding assay demonstrating the binding of Gp2/Gp2
Alexa488
 to Eσ
70
. 
An autoradiograph of a 4.5% (w/v) polyacrylamide native gel showing the binding of 
32
P-Gp2 (left panel) and 
32
P-Gp2
Alexa488
 (right panel) to Eσ
70
. The molar ratios of Eσ
70
 with respect to Gp2 are indicated at the top of 
each lane. The migratory positions of free versions of 
32
P-Gp2 (lane 1 and 5) and 
32
P-Gp2-Eσ
70
 complexes (lanes 
2-4 and 6-8) are indicated with arrows. 
 
 
3.5. FA experimental setup 
 
 FA experiments were conducted using a Fluoromax-3 spectrofluorometer as described in 
section 2.7.2. To begin, the ideal concentration of Gp2Alexa488 was established; it was determined that 
50 nM Gp2Alexa488 gave a sufficient fluorescence signal above the background. The Gp2Alexa488 was 
diluted in 400 μl of low glycerol storage buffer as this is considered a sufficient volume from which 
to take accurate measurements as well as allowing for an increase in volume upon the addition of 
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protein. Low glycerol storage buffer was used as it only contains 5% glycerol which does not 
significantly affect the viscosity of the solution and therefore impair the movement of the proteins. 
All experiments were conducted at 37C as this was consistent with in vitro transcription assays. 
Measurements were recorded using a slit size of 0.5 nm and excitation and emission wavelengths of 
495 nm and 519 nm respectively as per the requirements for Alexa-488.  The G-factor is a constant 
which defines the ratio of the sensitivity of detection of fluorescence intensities between the parallel 
and perpendicular components of the emitted light. The G-factor for Gp2Alexa488 under these 
experimental conditions was initially measured and determined to be 0.63; this value was 
maintained for all future experiments. Binding curves were generated by titrating in either E or 
reconstituted Eσ formed with a 1:4 molar excess of σ-factor. The anisotropy was measured 5 times 
in immediate succession. The resulting curve was fitted and the Kd calculated from the tight binding 
equation shown below: 
A = AD + (ADE – AD) × ({(Kd + [E]0 + [Gp2]T) – √ – Kd – [E]0 – [Gp2]T2 – 4[E]0[Gp2]T)}/(2[Gp2]T)) 
Where A is the observed anisotropy, AD is the anisotropy of free Gp2
Alexa488, ADE is the anisotropy of 
bound Gp2Alexa488, Kd is the equilibrium dissociation constant, [Gp2]T is the total concentration of 
Gp2Alexa488 and [E]0 is the concentration of RNAP core (Bellamy and Baldwin, 2001). 
 
3.6. Effect of the σ-factor on Gp2 binding to E 
 
 An initial titration curve was generated to assess the binding between Gp2Alexa488 and EWT 
(Figure 3.6.1). An equimolar amount of E was required to saturate the 50 nM of Gp2Alexa488 signal 
which represents a 1:1 binding stoichiometry. The Kd in this instance was calculated to be 0.53 nM 
which represents a very tight binding interaction. It was previously described that Gp2 has no effect 
on the activity of E  suggesting that Gp2 can only inhibit in the context of Eσ (DeWyngaert and 
Hinkle, 1979) (also refer to chapters 4 and 5). To investigate the potential requirement for the σ-
factor in Gp2 function, the binding of Gp2Alexa488 to Eσ70 was measured to test whether this 
strengthened the binding interaction. Interestingly, Gp2Alexa488 bound to Eσ70 using the same 1:1 
molar stoichiometry and with the same affinity as E, Kd = 0.59 nM (Figure 3.6.1). As Gp2 is not an 
anti-σ, i.e. does not simply disrupt holoenzyme formation, this result implies that Gp2 does not 
require the σ-factor directly or indirectly, for initial binding to E. Gp2 is known to have no significant 
effect on transcription from the major alternative holoenzyme, Eσ54 (Wigneshweraraj et al., 2004). 
As there is a low sequence and structural similarity between σ70 and σ54 it is possible that the 
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different E-σ interaction may interfere with Gp2 binding. Therefore this lack of inhibition may simply 
be due to a relatively weak interaction between Gp2 and Eσ54 compared to that of Eσ70. Surprisingly 
Gp2Alexa488 actually bound to Eσ54 with a 1:1 molar stoichiometry and with a Kd of 0.78 nM which is 
comparable to that of E and Eσ70 (Figure 3.6.1). Thus the initial binding of Gp2 to E occurs completely 
independently of the σ-factor. 
 
 
Figure 3.6.1 Graph displaying the binding of Gp2 to E, Eσ
70
 and Eσ
54
 as measured by FA. 
Gp2
Alexa488
 (50 nM) binding to E. coli E (black line), Eσ
70
 (red line) and Eσ
54
 (blue) is represented by anisotropy 
which is displayed as a function of the concentration of E. The dotted line indicates the concentration (50 nM) 
at which binding becomes saturated. 
 
 
3.7. Important determinants for Gp2-E/Eσ binding 
 
 To test whether the Gp2 interactions observed with E, Eσ70 and Eσ54 are specific, the same 
binding curves were performed with the reciprocal controls; EE1188K and Gp2R56E-Alexa488 (Figure 3.7.1 
and Figure 3.7.2). As expected, Gp2 displayed no detectable binding to E, in either the context of 
Gp2Alexa488 + EE1188Kσ70 or Gp2R56E-Alexa488 + Eσ70. These results confirm that E1188 of the β’ subunit of E 
and R56 of Gp2 are essential determinants for the initial binding of Gp2 to E. Therefore the defective 
mutants EE1188K and Gp2R56E can serve as faithful negative controls in further functional studies. 
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Figure 3.7.1 Graph displaying binding of Gp2 to Eσ
70
 and E
E1188K
σ
70
 as measured by FA. 
Gp2
Alexa488
 (50 nM) binding to E. coli Eσ
70
 (circles) and E
E1188K
σ
70
 (squares) is represented by anisotropy which is 
displayed as a function of the concentration of E. The dotted line indicates the concentration (50 nM) at which 
binding becomes saturated. 
 
 
 
 
 
Figure 3.7.2 Graph displaying binding of Gp2 to Eσ
70
 and Gp2
R56E 
to Eσ
70
 as measured by FA. 
Gp2
Alexa488
 (50 nM) binding to Eσ
70
 (circles) and Gp2
R56E-Alexa488 
binding to Eσ
70
 (triangles) is represented by 
anisotropy which is displayed as a function of the concentration of E. The dotted line indicates the 
concentration (50 nM) at which binding becomes saturated. 
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3.8. Conclusions 
 
 The main objective of this study was to establish a reliable and quantitative, solution based 
protein-protein binding assay for detecting the interaction between Gp2 and RNAP. In this case, 
fluorescence anisotropy proved to be an ideal technique as Gp2 could be easily modified without 
detectably affecting its binding capability. In addition, the large size difference between Gp2 and 
RNAP provides a broad range in the change of anisotropy which would be advantageous for future 
analysis of mutant interactions (refer to chapters 4 and 5).  
 Gp2 binds to the RNAP core, E, using a 1:1 molar stoichiometry with a sub-nanomolar 
affinity; a Kd of 0.53 nM is indicative of a very tight binding inhibitor. Interestingly, the affinity of Gp2 
to E is independent of the presence of the σ-factor; Gp2 binds to Eσ70 with a Kd of 0.59 nM.  It 
remains possible that the overall interface between Gp2 and E could be altered upon σ-factor 
binding but any additional contacts are likely to be weak and may not detectably affect the Kd. 
Furthermore, these findings do not exclude the possibility that the affinity between Gp2 and E is 
affected when the holonzyme engages with the promoter DNA to form the RPc or at any subsequent 
steps in attempted RPo formation. It is conceivable that as the Eσ-promoter complex progresses 
through a series of conformational changes the affinity of Gp2 for E may change; for instance it may 
weaken as the DNA loads into the dw-DBC or it might tighten as the flexible mobile domains of the E 
are repositioned. The effect of the promoter DNA on Gp2 binding may be experimentally addressed 
by introducing variant duplexed oligonucleotides into the Gp2Alexa488-Eσ70 complex which mimic the 
entry and conformational change of the DNA during RPo formation.  An even more surprising result 
is that despite Gp2 being unable to inhibit transcription by Eσ54 (Wigneshweraraj et al., 2004), it 
seems it is still able to bind to this holoenzyme with a Kd of 0.78 which is not significantly different to 
that of E or Eσ70. This suggests that the additional ATP consuming, activation steps required during 
RPo formation in Eσ54-dependent transcription may either actively displace Gp2 from its binding site 
or render it functionally inactive by some other unknown mechanism.  
 It is also possible that as the strength of binding between Gp2 and E is already very tight, a 
potential further increase in affinity upon Eσ formation may be undetectable under these 
experimental conditions. In fact, the binding affinity can only be accurately quantified when the Kd is 
calculated to be greater than the starting concentration of the fluorescently labelled protein. The Kd 
values calculated from the experiments performed in this study were not greater than the 
concentration of Gp2Alexa488 which is a major weakness of this assay. Ideally, a significantly lower 
concentration of Gp2Alexa488 should be used, however considering the range of the current estimated 
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Kd, the fluorescent signal required would be undetectable. One way to counteract this problem of 
tight binding proteins is to conduct competition assays to produce a dissociation curve which can be 
fitted to determine the binding affinity more accurately. Alternatively the binding reactions could be 
performed in higher salt conditions which may compromise the interactions and increase the Kd to a 
broader and more detectable range.  
 FA experiments performed with the point mutants EE1188K and Gp2R56E-Alexa488 demonstrated 
that these charge reversal mutations render these proteins completely defective for binding. Thus it 
was confirmed that the E1188 and R56 residues are indeed essential determinants for binding and 
by extension the E1158 and R58 residues are also likely to have the same role. It is surprising and 
perhaps unlikely that the electrostatic interaction between just two pairs of amino acid residues 
could be responsible for such a tight binding affinity.  Therefore, although the initial binding of Gp2 
to E is very tight and entirely dependent on the glutamic acid and arginine residues of E and Gp2, 
these FA measurements do not provide any direct information on the extent of the surface interface 
(refer to chapter 4). It is possible that after the initial docking, via E1158, E1188, R56 and R58 the 
proteins form a more extensive binding interface involving other amino acid residues and perhaps 
even induces conformational rearrangements in the E/Eσ which could further secure Gp2 in a tightly 
bound position. In fact, recent work in this laboratory has explored the possibility that the interface 
between Gp2 and RNAP may be more extensive than previously described. It seems that 
substitutions at amino acid positions E24 and F27 in the loop interconnecting the β1 and β2 strands 
may form an auxiliary interaction between Gp2 and RNAP when the primary interaction is 
compromised. Thus, this additional contact site may contribute to the high binding affinity between 
Gp2 and RNAP (Shadrin et al., 2012). 
 In this chapter it has been shown how FA has been established for the accurate and reliable 
quantification of the binding affinity of Gp2 to RNAP and variant versions thereof. Such an approach 
could also have implications for pharmaceutical and synthetic biology applications. For instance, 
rifampicin is currently the only clinically used RNAP targeting antibiotic and is the first line treatment 
of tuberculosis. The Kd of rifampicin binding to RNAP has been calculated to be 130 nM. Therefore 
Gp2 actually represents an inhibitor of RNAP with potentially a 250 fold tighter binding affinity than 
the available therapeutic alternative.  
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CHAPTER 4 
INHIBITION OF E. COLI RNAP BY GP2: THE ROLE 
OF THE NEGATIVELY CHARGED STRIP OF AMINO 
ACID RESIDUES IN GP2  
 
 
 
 
 
 
 
 
 
 
 
4.  
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4.1. Introduction 
 
 Previously an atomic resolution solution structure of Gp2 was determined by NMR. This 
structure revealed that the protein adapts a β1 β21 β3 topology comprised of three β strands packed 
against an  helix of which the central β2 is flanked by the anti-parallel β1 and β3 strands (Camara et 
al., 2010). One prominent feature of this structure of Gp2 is the charge separation of amino acids 
possessing negative side chains at opposing sides of the protein to the positively charged binding 
determinants R56 and R58 (Figure 4.1.1).  
 
 
 
 
Figure 4.1.1 Charge separation of Gp2 protein.  
Ribbon representative of the NMR structure of Gp2 with the positively charged binding determinants, R56 and 
R58 coloured blue and the negatively charged aspartic and glutamic acid residues (E21, E34, D37, E38, E41, E44 
and E53) coloured red. 
 
 The negatively charged aspartic and glutamic acid residues E21, E34, D37, E38, E41, E44 and 
E53 form a contiguous negatively charged strip of surface exposed residues running from the β1-β2 
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loop down the -helix. The negative charge of side chains of these seven amino acid residues is 
partially conserved in orthologs of Gp2 (Figure 4.1.2) suggesting that this negatively charged strip 
(NCS) is important for function. The role of this NCS in Gp2 function is unknown and therefore the 
subject of this chapter. 
 
Figure 4.1.2 Sequence alignment of Gp2 orthologs. 
Alignment of the amino acid sequences all known Gp2 orthologs in the single-letter amino acid codon. The 
length of the proteins is noted at the C-terminus in terms of amino acid residues. A * represents an absolutely 
conserved amino acid residue, : indicates conservation between groups of strongly similar properties and . 
indicates conservation between groups of weakly similar properties. The NCS residues are highlighted in red.  
 
 An initial in vitro transcription experiment was conducted to test the inhibitory activity of 
single alanine mutations within the NCS. The results revealed that the individual point mutations at 
each of the seven residues had no detectable effect on Gp2 inhibitory activity (Figure 4.1.3) 
(Sheppard et al., 2011). This data suggests that either the negative charge of the residues in the NCS 
does not contribute significantly to Gp2 function or because of their high level of conservation as a 
whole it is more feasible that the negatively charged residues within the NCS may act collectively. As 
the NCS is positioned at the opposite side of the protein to the R56 and R58 residues which are 
required for binding to the β’ jaw, it is conceivable that the NCS could project into the downstream 
DNA-binding channel (dw-DBC) of RNAP to inhibit is activity by an unknown mechanism. 
Investigating the role of the NCS will provide crucial insights into the overall mechanism of action of 
Gp2. 
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Figure 4.1.3 Bar chart displaying the Inhibitory activity of Gp2 NCS point mutants. 
Results from an in vitro transcription assay showing the activity of E. coli Eσ
70
 from the lacUV5 promoter in the 
absence of Gp2 and in the presence of Gp2
WT 
or mutant versions of Gp2 with single alanine substitutions in the 
NCS. Transcription activity is shown in percentage above each bar (Sheppard et al., 2011). 
 
4.2. Objectives 
 
 The overall objective of this chapter is to explore the role that the NCS of Gp2 may play in 
the inhibition of RNAP. This objective was approached by investigating how the removal of the NCS 
may affect Gp2 function. To this end, four mutant versions of Gp2 were created by site-directed 
mutagenesis, containing a series of alanine and serine substitutions within the NCS. In collaboration 
with Prof. Steve Matthews at the centre of structural biology, Imperial College London, the ability of 
each mutant protein to fold correctly was first tested, then their binding affinities for Eσ70 were 
quantified and their inhibitory activities were determined both in vitro and in vivo. This data 
provides further insights into the overall molecular mechanism employed by Gp2 during inhibition of 
RNAP. This study was addressed with the following specific aims: 
 Over-express and purify mutant versions of Gp2 containing two, five, six and seven 
alanine/serine substitutions within the NCS. 
 Determine whether the mutations in the NCS of Gp2 compromise the structural integrity of the 
protein by 1-D NMR. 
 Establish if and with what affinity the NCS mutant proteins can bind to Eσ70 using the previously 
established FA assay (refer to chapter 3). 
 Determine the activity of each NCS mutant protein. 
 Explore the mechanism by which Gp2 inhibits the RNAP and what role the NCS may play. 
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4.3. Production of Gp2 NCS mutant proteins 
 
 Following the single alanine mutagenesis of the NCS, an additional mutant version of Gp2 
was constructed possessing two mutations (D37A and E38S) within the NCS (Gp2Mut2) at the most 
highly conserved residues in the Gp2 orthologs (Figure 4.1.2). To further perturb the charge of the 
NCS three further mutant versions of Gp2 were created in which five (Gp2Mut5), six (Gp2Mut6) and all 
seven (Gp2Mut7) residues in the NCS were substituted for alternating alanine and serine residues 
(Figure 4.3.1). These amino acids were chosen as substitutes due to the relatively small size of their 
side chains, which are less likely to distort the structure of the -helix.  
 
 
 
Figure 4.3.1 Structure of Gp2 with NCS mutations highlighted. 
Space filled representation of Gp2 with R56 and R58 residues coloured blue and NCS residues coloured red. 
The NCS alanine and serine substitutions are coloured yellow and their positions described beneath each 
structure. 
  
 
 The four mutant proteins were over-expressed from the pET28b+ and pET33b+ plasmids and 
purified to >90% homogeneity by nickel affinity chromatography (refer to sections 2.4.4 and 3.3). 
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4.4. 1-D NMR spectra of Gp2 NCS mutant proteins 
 
 Since the NCS mutant proteins are the product of a significant degree of modification (>10% 
for Gp2Mut7) it was a major concern that the extent of the substitutions may compromise the 
structural integrity of Gp2. To check whether the mutant proteins had retained their overall 
structure the 1-D NMR spectra of the mutants was measured and compared to that of Gp2WT (Figure 
4.4.1). These experiments were conducted in collaboration with Prof. Steve Matthews and 
colleagues at the Centre of Structural biology, Imperial College London. Resonances beneath 0.5 
ppm represent methyl and methylene groups buried in the hydrophobic core of the protein. In the 
Gp2 spectra the dispersion of resonances at -0.126 ppm to 0.045 ppm (Figure 4.4.1, enlarged box) 
specifically correspond to the H1 and H2 protons in the methyl groups of V20. Residue V20 forms 
part of the hydrophobic core of the protein which if disrupted significantly effects the folding of Gp2 
(Camara et al., 2010). The frequencies of the resonances from these protons can be shifted from the 
electronic ring currents of neighbouring aromatic side chains (ring current shift). Therefore a change 
in the local environment of V20 will be represented by this spectrum. For instance F16 is buried 
within the hydrophobic core of the protein, therefore a substitution to alanine results in a loss of 
resonances below 0.5 ppm, signifying a disruption to the structure, which results in a significant 
reduction in inhibitory activity (Camara et al., 2010). However, the frequencies of these resonances 
are retained in the spectra of all the NCS mutant proteins. Similarly the amide and aromatic side 
chains of the NCS mutants display a dispersion of resonances between 6.5 ppm to 9 ppm which are 
comparable to that of Gp2WT.  
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Figure 4.4.1 1-D NMR spectra of Gp2 and NCS mutants.  
Detail of proton (
1
H)NMR spectra from Gp2
WT
 and  NCS mutants. The chemical shift from the amide and 
aromatic protons are shown on the left side whereas the methyl and methylene groups are shown on the 
right. The enlarged region shows the ring current-shifted methyl groups from residue V20. The inserted box is 
an (
1
H)NMR spectra from Gp2
F16A
 in which the structure is significantly disrupted due to mutation (Sheppard et 
al., 2011). 
 
 This data demonstrates that the structural features of Gp2WT are preserved in all the mutant 
proteins, implying that the substitutions within the NCS do not significantly perturb the correct 
folding of the protein. Consequently the mutant Gp2 proteins could be confidently used in assays to 
investigate Gp2 binding to and inhibition of RNAP. 
 
4.5. Binding of NCS mutants to Eσ70 
 
To test whether the residues in the NCS contributed to the ability of Gp2 to bind to Eσ70 the 
strength of the interaction was quantified by FA. Each Gp2 mutant protein along with Gp2WT was 
labelled with Alexa-488, hereafter referred to as Gp2* and used in a titration assay with Eσ70 (refer 
to sections 2.7.2 and 3.5). As expected the anisotropy of Gp2WT increased in a dose dependent 
manner upon increase in concentration of Eσ70, whereas no binding was detected for Gp2R56E* + Eσ70 
or Gp2WT* + EE1188Kσ70. In this experiment the Kd of Gp2
WT* was calculated to be 0.35 nM. The same 
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titration assays were then performed for each of the NCS mutants (Figure 4.5.1) and the Kd values 
were calculated from the fit of each of these binding curves (Table 4.5.1). 
 
 
 
Figure 4.5.1 Graph displaying the binding of Gp2
WT
* and NCS mutant versions to Eσ
70
 measured by FA. 
Gp2
WT
* (blue), Gp2
Mut2
* (purple), Gp2
Mut5
* (green), Gp2
Mut6
* (orange) and Gp2
Mut7
* (red) binding to Eσ
70
 is 
represented by anisotropy which is displayed as a function of the concentration of E. The dotted line indicates 
the concentration at which Gp2
WT
* binding becomes saturated. 
 
 The shape of the binding curves notably differs between Gp2WT and each of the NCS 
mutants. In particular there is a significant difference in amplitude resulting in lower bound 
anisotropy values (especially in Gp2Mut2*, Gp2Mut5* and Gp2Mut7*). This difference in amplitude relates 
to a change in the rotational diffusion which can be caused by a change in the lifetime of the 
fluorophore or a change to its local environment.  This implies that either the individual context of 
the Alexa-488 fluorophore in each of the Gp2 proteins changes due to the direct effect of the 
mutations or that the mutations effect the overall binding interface between each of the Gp2 
proteins and Eσ70 which ultimately changes the Alexa-488 surroundings. 
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Table 4.5.1 Kd values of NCS mutants. 
The average calculated Kd value representing the binding affinity of each Gp2 protein to Eσ
70
 was determined 
by FA.  
 
 The binding affinities, represented by the Kd values of each of the mutant proteins, are 
approximately 6-11 fold lower than that of Gp2WT. Although the variation of these Kd values and the 
shape of the binding curves suggests a slight change in the strength of the interaction, these binding 
affinities are all in the low nanomolar range and therefore still indicative of tight binding proteins. 
Furthermore, the saturation of NCS mutant protein binding to Eσ70 occurs at approximately the same 
concentration as that of Gp2WT*(represented by the dashed line in Figure 4.5.1), indicative of a 1:1 
binding stoichiometry. From these results it was concluded that the mutations within the NCS have 
only a marginal effect on the ability of the protein to bind to Eσ70. This is in marked contrast to a 
point mutation at R56, which under the same experimental conditions completely abolished the 
binding ability of Gp2 (refer to Figure 3.7.2) and therefore along with R58 remains the main 
determinants for the initial binding to RNAP.  
 
4.6. Inhibition of transcription by NCS mutant proteins 
 
 Since the primary function of the NCS does not seem to be for binding to Eσ70, the inhibitory 
activity of the mutant proteins was assessed in an in vitro transcription assay. The NCS mutant 
proteins were incubated with Eσ70 (refer to section 2.6.5) at 1:1, 1:2 and 1:4 ratios at which Gp2WT is 
known to almost completely abolish transcription (Figure 4.6.1 lanes 2-4). Interestingly, in contrast 
to Gp2WT the NCS mutants displayed gradually reduced inhibitory activity, correlating with the 
progressive removal of the negative charge of the side chains. At equimolar ratios of Gp2 to Eσ70, 
transcription activity was reduced to 1.2%, 53% and 97% for Gp2Mut2, Gp2Mut5 and Gp2Mut6 
Gp2 Kd (nM) SE 
WT 0.35 0.09 
Mut2 2.20 0.54 
Mut5 3.20 1.93 
Mut6 3.95 1.43 
Mut7 2.90 1.71 
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respectively. Whereas Gp2Mut7 has no effect on transcription activity at this molar ratio; compare 
lanes 2, 5, 8, 11 and 14.  However at a 1:4 molar ratio of Gp2Mut7 over Eσ70 there is a notable 
decrease in transcription (14%) (Figure 4.6.1, lane 16) suggesting that if present at high enough 
concentrations there still exists slight inhibitory activity. This inhibitory activity may be attributed, in 
part to steric hindrance; however such high ratios especially in the artificial environment of the 
experiment are unlikely to be representative of native conditions.    
 
 
 
 
Figure 4.6.1 Inhibitory activity of Gp2 NCS mutants. 
An autoradiograph of a 20% (w/v) polyacrylamide denaturing gel showing the synthesis of the ApApUpU 
transcript as indicated by the arrow whereby the underlined nucleotides are 
32
P-labelled. Transcription was 
performed by Eσ
70
 from the lacUV5 template in the presence of 1:1, 1:2 or 1:4 molar ratios of Gp2
WT
 or NCS 
mutant. The percentage activity of Eσ
70
 in the presence of the Gp2 proteins was calculated with respect to a 
reaction conducted in the absence of Gp2 and are indicated beneath each lane. 
 
 This data strongly suggests that the NCS residues specifically contribute to the inhibitory 
function of Gp2, and that the potency of inhibition is determined by the number of the negatively 
charged side chains within the NCS. In support of this view, in vivo complementation data conducted 
by Dr. Andrey Shadrin (a researcher in the Wigneshweraraj laboratory) also showed that T7 phage 
harbouring an amber mutation in gene 2 were progressively less effective in infecting BL21 cells 
when complemented with pET28b+:Gp2Mut2/Mut5/Mut6/Mut7 than with pET28b+:Gp2WT (Sheppard et al., 
2011). 
 
4.7. Is Gp2Mut7 retained in the RPo? 
 
 Gp2WT has no effect on transcription from a pre-formed RPo because it is unable to bind to 
Eσ70 (Camara et al., 2010), hence it was proposed that Gp2 and the dw-DNA compete for binding to 
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the β’ jaw. However, in the presence of the functionally defective mutant Gp2Mut7 the RPo is still able 
to form and therefore transcription can occur, but it is not known whether Gp2Mut7 remains bound or 
is displaced from this complex. To determine whether Gp2Mut7 is retained in the RPo that forms in its 
presence, EMSAs were conducted using Alexa-488 labelled Gp2WT and Gp2Mut7 as well as a 32P-
labelled lacUV5 promoter probe which allows for the visualisation of protein and DNA components 
by fluorescence imaging (FI) and autoradiography (A) respectively. Therefore Gp2*-Eσ70 and Eσ70-32P-
lacUV5 binary complexes as well as the hypothetical Gp2*-Eσ70-32P-lacUV5 ternary complex could be 
detected. The migration of free Gp2WT* and Gp2WT* bound to Eσ70 are indicated in Figure 4.7.1 lanes 
1 and 2 whereas free lacUV5 and Eσ70-32P-lacUV5 are indicated in lanes 5’ and 6’. As expected, when 
32P-lacUV5 was added to Eσ70 pre-incubated with Gp2WT* the predominate complex continued to be 
Gp2WT*- Eσ70 (lane 7) with only a small proportion of Eσ70 escaping Gp2WT* inhibition to form the RPo 
(lane 7’). In contrast and as expected, Gp2Mut7* had no noticeable effect on the formation of the 
RPo; compare lane 6’ to 8’ and Gp2Mut7* was undetectable at the migratory position of the RPo upon 
the addition of 32P-lacUV5, compare lane 8 to 8’.  
 
 
Figure 4.7.1 Native gel of Gp2
WT
 and Gp2
Mut7 
binding to Eσ
70
. 
A fluorescence image (FI) (lanes 1-6 and 7-8) and autoradiograph (A) (lanes 5’-8’) of a 4.5% (w/v) 
polyacrylamide native gel determining whether Gp2
Mut7
 is retained in the RPo. The migration positions of 
unbound 
32
P-lacUV5, Eσ
70
-
32
P-lacUV5, Gp2
WT
*, Gp2
WT
*-Eσ
70
 and RPo are as indicated. Reaction components 
are marked at the top of each lane.  
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 This result indicates that Gp2Mut7* is displaced from Eσ70 during the formation of the 
transcriptionally competent RPo which is able to form in its presence. In contrast, Gp2WT remains 
bound leading to efficient prevention of RPo formation and consequently inhibition of transcription. 
Therefore, like Gp2WT, formation of the RPo complex does not allow for Gp2Mut7 binding. However, 
whereas Gp2WT is able to compete with the dw-DBC for binding to the β’ jaw (refer to section 4.8) 
and consequently antagonise RPo formation in an order of addition dependent manner, the 
complete removal of the NCS seems to compromise this ability of Gp2Mut7. 
 
4.8. Conclusions 
 
 The results in this chapter have described how the NCS of amino acid side chains plays a 
major role in the inhibitory activity of Gp2. It was confirmed by NMR that the substitution of amino 
acids within the NCS does not detectably compromise the structural integrity of the Gp2 protein. FA 
measurements demonstrated that the binding affinities of each of the NCS mutant proteins to Eσ70 
were in the low nanomolar range and did not differ significantly from that of Gp2WT. These results 
imply that the NCS is not essential for the initial binding of Gp2 to the Eσ70. However, the shape of 
the binding curves does differ considerably, which actually may be informative to the specifics of the 
interaction. The difference in amplitudes of the anisotropy may suggest a change to the local 
environment of the Alexa-488 fluorophore. As the 1-D NMR spectra showed that the mutant 
proteins are all folded correctly the discrepancies in the binding curves may be due to an overall 
change in the surface interaction between Gp2 and the dw-DBC of RNAP. Therefore although R56 
and R58 are the major determinants for the initial binding or docking of Gp2 to the ’ jaw, the NCS, 
and indeed other residues, may contribute to the overall interaction or could be required for final 
positioning of Gp2. This is especially plausible considering the potentially strong intermolecular 
forces between the NCS and the positively charged ‘walls’ of the dw-DBC. These additional 
interactions may involve amino acid residues in other domains of the dw-DBC and could help explain 
how Gp2 has such a tight binding affinity. Alternatively, it has been shown that the oligonucleotide 
sequence in protein-DNA and amino acid residues in protein-protein interaction studies can affect 
the properties of an attached fluorophore, potentially quenching the intensity of the emission 
(Anderson et al., 2008). Therefore the substitution of the amino acid residues in the NCS may 
directly influence the behaviour of Alexa-488. Despite any discrepancies in binding, these subtle 
differences cannot account for such drastic changes in Gp2 inhibitory activity.  
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 The results from the in vitro transcription assay clearly show that there is a gradual decrease 
in the inhibitory activity of Gp2 which correlates with the progressive removal of the NCS. Complete 
removal of the NCS, entirely abolishes Gp2 activity, therefore the NCS is the major determinant for 
inhibitory function of Gp2. This finding is supported by an in vivo assay which showed that amino 
acid substitutions in the NCS significantly impaired the ability of T7 to infect E. coli (Sheppard et al., 
2011). The absolute removal of the NCS as judged by Gp2Mut7 results in a complete loss of inhibitory 
activity which implies that Gp2 function is entirely dependent on the conservation of this feature. 
Therefore Gp2 is unlikely to antagonise RPo formation simply by steric hindrance or mechanisms 
that involve the presence of the protein per se.  
 As Gp2 is a potent inhibitor of Eσ70 it is likely that Gp2 has evolved to function by disrupting 
a number of protein-DNA as well as protein-protein interactions which are necessary for RPo 
formation. To further explore the role of the NCS in the context of the molecular mechanism of 
inhibition of RNAP by Gp2 an NMR structure of Gp2 bound to a ’ jaw fragment (residues 1153-
1213) was determined (James et al., 2012). The complex with Gp2 extends the -sheet of the ’ jaw 
fragment to an arrangement consisting of seven -strands running in an anti-parallel conformation. 
As predicted, the major Gp2 binding determinants R56 and R58 are located in close proximity to one 
of the RNAP binding determinants, residue E1188 of the ’ jaw (Figure 4.8.1) which generates 
significant electrostatic interactions, aligning  the 3 and 2 strands of the ’ jaw fragment with the 
3 and 1 of Gp2.  Additionally it seems that this positioning, extends the residues of the NCS of Gp2 
by residues E1158, D1181, D1184, E1187 and E1188 of the ’ jaw (Figure 4.8.2), thus supporting the 
view that the NCS is an important feature in Gp2 function. 
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Figure 4.8.1 Structure of the Gp2-’ jaw fragment with binding determinants. 
Ribbon representation of the Gp2-’ jaw fragment complex. Gp2 is shown in cyan and the ’ jaw fragment in 
green. The R56, R58 and E1188 residues are shown in stick representation and coloured dark blue. Adapted 
from (James et al., 2012). 
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Figure 4.8.2 Structure of Gp2-’ jaw fragment with NCS. 
Ribbon representation of the Gp2-’ jaw fragment complex. Gp2 is shown in cyan and the ’ jaw fragment in 
green. The NCS residues (E21, E34, D37, E38, E41, E44 and E53) and the ’ jaw NCS extension residues (E1158, 
D1181, D1184, E1187, E1188) are shown in stick representation and coloured red. Adapted from (James et al., 
2012). 
 
 To provide further insights into the precise mechanism of inhibition by Gp2, this structural 
complex was used together with the E. coli RNAP core (Opalka et al., 2010) and the transcription 
initiating T. aquaticus (Murakami et al., 2002b) structures to generate a composite structural model 
of the Gp2-RNAP complex (James et al., 2012). Previous results have implied that Gp2 may inhibit 
Eσ70 activity by directly competing for binding to the dw-DBC with the dw-DNA. The structural model 
showed that the surface of Gp2 binding does indeed face into the dw-DBC, where the dw-DNA is 
predicted to be positioned. Moreover, NMR titration experiments with the ’ jaw fragment and ds-
DNA fragment provided the first experimental evidence that the ’ jaw fragment does specifically 
interact with the dw-DNA. Therefore these findings strengthen the proposal that Gp2 may function 
to antagonise the interactions between the ’ jaw and the dw-DNA. To experimentally test this, 
NMR spectra were obtained from competition experiments whereby Gp2 was titrated into a ’ jaw 
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fragment-ds-DNA complex. In this context, Gp2 was able to successfully displace the ds-DNA from 
the ’ jaw fragment. Additionally the presence of Gp2 prevented the crosslinking of a ds-DNA 
segment to the ’ jaw fragment (James et al., 2012). These results strongly support the view that 
Gp2 antagonises interactions between the dw-DNA interactions and the dw-DBC which are 
necessary for RPo formation.  
 Due to the negative nature of the NCS and the extension of this charge by the ’ jaw it was 
proposed that Gp2 may antagonise the interactions between the dw-DNA and the dw-DBC by 
projecting the NCS into the dw-DBC and electrostatically repelling the negatively charged dw-DNA. 
However in the current structural model the negatively charged residues of the NCS are 
predominantly facing towards the ’ jaw and the ’i6 domains rather than projecting out into the 
active site cleft of the dw-DBC (Figure 4.8.3). Therefore this current structural model orientates Gp2 
in a position that makes electrostatic repulsion of the dw-DNA unlikely.  
 
 
Figure 4.8.3 Structural composite model of E. coli RNAP core and Gp2. 
Surface representation of Gp2 bound to the E. coli RNAP core. Gp2 is shown in cyan and the ’ jaw fragment in 
green. The NCS residues are coloured red but are predominately hidden in this model. The active site is 
coloured yellow. The dw-DBC and the  dw-lobe, ’ clamp and ’i6 mobile modules are circled and labelled. 
Adapted from (James et al., 2012). 
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 Alternatively and/or additionally the NCS may be better orientated to interact with the 
positively charged domains of the dw-DBC and ‘lock’ Eσ70 in a conformation unfavourable for RPo 
formation. Structural analysis has revealed that the two ‘pincers’ of RNAP can exist in numerous 
conformational states which can vary the diameter of the active-centre cleft between > 20 Å when 
open and 8- 12 Å when closed (Chakraborty et al., 2012). It is conceivable that the diameter of the 
active cleft may dictate the entry and the conformational state of the DNA. During early stages of 
transcription initiation the ’ clamp and the  dw-lobe which comprise the ‘pincers’ of RNAP (Figure 
4.8.3) must move apart to permit the ds-DNA to enter the active-centre cleft but later in initiation 
the ’ clamp must close to form a stable RPo. Therefore Gp2 could potentially target the movement 
of the ’ clamp and  dw-lobe to either restrict access of the ds-DNA or to  prevent the closure of 
the ‘pincers’. Another possible mechanism by which Gp2 can effect interdomain-protein interactions 
or conformational changes involves the flexible and highly negatively charged σ70 R1.1 domain which 
also resides in the dw-DBC. The potential role of σ70 R1.1 in Gp2-mediated inhibition is the subject of 
chapter 5. 
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CHAPTER 5 
THE ROLE OF σ70 REGION 1.1 DOMAIN DURING 
GP2-MEDIATED INHIBITION OF RNAP 
 
 
 
 
 
 
 
 
 
 
 
 
5.  
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5.1. Introduction 
 
 In order to initiate transcription, the RNAP core must interact with a dissociable promoter 
specificity factor known as a σ-factor. The σ-factor is responsible for the recognition of the 
consensus promoter elements as well as steps in DNA strand-separation. E. coli possess seven 
different σ-factors (refer to section 1.2.5) of which the RNAP core predominately associates with σ70 
which is responsible for initiating the transcription of the housekeeping genes, particularly during 
exponential growth. σ70-like factors are compromised of four domains (Figure 5.1.1), separated by 
flexible linkers, which form contacts either with the β and β’ subunits of RNAP or the promoter DNA. 
The major determinants for promoter recognition are located in regions 2.4 and 4.2, which contact 
the -10 and -35 promoter elements respectively whereas domain 3.0 is responsible for interacting 
with the extended -10 promoter motif (Barne et al., 1997). 
 
 
 
Figure 5.1.1 Conserved domains and functions of σ
70
 type factors. 
The conserved regions and non-conserved region (NCR) of the σ
70
 type factors are indicated. Arrows point to 
the regions of contact between the σ-factor and the discriminator region, the -10, extended -10 and -35 
promoter elements of the DNA. The subdomains, regions 1.1 and 2.3 are required for auto-inhibition and DNA 
strand-separation respectively. Adapted from (Gruber and Gross, 2003). 
 
 Domain 1 is only present in a specific subset of σ70-like factors and although it tends to vary 
in sequence, its overall negative charge is always conserved (Gruber and Gross, 2003). High 
resolution structures of fragments of free σ (Malhotra et al., 1996;Schwartz et al., 2008;Campbell et 
al., 2002) and of the T. aquaticus and T. thermophilus holoenzymes (Murakami et al., 
2002b;Vassylyev et al., 2002) have provided valuable information on the extensive E-σ contacts and 
transcription initiation transition steps however, to date R1.1 remains unresolved in these 
structures, most likely due to its flexible nature as seen by DNA footprinting (Nagai and Shimamoto, 
1997). However, biochemical experiments have shown R1.1 to function as an auto-inhibitory 
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regulator by concealing the DNA binding determinants in the free protein, presumably to prevent 
binding of the σ-factor to the promoter DNA in the absence of RNAP core (Dombroski et al., 1992). 
This view is supported by LRET, FRET and crosslinking data which compared the interdomain 
distances between free σ and the holoenzyme; (Schwartz et al., 2008;Mekler et al., 2002;Callaci et 
al., 1999), implying that the free σ is much more compact in structure and therefore must undergo 
large scale conformational changes to form its extensive interactions upon binding to RNAP core. 
Further to these observations, it has also been suggested that the positioning of R1.1 is critical for 
steps in transcription initiation. It was proposed from structural analyses that in the context of Eσ70 
the location of R1.1 corresponds to the main channel; which could make it responsible for the 
widening of the ‘pincers’ to facilitate entry of the ds-DNA (Murakami et al., 2002b). The location of 
R1.1 in the downstream portion of the main channel was confirmed by FRET experiments. 
Moreover, it was also demonstrated that during RPo formation, R1.1 is repositioned from the inside 
of the positively charged channel to make alternative interactions with the also positively charged β-
pincer tip formed by the dw-lobe. From this observation it was proposed that the highly negatively 
charged R1.1 acts as a molecular mimic of the dw-DNA and therefore serves as a placeholder for the 
DNA until proficient RPo can occur (Mekler et al., 2002). 
 Some of the very early work on Gp2 noted that its inhibitory effect on DNA binding to RNAP 
is 2-fold more effective in the context of Eσ70 than the RNAP core (DeWyngaert and Hinkle, 1979). 
This is surprising; recall that in chapter 3 it was demonstrated that Gp2 binds to the RNAP core with 
the same affinity as Eσ70. Therefore this early observation could imply that although σ70 may not 
influence the binding affinity of Gp2 it could, in part, contribute to the inhibitory activity of Gp2.  
Gp2, like R1.1 has regions of high negative charge and is also located in the same vicinity of the dw-
DBC of RNAP. Therefore, the role, if any, of this specific domain of σ70 in Gp2 inhibition of Eσ70 was 
explored. It was hypothesised that as Gp2 targets a stage en route to RPo formation, it may be 
possible that Gp2 could exploit the properties and essential function of R1.1 during this process. 
 Recent experiments by Mekler et al, which used Gp2 purified from this study, explored the 
mechanism of action of Gp2; specifically focusing on how the inhibitor influences the binding of 
promoter DNA to Eσ70. Assays were performed using an engineered T5N25 promoter which includes 
consensus -10 and -35 elements, an optimised UP element as well as an extended -10 motif. This 
strong promoter probe referred to as T5N25CONS enables the formation of a stable ternary Gp2-
Eσ70-DNA complex which displays some of the hallmarks of the RPo but crucially is transcriptionally 
inactive. Thus, this ternary Gp2- Eσ70-DNA complex can be considered as an intermediate complex 
that forms during RPo formation. DNA footprints of these complexes show that Gp2 reduces the 
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DNaseI dw-DNA protection from the +20 to the +8 site which supports the overall view that Gp2 
reduces the affinity of the dw-DNA for the dw-DBC. KMnO4 DNA footprinting revealed that the 
upstream edge of the transcription bubble (up to -6) was resistant to Gp2 inhibition and therefore 
single-stranded, whereas the downstream portion (-5 to +2) remained duplexed. These observations 
strongly supports previous in vitro transcription experiments from our laboratory which implied that 
Gp2 effects a late stage of RPo formation associated with DNA strand separation around the + 1 site 
(Camara et al., 2010).  Quantitative binding assays were then used to dissect the effect of Gp2 on the 
binding of Eσ70 to different portions of the T5N25CONS promoter. Results showed that Gp2 has no 
significant effect on the binding of DNA upstream of the -10 site to Eσ70 but does inhibit the binding 
of single-stranded downstream extensions of the template strand around the active site. These 
findings suggest that the inhibitory effects of Gp2 are not confined solely to its site of binding at the 
β’ jaw. Hence, this study not only investigated the possible contribution of R1.1 in Gp2 inhibition but 
also how it may directly/indirectly influence the binding of different segments of promoter DNA to 
Eσ70. 
 
5.2. Objectives 
 
 The primary focus of this chapter is to explore the potential contribution that σ70 R1.1 may 
have in the inhibition of Eσ70 by Gp2.  This study will involve the in vitro analysis of R1.1 deleted 
versions of σ70 in the context of the Gp2 inhibition of Eσ70. The main objective is to determine 
whether R1.1 is required for Gp2 inhibition of Eσ70 and to investigate the role that R1.1 may play in 
the mechanism of inhibition. In addition, this study will also further investigate the extent to which 
Gp2 restricts the entry of the promoter DNA and whether R1.1 may be involved in this antagonistic 
effect. This data will provide further insights into the overall molecular mechanism employed by Gp2 
during the inhibition of transcription initiation. This study includes the following individual aims: 
 Over-express and purify σ70ΔR1 and σ70ΔR1.1 as well as the isolated R1.1 peptide. 
 Determine the binding affinity of Gp2 to RNAP reconstituted with the mutant versions of σ70. 
 Investigate the inhibitory activity of Gp2 on Eσ70 transcription using σ70ΔR1 and σ70ΔR1.1 and with 
R1.1 added in trans. 
 Explore the effect of Gp2 on the interactions between Eσ70 and various segments of the 
promoter DNA and the potential contribution of R1.1. 
 Unravel the mechanism by which R1.1 may contribute to the inhibition of Eσ70 by Gp2. 
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5.3. The effect of the σ70 N-terminal on Gp2 inhibitory activity 
 
Gp2 binds to the β’ jaw domain which forms part of the dw-DBC of RNAP. The N-terminal 
domain of σ70 is also believed to localise within this channel upon Eσ70 formation but at some stage 
prior to RPo formation it is repositioned to the tip of the β dw-lobe at the exterior of the channel. On 
the basis of this expected close proximity, preliminary experiments were performed to ascertain if 
the N-terminus of σ70 influences Gp2 binding and activity. FA binding experiments were conducted 
with both the full length Eσ70 and a version of the Eσ70 lacking σ70 amino acid residues 1-130 referred 
to as Eσ70ΔR1 (Figure 5.3.1). It was predicted that as Gp2 binds to RNAP core (E) and Eσ70 with equal 
affinities, the removal of the σ70 N-terminal domain was unlikely to affect Gp2-E binding affinity.   
 
 
 
Figure 5.3.1 Graph displaying the binding of Gp2* to Eσ
70
 and Eσ
70ΔR1 
as measured by FA. 
Gp2* (50 nM) binding to Eσ
70
 (circles) and Eσ
70ΔR1
 (diamonds) is represented by anisotropy which is displayed 
as a function of the concentration of E. The dotted line indicates the concentration at which Gp2* binding 
becomes saturated. 
 
 As expected Gp2* binds to Eσ70ΔR1 with the same equimolar stoichiometry and equivalent 
affinity as to the full length Eσ70 with Kd values of 0.83 nM and 0.40 nM respectively. This confirms 
that at least in the context of Eσ70, σ70 domains R1.1 and R1.2 have no detectable effect on Gp2 
binding.  
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 Next, it was considered whether R1 of σ70 could contribute to the inhibitory activity of Gp2. 
To investigate this potential contribution, the effect of the removal of the σ70 N-terminal on Gp2-
mediated inhibition of transcription was tested. The inhibitory activity of Gp2 was assessed in an in 
vitro transcription assay; Eσ70WT or Eσ70ΔR1 was pre-incubated with either Gp2WT or the defective 
mutant Gp2R56E prior to the addition of the lacUV5 DNA template (Figure 5.3.2). 
 
 
 
 
 
 
 
 
Figure 5.3.2 Inhibitory activity of Gp2 on Eσ
70
 and Eσ
70ΔR1 
transcription. 
An autoradiograph of a 20% (w/v) polyacrylamide denaturing gel showing the synthesis of the ApApUpU 
transcript as indicated by the arrow whereby the underlined nucleotides are 
32
P-labelled. Transcription was 
performed by Eσ
70
 (top panel) and Eσ
70ΔR1
 (bottom panel) from the lacUV5 template in the presence of 1:1, 1:2 
or 1:4 molar ratios of Gp2
WT
 or 1:4 molar excess of Gp2
R56E
. The percentage activity (% A) of Eσ
70
 in the 
presence of the Gp2 proteins was calculated with respect to reactions conducted in the absence of Gp2 (lanes 
1 and 6) and are indicated beneath each lane. 
 
 Removal of the σ70 N-terminal reduced transcription inhibition by up to 25% providing the 
first piece of experimental evidence to show that the N-terminal of σ70 is required for the efficient 
inhibition of Eσ70 transcription by Gp2. Even increasing the molar ratio of Eσ70:Gp2 from 1:1 to 1:4 
(lanes 7-9) did not detectably recover Gp2 inhibition, implying that the potential role of σ70 N-
terminal may not be attributed simply to increasing Gp2 binding or activity but as an extension of 
the overall inhibitory mechanism. Control reactions were performed with the point mutant Gp2R56E 
which is defective for binding and therefore has no effect on transcription.  Transcription reactions 
with Eσ70ΔR1 and 1:4 molar excess of Gp2R56E displayed no change in levels of the ApApUpU transcript 
(compare lanes 6 and 10), demonstrating that the inhibition shown in lanes 2-4 and 7-9 is specific to 
Gp2WT. 
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5.4. The contribution of σ70 R1.1 domain to inhibition of Eσ70 by Gp2 
 
 Thus far, experiments were performed using a σ70 N-terminal deletion mutant deficient in 
regions 1.1 and 1.2. However, it is explicitly R1.1 that is believed to act as DNA mimic and thus serve 
as a placeholder for the dw-DNA, whereas R1.2 is known to make protein-DNA contacts with the 
discriminator region (Haugen et al., 2006). Although mutations in R1.2 have been shown to effect 
various stages of transcription initiation and elongation (Baldwin and Dombroski, 2001), therefore it 
was considered whether if it is solely R1.1 (and not R1.2) of σ70 which is responsible for the Gp2-
mediated inhibition of transcription. Henceforth, a further mutant version of σ70 was constructed 
which lacked only the first 100 amino acid residues comprising exclusively region 1.1, referred to as 
Eσ70ΔR1.1. The ability of Gp2 to inhibit Eσ70 reconstituted with either the full length σ70 or σ70ΔR1.1 was 
again determined using an in vitro transcription assay (Figure 5.4.1). The incubation of 2-fold molar 
excess of Gp2 with Eσ70WT before the addition of the lacUV5 promoter template completely 
abolished transcription (lane 2) as observed previously. Consistent with the preliminary σ70ΔR1 
experiment, Eσ70ΔR1.1 was inhibited far less efficiently (55% inhibition) than Eσ70WT. Using 
comparable experimental conditions the affinities of Gp2* for Eσ70 and Eσ70ΔR1.1 were measured by 
FA and were found to be equivalent (Figure 5.4.5). Therefore, it seems that full inhibition of Eσ70 by 
Gp2 specifically requires R1.1 of σ70.  
 
 
 
 
 
 
 
Figure 5.4.1 Inhibitory activity of Gp2 on Eσ
70WT
 and Eσ
70ΔR1.1 
transcription. 
An autoradiograph of a 20% (w/v) polyacrylamide denaturing gel showing the synthesis of the ApApUpU 
transcript as indicated by the arrow whereby the underlined nucleotides are 
32
P-labelled. Transcription was 
performed by Eσ
70WT
 (lanes 1 and 2) and Eσ
70ΔR1.1
 (lanes 3 and 4) from the lacUV5 template in the presence of 
1:2 molar excess of Gp2
WT
. The percentage activity (% A) of Eσ
70
 in the presence of Gp2 (lanes 2 and 4) was 
calculated with respect to a reaction conducted in the absence of Gp2 (lanes 1 and 3) and is indicated beneath 
each lane. 
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 To confirm that it is the presence and presumably the localisation of R1.1 that is responsible 
for the inhibitory effect of Gp2 rather than a structural side-effect of the deletion, R1.1 (σ70 amino 
acids residues 1-100) was isolated and its in trans effect on Eσ70ΔR1.1 transcription assessed in the 
presence and absence of Gp2 to test whether it allows for the full inhibition of Eσ70 by Gp2 (Figure 
5.4.2). The addition of R1.1 almost fully complemented for the reduced inhibitory activity of Gp2 on 
Eσ70ΔR1.1 (lanes 4-7). Transcription was reduced to that seen with Eσ70, with full inhibition occurring at 
a 1:4 molar excess of R1.1 over σ70ΔR1.1 (lane 6). Thus, the presence of the isolated R1.1 domain in 
trans with Eσ70ΔR1.1 allows Gp2 to efficiently inhibit transcription initiation.  
 
 
 
Figure 5.4.2 The in trans effect of σ
70R1.1 
on Gp2-mediated inhibition of Eσ
70ΔR1.1 
transcription. 
An autoradiograph of a 20% (w/v) polyacrylamide denaturing gel showing the synthesis of the ApApUpU 
transcript as indicated by the arrow whereby the underlined nucleotides are 
32
P-labelled. Transcription was 
performed by Eσ
70ΔR1.1
 from the lacUV5 template in the absence (lane 1) and presence of 1:2 molar excess of 
Gp2
WT
 (lanes 2-5). R1.1
 
was added in trans to the reactions at molar ratios indicated above each lane. The 
percentage activity (% A) of Eσ
70
 in the presence of Gp2 and/or R1.1
 
was calculated with respect to a reaction 
conducted in the absence of Gp2 and are indicated beneath each lane. 
 
 Furthermore the in trans effect of R1.1 proved not to be order of addition dependent (Figure 
5.4.3) which suggests that under these experimental conditions Gp2 and R1.1 are able to bind to the 
dw-DBC independently of each other, supporting the view that R1.1 does not influence the initial 
binding of Gp2 to the Eσ70. Control reactions established that the in trans presence of the isolated 
R1.1 domain in Eσ70ΔR1.1, in the absence of Gp2, did not antagonise the ability of Eσ70ΔR1.1 to transcribe 
(compare Figure 5.4.2 lanes 1 and 3). In fact, the in trans addition of R1.1 in the absence of Gp2 
notably increased transcription by 44%. This effect may be due to the auxiliary role that R1.1 has in 
support of transcription; prior to its displacement from the dw-DBC, R1.1 is believed to hold open 
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the ‘pincers’ of RNAP facilitating the entry of the ds-DNA into the channel (Murakami et al., 2002b). 
Therefore in the absence of Gp2, R1.1 promotes the formation of the RPo. 
 
 
 
Figure 5.4.3 The effect of the order of addition of in trans R1.1
 
on Gp2-mediated inhibition of transcription.  
An autoradiograph of a 20% (w/v) polyacrylamide denaturing gel showing the synthesis of the ApApUpU 
transcript as indicated by the arrow whereby the underlined nucleotides are 
32
P-labelled. Transcription was 
performed by Eσ
70ΔR1.1
 from the lacUV5 template in the absence (lane 1) and presence of 1:2 molar excess of 
Gp2 and 1:8 molar excess of R1.1
 
 (lanes 2 and 3). The order of addition of the major components of each 
reaction is illustrated above. The percentage activity (% A) of Eσ
70
 in the presence of the Gp2 and R1.1 was 
calculated with respect to the reaction conducted in the absence of Gp2 and R1.1 (lane 1) and are indicated 
beneath each lane. 
 
 It seems that the R1.1 domain of σ70 is required for the efficient inhibition of Eσ70 by Gp2. To 
further corroborate this finding the effect of Gp2 on transcription from holoenzymes formed from 
alternative σ-factors was explored. The E. coli σ-factor, σ38 is responsible for the transcription of 
genes during the stationary phase. The promoter specificity of σ38 overlaps with that of σ70 (Gruber 
and Gross, 2003) but crucially it does not contain a R1.1 domain. Therefore it can serve as a valuable 
tool for evaluating the role of R1.1 in Gp2-mediated inhibition, in the context of a holoenzyme that 
natively lacks R1.1. To this end, the ability of Gp2 to inhibit transcription from Eσ reconstituted with 
either σ70WT, σ70ΔR1.1 or σ38 was compared using the E. coli osmE promoter (Bordes et al., 2000) (Figure 
5.4.4).  
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Figure 5.4.4 Inhibitory activity of Gp2 on Eσ
70WT
, Eσ
70ΔR1.1 
and Eσ
38
 transcription. 
Top: An autoradiograph of a 20% (w/v) polyacrylamide denaturing gel showing the synthesis of the 
ApApCpApC transcript as indicated by the arrow whereby the underlined nucleotides are 
32
P-labelled. 
Transcription was performed by Eσ
70WT
, Eσ
70ΔR1.1
 and Eσ
38 
from the osmE template in the absence (lanes 1, 3, 5, 
7 and 9) and presence of 2-fold molar excess of Gp2 (lanes 2, 4, 6, 8 and 10). R1.1 was added in trans using a 8-
fold molar excess to reactions with and without Gp2 (lanes 5, 6, 9 and 10). The percentage activity (% A) of 
each holoenzyme in the presence of Gp2 and/or R1.1 was calculated with respect to a reaction conducted in 
the absence of Gp2 (lanes 1, 3, 5, 7 and 9) and are indicated beneath each lane. Bottom: Graphical 
representation of lanes 1, 2, 3, 4, 6, 7, 8 and 10.  
 
 A 4-fold molar excess of Gp2 over σ70WT almost completely abolished the synthesis of the 
ApApCpA osmE transcript (lane 2) as seen previously on the lacUV5 promoter template. In contrast, 
under the same experimental conditions, Eσ38-dependent transcription was only inhibited by 80% 
(lane 8). As expected, full inhibition of transcription by Eσ70 on the osmE promoter was R1.1-
dependent (compare lanes 3-6). Remarkably, the in trans addition of R1.1 to Eσ38 allowed for the 
further inhibition of transcription by Gp2 to levels comparable to that of Eσ70WT (lanes 1-2 and 7-10), 
suggesting that R1.1 actively contributes to the full inhibition of RNAP by Gp2. 
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 The affinity of Gp2 for Eσ70WT, Eσ70ΔR1.1, Eσ38 and the major alternative holoenzyme Eσ54 was 
measured by FA (Figure 5.4.5). Recall that Gp2 has no significant effect on Eσ54-dependent 
transcription (Wigneshweraraj et al., 2004), however unlike σ38, σ54 does contain a region 1 domain 
which functions to regulate isomerisation to the RPo in a comparable manner to σ70 R1.1 (Cannon et 
al., 1999). The affinity of Gp2 for each of these holoenzymes was found to be equivalent, with Kd 
values in the same range (Table 5.4.1). Thus, the β’ jaw, not R1.1 constitutes as the major docking 
site of Gp2, however an interaction between R1.1 and Gp2 cannot be excluded. Furthermore, this 
interesting result signifies that Gp2 is able to selectively inhibit each of the holoenzymes with 
differing degrees, even though the initial binding of Gp2 is comparable.  These results strongly 
suggest that R1.1 of σ70 forms part of the mechanism which contributes to the full and specific 
inhibition of Eσ70 transcription by Gp2.  
 
 
Figure 5.4.5 Graph displaying the binding of Gp2* to variant holoenzymes as measured by FA. 
Gp2* binding to Eσ
70WT
 (circles), Eσ
70ΔR1.1 
(diamonds), Eσ
38
 (squares) and Eσ
54 
(triangles) is represented by 
anisotropy which is displayed as a function of the concentration of E. The dotted line indicates the 
concentration at which Gp2
WT
* binding to Eσ
70
 becomes saturated. 
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E Kd (nM) S.E. 
E 0.53 0.27 
Eσ70 0.44 0.34 
Eσ70ΔR1.1 0.66 0.06 
Eσ38 0.77 0.14 
Eσ54 0.78 0.40 
 
 
Table 5.4.1 Affinity of Gp2* binding to variants of E. 
Kd values were calculated from FA assays shown in Figure 5.4.5. 
 
5.5. The effect of Gp2 on promoter-less transcription 
 
 To further corroborate the role of R1.1 in the inhibition of RNAP by Gp2, experiments were 
conducted with a promoter-less minimal scaffold, here after referred to as the MS. The MS template 
consists of an 18 nucleotide long DNA duplex (lacking the -10 and -35 consensus promoter elements) 
and an 8 nucleotide long RNA-DNA heteroduplex separated by two unpaired DNA bases (Figure 
5.5.1). Crucially, transcription from the MS can occur independently of the σ-factor. The addition of 
α32P-UTP to the RNAP-MS probe complex results in the synthesis of a 9 nucleotide-long α32P-UTP-
labelled RNA product, hereafter called RNA-U (Kulbachinskiy et al., 2004) independent of the σ-
factor (Figure 5.5.2 lane 1). 
 
 
 
Figure 5.5.1 Sequence of the MS. 
Sequences and assembly of the minimal nucleic acid scaffold formed from an RNA-8mer (red) which is bound 
to the template strand of the DNA (blue), which in turn is annealed to the non-template strand of the DNA 
(black). Transcription from this MS results in the addition of a uridine at the 3’ end of the RNA. 
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 Gp2 inhibits the synthesis of RNA-U by RNAP from the MS only in the presence of σ70 (Figure 
5.5.2 lane 5); σ-independent transcription (lanes 1-3) seems to be almost completely unaffected by 
Gp2, implying that Gp2 does rely significantly on σ70 for full inhibition of the RNAP.  
 
 
 
 
Figure 5.5.2 Inhibitory effect of Gp2 on Eσ
70WT
 and Eσ
70ΔR1.1 
transcription from the MS. 
An autoradiograph of a 20% (w/v) polyacrylamide denaturing gel showing the synthesis of the RNA-U 
transcript. Transcription was performed by Eσ
70WT
 (lanes 1, 2 and 3) and Eσ
70ΔR1.1 
(lanes 4, 5 and 6) from the MS 
template in the absence (lanes 1 and 4) and presence (lanes 2, 3, 5 and 6) of 1:2 molar excess of Gp2. Order of 
addition reactions were conducted as shown in the schematic above. The percentage activity (% A) of Eσ
70
 in 
the presence of the Gp2 proteins was calculated with respect to the reactions conducted in the absence of 
Gp2 and are indicated beneath each lane. 
 
 Further to and consistent with previous results (Figure 5.4.1), Eσ70ΔR1.1-dependent 
transcription also displayed no significant inhibition of RNA-U synthesis by Gp2 (lanes 7-9) suggesting 
that specifically R1.1 of σ70 is required for the full inhibition of RNAP by Gp2. In support of this view, 
when the isolated R1.1 domain was added in trans to Eσ70ΔR1.1 it conferred a significant degree of 
sensitivity to Gp2 (Figure 5.5.3 lane 4). Results from these MS assays confirm that Gp2 inhibition of 
transcription by Eσ70 is dependent on σ70 with a specific requirement for R1.1.  
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Figure 5.5.3 The in trans effect of R1.1 on Gp2-mediated inhibition of Eσ
70ΔR1.1 
transcription. 
An autoradiograph of a 20% (w/v) polyacrylamide denaturing gel showing the synthesis of the RNA-U 
transcript. Transcription was performed by Eσ
70ΔR1.1
 from the MS template in the absence (lane 1 and 3) and 
presence (lanes 2 and 4) of 1:2 molar excess of Gp2. R1.1
 
was added in trans to the specific reactions (lanes 3 
and 4) at a 1:8 molar ratio. The percentage activity of Eσ
70
 in the presence of Gp2 and/or R1.1
 
was calculated 
with respect to the reactions conducted in the absence of Gp2 and are indicated beneath each lane. 
 
 
5.6. The effect of Gp2 and R1.1 on DNA entry into the active site 
 
 Experiments investigating the effect of Gp2 on transcription initiation have so far shown that 
the promoter DNA is able to engage with Eσ70 to form the RPc and initiate DNA strand-separation 
but is not able to form a fully stable, transcriptionally competent RPo complex (Camara et al., 2010). 
Recently, fluorescent RNAP beacon assays were performed to quantitatively assess how and to what 
extent the template DNA strands can access the main channel of RNAP. In these assays the T5N25 
promoter was engineered to allow for the formation of a transcriptionally inactive, yet stable Gp2-
Eσ70-DNA quaternary complex. As expected, Gp2 decreased the overall affinity of the dw-DNA to the 
dw-DBC, however the effect of Gp2 was not limited to just the dw-DNA. Interestingly, Gp2 also 
decreased the binding affinities of the template and non-template strands of the promoter DNA 
around the active site (Mekler et al., 2011b). With this in mind, this study intended to determine the 
point at which Gp2 prevents entry of the promoter DNA into the main channel. To this end, the 
minimal length of promoter DNA required for Gp2 inhibition to occur was established by assessing 
the effect Gp2 may have on the binding of DNA fragments to Eσ70 as judged by Eσ70-DNA complex 
formation in EMSAs. 
 An initial EMSA was conducted using a 32P-labelled version of the lacUV5 (-45/+20)(-45/+20) 
probe as this is consistent with the template used in in vitro transcription assays which represents 
the minimal footprint of Eσ70. As expected the binding of Eσ70 to this probe is almost completely 
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abolished by Gp2, with <5% Eσ70-DNA complexes surviving (Figure 5.6.1). In contrast, Gp2 has no 
effect on the binding of the (-45/-7)(-45/-7) probe (100% Eσ70-DNA complex survival). This result 
confirms that Gp2 does not interfere with the interactions between Eσ70 and the consensus 
promoter DNA required for RPc formation. Therefore further EMSAs were performed with a series of 
lacUV5 templates in which the downstream endpoints were extended in 1 bp increments. Results 
showed that there was only a slight effect on the -6, -5, -4 and -3 truncated probes (>95% Eσ70-DNA 
complex survival). However, EMSAs conducted with probes truncated at positions -2, -1 and +1 
showed approximately 50%, 85% and 95% reduction in Eσ70-DNA complex formation in the presence 
of Gp2.  
 
 
 
 
 
 
 
 
 
Figure 5.6.1 The effect of Gp2 on lacUV5 binding to Eσ
70
. 
Graph showing the percentage complex (% C) formed from DNA binding to Eσ
70
 in the presence of 1:2 molar 
excess of Gp2. The double stranded lacUV5 probes with different downstream endpoints are indicated on the 
x-axis.  
 
 These results imply that Eσ70 sensitivity to Gp2 increases as the DNA approaches the active 
centre (around positions -2 and -1). Gp2 specifically prevents the entry of the DNA into the Eσ70 at 
the active centre presumably to prevent the positioning of the transcription start site base (+1) at 
the Mg2+ ions. Furthermore, unlike the interaction with the full length DNA probe (-45/+20)(-
45/+20), the effect of Gp2 on the entrance of DNA around the active site occurs in an order of 
addition independent manner (data not shown). Presumably the Eσ70-DNA contacts of the shorter 
probes are not extensive enough to successfully compete with the effect of Gp2. Therefore the 
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inhibitory effect of Gp2 extends beyond its site of binding at the dw-DBC and crucially attenuates the 
entrance of double-stranded DNA beyond the active site.  
 The prevention of DNA binding is unlikely to be a simple case of steric hindrance as the Gp2 
binding site at the β’ jaw is located quite distal from the active centre. In support of this view, the 
removal of the NCS as in Gp2Mut7 completely eliminates the antagonistic effect of Gp2 (Figure 5.6.2 
lane 4) to the same extent as the non-binding mutant Gp2R56E, which demonstrates that Gp2 binding 
per se does not prevent DNA entry around the active site. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6.2 EMSA of 
32
P-lacUV5 binding to Eσ
70
 in the presence of Gp2
WT
, Gp2
R56E 
and Gp2
Mut7
. 
An autoradiograph of a 4.5% (w/v) polyacrylamide native gel showing the effect of Gp2
WT
 (lane 2), Gp2
R56E
 
(lane 3)
 
and Gp2
Mut7
 (lane 4)
 
on the binding of the (-45/+1)(-45/+1) lacUV5 probe to Eσ
70
. The migration 
positions of unbound 
32
P-lacUV5 and Eσ
70
-
32
P-lacUV5 are as indicated. The percentage of Eσ
70
-
32
P-lacUV5 
complex formation (% C) is calculated relative to a reaction conducted in the absence of Gp2 (lane 1) and is 
shown beneath each lane. 
 
 To investigate whether R1.1 also contributes to this inhibitory effect of Gp2, further EMSAs 
with the (-45/+1)(-45/+1) probe were conducted using Eσ70ΔR1.1 (Figure 5.6.3). The effect of Gp2 was 
markedly reduced in the absence of R1.1 (compare lanes 2 and 4) and, as expected, partially 
restored when the isolated R1.1 domain was added in trans (lane 6). Therefore this Gp2-mediated 
attenuation of DNA entry into the active centre requires the NCS of Gp2 as well as the presence of 
the negatively charged R1.1 domain of σ70. These results imply that the prevention of DNA 
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entry/positioning around the active centre is a result of the indirect and long-range antagonistic 
effects of Gp2. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6.3 EMSA of 
32
P-lacUV5 binding to Eσ
70
 and Eσ
70ΔR1.1 
in the presence of Gp2 and/or R1.1. 
An autoradiograph of a 4.5% (w/v) polyacrylamide native gel showing the effect of Gp2 and/or R1.1 on the 
binding of the (-45/+1)(-45/+1) lacUV5 probe to Eσ
70
. The absence or presence of Gp2 and/or R1.1 in the 
reaction is indicated above each lane. The migration positions of unbound 
32
P-lacUV5 and Eσ
70
-
32
P-lacUV5 are 
as indicated. The percentage of Eσ
70
-
32
P-lacUV5 complex formation (% C) is calculated relative to a reaction 
conducted in the absence of Gp2 and R1.1 (lane 1) and is shown beneath each lane. 
 
 
5.7. The effect of Gp2 on accessibility to single-stranded DNA 
 
 Thus far it seems that Gp2 cooperates with R1.1 to prevent entry of ds-DNA around the 
active site. Next it was investigated whether Gp2 may also restrict access to single-stranded (ss) 
DNA. Additional EMSA experiments were conducted using fork junction probes with either non-
template or template downstream extensions; (-45/+20)(-45/-7) and (-45/-7)(-45/+20) respectively. 
Recall that the (-45/+20)(-45/+20) promoter probe is sensitive to Gp2 inhibition whereas the (-45/-
7)(-45/-7) probe is resistant to Gp2. EMSA experiments revealed that Gp2 had no detectable effect 
on the binding of Eσ70 to either of the fork junction probes (Figure 5.7.1.A).  
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A      B 
 
 
Figure 5.7.1 Effect of Gp2 and R1.1
 
on binding and productive engagement of ss-DNA at the active site. 
A) An autoradiograph of a 4.5% (w/v) polyacrylamide native gel showing the effect of Gp2
 
on the binding of the 
(-45/-7)(-45/+20) or (-45/+20)(-45/-7) lacUV5 probes to Eσ
70
. The binding reactions were conducted in the 
absence (lanes 2 and 5) or presence (lanes 3 and 6) of Gp2. The migration positions of unbound 
32
P-lacUV5 and 
Eσ
70
-
32
P-lacUV5 are as indicated. The percentage of Eσ
70
-
32
P-lacUV5 complex formation is calculated relative to 
a reaction conducted in the absence of Gp2 and R1.1 (lanes 2 and 5) and is shown beneath each lane. B) An 
autoradiograph of a 20% (w/v) polyacrylamide denaturing gel showing the synthesis of the ApApUpU 
transcript as indicated by the arrow whereby the underlined nucleotides are 
32
P-labelled. Transcription was 
performed by either Eσ
70WT
 or Eσ
70ΔR1.1
 from the lacUV5 template in the absence (lanes 1 and 3) and presence 
of 1:4 molar excess of Gp2 (lanes 2, 4 and 5). R1.1
 
was added in trans using a 1:8 molar excess (lane 5). The 
percentage activity of each holoenzyme in the presence of Gp2 and/or R1.1
 
was calculated with respect to a 
reaction conducted in the absence of Gp2 (lanes 1 and 3) and are indicated beneath each lane. 
 
 
 Although, in these experimental conditions Gp2 does not affect fork junction binding, it does 
not necessarily mean that the ss-DNA section of the fork junction is correctly positioned within the 
RNAP. Therefore to test whether Eσ70 can productively engage with the ss-DNA, the (-45/-7)(-
45/+20) fork junction DNA, which retains the +1 transcription start site, was used as a template in an 
in vitro transcription assay. Results showed that synthesis of the ApApUpU transcript was effectively 
abolished in the presence of Gp2 (Figure 5.7.1.B lane 2). Therefore although the fork junction DNA is 
able to bind to Eσ70, it seems the ss-DNA extension of the template strand is not permitted to access 
the active site of RNAP. Remarkably this inhibitory effect of Gp2 on transcription from the (-45/-7)(-
45/+20) probe also seems to be entirely R1.1-dependent (compare Figure 5.7.1.B lanes 2 ,4 and 5) as 
removal of R1.1 results in a complete loss of Gp2 inhibition but can be fully recovered when added 
back in trans. This result implies that potentially the primary role of R1.1 in Gp2-mediated inhibition 
of transcription is to prevent Eσ70 from productively engaging with the template strand.  
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5.8. Conclusions 
 
 The work in this chapter has further explored the effect of Gp2 on various aspects of 
transcription initiation. In particular, it has been described how the highly flexible and negatively 
charged R1.1 domain of σ70 contributes to the Gp2-mediated inhibition of Eσ70-dependent 
transcription. Under the experimental conditions described here, Gp2 inhibition was reduced 
significantly in the absence of R1.1. The specificity of this result was tested by the in trans addition of 
R1.1, which notably restored the full Gp2 inhibitory effect. FA binding experiments shown in this 
chapter and previous chapters have illustrated that Gp2 can bind to the RNAP core independently of 
the associated σ-factor. In accordance with this observation, FA experiments also demonstrated that 
R1.1 is not required for the initial binding of Gp2 to RNAP. However, it remains to be known how the 
affinity of Gp2 for Eσ70 may change upon DNA binding.  Since, Gp2 and the dw-DNA compete for 
binding to the β’ jaw a potential role of R1.1 may be to sustain the high affinity that Gp2 has for 
RNAP upon the addition of DNA. This is a premise that may be experimentally explored in the future 
by fluorometric means. 
 It has been noted previously that despite its tight binding affinity for RNAP, Gp2 has no 
effect on transcription performed using the major alternative promoter specificity factor, σ54. The 
reasons for the resistance of Eσ54-dependent transcription to Gp2 remain unknown but presumably 
involve the dependency of this process on activation and energy consumption (Wigneshweraraj et 
al., 2004). In this study, it was reported for the first time that Gp2 is able to partially inhibit Eσ38 
which is responsible for the transcription of the stationary phase genes. Transcription by Eσ38 was 
notably less affected by Gp2 compared to Eσ70 but remarkably, complete inhibition was restored 
upon the in trans addition of the σ70 R1.1 domain. Therefore it seems that R1.1 provides a 
mechanism for the selective inhibition of σ70-dependent transcription independent of specific 
promoter sequence interactions. This observation suggests that Gp2 may have evolved to 
predominantly target the expression of the major housekeeping genes which ultimately results in 
the most detrimental effect on the E. coli cell. The effect of Gp2 on the other five remaining 
holoenzyme variants remains to be determined but work is in progress to assess the global effect of 
Gp2 on E. coli transcription using an in vivo transcriptomics approach. 
 In vitro transcription experiments were conducted using the promoter-less MS in an attempt 
to investigate the dependence of Gp2 inhibition on σ70 interactions. Notably, Gp2-mediated 
inhibition of transcription from the MS was less effective than with the duplex DNA promoter 
template. This may be because the DNA-RNA hybrid represents a more stable conformation which 
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presumably can compete more effectively against the effects of Gp2. Nonetheless, results from the 
MS assay further confirmed that the dependency of Gp2 inhibition on σ70 was attributed 
predominantly to R1.1.  
 Following on from a recent study which investigated the effect of Gp2 on Eσ70-promoter 
interactions it was further explored how Gp2 restricts DNA entry into Eσ70. Gp2 strictly prevents the 
entry of ds-DNA at position +1 which represents the active site of the enzyme. This antagonistic 
effect is completely dependent on the NCS of Gp2 which supports the view that this feature is a 
necessary determinant for inhibitory function (Sheppard et al., 2011). Consistent with the previous 
in vitro transcription assays, this antagonistic effect of Gp2 is also partially dependent on R1.1.  
 Experiments conducted using fork junction probes revealed that in contrast with ds-DNA 
probes of equivalent length, Gp2 did not affect their binding to the Eσ70. However Gp2 was still able 
to attenuate proficient transcription from the extended template version of this probe 
demonstrating that Gp2 attenuates the correct positioning of the ss-DNA extensions. This effect of 
Gp2 may be as a result of conformational changes within the RNAP which include the restricted 
movement of the β’ clamp. FRET experiments have shown that in the presence of Gp2, the 
conformation of the β’ clamp only exists in a ‘closed’ to ‘collapsed’ state in which the width of the 
channel is not sufficient to accommodate either ds or ss-DNA (Chakraborty et al., 2012). 
  In comparison to in vitro transcription assays with ds-DNA templates the effect of Gp2 on 
the fork junction template was entirely dependent on the presence of R1.1. This implies that the 
prevention of dw-DNA binding to the dw-DBC is mainly caused by Gp2 specific effects which are only 
partially influenced by the presence of R1.1. In contrast, attenuation of the positioning of ss-DNA, 
such as that of the ‘transcription bubble’ is exclusively a result of the effects of the presence of R1.1 
during Gp2 inhibition.  Due to the nature of this assay the positioning of the non-template strand 
could not be studied in the same context. Results from these fork junction experiments described 
here are in support of fluorometric binding assays which demonstrated that Gp2 reduced the 
binding affinity of fork junctions with template strand over-hangs and ss non-template segments 
close to the active site (Mekler et al., 2011b). The overall finding that Gp2 prevents DNA entry 
and/or positioning around the active site is remarkable considering that both Gp2 and R1.1 bind at 
downstream locations quite distinct from this region. This observation indicates that Gp2 acts via 
R1.1 using long-range antagonistic effects.  
 During transcription initiation R1.1 acts as a DNA mimic to serve as a placeholder for the dw-
DNA, which is ultimately displaced during RPo formation. Results thus far suggest that during Gp2-
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mediated inhibition of transcription, R1.1 is required to prevent the entry and positioning of the 
DNA around the active site. Therefore it was proposed that Gp2 may be exploiting the function of 
R1.1 by prolonging its role as a DNA placeholder. To test whether Gp2 also functions to prevent the 
movement of R1.1, FRET assays were conducted to compare the position of R1.1 in the presence and 
absence of Gp2.  The position of a fluorescein probe incorporated in R1.1 was measured relative to 
rifampicin that binds to RNAP between the upstream and downstream lobes of the  subunit. The 
degree of quenching of the fluorescein probe by rifampicin is inversely proportional to distance. As 
predicted, the quenching efficiency in the RPo was much lower than with Eσ70 and Eσ70-Gp2, 
indicating that Gp2 antagonises the obligatory displacement of R1.1 so that its positioning is more 
reminiscent to that of the RPc (Figure 5.8.1) (James et al., 2012). It remains to be known whether 
Gp2 restricts R1.1 movement by directly contacting the domain, this may be explored using 
crosslinking methods. The findings described here confirm that T7 Gp2 has cleverly evolved a 
mechanism to exploit the native function of R1.1 to prevent a stable RPo from forming.  
 As yet R1.1 has eluded structural biologists due to its highly acidic and flexible nature. 
However, by using Gp2 as a tool to secure the position of R1.1 in the dw-DBC may enable the 
successful determination of its structure in a context not too dissimilar to that of the native 
holoenzyme. Such a structure may also clarify the positioning of Gp2 and the orientation of its NCS 
which would provide invaluable insights into the overall molecular mechanism of inhibition. 
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Figure 5.8.1 A model of the effect of Gp2 on R1.1 positioning in Eσ
70
.  
A cartoon depicting how the binding of Gp2 (light blue) to the β’ jaw (green) of Eσ
70
 (E is grey, σ
70
 is purple) 
antagonises the correct positioning of DNA (non-template is dark blue, template is orange) around the active 
site (yellow dot) and in the dw-DBC as well as prevents the obligatory movement of R1.1 required to form the 
RPo. Adapted from (James et al., 2012). 
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CHAPTER 6 
A PRELIMINARY CHARACTERISATION OF THE 
XP10 PHAGE-ENCODED, RNAP INHIBITOR, P7 
 
 
 
 
 
 
 
 
 
 
 
 
6.  
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6.1. Introduction 
 
 P7 was originally isolated from Xp10 bacteriophage-infected Xanthomonas oryzae whole 
cells extracts. When assessed for transcriptional activity, the Xp10-infected cell extracts were able to 
attenuate RNA synthesis relative to extracts from uninfected cells (Liao and Kuo, 1986;Nechaev et 
al., 2002). This inhibitory activity was attributed to a 7 kDa protein, P7, which co-purifies with the X. 
oryzae RNAP by binding to the β’ subunit and therefore is likely to be responsible for the host 
transcription shut-off during Xp10 infection (Nechaev et al., 2002). Recombinant P7 was found to 
inhibit in vitro transcription by attenuating RPo formation, as it has no effect on pre-formed RPo 
complexes. In addition, P7 seems to operate as a bi-functional inhibitor of RNAP as it also displays 
characteristics of an anti-terminator (Nechaev et al., 2002). 
 The inhibitory effects of P7 seem to be limited to X. oryzae as it has no effect on 
transcription from E. coli Eσ70. This specificity of inhibition suggested that P7 may bind to an 
evolutionary variable region of the β’ subunit. The location of P7 binding to the X. oryzae β’ subunit 
was determined by far-Western blotting and bacterial two-hybrid based interaction analyses. The 
results indicated that the precise site of P7 binding to the X. oryzae β’ subunit mapped to amino acid 
residues 6-9 which comprise the N6L7F8N9 sequence. The same positions in E. coli possess a K6F7L8K9 
sequence and therefore are likely to be responsible for conferring resistance to P7. Moreover, a 
mutant form of E. coli RNAP with β’ amino acid residues 6-9 corresponding to that of the X. oryzae 
RNAP is sensitive to P7 inhibitory activity and therefore serves as a useful tool in in vitro studies. The 
β’ N-terminal residues are missing in the Thermus aquaticus and Thermus thermophilus RNAP 
structures and the E. coli insertion element of this region has, as yet, not been resolved. Therefore it 
is not currently possible to pinpoint the precise location of P7 binding in the context of the currently 
available structures of bacterial RNAP. However, the general region of P7 binding is deduced to be in 
the vicinity of three major functional mobile modules of RNAP; the β’ Zn-binding element, the β’ 
zipper and the β’ coiled-coil as well as σ domains 2 and 3 (Figure 6.1.1). The β’ Zn-binding element 
and the β’ zipper are parts of the RNA exit channel, which forms interactions with the nascent RNA. 
These two elements are required for efficient termination by recognition of hairpin loop structures 
in the RNA (Epshtein et al., 2007b;King et al., 2004). Therefore P7 may act as an anti-terminator by 
influencing either or both of these elements and their interactions with the RNA to decrease 
termination efficiency. Additionally the β’ zipper also interacts with the promoter spacer region to 
facilitate the formation of a stable RPc complex (Yuzenkova et al., 2011) and the β’ Zn-binding 
element is positioned to perhaps recognise the -35 promoter element (Murakami et al., 
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2002b;Vassylyev et al., 2002). Whereas the β’ coiled-coil represents a major σ-factor docking site 
and specifically induces σ70 R2.2 to contact the non-template strand around the -10 promoter 
element region (Young et al., 2001). Therefore it is also conceivable that P7 could influence the 
function of one of these three mobile modules or regions of the σ-factor to antagonise holoenzyme-
promoter DNA interactions required for proficient transcription initiation. 
 
 
Figure 6.1.1 Structural context of P7 binding. 
Ribbon representation of Thermus aquaticus Eσ
A
 with the β’ (pink), β (purple), 1 (green), 2 (yellow), ω 
(brown) and the σ-factor (red) individually coloured. The predicted location of P7 binding at β’ amino acid 
residues 6-9 is highlighted in blue. The β’ coiled coil, zipper and Zn-binding element mobile modules are 
indicated with arrows.  
 
Although the site of P7 binding to the X. oryzae RNAP has been determined, it is not known 
which amino acid residues in P7 contribute to the binding to RNAP since the structure of P7 is 
currently unresolved.  
 
6.2. Objectives 
 
 The overall purpose of this study is to provide an initial characterisation of the Xp10 P7 
protein, with a particular focus on the mechanism of inhibition of transcription initiation. This study 
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will include a comprehensive mutagenesis screen of the P7 protein to determine which amino acid 
residues are important for binding function and how their function might be influenced by their 
structural context. Biochemical assays will be employed to investigate the mechanism by which P7 
inhibits transcription initiation. The results from this study will provide further insights into the 
overall molecular mechanism employed by P7 during the inhibition of transcription initiation and 
form the basis for a future in depth analysis of P7 structure-function. This initial characterisation of 
the mechanism of action of P7 will include the following aims: 
 Establish and optimise a screen for assessing the binding of a single alanine mutant library of P7 
to X. oryzae RNAP. 
 Determine the structure of P7 in collaboration with Prof. Steve Matthews from the CSB, Imperial 
College London. 
 Assess the relative binding ability of the single alanine mutants in the context of the structure. 
 Investigate the mechanism by which P7 inhibits transcription initiation. 
 
6.3. Determination of P7 residues important for binding. 
 
 A previous study mapped the P7 interaction site on X. oryzae RNAP to the N6L7F8N9 amino 
acid residues at the N-terminal of the β’ subunit (Yuzenkova et al., 2008). The aim in this study was 
to investigate this interaction further, by determining which residues in P7 are important for binding 
to RNAP. To assess the contribution of each individual amino acid residue of P7 in binding to X. 
oryzae RNAP it was necessary to generate a mutant library of P7 proteins which could be used in a 
comprehensive interaction screen. The substitution of amino acid residues with alanine is a common 
approach to assessing whether the properties of an amino acid residue contribute to function as 
alanine itself possesses one of the most simplistic side chains. To conduct in vitro experiments a 
library of 70 recombinant P7 proteins (omitting the 3 native alanines and the methionine) would 
need to be over-expressed and purified. However, purified recombinant P7WT can be unstable as it 
has a tendency to precipitate out of solution, therefore it needs to be carefully handled and stored 
to prevent inconsistencies between experiments. For that reason, the purification of a library of P7 
mutant proteins all with potentially differing degrees of solubility and stability may yield variable 
results. Instead, it was decided that an in vivo approach would be more manageable and 
consequently produce more reliable and reproducible results. Thus a bacterial two-hybrid assay was 
used to measure the interaction between the alanine mutant P7 library and RNAP.  
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 Conventional bacterial two-hybrid systems such as the adenylate cyclase system rely on the 
chance interaction of the protein binding partners in order to reconstitute the adenylate cyclase 
enzyme and synthesise cyclic adenosine monophosphate (cAMP).  cAMP subsequently binds to the 
cAMP receptor protein (CRP) to activate transcription of the lacZ gene. Here, an activator 
dependent, transcriptional bacterial two-hybrid system was employed; which directly couples the 
binding of the encoded proteins to the transcriptional output of the lacZ gene. This system makes 
use of the well defined properties of the RNAP -CTD and the bacteriophage  CI protein (CI)  
(Dove and Hochschild, 2004). Contacts between the  operator (OR2) bound CI protein and the -
CTD of the E. coli RNAP are required for efficient activation of transcription (Kedzierska et al., 
2007;Dove et al., 1997)(Figure 6.3.1.A). This system requires two expression vectors; the prey 
plasmid, pBR in which the P7 gene replaces the E. coli RNAP -CTD sequence by fusion to the linker 
of the NTD of the rpoA gene and the bait plasmid, pACCI, which contains an N-terminal fragment of 
the X. oryzae rpoC gene fused to the C-terminus of the CI gene. Upon IPTG induced expression, in 
the KS1 reporter strain (bearing the placOR2-62 promoter), an interaction between the P7 protein 
and the X. oryzae RNAP β’ subunit fragment, generates an -CI chimaera which is bound at the 
OR2 operator located 62 bps upstream of the transcription start site and can successfully activate 
transcription of the lacZ gene (Figure 6.3.1.B). LacZ encodes for the enzyme, -galactosidase which 
can hydrolyse the lactose analogue, ortho-nitrophenyl-β-D-galactopyranoside (ONPG) into galactose 
and ortho-nitrophenol of which the later is yellow in colour and therefore provides a quantitative 
read-out by spectrophotometer analysis at 420 nm (refer to section 2.4.9). The degree of binding is 
directly proportional to the intensity of the yellow colour, therefore provides a means for not only 
identifying a binding interaction but also the relative strength of the interaction compared to other 
binding partners. The single alanine mutant library of P7 proteins was constructed by site-directed 
mutagenesis using the pBR-P7WT plasmid as a template (refer to section 2.3.11). Although it had 
been previously established that only residues N6L7F8N9 of the X. oryzae RNAP β’-subunit are 
sufficient for P7 binding, a more substantially sized peptide is required for such interaction assays. 
The previous P7 interaction study observed that P7 binding to the first 85 amino acids of X. oryzae 
RNAP produced one of the highest β-galactosidase read-outs, therefore this fragment would be ideal 
for generating a wide range over which to assess weaker binding P7 mutants. In order to compare 
the binding abilities of each P7 mutant under the exact same experimental conditions a 96-well 
plate, high-throughput format was established and optimised for the simultaneous quantification of 
the interaction between the X. oryzae RNAP β’ N-terminal fragment and the P7 mutant library.  
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Figure 6.3.1 Activator dependent transcriptional bacterial two-hybrid system. 
(A) A schematic illustrating the arrangement of the transcription machinery at the  operator (OR2) of the KS1 
reporter strain. E. coli RNAP binds to the -35 and -10 promoter elements via the σ
70
 subunit. The CI proteins 
bind as a dimer to the  operator (OR2) positioned 62 bp upstream from the transcription start site of the lacZ 
gene. The CI proteins activate transcription from the lacZ promoter by contacting the -CTDs. (B) The P7 
protein and the X. oryzae β’ 
1-85
 fragment are fused to the  linker-CTD and the CI-CTD respectively. Contact 
between P7 and X. oryzae β’ 
1-85
 activates transcription of the lacZ gene. 
 
 The binding ability of each P7 alanine mutant to the X. oryzae RNAP β’ fragment can be 
represented in terms of Miller Units and compared to that of P7WT (Figure 6.3.3). From this screen, 
each amino acid residue of P7 was categorised according to the binding ability of its respective 
alanine mutant (Table 6.3.1). Class I mutants possess greater than 75% -galactosidase activity, 
which represents binding in a similar range to that of P7WT. This relatively high binding suggests that 
the respective amino acid residues of these point mutants are less likely to be important for P7 
binding. Class II and class III mutants exhibit 51-74% and 26-50% β-galactosidase activity 
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respectively, therefore represent amino acid residues which may partially contribute to function but 
ultimately are non-essential for overall binding. Whereas, the most interesting residues are the class 
IV mutants which have retained less than 25% -galactosidase activity, indicative of very weak 
binding. This implies that the class IV amino acid residues are the most important for P7 binding to 
RNAP. The overall analysis of the mutagenesis screen revealed that P7 is fairly sensitive to mutation 
as almost 40% of the tested proteins are classified as class IV mutants, whereas only 23% of the 
proteins are class I mutants. The class IV mutants are also well distributed across the amino acid 
sequence which suggests that the surface interface, between P7 and X. oryzae RNAP may be quite 
extensive. However, there are two clusters of class IV residues within the amino acid sequence; the 
GSVLTVKV residues at positions 19-26 and the FDR residues at positions 39-41. It is possible that 
these residues function together to form crucial interactions with X. oryzae RNAP.  
 
Class % β-galactosidase Activity Number of P7 Mutant Proteins 
I >75% 16 
II 51-74% 17 
III 26-50% 9 
IV <25% 27 
 
Table 6.3.1 Classification of P7 mutant proteins. 
 
 One limitation to this type of assay is that low β-galactosidase activity is not necessarily a 
result of binding ability per se. It may for instance, be a consequence of low expression levels of the 
mutant P7 protein. Reliable results from this screen depend on equal expression levels and protein 
turnover throughout the P7 mutant library. To experimentally address whether the class IV mutants 
were all present at the same levels as the other mutant proteins, Western blot analysis was 
performed from cell lysates extracted from the bacterial two-hybrid screen. To this end, polyclonal 
antibodies were raised against peptides of the P7 sequence (VEEDFDRADYGSDPEF and 
SYLKRNGGIKDLTKV) and subsequently affinity purified using the recombinant P7 protein and then 
purified against a non-P7 expressing cell background to eliminate cross-reactivity (refer to sections 
2.5.1, 2.5.2, and 2.5.3). All cell lysates tested did exhibit detectable amounts of the -NTD-P7 mutant 
fusion proteins (Figure 6.3.3 bottom panel). However the intensity of some of the class IV mutant 
bands does differ significantly relative to other class IV mutants as well as a class III mutant control 
and P7WT. Since the P7 mutant plasmids were all created from the same parental plasmid using the 
same technique it is unlikely that the difference in expression is due to the transcriptional or 
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translational differences, but perhaps more the stability of the mutant proteins. It is conceivable that 
the observed decreases in β-galactosidase activity may be caused by aberrant folding of the mutant 
proteins which could result in protein degradation (as judged by Western blotting). In addition, a loss 
in interaction could also be due to the formation of an anomalous protein structure whereby the 
surface interface may either be masked or no longer formed correctly.  Therefore the results from 
the screen may not necessarily reflect directly on the contribution of specific residues for binding to 
X. oryzae RNAP but potentially on their requirement for the correct folding or maintenance of the 
structural integrity of the protein which consequently may be needed to successfully interact with 
the X. oryzae RNAP. Therefore, from the Western blot analysis it seems that at least four residues; 
V26, F39, D40 and R41 are necessary for maintaining structural integrity whereas F4, I7, G9, Y10, N12, F14, 
S20 and V24 exhibit levels most comparable to P7WT and are therefore more likely to be bona fide 
determinants for binding. 
 In addition to the two-hybrid screen, a sequence alignment of known P7 orthologs was 
conducted to inform upon which amino acid residues were evolutionary conserved and therefore 
functionally important. However, Xp10 P7 only shares sequence homology with two other putative 
proteins, from the OP1 and Xop411 Xanthomonas phage (Figure 6.3.2). The alignment demonstrates 
that the overall sequence of P7 is highly conserved which explains why P7 is quite sensitive to 
mutation but provides little insight into which residues may be more important for function. 
 
 
Figure 6.3.2 Sequence alignment of P7 orthologs. 
Alignment of the amino acid sequences of all known P7 orthologs in the single-letter amino acid codon. A * 
represents an absolutely conserved amino acid residue, : indicates conservation between groups of strongly 
similar properties and . indicates conservation between groups of weakly similar properties. P7 class I residues 
are coloured green, class II blue, class III orange and class IV red.  
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Figure 6.3.3 Bacterial two-hybrid β-galactosidase screen of P7.   
Top panel: Single alanine mutant versions of P7 (x-axis) were used in a bacterial two-hybrid β-galactosidase assay. The binding of P7
WT
-E. coli RNAP -NTD fusion to an X. 
oryzae RNAP β’ fragment-bacteriophage CI fusion successfully activates transcription of the lacZ gene encoding β-galactosidase. The percentage Miller Units (y-axis) 
represent β-galactosidase activity as a result of mutant P7 fusion proteins binding to the X. oryzae RNAP β’ fragment fusions compared to that of P7
WT
. The P7 mutant 
proteins are classified into four categories; class I  75% Miller Units (green), class II = 51-74% Miller Units (blue), class III = 26-50% Miller Units (orange) and class IV < 25% 
Miller Units (red). The single codon amino acid sequence of P7 is shown above and colour-coded according to class.  Bottom panel: Western blot analysis of the expression 
of the class IV mutant proteins. The molecular weights of the protein marker (M) are indicated in kDa. WT+ represents Western blot analysis of P7
WT
 under IPTG inducing 
conditions, whereas WT- is Western blot detection conducted under non-inducing conditions. The class IV amino acid residues are displayed in red, whereas a borderline 
class IV/III residue (G31) is in orange and class I controls in green. The migration of E. coli RNAP -NTD-P7 fusions is indicated by an arrow.                                           
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6.4. Structural determination of P7 
 
 To provide further insights into the potential functional contribution of specific class IV 
residues the structure of P7 was determined. The results of the mutagenesis screen were initially 
interpreted in the secondary structure of P7, which was determined using two types of prediction 
software (Figure 6.4.1). The Chou & Fasman Secondary Structure Prediction (CFSSP) was used to 
predict which residues are likely to form turns in the protein. A total of 11 turns were predicted, 
which included a turn at the beginning of the G19S20V21L22T23V24K25V26 class IV cluster and a turn at 
the end of the F39D40R41 cluster. Jpred3 was used to predict which residues are likely to form 
secondary structure features such as -helices and β-strands. At least 2 -helices were predicted, 
comprising residues 50-59 and residues 65-71. A β-strand was predicted to comprise residues 21-26 
which encompasses most of the G19S20V21L22T23V24K25V26 cluster and a second shorter β-strand 
formed by residues 33-36.  
 
 
 
Figure 6.4.1 Secondary structure prediction of P7. 
A summary of the secondary structure prediction of the P7 protein was created using CFSSP and Jpred3. The 
original P7 single codon amino acid sequence of P7 is shown at the top. CFSSP was used to predict the turns in 
the protein (T). Jhmm and Jpssm represent a Jnet hmm profile and a Jnet PSIBLAST ppssm profile prediction 
respectively. Jnet provides a final secondary structure prediction of the -helices (H) and β-strands (E). Lupas 
predicts coiled coil elements with 14, 21 and 28 window sizes. Jnet was also used to predict buried residues (B) 
with 0, 5 or 25% solvent exposure. The reliability of the prediction ranges from 0 to 9, with 9 being the highest 
accuracy. 
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 No coiled coil elements were predicted as it is likely that the P7 protein is too small for such 
composite features. Amino acid residues were also predicted to be buried in the hydrophobic core of 
the protein with varying degrees of exposure, for instance many of the hydrophobic and aliphatic 
residues including isoleucine, leucine and valine are predicted to have only 5% solvent exposure 
whereas V54 is likely to be deep within the hydrophobic core as it is predicted to have 0% solvent 
exposure.  
 To obtain a tertiary structure of P7, the recombinant protein was over-expressed from 
pET28b+ and Ni2+ affinity purified (refer to sections 2.4.1 and 2.4.4) (Figure 6.4.2) and the structure 
was resolved by Prof. Steve Mathews and Dr. Bing Liu using NMR spectroscopy.  
 
 
 
Figure 6.4.2 Nickel affinity chromatography of P7.  
Image of a 12.5% + 15% (w/v) SDS-PAGE gel from the nickel affinity purification of recombinant Xp10 P7. M = 
Marker, - = without IPTG induction, +1 = 1 hr after IPTG induction, +3 = 3 hrs after IPTG induction, S = soluble 
fraction, I = insoluble fraction, FT = flow-through, W = low imidazole wash. The molecular weight of the protein 
markers is shown in kDa and the migratory position of P7 is indicated with an arrow. 
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 The high resolution, 3-D NMR structure of P7 revealed the protein to comprise 3 β-strands, 
of which the central strand runs anti-parallel, followed by a turn and an -helix (Figure 6.4.3).  
 
 
 
Figure 6.4.3 NMR structure of P7. 
An NMR structure of P7 shown in the ribbon representation, possessing a β1β2β31 topology whereby the 
central β-strand runs anti-parallel. 
 
 The secondary structure predictions were overlaid onto the NMR structure to validate the 
accuracy of the predictions (Figure 6.4.4).  The overlay showed that the CFSSP software correctly 
predicted 7/11 of the turns in the protein including the turn in the F39D40R41 cluster, whereas Jpred3 
accurately predicted the -helix and the central β-strand which is comprised by the 
V21L22T23V24K25V26 portion of the larger class IV cluster (Figure 6.4.4, left). In addition, almost all of the 
aliphatic and hydrophobic amino acid residues predicted to possess  5% solvent exposure are in 
fact located in the central region of the protein and are positioned to project their hydrophobic side 
chains into the core (Figure 6.4.4, right). 
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Figure 6.4.4 NMR structure of P7 with the secondary structure prediction overlay. 
Left: An NMR structure of P7 as in Figure 6.4.3 but with the secondary structure prediction overlay; -helices 
(pink), β-strands (orange), turns (blue) and the amino acid residues with  5% solvent exposure are shown in 
the stick representation. The F39 and V21-V26 residues which form part of the class IV clusters are indicated. 
Right: Top view orientation of the P7 structure displaying the location and projection of the hydrophobic 
residues with  5% predicted solvent exposure (coloured as in the left figure). 
 
 The availability of a high resolution 3-D structure of P7 allowed for the positioning of the 
class IV residues in a structural context with the aim of deciphering the potential roles of the 
individual residues as well as the clusters. As in the primary structure the class IV residues are 
dispersed throughout the secondary structure features (Figure 6.4.5, left). It seems that many of the 
class IV residues may be necessary for structural integrity. For instance, the G19S20V21L22T23V24K25V26 
cluster which forms the β1-β2 loop and β2 strand and is centrally positioned in the protein along with 
many of the side chains of the hydrophobic residues of the β2-strand appear to project into the core 
of the protein rather than projecting outwards to form a potential interaction with RNAP (Figure 
6.4.5 right). The class IV amino acid residues F50, V51, V54 and Y57 which reside in the -helix are 
also hydrophobic and project into the core of the protein (Figure 6.4.5, right). Similarly, the smaller 
F39D40R41 cluster forms a linker region between the β3-strand and -helix which may be required for 
correct protein folding.  
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Figure 6.4.5 NMR structure of P7 with mapping of the class IV amino acid residues. 
Left: An NMR structure of P7 as in Figure 6.4.3 but with the class IV residues labelled and highlighted in red. 
Right: Top view orientation of the P7 structure displaying the location and projection of the side chains of the 
hydrophobic class IV residues within the β2 strand (L
22
T
23
V
24
K
25
V
26
) and the -helix (F
50
, V
51
, V
54
 and Y
57
). 
 
 Therefore it seems that 12 of the class IV residues either form part of the hydrophobic core 
of the protein and/or are required for preserving vital structural features. This means that 15 class 
IV residues remain, which are more likely to be major determinants for binding to RNAP or forming 
part of the overall surface interface. These include amino acid residues, F4, I7, G9, Y10, N12, F14, Q17, 
G19, S20, V21, Y44, S46, L58, G62 and I64. 
  
6.5. Mechanism of inhibition of transcription initiation by P7 
 
 A previous preliminary biochemical analysis of P7 established that it inhibits transcription 
initiation from -10/+35 promoters by preventing RPo formation (Nechaev et al., 2002). To continue 
the investigation into the molecular mechanism of inhibition of transcription initiation by P7, a 
mutant form of the E. coli RNAP was created for in vitro biochemical experiments as this is the best 
studied bacterial RNAP. This mutant E. coli RNAP contains amino acid substitutions at β’ subunit 
residues 6-9 (K6F7L8K9) so that it resembles that of the X. oryzae RNAP (N6L7F8N9) and therefore 
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confers P7 sensitivity (Yuzenkova et al., 2008). The in vitro activity of P7 was tested using the P7 
sensitive version of the E. coli RNAP, which is referred to as ENN.  
 To determine the stage of transcription which is targeted by P7, order of addition in vitro 
transcription assays were performed using a homoduplex lacUV5 DNA template and a heteroduplex 
lacUV5 DNA template with mismatches between the -10 and +3 sites, which mimics the 
conformation of the DNA in the RPo. Order of addition experiments were conducted with each 
template by adding P7 before or after the DNA. Additionally, as P7 was previously shown to restrict 
the σ70 interdomain movements of σ R2.4 and R4.2 (Nechaev et al., 2002), order of addition 
experiments were also performed to test if P7 had an antagonistic effect on ENNσ70 formation or 
stability. Results from experiments using the homoduplex probe revealed that P7 successfully 
inhibits transcription when added to the reaction prior to the DNA but not after (compare Figure 
6.5.1 lanes 2 and 3 to 4). This suggests that P7 is unable to inhibit transcription initiation if the RPo 
has been pre-formed, which confirms that P7 must target a stage prior to RPo formation as has been 
suggested previously (Nechaev et al., 2002). Parallel reactions using the heteroduplex template 
showed that P7 can also still inhibit pre-opened DNA by up to 70% (compare Figure 6.5.1 lane 5 to 6 
and 7), therefore it is unlikely to antagonise the process of DNA strand-separation per se but may 
still partially effect conformational changes in ENNσ70 or interactions with the DNA which are 
associated with DNA strand-separation. In addition, P7 inhibition does not seem to be dependent on 
the order of addition of the σ-factor (compare Figure 6.5.1 lanes 2 to 3 and 6 to 7). This observation 
corroborates the view that P7 does not function simply to prevent holoenzyme formation.  
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Figure 6.5.1 The order of addition effect of P7 on transcription initiation. 
An autoradiograph of a 20% (w/v) polyacrylamide denaturing gel showing the synthesis of the ApApUpU 
transcript as indicated by the arrow whereby the underlined nucleotides are 
32
P-labelled. Transcription was 
performed by E
NN
σ
70
 from a homoduplex lacUV5 template (lanes 1-4) and heteroduplex template (lanes 5-8) in 
the absence (lanes 1 and 5) and presence of 1:2 molar excess of P7 (lanes 2-4 and 6-8). The order of addition of 
the major components of each reaction is illustrated above. The percentage activity (% A) of E
NN
σ
70
 in the 
presence of P7
 
was calculated with respect to the reaction conducted in the absence of P7 with the same 
lacUV5 template (lanes 1 and 5), and are indicated beneath each lane. 
 
 To test whether P7 may antagonise RPc formation, EMSA experiments were conducted using 
a short version of the lacUV5 probe which contains only the upstream portion of the DNA (-45 to -7), 
which is sufficient for RPc formation but is inadequate for isomerisation to the RPo. Results revealed 
that P7 has no effect on the binding of the (-45/-7)(-45/-7) DNA to ENNσ70 compared to reactions 
conducted with either storage buffer (SB) or EWTσ70 (Figure 6.5.2). Therefore, it seems that P7 does 
not inhibit transcription initiation by preventing the engagement of the DNA with ENNσ70. Additional 
EMSAs were performed using a longer lacUV5 probe (-45/+20)(-45/+20) and at  4C whereby the 
predominant complex is the RPc. This experiment also showed that P7 had no effect on RPc 
formation (data not shown). 
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Figure 6.5.2 Effect of P7 on upstream 
32
P-lacUV5 binding to E
WT
/
NN
σ
70
. 
An autoradiograph of a 4.5% (w/v) polyacrylamide native gel showing the effect of P7 on the binding of the (-
45/-7)(-45/-7) 
32
P-lacUV5 probe to E
WT
σ
70
 or E
NN
σ
70
. The order of addition of the major components of each 
reaction (including SB – storage buffer) is illustrated above. The migration positions of unbound 
32
P-lacUV5 and 
Eσ
70
-
32
P-lacUV5 are as indicated. The percentage of Eσ
70
-
32
P-lacUV5 complex formation (% C) is calculated 
relative to a reaction conducted in the absence of P7 and Eσ
70 
(lane 1) and is shown beneath each lane. 
 
 To investigate how P7 may affect events after RPc leading to RPo formation, similar EMSA 
experiments were conducted with the (-45/+20)(-45/+20) lacUV5 templates at 37C where the most 
predominant complex is the RPo (Figure 6.5.3). Complexes were challenged with heparin which 
abolishes the RPc and intermediate Eσ-promoter DNA complexes that have not acquired full RPo 
status. P7 had no detectable effect on complexes formed by EWTσ70. Reactions with ENNσ70 formed 
comparable RPo complexes to EWTσ70 (compare lanes 2 and 6), however interestingly in the presence 
of P7 a faster migrating complex is formed (lane 8). This complex is almost completely disrupted in 
the presence of heparin (lane 9) which suggests it has not yet formed a stable RPo. This result 
suggests that P7 prevents full isomerisation of the RPc to RPo by most likely stabilising or ‘trapping’ a 
normally transient intermediate Eσ70-promoter complex. The formation of this P7 ‘trapped’ complex 
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was also observed when EMSAs were conducted using the T7A1, PR3, T5N25 and T5N25CONS 
promoter probes (data not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.5.3 Effect of P7 on 
32
P-lacUV5 binding to E
WT
/
NN
σ
70
. 
An autoradiograph of a 4.5% (w/v) polyacrylamide native gel showing the effect of P7 on the binding of the (-
45/+20)(-45/+20) 
32
P-lacUV5 probe to E
WT
σ
70
 or E
NN
σ
70
. The order of addition of the major components of each 
reaction is illustrated above. The migration positions of unbound 
32
P-lacUV5 and Eσ
70
-
32
P-lacUV5 are as 
indicated. The percentage of Eσ
70
-
32
P-lacUV5 complex formation (% C) is calculated relative to a reaction 
conducted in the absence of P7 and Eσ
70 
(lane 1) and is shown beneath each lane. 
 
 Next, order of addition experiments were performed to investigate how P7 may affect the 
equilibrium between heparin sensitive (RPc) complexes and heparin stable (RPo) complexes. When 
P7 was added prior to the DNA, the same complexes were formed as in Figure 6.5.3 lane 8 with 70% 
of the complex forming a faster migrating and heparin sensitive P7-trapped complex and 30% 
forming a slower migrating, heparin stable RPo complex (Figure 6.5.4 lane 6). If P7 is added after the 
pre-incubation of ENNσ70 with the DNA, i.e. after RPo formation then the equilibrium between P7-
trapped complex and RPo is shifted (lane 8) to a 55:45% equilibrium in favour of the RPo complex.  
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Figure 6.5.4 The order of addition effect of P7 on 
32
P-lacUV5 binding to E
NN
σ
70
. 
An autoradiograph of a 4.5% (w/v) polyacrylamide native gel showing the effect of P7 on the binding of the (-
45/+20)(-45/+20) lacUV5 probe to E
NN
σ
70
. The order of addition of the major components of each reaction is 
illustrated above and the addition of heparin is indicated above each lane. The migration positions of unbound 
32
P-lacUV5 and Eσ
70
-
32
P-lacUV5 are as indicated. The percentage of Eσ
70
-
32
P-lacUV5 complex formation (% C) is 
calculated relative to a reaction conducted in the absence of P7 and Eσ
70 
(lane 1) and is shown beneath each 
lane. 
 
 The extent of the engagement of promoter DNA with ENNσ70 in the P7 ‘trapped’ complex is 
unknown. To explore how P7 affects ENNσ70-promoter DNA interactions a fluorescent binding assay, 
referred to as the RNAP beacon assay was employed to quantitatively assess the binding between 
the ENNσ70 and various segments of the promoter in the presence of P7 (refer to section 2.7.4). In the 
RNAP beacon assay (Figure 6.5.5) the σ70 amino acid residue C211 is labelled with the fluorophore 
tetramethylrhodamine-5-maleimide (TMR). C211 is located in σ R2.3, in the vicinity of a highly 
conserved cluster of aromatic tryptophan and tyrosine amino acid residues which effectively quench 
the fluorescence of TMR by photoinduced electron transfer. Interaction of σ R2.3 with the non-
template strand of the -10 element disrupts the contacts between C211-TMR and the aromatic 
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residues of σ R2.3 which reduces the quenching and consequently augments the fluorescent signal. 
This allows the binding of Eσ70-TMR to DNA templates containing the -10 promoter element to be 
measured fluorescently and as a function of time.  
 
 
 
Figure 6.5.5 RNAP beacon assay. 
A schematic representation of the RNAP beacon assay. The orange circle represents the TMR fluorophore 
conjugated to σ
70
 amino acid residue C211. The aromatic amino acid residues tyrosine (Y) and tryptophan (W) 
effectively quench the fluorescence by photoinduced electron transfer. Binding of DNA to that region disrupts 
the contacts between the aromatic residues and TMR, resulting in increased fluorescence emission. Inspired 
by (Mekler et al., 2011c).  
 
 RNAP beacon assays were conducted together with Dr. Vladimir Mekler at the Waksman 
Institute of Microbiology, State University of New Jersey to investigate how P7 may affect ENNσ70 
affinity for specific segments of promoter DNA. Experiments were either conducted using the T5N25 
promoter DNA or a derivative containing a consensus -35 element, an optimised UP element and the 
extended -10 element referred to as T5N25CONS. The binding kinetics of these promoter DNA 
fragments to Eσ70-TMR has been well characterised and therefore provides a basis for this inhibitory 
study (Mekler et al., 2011c;Mekler et al., 2011a;Mekler et al., 2011b). 
 To begin, experiments were conducted using the T5N25 (-65/+35)(-65/+35) DNA fragment as 
this possesses a middle range affinity which is convenient for a preliminary investigation. The 
addition of this DNA fragment to ENNσ70-TMR rapidly increased the fluorescent signal from 27,000 
to 84,000 counts/s, which is indicative of a high binding affinity (Figure 6.5.6, blue line). However, 
when ENNσ70-TMR is pre-incubated with saturating amounts of P7 the addition of the DNA fragment 
yields a much lower fluorescent signal of 43,000 counts/s which demonstrates that P7 has reduced 
the binding affinity of this DNA fragment to ENNσ70 (Figure 6.5.6, red line). In contrast, and as 
expected if P7 is added after the formation of the ENNσ70-promoter complex then it has only a 
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negligible effect and reduces fluorescence from 88,000 to 87,000 counts/s over the timecourse 
(Figure 6.5.6, green line). This result is consistent with the in vitro transcription and EMSA data which 
suggests that P7 has a much greater effect prior to the addition of the DNA. This data, together with 
the EMSA results also implies that P7 reduces the affinity of ENNσ70 for the promoter DNA but 
importantly does not prevent complex formation between ENNσ70 and the promoter DNA. 
 
 
 
Figure 6.5.6 The effect of P7 on E
NN
σ
70
 interactions with the full length T5N25 promoter. 
A time dependent increase in fluorescence upon E
NN
σ
70
-TMR binding to the T5N25 (-65/+35)(-65/+35) DNA 
fragment is shown in blue. The pre-incubation of E
NN
σ
70
-TMR with P7 before addition of the DNA fragment is 
shown in red, whereas the addition of P7 after E
NN
σ
70
-TMR-DNA fragment binding is shown in green. 
 
 Additional RNAP beacon assays were conducted to identify specific ENNσ70-promoter DNA 
interactions that may be targeted by P7 and therefore responsible for the prevention of RPo 
formation. To test whether P7 may antagonise interactions with the -10 promoter element a single-
stranded T5N25 (-12/-6) fragment was used in the RNAP beacon assay. This oligonucleotide 
comprises the consensus -12TATAAT-6 sequence of the -10 promoter element on the non-template 
strand. The -10 promoter element is contacted by σ R2.4 in the RPo and the non-template strand of 
this region is specifically recognised by Eσ70 to stabilise the complex during DNA strand-separation 
(Marr and Roberts, 1997). Because this oligonucleotide has a very low affinity for Eσ70 it may not be 
possible to detect any change in signal if ENNσ70 is pre-incubated with P7 which would be quite 
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ambiguous to interpret. Therefore, considering this oligonucleotide binds weakly and P7 is likely to 
still be able to compete (as seen in Figure 6.5.4, lane 8), the addition of P7 and DNA was conducted 
in the reverse order, i.e. ENNσ70 was incubated with T5N25 (-12/-6) first and then P7 was added. Here 
it was shown that P7 does not antagonise the interactions between ENNσ70-TMR and the T5N25 (12/-
6) fragment, in fact a slight increase in fluorescence from 49,000 to 52,000 counts/s was actually 
detected (Figure 6.5.7). Therefore, it seems that P7 is unlikely to antagonise the interactions with the 
-10 promoter element in the RPo but may instead increase the affinity between Eσ70 (σ R2.4) and 
this promoter DNA fragment. However this interaction needs to be investigated further using ds-
DNA fragments. 
 
Figure 6.5.7 The effect of P7 on E
NN
σ
70
 interactions with the T5N25 -10 promoter element. 
A time dependent measurement of fluorescence of E
NN
σ
70
-TMR is shown in blue, the addition of the single-
stranded T5N25 (-12/-6) DNA fragment and P7 are indicated with arrows. 
 
 The DNA promoter fragment was extended downstream to include the discriminator region 
and the transcription start site; -12TATATTAGATTCAT+2. The discriminator region refers to the section 
of DNA between the -10 promoter element and the transcription start site, of which the non-
template strand is known to be contacted by σ R1.2 (Haugen et al., 2006). An identical binding assay 
with the single-stranded T5N25 (-12/+2) DNA fragment showed contrasting results to the (-12/-6) 
oligonucleotide; the addition of P7 to the ENNσ70-TMR- T5N25 (-12/+2) complex significantly reduced 
the fluorescent signal from 49,000 to 36,000 counts/s (Figure 6.5.8). This implies that P7 may 
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target, directly or indirectly interactions between ENNσ70, specifically σ R1.2 and the discriminator 
region. This finding needs to be further investigated using alternative sequences, as the sequence of 
the discriminator region has been shown to be crucial for the regulation of RNAP at certain 
promoters (Haugen et al., 2006). 
 
Figure 6.5.8 The effect of P7 on E
NN
σ
70
 interactions with the T5N25 discriminator region. 
A time dependent measurement of fluorescence of E
NN
σ
70
-TMR is shown in blue, the addition of the single-
stranded T5N25 (-12/+2) DNA fragment and P7 are indicated with arrows. 
 
 Since transcription initiation from the extended -10 type promoters appears to be resistant 
to P7 (Nechaev et al., 2002), the effect of P7 on ENNσ70 interactions with a promoter fragment 
containing this element was tested (Figure 6.5.9). The T5N25CONS (-26/-6)(-26/-12) upstream fork 
junction does not contain a -35 promoter element but does still have an extended -10 promoter 
element and the -10 promoter element which due to the nature of the assay is necessary for 
fluorescence quenching, however, recall that binding of the -10 element does not seem to be 
effected by P7 (Figure 6.5.7).  Results showed that the pre-incubation of ENNσ70-TMR with P7 has no 
significant effect on T5N25CONS (-26/-6)(-26/-12) binding which suggests that P7 does not target 
this promoter element. This result is consistent with the observation that P7 displays significantly 
less inhibitory activity on transcription initiation from extended -10 promoters (Nechaev et al., 
2002). 
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Figure 6.5.9 The effect of P7 on E
NN
σ
70
 interactions with the T5N25 extended -10 promoter element. 
A time dependent measurement of fluorescence of E
NN
σ
70
-TMR binding to T5N25CONS (-26/-6)(-26/-12) is 
shown in blue whereas E
NN
σ
70
-TMR-P7 binding to T5N25CONS (-26/-6)(-26/-12) is shown in red. 
 
 Results thus far suggest that P7 may antagonise interactions between the ENNσ70 and the 
discriminator (specifically the non-template -6 to +2 segment) as only promoter DNA fragments 
containing this region display a reduced binding affinity. However upstream segments of the 
promoter DNA (-65 to -26) have not been directly tested. This portion of the promoter DNA 
encompasses the -35 element which is a potential target for P7 inhibition for two reasons. Firstly, P7 
seems to affect the interdomain distance between σ R2.4 and 4.2 which contact the -10 and -35 
promoters. Secondly, ENNσ70 transcription initiation from extended -10 promoters is resistant to P7, 
recall that ENNσ70 contacts with an extended -10 promoter make the -35 promoter element 
dispensable; therefore it seems plausible that P7 may target interactions with the -35 promoter 
element. To experimentally test whether interactions with the -35 promoter element are a target of 
P7 inhibition, further fluorescent binding assays were performed with the T5N25CONS (-38/-11)(-
38/-12) upstream fork junction. This upstream fork junction encompasses the -35 promoter element 
but not the discriminator region which is already proposed to be involved in P7 inhibition. Addition 
of P7 to the ENNσ70-TMR- T5N25CONS (-38/-11)(-38/-12) complex decreases the fluorescent signal 
from 46,000 to 38,000 counts/s (Figure 6.5.10). This implies that P7 inhibition may also be 
dependent on the -35 element; recall that P7 has no effect on ENNσ70-TMR interactions with the -26 
to -6 segment (Figure 6.5.9), therefore P7 specifically antagonises binding of the -38 to -26 section of 
promoter DNA. 
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Figure 6.5.10 The effect of P7 on E
NN
σ
70
 interactions with the T5N25 promoter -35 promoter. 
A time dependent measurement of fluorescence of E
NN
σ
70
-TMR binding to T5N25 (-38/-11)(-38/-12). The 
addition of the (-38/-11)(-38/-12) fragment and P7 are indicated with arrows. 
 
 These RNAP beacon experiments have so far demonstrated that P7 may form a ‘trapped’ 
complex (as seen in Figure 6.5.3 and Figure 6.5.4) by directly or indirectly reducing the affinity of 
ENNσ70 to the -35 promoter element and/or the discriminator region (Figure 6.5.11), but not 
interactions with the -10 promoter element in the RPo. Additionally it seems that contacts with the 
extended -10 promoter allow ENNσ70 to escape inhibition by P7. 
 
 
 
Figure 6.5.11 Summary of potential E
NN
σ
70
-promoter DNA interactions targeted by P7. 
A schematic illustrating the location of the E
NN
σ
70
-promoter DNA interactions which are proposed to be 
antagonised by P7. The -35, -10 and extended -10 promoter elements are labelled along with the transcription 
start site. The positions of the DNA fragment end points used in the RNAP beacon assays are indicated on the 
top strand.  
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6.6. Discussion 
 
 A bacterial two-hybrid approach was used to map the residues in P7 which are important for 
binding to the X. oryzae RNAP. The mutagenesis screen revealed that P7 is quite sensitive to 
mutation, which implies that the interaction interface could potentially be quite extensive. The P7 
residues were categorised into four classes according to the ability of their respective alanine 
mutant counterparts to bind to the X. oryzae RNAP β’-subunit fragment and induce expression of β-
galactosidase. Using this categorisation 27 class IV residues were identified as being important for P7 
binding including two clusters: G19S20V21L22T23V24K25V26 and F39D40R41. Although Western blot analysis 
of the cell lysates revealed that the class IV mutants were all expressed, there was notable variation 
in the apparent levels of expression. Secondary structure prediction software proceeded by NMR 
spectroscopy was used to resolve a high resolution, 3-D representation of P7. When the class IV 
residues were mapped in the context of the tertiary structure it became apparent that some of 
these residues may not be directly responsible for binding per se. In particular, many of the class IV 
residues seemed to be positioned to form the hydrophobic core of the protein, including residues 
within the central β-strand formed by the majority of the G19S20V21L22T23V24K25V26 cluster and 
residues in the -helix. Moreover, the F39D40R41 cluster comprises an apparent turn in the protein 
between the β3-strand and the -helix. Therefore 12 of the class IV residues are potentially 
required for maintaining structural integrity and/or the correct folding of the protein. Unstable or 
aberrant proteins are more likely to be degraded, which may explain the discrepancies in the 
apparent expression levels of some of the class IV mutants. However, this does not eliminate the 
possibility that these residues may play an additional role in forming an interaction with the β’ 
subunit as well as maintaining structural features. The screen has highlighted 15 further class IV 
residues (F4, I7, G9, Y10, N12, F14, Q17, G19, S20, V21, Y44, S46, L58, G62 and I64), although as yet, none of 
these have been directly confirmed as important for binding to the RNAP. 
 The binding of P7WT to ENN and variants could be further studied by fluorescence anisotropy 
(refer to chapter 3).  This would allow confirmation of the P7 residues important for binding to 
ENNσ70. For site specific labelling, the fluorophore is typically conjugated via a sulphydryl group but as 
P7 does not contain a native cysteine, this amino acid residue would need to be introduced. The 
mutagenesis screen and structure could be used to select suitable class I and surface exposed amino 
acid residues as candidates such as S8, S16, P48, K59, R60. Alternatively as P7 is encoded in pET28b+ and 
pET33b+, a cysteine residue could be introduced within the N-terminal tag of the recombinant 
protein.  
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 In addition, a structure of P7 bound to a X. oryzae β’ N-terminal fragment could be used to 
form a model of a Eσ70-P7 complex which would provide a more informative perspective on the 
orientation of the binding partners and therefore the prospective binding determinants. A structural 
complex would also help decipher which mobile modules of RNAP (β’ Zn-binding element, β’ zipper 
or β’ coiled-coil) may be influenced by P7 binding. Ultimately the mutagenesis screen could be 
implemented together with structural and biochemical data to decipher which residues are 
important for the function of P7 as an inhibitor of transcription initiation and as an anti-terminator. 
 Biochemical studies set out to determine the steps in transcription initiation which are 
targeted by P7. In vitro transcription assays and EMSAs confirmed that P7 has no detectable effect 
on the initial engagement of the DNA with ENNσ70 and cannot inhibit transcription from a pre-formed 
ENNσ70-promoter DNA complex. Thus P7 may not prevent RPc formation but does seem to inhibit a 
stage prior to RPo formation. Furthermore, EMSAs also revealed that P7 appears to trap an ENNσ70-
promoter DNA complex which is faster migrating and heparin sensitive. As this P7 ‘trapped’ complex 
migrates differentially to a fully competent RPo complex it possibly represents a markedly distinct 
conformation. Heparin stability is commonly used as a hallmark of the RPo complex or late 
intermediates; therefore P7 seems to trap an early intermediate whereby the ‘transcription bubble’ 
has not yet formed and hence the DNA is unable to compete with heparin. KMnO4 experiments 
could be conducted to assess the extent, if any, of the DNA strand-separation in the P7 ‘trapped’ 
complex. 
 Results from order of addition binding experiments show that P7 disrupts the equilibrium 
between a heparin unstable and heparin stable complex. Therefore P7 may antagonise ENNσ70-
promoter DNA interactions or conformational changes in ENNσ70 required for DNA isomerisation. To 
investigate if P7 may affect the interactions of ENNσ70 with promoter DNA, binding experiments were 
conducted using the RNAP beacon assay. By conducting preliminary fluorescence based binding 
experiments with specific segments of a P7 sensitive promoter DNA fragment it was shown that P7 
may affect the interactions between ENNσ70 (σ R1.2) and the discriminator region as well as (σ R4.2) 
and the -35 promoter element.  
 During transcription initiation the discriminator region is contacted by σ R1.2. The sequence 
of the discriminator region can influence the strength of this interaction and consequently the 
lifetime of the Eσ70-promoter DNA complex. Furthermore this interaction is known to be subject to 
regulation by transcription factors (Haugen et al., 2006;Haugen et al., 2008). Thus, it is conceivable 
that P7 may weaken the interaction between the discriminator and σ R1.2 which may shorten the 
lifetime of the RPo, shifting the equilibrium to the left and thus ‘trapping’ an intermediate complex. 
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 Since transcription from extended -10 promoters does not rely on the -35 promoter element 
the results from the RNAP beacon assay, which show a P7 dependency on the -35 promoter element 
region, may explain why transcription initiation from extended -10 promoters is resistant to P7 
inhibition. Recently it has been shown that at certain promoters the β’ zipper can facilitate RPo 
formation by interacting with the spacer region to compensate for σ70  interactions with the -35 
promoter element, in a similar manner to the extended -10 promoter (Yuzenkova et al., 2011). 
Therefore it would be interesting to investigate whether transcription initiation from this novel type 
of promoter is also resistant to P7 inhibition.  
 It should be emphasised that all the RNAP beacon assay results shown here are preliminary 
experiments and need repeating with suitable controls (i.e. in the absence of P7 and/or presence of 
a P7 mutant defective in binding) and with different orders of addition. Furthermore, the effect of P7 
on ENNσ70 interactions with downstream DNA has not yet been assessed; these interactions are 
crucial for forming a stable RPo and therefore may also be targeted by P7. The P7 ‘trapped’ complex 
may also be further characterised using DNase I and ExoIII footprinting to determine how the Eσ70 is 
occupied by the promoter DNA. 
 Currently, the characterisation of the mechanism of inhibition of transcription by P7 has 
been conducted using a mutant version of the E. coli RNAP as this represents the best studied 
bacterial RNAP for which composite structures and a plethora of biochemical resources are 
available. However X. oryzae itself is a major rice pathogen and therefore the study of its 
transcriptional components has relevance to the agricultural industry. Since there appears to be 
significant variation between the E. coli RNAP β’ subunit and the X. oryzae counterpart (with only 
72% sequence homology at the amino acid level) and it has been shown that the choice of DNA 
templates can influence the potency of an inhibitor (Haupenthal et al., 2012), it may be more 
accurate to also investigate the effect of P7 using a more native and relevant system. This approach 
may also have implications for the continued study of P7 as an anti-terminator of transcription. 
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CHAPTER 7 
OVERVIEW 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7.  
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7.1. Work leading to this study 
 
 This study aimed to explore the molecular mechanisms of action of two phage-encoded 
proteins; T7 Gp2 and Xp10 P7, which bind directly to the bacterial RNAP and inhibit its activity during 
transcription initiation. Work leading to this study had shown that Gp2 and P7 target steps which 
prevent the formation of a transcriptionally competent RPo; the precise details of which remained to 
be elucidated (Figure 7.1.1 and Figure 7.1.2). 
 Previously, it was established that Gp2 binding to RNAP was dependent on the conservation 
of the E1158 and E1188 amino acid residues of the β’ jaw (Nechaev and Severinov, 1999). The β’ jaw 
forms part of the dw-DBC and amongst other functions is required for stable DNA strand-separation 
(Ederth et al., 2002b). During the course of this study it was demonstrated by NMR titration 
experiments that the dw-DNA directly contacts the β’ jaw and that this interaction can be disrupted 
by Gp2, which competes for binding to an overlapping site (James et al., 2012).  Early research from 
this laboratory included a structure-function analysis of Gp2, which revealed that amino acid 
residues R56 and R58, which project out from the β3 strand were also required for binding to the β’ 
jaw (Camara et al., 2010). Despite the identification of the major determinants for Gp2-RNAP 
binding, the affinity of the interaction had never been measured (Figure 7.1.1.).  
 An initial investigation into the mechanism of inhibition of RNAP by Gp2 had demonstrated 
that Gp2 antagonises a late stage of RPo formation associated with DNA strand-separation around 
the transcription start site (Camara et al., 2010). This idea was later supported by DNA footprinting 
methods which showed by generating a Gp2-Eσ70-promoter DNA quaternary complex that only the 
upstream portion of the ‘transcription bubble’ is able to form whereas the DNA around the 
transcription start site remains in its duplex conformation (Mekler et al., 2011b). However, the 
overall molecular mechanism of action employed by Gp2 to antagonise the interactions between 
RNAP and the promoter DNA was yet to be unravelled. Analysis of the structure of Gp2 had revealed 
a continuous negatively charged strip (NCS) of aspartic and glutamic acid residues running from the 
β1-β2 loop down the -helix (Camara et al., 2010). The potential role of the NCS in the Gp2-mediated 
inhibition of RNAP had not been investigated (Figure 7.1.1.). Furthermore, like Gp2, σ R1.1 is also 
negatively charged and known to reside in the dw-DBC, proximal to the Gp2 binding site. 
Considering that the displacement of R1.1 from the dw-DBC is a pre-requisite for RPo formation it 
was proposed that R1.1 may also play a role in the mechanism by which RNAP is inhibited by Gp2 
(Figure 7.1.1.).  
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Figure 7.1.1 How does Gp2 inhibit RPo formation? 
A cartoon depicting the effects of Gp2 on RPo formation by Eσ
70
 (grey and purple respectively). The active site 
is represented by a yellow dot whereas the DNA template strand is shown in orange and the non-template 
strand in dark blue. Gp2 (light blue) binds to the β’ jaw (green), of which the affinity of the interaction has not 
be previously measured (). Gp2 prevents the binding of the dw-DNA to the β’ jaw and antagonises DNA 
strand-separation around the transcription start site (illustrated by red bars) by an undefined mechanism. The 
role of the NCS (red patches) of Gp2 has not been investigated () and the potential contribution of σ R1.1 has 
not been determined (). 
 
 In contrast to Gp2, P7 represents a relatively uncharacterised phage-encoded protein. Prior 
to this study, it was established that P7 binds to a markedly distinct region of the β’ subunit, located 
more at the upstream face of RNAP. Interaction studies mapped the specific binding site to the 
N6L7F8N9 amino acid residues (Yuzenkova et al., 2008). However, the amino acid residues in P7 which 
are important for binding remain uncharacterised (Figure 7.1.2.). A preliminary investigation into 
the effect of P7 on RNAP activity had shown that it may prevent RPc formation by restricting the 
movement of σ R2.4 and 4.2 which are required for promoter recognition (Nechaev et al., 2002). 
However, the precise mechanism by which P7 antagonises Eσ70-promoter DNA interactions has not 
been investigated (Figure 7.1.2.). 
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Figure 7.1.2 How does P7 inhibit RPo formation? 
A cartoon depicting the effects of P7 on RPo formation by Eσ
70
 (grey and purple respectively). The active site is 
represented by a yellow dot whereas the DNA template strand is shown in orange and the non-template 
strand in dark blue. P7 (light green) binds at the upstream face of RNAP; P7 amino acid residues required for 
binding are not known (). P7 restricts the interdomain distance between σ R2.4 and 4.2 (illustrated by red 
dotted arrows). The effect of P7 on Eσ
70
-promoter DNA interactions has not been investigated (). 
 
 
7.2. Advances made 
 
 From this study we have now proved Gp2 to be a tight binding and potent inhibitor of 
bacterial RNAP. Results from FA experiments have established that Gp2 binds to the RNAP core with 
a 1:1 stoichiometry and a low nanomolar affinity and that this initial binding of Gp2 to RNAP occurs 
independently of the σ-factor. It seems that the number of negatively charged amino acid residues 
within the NCS determines the potency of Gp2; making this the major feature for the inhibitory 
function of Gp2 (Figure 7.2.1.). Using a structural complex of Gp2 and a fragment of the β’ jaw we 
showed that the arrangement of the interaction, extends the residues of the NCS of Gp2 by aspartic 
and glutamic acid residues of the β’ jaw (James et al., 2012), thus supporting the view that the NCS is 
an important feature in Gp2 function. Since, R56 and R58 as well as the NCS amino acid residues are 
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highly conserved in Gp2 orthologs the phage encoding these proteins are also likely to employ the 
same or at least very similar mechanisms of bacterial RNAP inhibition.  
 The complete removal of the NCS also compromises the ability for Gp2 to remain bound to 
RNAP upon addition of the promoter DNA. This result supports the view that Gp2 and the dw-DNA 
compete for binding to the β’ jaw (James et al., 2012) (Figure 7.2.1.). By using the current 
structural model of Gp2 bound RNAP we have shown that Gp2 is orientated so that the NCS is 
positioned to face into the positively charged walls of the β’ jaw and the β’i6 of the dw-DBC. 
Therefore we propose that the role of the NCS of Gp2 may not solely be to electrostatically repel the 
DNA away from the dw-DNA but may instead be to ‘lock’ the RNAP in a conformation which is 
unfavourable for DNA entry. This is supported by recent single-molecule FRET experiments which 
demonstrated that Gp2 restricts the movement of the  β’ clamp in favour of a closed and/or 
collapsed state, narrowing the channel width to 8- 12 Å (Chakraborty et al., 2012) (Figure 7.2.1.). 
This locking mechanism does not occur if the NCS is removed (unpublished data). 
 We have also described how the highly flexible and negatively charged R1.1 domain of σ70 is 
required for the full Gp2-mediated inhibition of Eσ70-dependent transcription. During the course of 
this study FRET experiments were performed to demonstrate that the presence of Gp2 prevents the  
movement of σ R1.1 from the dw-DBC (Mekler et al., 2011b) (Figure 7.2.1.). Together Gp2 and 
R1.1 exert long range antagonistic effects to attenuate the entry of the DNA around the active 
centre and the correct placement of the single-stranded DNA template strand at the active site 
(Figure 7.2.1.). Ultimately these direct and indirect effects of Gp2 result in the formation of a 
partially open and transcriptionally inactive ‘transcription bubble’ (Mekler et al., 2011b). 
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Figure 7.2.1 Overall mechanism of inhibition of Eσ
70
 by Gp2. 
A cartoon depicting the effect of Gp2 on RPo formation by Eσ
70 
(grey and purple respectively). The active site is 
represented by a yellow dot, whereas the DNA template strand is shown in orange and the non-template 
strand in dark blue. Gp2 (light blue) contains a NCS (red patches) which forms the major feature for inhibitory 
activity (). Gp2 competes with the dw-DNA for binding to the β’ jaw (green) () The binding of Gp2 narrows 
the width of the main channel (illustrated by the red dashed arrows) (). Gp2 restricts the movement of σ 
R1.1 from the dw-DBC () and together they antagonise the binding of promoter DNA around the active 
centre (). These effects of Gp2 result in the formation of a partially open and transcriptionally inactive 
‘transcription bubble’. 
 
 We used a structure-function analysis of P7 to inform upon which amino acid residues in P7 
may be required for binding to RNAP. The results of a two-hybrid screen were assessed in the 
context of the newly resolved NMR structure of P7 (Figure 7.2.2.). We identified approximately 15 
amino acid residues that may be important determinants for binding and 13 additional amino acid 
residues which are likely to be required for maintenance of the structural integrity of the protein.  
 We employed both biochemical and biophysical methods to investigate the mechanism of 
inhibition of transcription initiation by P7. Previously it was shown that P7 reduces the distance 
between σ R2.4 and 4.2 (Figure 7.2.2.), suggesting that P7 may prevent RPc formation. Our results 
from in vitro transcription assays suggested that P7 may not prevent RPc formation but does 
antagonise a stage en route to the formation of the RPo. In addition, EMSA experiments revealed 
that P7 traps a markedly distinct ENNσ70-promoter DNA complex which is both fast migrating and 
heparin sensitive. We also conducted preliminary RNAP beacon assay experiments which suggested 
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that P7 may specifically disrupt ENNσ70 interactions with the -35 promoter element and the 
discriminator region (Figure 7.2.2.). These findings will be subject to further investigations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.2.2 Insights into the mechanism of inhibition of E
NN
σ
70
 by P7. 
A cartoon depicting the effect of P7 on RPo formation by Eσ
70 
(grey and purple respectively). The active site is 
represented by a yellow dot, whereas the DNA template strand is shown in orange and the non-template 
strand in dark blue. The structure of P7 (light green) has been resolved and 27 amino acid residues (red) have 
been indentified to be either directly or indirectly required for binding (). P7 restricts the interdomain 
distance between σ R2.4 and 4.2 (illustrated by red dotted arrows) () and may specifically antagonise ENNσ70 
interactions with the -35 promoter element and the discriminator region (). 
 
7.3. Future perspectives 
 
 In this study we have answered many of the objectives originally proposed, although in 
doing so many more questions have arisen; in particular, two major lines of enquiry may be explored 
in the immediate future to develop the existing findings. 
 The work described here and in previous studies has demonstrated Gp2 to be both σ-factor 
and promoter specific. The current mechanism of inhibition of RNAP by Gp2 has suggested that T7 
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has evolved to target the activity of the major housekeeping holoenzyme, Eσ70 from the -10/-35 type 
promoters. In contrast, transcription from extended -10 promoters and initiation directed by σ54 
both appear to be resistant to Gp2 (Nechaev and Severinov, 1999;Wigneshweraraj et al., 2004), 
whereas transcription by Eσ38 is only partially inhibited by Gp2. However, the effect of Gp2 has only 
been studied in vitro from a limited number of promoters. The effect of Gp2 on transcription may be 
assessed in a more biologically relevant manner using an in vivo transcriptomics approach. The 
growth effect of the over-expression of recombinant Gp2 in E. coli cells may be monitored over a 
time-course to determine the point at which growth becomes attenuated. At this point RNA can be 
extracted and used for microarray analysis. Results will demonstrate the global effect of Gp2 on the 
E. coli transcriptome; detailing which specific promoters are differentially expressed in the presence 
of Gp2. This will establish which holoenzymes and promoter types are sensitive or resistant to Gp2 
inhibition.  
 The preliminary investigation into the effect of P7 on ENNσ70-promoter DNA interactions 
identified a markedly distinct complex. The P7 ‘trapped’ complex is both faster migrating and 
heparin sensitive compared to its RPo counterpart and possibly represents a normally transient 
intermediate complex. This P7 ‘trapped’ complex may be furthered characterised using DNA 
footprinting methods. DNaseI and or ExoIII footprinting could be used to determine how the 
occupation of the DNA by ENNσ70 changes in the presence of P7. Whereas KMnO4 footprinting would 
establish if and to what extent the DNA strands are separated. A combination of these methods will 
inform upon the possible effect of P7 on promoter DNA interactions which will provide a basis for 
continued RNAP beacon experiments.  
 Overall this research has provided valuable insights into the molecular mechanisms of action 
of two novel regulators of bacterial RNAP. This work has contributed to our understanding of the 
regulation of transcription initiation as well as extending our appreciation for the complexity of the 
essential enzyme, RNAP. 
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0022-2836/$ - see front matter © 2011 EGp2, a 7 kDa protein encoded by T7 bacteriophage, is a potent inhibitor of
Escherichia coli RNA polymerase (RNAp), the enzyme responsible for
transcription of all bacterial genes and early viral genes. A prominent
feature in the structure of Gp2 is a contiguous strip of seven negatively
charged amino acid residues (negatively charged strip or NCS), located
along one side of the molecule. The role of the NCS in Gp2 function is not
known. Here, the in vivo and in vitro properties of altered forms of Gp2 with
amino acid substitutions in the NCS are described. While mutations in the
NCS do not compromise the folding or the ability of Gp2 to bind to the
RNAp β′ subunit, disruption of the NCS significantly attenuates Gp2
function in vivo and its ability to inhibit RNAp in vitro. Efficient inhibition of
the RNAp by Gp2 also involves the amino terminal region 1 domain of the
RNAp promoter specificity subunit σ70, located in the vicinity of the
primary Gp2 binding site in β′. The results are discussed in the context of
hypothetical molecular mechanisms of RNAp inhibition by Gp2.© 2011 Elsevier Ltd. All rights reserved.ress:
k.
polymerase; RPc,
promoter complex;
, DNA-binding
n.
lsevier Ltd. All rights reserveTranscription of DNA is catalysed by the DNA-
dependent RNA polymerase (RNAp). Bacterial
RNAp is a multisubunit enzyme comprised of a
five-subunit catalytic core (α2ββ′ω; abbreviated E)
and one of several σ subunits, each conferring upon
the catalytic core an ability to initiate transcription
from specific DNA sites called promoters.1 Most
bacterial promoters with conserved sequences neard.
Fig. 1 (legend on next page)
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625Inhibition of E. coli RNAp by T7 Gp2 Proteinpositions −35 and −10, with respect to the
transcription start site (the +1 site), depend on the
RNAp containing a housekeeping σ factor (σ70 in
Escherichia coli). Under certain stress conditions, a
relatively small subset of E. coli promoters is used
by the RNAp containing a major variant σ factor,
σ54.2 The initiation of transcription by Eσ70 is a
multistep process and represents a major regulatory
step of gene expression. The σ70 factor directed
binding of the RNAp to the promoter results in the
formation of a competitor-sensitive closed promoter
complex (RPc). The transition of the RPc to
transcription-initiation competent open promoter
complex (RPo) occurs through several intermedi-
ates and is accompanied by large-scale conforma-
tional changes in Eσ70 and promoter DNA.3–5 In
RPo, the strands of promoter DNA are locally
melted to form the transcription bubble, the +1 site
of the template DNA strand is placed at the RNAp
catalytic site and the duplex DNA downstream of
the transcription bubble is tightly held in a trough,
called the downstream DNA binding channel
(downstream-DBC), formed by the structurally
flexible RNAp domains β′ jaw, β′ clamp, β′ I6
and β downstream lobe.4,6 Interactions between
promoter DNA and the downstream-DBC are
responsible for several of the discrete kinetic steps
observed en route to the RPo as well as for stable
maintenance of the transcription bubble once the
RPo formation is complete.3,7
Bacterial RNAp is a major target for numerous
regulatory proteins and small ligands that fine-tune
gene expression levels to the changing needs of the
cell. Several bacteriophages (phages) encode small
molecular mass regulatory proteins that modify the
activity of host RNAp to favour the expression of
phage genes.8 The E. coli bacteriophage T7 provides
a paradigm of how a phage-encoded regulatory
protein modifies the activity of host bacterium
RNAp. The transcription of the T7 genome occurs
in three stages. Early T7 genes are transcribed by
Eσ70, whereas middle and late T7 genes are
transcribed by phage-encoded RNAp. The product
of the middle T7 gene 2, a 7 kDa protein called Gp2,Fig. 1. The negatively charged strip of amino acids in Gp2.
side chains of the negatively charged amino acid residues that
R58 are indicated. (b) Effect of single alanine substitutions on
vitro transcription inhibition assay and reports the activity of E
in the presence of equimolar amounts of each Gp2 single-alanin
in the absence of Gp2. In independent experiments, data ob
transcription inhibition assay was done as described10 and the
components, time added and incubation time. (c) The structur
same orientation and colouring as in (a). The consecutive alan
the Gp2 mutants are depicted in yellow. The lower panel sho
proteins from known phage genomes in the single-letter amino
the structure of Gp2 are indicated. The symbols in the seq
residues; (.) semi-conserved residues. The amino acid residues
efficiency of T72am64 phage on E. coli strain BL21 transformebinds to the β′ jaw domain in the downstream-DBC
of the host RNAp and prevents RPo formation by
Eσ70.9,10 A contiguous strip of seven negatively
charged amino acids (E21, E34, D37, E38, E41, E44
and E53) at one side of the molecule and two
invariant and functionally indispensable positively
charged arginine residues (R56 and R58) on the
opposite side are notable features in the high-
resolution solution structure of Gp2 (Fig. 1a).10 The
role of the negatively charged strip (NCS) in T7 Gp2
is not known. Because R56 and R58 are essential for
Gp2 interaction with the β′ jaw domain, NCS, which
should be located on the side opposite the RNAp-
binding side of Gp2, could be projected into
downstream-DBC and interfere with the positioning
of DNA in the channel and/or with σ70 region 1,
which is thought to occupy the downstream-DBC in
free Eσ70.5 Here, we describe the in vivo and in vitro
properties of four altered forms of Gp2, which carry
alanine or serine substitutions of two, five, six, or all
seven amino acid residues of the NCS. Our results
show that removal of the negatively charged side
chains from the NCS does not affect the structural
integrity of Gp2 or compromise its ability to bind
Eσ70. However, the mutant Gp2 forms are signifi-
cantly attenuated for transcription inhibition, with
progressive decrease in inhibition efficiency follow-
ing removal of negatively charged side chains from
the NCS. We demonstrate that efficient inhibition of
Eσ70 by Gp2 requires region 1 of σ70. The results
thus indicate an important role of the NCS in the
inhibition of the RNAp by Gp2 and support a model
in which the primary Gp2–RNAp interaction serves
to position the NCS in the downstream-DBC.
Mutagenesis of the NCS in T7 Gp2
The NMR structure of Gp2 shows that the protein
adopts a compact globular fold comprising a three-
stranded β-sheet packed against an α-helix in a
β1β2α1β3 topology with the central β2 strand
flanked by anti-parallel β1 and β3 strands. Residues
E21, E34, D37, E38, E41, E44 and E53, which form
the NCS, are located in or are proximal to the α1(a) Ribbon representation of Gp2 highlighting (in red) the
contribute to the NCS. The functionally essential R56 and
inhibition of Eσ70. The graph indicates results from an in
σ70 in synthesizing the ApApUpU transcript from lacUV5
emutant. The results are normalized to the activity of Eσ70
tained fall within 10% of the values shown. The in vitro
schematic at the top indicates the concentration of reaction
e of Gp2 shown as a space filled representation and in the
ine or serine substitutions introduced into Gp2 to generate
ws an alignment of the amino acid sequences of Gp2-like
acid code. The localization of β strands and the α helix in
uence alignment are: (⁎), identical residues; (:)conserved
targeted for mutagenesis are highlighted in red. (e) Plating
d with pET33:Gp2 encoding mutant Gp2 proteins.
626 Inhibition of E. coli RNAp by T7 Gp2 Proteinhelix (E34, D37, E38, E41 and E44), the β1 (E21), and
β3 strands (E53) (Fig. 1a). Initially, we made single
alanine substitutions at each NCS residue and tested
the ability of Gp2 point mutants to inhibit E. coli
Eσ70 in an in vitro transcription assay. In this assay,
the incubation of Eσ70 with equimolar amounts of
WTGp2 before the addition of the lacUV5 promoter
effectively abolishes the synthesis of the ApApUpU
transcript by Eσ70 (Fig. 1b).10 The results revealed
that single alanine substitutions of NCS residues
had no detectable effect on the ability of Gp2 to
inhibit Eσ70 in an in vitro transcription assay,
indicating that the NCS either does not contribute
to the function of Gp2 or that the negatively charged
side chains of the NCS act synergistically. Therefore,
we made four additional mutants in which two
(Mut2Gp2), five (Mut5Gp2), six (Mut6Gp2) or all seven
(Mut7Gp2) NCS residues were substituted with
alanine or serine (Fig. 1c). Mut2Gp2 contains an
alanine (D37A) and a serine (E38S) in two positions
that contain negatively charged side chains in all 13
known Gp2 homologs. Mut5Gp2 contains alanine
(D37 and E41) and serine (E34, E38 and E44) instead
of negatively charged residues in or close to the α1
helix (Fig. 1a). The choice of residues introduced
instead of the native negatively charged amino acids
was structure-based and dictated by the desire to
maintain the structural integrity of α1. In
Mut6Gp2
and Mut7Gp2, the remaining NCS residues (E53, or
E53 and E21, respectively) are changed to alanine.Amino acid substitutions in NCS impair the
ability of T7 to infect E. coli
Initially, the activities of all Gp2 mutants were
tested in an in vivo complementation assay.10 To this
end, E. coli BL21 cells containing the pET-based
plasmid expressing wild type gene 2 or gene 2
mutants were infected with T7 phage harbouring an
am64 amber mutation in gene 2. T72am64 infections
of wild-type E. coli BL21 cells are not productive,
since Gp2 function is essential for phage
development.11 However, E. coli BL21 cells contain-
ing the plasmid expressing WTGp2 are productively
infected by T72am64, as judged by the efficiency of
plaque formation, calculated as a ratio of numbers of
plaques observed on non-suppressing to suppres-
sing hosts. In contrast, the efficiency of plaque
formation is much reduced (N10-fold) on lawns of
E. coli BL21 cells harbouring the functionally
defective R56EGp2 mutant that is defective for Eσ70
binding (Fig. 1d).10 Plaque formation by T72am64 on
lawns formed by E. coli BL21 cells harbouring
plasmids expressing the NCS mutants was also
affected but to a lesser extent: Mut5Gp2, Mut6Gp2 and
Mut7Gp2-producing cells allowed ~58%, ~62% and
~68%, respectively, less plaques to form than those
formed by cells expressing WTGp2. Plaque formationon lawns of cells containing plasmid expressing
Mut2Gp2 was reduced by only ~27%. Overall, the
results of the in vivo complementation assay indicate
that the NCS contributes to Gp2 function in vivo,
though the effects of NCS substitutions, including
themutation that removes all the negatively charged
amino acids from the NCS (Mut7Gp2), is less than the
effect of the point substitution R56E affecting the
Gp2–RNAp interaction. Attempts to determine the
relative in vivo expression levels of wild-type and
mutant Gp2 by Western blotting were unsuccessful
because the expression level of plasmid-borne
Gp2 appeared to be below the minimum detection
limit of the anti-Gp2 antibodies available to us (data
not shown).Multiple amino acid substitutions in NCS do not
affect the structure of the protein
To evaluate the properties of Gp2 mutants at a
molecular level, all Gp2 mutants, as well as the
WTGp2 control, were overproduced as amino-
terminal His6-tagged fusion proteins and purified
to N90% homogeneity by nickel affinity chroma-
tography. The level of expression of all Gp2
mutants was comparable to that of WTGp2 (data
not shown). Initially, the (1H)NMR spectra of all
mutants were measured and compared to that of
WTGp2. The (1H)NMR spectrum of WTGp2 is
characteristic of a small, folded domain, as judged
by the dispersion of resonances below ~0.5 ppm
(corresponding to Hγ1 and Hγ2 protons from V20
at −0.126 ppm and 0.046 ppm, respectively; Fig.
2a).10 These resonances typically represent buried
protons of methyl or methylene groups in hydro-
phobic cores. Their frequencies are shifted by
electronic ring currents from the plane of a
neighbouring aromatic side chain. Similarly, there
is good dispersion of resonances in the amide and
aromatic regions (6.5~9 ppm; Fig. 2a).10 The results
indicate that these features are retained in the
spectra of Mut2Gp2, Mut5Gp2, Mut6Gp2 and Mut7Gp2
(Fig. 2a and data not shown), indicating that
removal of the negatively charged side chains at
positions 21, 34, 37, 38, 41, 44 and 53 does not
affect the native structure of Gp2. In Fig. 2b, the
(1H)NMR spectrum of a Gp2 in which the
structure is significantly disrupted by a mutation
(F16A) is shown for comparison.10
Multiple amino acid substitutions in the NCS have
little effect on the affinity of Gp2 for E. coli RNAp
We developed a fluorescence polarization (FP)
assay to quantify the strength of the interaction
between Gp2 and Eσ70 to measure the effect of
NCS substitutions on RNAp binding. Gp2 was
modified with a thiol-reactive Alexa488-
Fig. 2. The (1H)NMR spectra of Gp2. (a) Detail of proton (1H)NMR spectra from WTGp2 obtained as described,10
showing the amide/aromatic protons (left) and the methyl/methylene groups (right) in the 0 ppm region for WTGp2. The
boxed region within the 0 ppm region is enlarged to show the ring current-shifted methyl groups from V20 for WTGp2
and mutants (for details, see the text). (b) A (1H)NMR spectrum of an altered form of Gp2 (F16AGp2)10 in which the
structure is significantly disrupted by the mutation.
627Inhibition of E. coli RNAp by T7 Gp2 Proteinfluorophore at a single, surface-exposed, non-
essential cysteine residue at position 60 (C60).10
The 32P-labelled version of Alexa488-modified
WTGp2 (WT⁎Gp2) bound Eσ70 as well as 32P-
labelled non-modified Gp2 in a native gel assay
(developed to monitor complex formation between
[32P]Gp2 and Eσ70 (Fig. 3a),10) indicating that the
presence of the Alexa488-fluorophore at C60 does
not detectably affect the binding of Gp2 to Eσ70 or
the inhibition of Eσ70 by Gp2 (data not shown).
Incubation of WT⁎Gp2 with increasing concentra-
tions of wild type Eσ70 led to a large change in
anisotropy of WT⁎Gp2 (Fig. 3b). Control reactions
with the Alexa488-modified version of R56EGp2
confirmed that the increase in anisotropy is due to
specific binding of Gp2 to Eσ70 (Fig. 3b). As
expected, we failed to detect an interaction
between WT⁎Gp2 and Eσ70 reconstituted with a
mutant form of RNAp core, which contains a
charge reversal substitution (E1188K)12 in the β′
jaw domain and is unable to bind to Gp2 (Fig. 3c).
The anisotropy of WT⁎Gp2 continued to increase
with increasing amounts of Eσ70 in a dose-
dependent manner and achieved saturation at
about ~50 nM Eσ70, indicating that Gp2 binds to
Eσ70 with a 1:1 binding stoichiometry and withsub-nanomolar affinity (Kd 0.4±0.02 nM). We
conclude that the FP assays allows sensitive and
quantitative detection of RNAp interaction with
Gp2.
We used the FP assay to measure the strength
of the interaction between Alexa488-fluorophore-
labelled versions of Gp2 mutants harbouring
substitutions in the NCS. As shown in Fig. 3d,
the affinity of Alexa488-fluorophore-labelled ver-
sions of Mut2Gp2, Mut5Gp2, Mut6Gp2 and Mut7Gp2
for Eσ70 was reduced ~3–12-fold compared to
the WT⁎Gp2–Eσ70 interaction. Nevertheless, the
Kd values determined for interaction between
Mut2⁎Gp2, Mut5⁎Gp2, Mut6⁎Gp2 and Mut7⁎Gp2 and
Eσ70 still reflect a very tight binding affinity and
all Gp2 mutants bound to Eσ70 with a 1:1 molar
ratio under our experimental conditions (Fig. 3d
and data not shown). We conclude that muta-
tions in the NCS have only a small effect on the
affinity of Gp2 for host RNAp and stoichiometric
binary complexes containing Eσ70 and Gp2 can
be obtained readily with each mutant. The results
are consistent with the earlier finding that the
two surface-exposed invariant arginine residues
(R56 and R58) in Gp2 are the major determinants
for binding the host RNAp.10
628 Inhibition of E. coli RNAp by T7 Gp2 ProteinMultiple amino acid substitutions in the NCS
attenuate theabilityofGp2 to inhibit theE.coliRNAp
The ability of Gp2 mutants to inhibit Eσ70 was
tested in an in vitro transcription assay. The Mut2Gp2
mutant present in equimolar amounts with Eσ70
inhibits ApApUpU transcript synthesis as well as
WTGp2 (Fig. 3e, lane 5). In contrast, under identical
conditions Mut5Gp2 and Mut6Gp2 display a signifi-
cantly reduced (by ~53% and ~97%, respectively)
ability to inhibit ApApUpU synthesis by Eσ70 (Fig.
3e, lanes 8 and 11, respectively). We observe an
increased inhibition of transcription activity of Eσ70
in vitro at higher concentrations of Mut5Gp2 and
Mut6Gp2 (Fig. 3e, lanes 8–13). However, Mut7Gp2,
even when present at ~4-fold molar excess over
Eσ70, has only a marginal inhibitory effect on Eσ70
transcription. Thus, we propose that the NCS could
be involved in inhibitory interactions that Gp2
makes en route to RPo formation but is not required
for the initial binding of Gp2 to the RNAp (Fig. 3d).
Overall, the results from the in vitro transcription
assay are consistent with the results from the
efficiency of plaque formation assays (Fig. 1d),
suggesting that amino acid substitutions in NCS
impair the ability of Gp2 to effectively inhibit the
E. coli RNAp.
To determine whether Mut7Gp2 is retained in the
RPo that evidently forms in its presence, we
conducted native gel mobility-shift assays using
Alexa488-fluorophore-labelled Gp2 and the [32P]
lacUV5 promoter probe. Gp2 containing promoter
complexes can be visualised by the presence of a
fluorescence signal whereas promoter DNA con-
taining promoter complexes can be visualised by
the presence of a radioactive signal on the native
gel. Double labelling reports on the formation of
promoter complexes containing Gp2. As shown in
Fig. 3f, the WT⁎Gp2-Eσ70 and Mut7⁎Gp2–Eσ70 binary
complexes migrate detectably faster than the RPo
on the native gel (compare lanes 2, 4 and 6’). The
addition of the [32P]lacUV5 promoter probe to the
WT⁎Gp2–Eσ70 complex, as expected, did not lead to
the RPo formation (Fig. 3f, lane 7′) and only the
fluorescence signal originating from the WT⁎Gp2-
Eσ70 complex was present in the corresponding
lane (Fig. 3f, compare lanes 7 and 7′). Consistent
with earlier result (Fig. 3e), the addition of [32P]
lacUV5 promoter probe to the Mut7⁎Gp2–Eσ70
complex had only a marginal effect on RPo
formation (Fig. 3f, lane 8′); no fluorescence signal
was detectable in RPo formed in the presence of
Mut7⁎Gp2, indicating that Mut7Gp2 dissociates from
Eσ70 upon formation of RPo (Fig. 3f, compare lanes
8 and 8′). In support of this view, the fluorescence
signal corresponding to the Mut7⁎Gp2–Eσ70 com-
plex in the lane containing the [32P]lacUV5 probe is
diminished by N50% (Fig. 3f, compare lanes 4 and
8), thus reflecting formation of the RPo by theMut7⁎Gp2-bound Eσ70. It appears that in the
absence of the NCS, Gp2 is efficiently displaced
from the RNAp at some point en route to the RPo.
In contrast, no such displacement of WTGp2 occurs,
leading to efficient inhibition of RPo formation by
Eσ70. Clearly, the NCS seems to contribute to the
ability of Gp2 to inhibit the RNAp efficiently,
which is compromised in its absence.Efficient inhibition of E. coli Eσ70 by Gp2
requires region 1 σ70 region 1
The results described above indicate that the
NCS in Gp2 is important for efficient inhibition of
Eσ70. In an earlier study, Mekler et al. showed that
region 1.1 (residues 1–100), the negatively charged
multifunctional amino-terminal domain found in
most primary σ factors, such as E. coli σ70, is
located in the vicinity of the downstream-DBC
when promoter DNA is not present.5 The σ70
region 1.1 has been suggested to serve as a
“molecular placeholder” for downstream duplex
DNA.5 During RPo formation, the σ70 region 1.1 is
repositioned from the downstream-DBC, a step
that is necessary for efficient and stable formation
of RPo. On the basis of the expected proximity of
the NCS in RNAp-bound Gp2 and the negatively
charged σ70 region 1.1 in Eσ70 in the absence of
promoter DNA (Fig. 4a), we considered the
possibility that Gp2 inhibition of Eσ70 could
involve the σ70 region 1.1. To this end, we
conducted in vitro transcription assays with Eσ70
reconstituted with σ70 deleted for region 1
(residues 1–130; here called σ702-4). Initially, we
used the FP assay to establish that Gp2 binds to
the Eσ70 reconstituted with σ702-4 with an affinity
similar to that of the wild-type Eσ70 (Fig. 4b).
However, the ability of Gp2 to inhibit Eσ702-4 is
detectably impaired when compared to reactions
containing Eσ70 (Fig. 4c). Overall, the results
indicate that efficient inhibition of Eσ70 by Gp2
requires the σ70 region 1.
Perspectives: insights into the mechanisms
of inhibition of Eσ70 by Gp2
In this study we demonstrated that the NCS has
a major role in the ability of Gp2 to function as a
potent inhibitor of E. coli Eσ70. The results show
that the NCS plays a relatively small role in the
initial binding of Gp2 to Eσ70 and that multiple
substitutions in the NCS do not compromise the
overall structural integrity of the protein. There
appears to be a clear progressive decrease in
efficiency of Eσ70 inhibition with the progressive
decrease in the number of negatively charged
residues in the NCS. In the restraint-driven
structural model of the Gp2–bacterial RNAp
Fig. 3 (legend on next page)
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Fig. 3. The binding of Gp2 mutants to E. coli Eσ70. (a) An autoradiograph of a 4.5% (w/v) polyacrylamide native gel
showing the binding of [32P]WTGp2 (left), [32P]WT⁎Gp2 (right) to Eσ70. Themigration positions of [32P]Gp2/Gp2⁎ (lanes 1
and 5) and the Eσ70–Gp2 complex (lanes 2–4 and 6–8) are indicated. The molar ratio of Eσ70 with respect to Gp2 in each
lane is shown at the top. The binding assay was done as described10 in RNAp-binding buffer (10 mM Tris–HCl, pH 8,
100 mM NaCl, 0.1 mM EDTA, 5% (v/v) glycerol) and the schematic at the top indicates the concentration of reaction
components, time added and incubation time. (b) Equilibrium protein binding assays with Alexa488-fluorophore-labelled
Gp2 and Eσ70. A Fluoromax-3 spectrofluorimeter fitted with automated polarization filters was used to measure
fluorescence anisotropy. Data were recorded using an excitation wavelength of 495 nm and an emission wavelength of
519 nm. The binding assays were done at 37 °C in a reaction volume of 400 μl in RNAp binding buffer. Small amounts of
the Eσ70 (reconstituted in situ with ~4-fold molar excess of σ70 over E) were titrated into 50 nM Alexa488-fluorophore-
labelled Gp2. Five measurements of anisotropy were averaged and each protein titration was done in at least duplicate.
Data were fit using the tight binding equation in the Grafit 5 software (Erithacus Software) as described.13 The graph
shows the increase in anisotropy of wild type WT⁎Gp2 (open circles) and R56E⁎Gp2 (filled circles) as a function of the
concentration of Eσ70, where the concentration at saturation is indicated by the dotted line. (c) As in (b) but reactions were
done with WT⁎Gp2 and either Eσ70 (open circles) or E1188KEσ70 (open boxes). (d) A graph showing the increase in
anisotropy of wild type WT⁎Gp2 (open circles), R56E⁎Gp2 (filled circles) and Mut5⁎Gp2 (filled triangles) as a function of the
concentration of Eσ70. The Kd values calculated for the interaction of
WT⁎Gp2 and ⁎Gp2mutants with Eσ70 are given in the
table. (b)–(d) At least two independent experiments were done to obtain the Kd values; all data were within 5~10% of the
Kd values shown. (e) An autoradiograph of a 20% (w/v) denaturing gel showing synthesis of the transcript ApApUpU
(indicated by the arrow, where the underlined nucleotides are 32P-labelled) from the lacUV5 promoter by Eσ70 in the
presence of WTGp2 (lanes 2–4), Mut2Gp2 (lanes 5–7), Mut5Gp2 (lanes 8–10), Mut6Gp2 (lanes 11–13) and Mut7Gp2 (lanes 14–
16). The percentage of ApApUpU synthesised (%A) by Eσ70 in the presence of Gp2 with respect to reactions in the absence
of Gp2 are given at the bottom of the gels. In independent experiments, all data were within 15% of the %A value shown.
The in vitro transcription assay was done as described10 and the schematic at the top indicates the concentration of
reaction components, time added and incubation time. (g) Experiments to determine whether Mut7Gp2 is retained in the
RPo (for details, see the text). A fluorescence image (FI; lanes 1–8) and autoradiograph (A; lanes 5′–8′) of a 4.5% (w/v)
polyacrylamide native gel showing the migration positions of Gp2, Gp2-Eσ70, unbound [32P]lacUV5 promoter probe and
the RPo. The reaction components present in each lane are shown at the top and the schematic indicates the concentration
of reaction components, time added and incubation time. The faster migrating complexmarkedwith an asterisk (⁎) in lane
6′ is a heparin-sensitive Eσ70–[32P]lacUV5 promoter complex that has not acquired the RPo status (data not shown).
630 Inhibition of E. coli RNAp by T7 Gp2 Proteincomplex,10 the NCS projects into the downstream-
DBC (Fig. 4a) and is surrounded by structurally
flexible domains of the E. coli RNAp (β′ jaw, Gp2-
binding site; β′ I6, β′ downstream lobe; β′,
downstream clamp) that form the downstream
DBC and play a role in RPo formation andstability.4,7 Our results support the view that the
NCS in Gp2 antagonises protein–protein and/or
protein–DNA interactions that occur en route to the
RPo. We propose three, not necessarily mutually
exclusive, mechanisms by which Gp2 might inhibit
RPo formation by Eσ70.
Fig. 4. (a) Restraint-driven model
of Gp2 bound to the Thermus aquatics
EσA (σA is the T. aquaticus equivalent
of E. coli σ70) shown as a surface
representation. The subunits of T.
aquaticus EσA are coloured grey and
Gp2 is shown in light blue with the
NCS indicated in red. The path of the
downstream duplex DNA in the
downstream-DBC is indicated by
the dotted arrow. Dotted circles
indicate the structurally flexible
domains of the bacterial RNAp that
contribute to the downstream-DBC;
T. aquaticus RNAp does not have the
β′ I6 domain. The approximate
location of σ70 region 1.1 is indicated
by the red oval. (b) A graph showing
the increase in anisotropy of wild
type WT⁎Gp2 as a function of Eσ70
(open circles) and Eσ702-4 concentra-
tion (open triangles).E. coliσ702-4was
constructed and purified exactly as
described.14 Eσ70 and Eσ702-4 were
reconstituted in situ using ~4-fold
molar excess of E over σ70 and σ702-4,
respectively. The Kd values calculat-
ed for the interaction of WT⁎Gp2with
Eσ70 and Eσ702-4 are shown in the
table. At least two independent
experiments were done to obtain
the Kd values. The data obtained
were all within 5~10% of the Kd
values shown. (c)An autoradiograph
of a 20% (w/v) polyacrylamide
denaturing gel showing synthesis of
the transcript ApApUpU (indicated
by the arrow, where the underlined
nucleotides are 32P-labelled) from the
lacUV5 promoter by Eσ70 and Eσ702-4
in the presence of increasing
amounts (~1, 2 and ~4-fold molar
excess over Eσ70/Eσ702-4)) of
WTGp2
(lanes 2–4 and 7–9, respectively).
Reactions containing an ~4-fold
molar excess of R56EGp2 over Eσ70/
Eσ702-4 are shown as a control (lanes
5 and 10). The percentage of ApA-
pUpU synthesised (%A) by Eσ70 and
Eσ702-4 in the presence of Gp2 with
respect to reactions in the absence of
with Gp2 (lanes 1 and 6) are given at
the bottom of the gels. All data
obtained in independent experi-
ments were within 15% of the %A
value shown. The in vitro transcrip-
tion assay was done as described10
and the schematic at the top indicates
the concentration of reaction compo-
nents, time added and incubation
time.
631Inhibition of E. coli RNAp by T7 Gp2 Protein
632 Inhibition of E. coli RNAp by T7 Gp2 ProteinMechanism 1
Electrostatic interactions between the NCS and
positively charged surfaces of the β′ downstream
lobe and the β′ downstream clamp domains
could “lock” RNAp in a conformation unfavour-
able for RPo formation.
Mechanism 2
The NCS could electrostatically antagonise
interactions between the downstream-DBC and
the duplex downstream DNA, which is an
essential step for RPo formation and stability.
Mechanism 3
The NCS could electrostatically reposition re-
gion 1 of σ70 to a location unfavourable for
efficient RPo formation to occur. Therefore, in the
absence of region 1 of σ70 region 1, Gp2 is unable
to inhibit Eσ70efficiently. In support of this view,
E. coli RNAp reconstituted with σ factors natu-
rally lacking region 1.1 (e.g. Eσ38) is markedly
less sensitive than Eσ70to Gp2.9
The availability of Gp2 mutants, such as
Mut7Gp2, that bind tightly but fail to inhibit
Eσ70, opens ways for addressing experimentally
the mechanisms by which Gp2 might inhibit
Eσ70. Such endeavours are underway in our
laboratories.Acknowledgements
This work was supported by a Biotechnology
and Biological Sciences Research Council (BBSRC)
grant (to S.W, E.C and S.M.) and a UK
Biochemical Society travel grant (to S.W.). S.W.
is a recipient of a David Phillips Fellowship (BB/
E023703). Work in K.S. laboratories was sup-
ported by NIH grant GM64530, Russian Acade-
my Presidium Molecular and Cell Biology
program grant, and Federal Program “Scientific
and scientific-pedagogical personnel of innovative
Russia 2009-2013”, state contract 02.740.11.0771.
N.A. was partially supported by a Charles and
Johanna Busch Postdoctoral Fellowship from the
Waksman Institute, Russian Foundation for Basic
Research grant 08-04-00968-а, and Russian Min-
istry of Education and Science State contract
P1166.References
1. Haugen, S. P., Ross, W. &Gourse, R. L. (2008). Advances
inbacterial promoter recognitionand its control by factors
that do not bind DNA. Nat. Rev. Microbiol. 6, 507–519.
2. Wigneshweraraj, S., Bose, D., Burrows, P. C., Joly, N.,
Schumacher, J., Rappas, M. et al. (2008). Modus
operandi of the bacterial RNA polymerase containing
the sigma54 promoter-specificity factor. Mol. Micro-
biol. 68, 538–546.
3. Davis, C.A., Bingman, C.A., Landick, R., Record,M. T.,
Jr & Saecker, R. M. (2007). Real-time footprinting of
DNA in the first kinetically significant intermediate in
open complex formation by Escherichia coli RNA
polymerase. Proc. Natl Acad. Sci. USA, 104, 7833–7838.
4. Murakami, K. S., Masuda, S., Campbell, E. A.,
Muzzin, O. & Darst, S. A. (2002). Structural basis of
transcription initiation: an RNA polymerase holoen-
zyme-DNA complex. Science, 296, 1285–1290.
5. Mekler, V., Kortkhonjia, E., Mukhopadhyay, J.,
Knight, J., Revyakin, A., Kapanidis, A. N. et al.
(2002). Structural organization of bacterial RNA
polymerase holoenzyme and the RNA polymerase-
promoter open complex. Cell, 108, 599–614.
6. Opalka, N., Brown, J., Lane,W. J., Twist, K. A., Landick,
R., Asturias, F. J. & Darst, S. A. (2010). Complete
structural model of Escherichia coli RNA polymerase
from a hybrid approach. PLoS Biol. 8, e1000483.
7. Ederth, J., Artsimovitch, I., Isaksson, L. A. & Landick,
R. (2002). The downstream DNA jaw of bacterial RNA
polymerase facilitates both transcriptional initiation
and pausing. J. Biol. Chem. 277, 37456–37463.
8. Nechaev, S. & Severinov, K. (2003). Bacteriophage-
induced modifications of host RNA polymerase.
Annu. Rev. Microbiol. 57, 301–322.
9. Nechaev, S. & Severinov, K. (1999). Inhibition of
Escherichia coli RNA polymerase by bacteriophage T7
gene 2 protein. J. Mol. Biol. 289, 815–826.
10. Camara, B., Liu, M., Reynolds, J., Shadrin, A., Liu, B.,
Kwok, K. et al. (2010). T7 phage protein Gp2 inhibits
the Escherichia coli RNA polymerase by antagonizing
stable DNA strand separation near the transcription
start site. Proc. Natl Acad. Sci. USA, 107, 2247–2252.
11. Savalia, D., Robins, W., Nechaev, S., Molineux, I. &
Severinov, K. (2010). The role of the T7 Gp2 inhibitor
of host RNA polymerase in phage development.
J. Mol. Biol. 402, 118–126.
12. Wigneshweraraj, S. R., Burrows, P. C., Nechaev, S.,
Zenkin, N., Severinov, K. & Buck, M. (2004). Regulat-
ed communication between the upstream face of RNA
polymerase and the beta' subunit jaw domain. EMBO
J. 23, 4264–4274.
13. Bellamy, S. R. & Baldwin, G. S. (2001). A kinetic
analysis of substrate recognition by uracil-DNA
glycosylase from herpes simplex virus type 1. Nucleic
Acids Res. 29, 3857–3863.
14. Wilson, C. & Dombroski, A. J. (1997). Region 1 of
sigma70 is required for efficient isomerization and
initiation of transcription by Escherichia coli RNA
polymerase. J. Mol. Biol. 267, 60–74.
doi:10.1016/j.jmb.2011.09.029 J. Mol. Biol. (2011) 413, 1016–1027
Contents lists available at www.sciencedirect.com
Journal of Molecular Biology
j ourna l homepage: ht tp : / /ees .e lsev ie r.com. jmbMolecular Mechanism of Transcription Inhibition by
Phage T7 gp2 Protein
Vladimir Mekler 1⁎, Leonid Minakhin 1, Carol Sheppard 2,
Sivaramesh Wigneshweraraj 2 and Konstantin Severinov 1, 3⁎
1Department of Molecular Biology and Biochemistry, Waksman Institute for Microbiology, Rutgers,
The State University of New Jersey, Piscataway, NJ 08854, USA
2Section of Microbiology, Faculty of Medicine and Centre for Molecular Microbiology and Infection,
Imperial College London, SW7 2AZ, UK
3Institutes of Molecular Genetics and Gene Biology, Russian Academy of Sciences, Moscow 119991, RussiaReceived 23 July 2011;
received in revised form
14 September 2011;
accepted 15 September 2011
Available online
21 September 2011
Edited by R. Ebright
Keywords:
RNA polymerase;
transcription inhibition;
T7 bacteriophage;
open promoter complex;
protein beacon assay*Corresponding authors. K. Severin
at Waksman Institute, 190 Frelingh
Piscataway, NJ 08854, USA. E-mail
mekler@waksman.rutgers.edu;
severik@waksman.rutgers.edu.
Abbreviations used: RNAP, RNA
tetramethylrhodamine.
0022-2836/$ - see front matter © 2011 EEscherichia coli T7 bacteriophage gp2 protein is a potent inhibitor of host
RNA polymerase (RNAP). gp2 inhibits formation of open promoter
complex by binding to the β′ jaw, an RNAP domain that interacts with
downstream promoter DNA. Here, we used an engineered promoter with
an optimized sequence to obtain and characterize a specific promoter
complex containing RNAP and gp2. In this complex, localized melting of
promoter DNA is initiated but does not propagate to include the point of the
transcription start. As a result, the complex is transcriptionally inactive.
Using a highly sensitive RNAP beacon assay, we performed quantitative
real-time measurements of specific binding of the RNAP–gp2 complex to
promoter DNA and various promoter fragments. In this way, the effect of
gp2 on RNAP interaction with promoters was dissected. As expected, gp2
greatly decreased RNAP affinity to downstream promoter duplex.
However, gp2 also inhibited RNAP binding to promoter fragments that
lacked downstream promoter DNA that interacts with the β′ jaw. The
inhibition was caused by gp2-mediated decrease of the RNAP binding
affinity to template and non-template strand segments of the transcription
bubble downstream of the −10 promoter element. The inhibition of RNAP
interactions with single-stranded segments of the transcription bubble by
gp2 is a novel effect, which may occur via allosteric mechanism that is set in
motion by the gp2 binding to the β′ jaw.© 2011 Elsevier Ltd. All rights reserved.Introduction
RNA polymerase (RNAP) is among the most
highly regulated enzymes in the bacterial cell.ov is to be contacted
uysen Road,
addresses:
polymerase; TMR,
lsevier Ltd. All rights reserveBacteriophages have developed ingenious mecha-
nisms to modify host RNAP to make it serve viral
needs. Interactions between phage-encoded factors
and host RNAPs have long served as a rich source of
paradigms for transcriptional regulation (reviewed
in Refs. 1 and 2). One such example is provided by
Escherichia coli bacteriophage T7. The transcription of
T7 phage genome proceeds in three stages. Early T7
genes are transcribed from several very strong
promoters by E. coli RNAP containing primary σ70
subunit (Eσ70), whereasmiddle and late T7 genes are
transcribed by phage-encoded RNAP.3 The product
of the middle T7 gene 2, a 7-kDa protein called gp2,d.
1017Transcription Inhibition by Phage T7 gp2 Proteinbinds to the β′ jaw domain of the host RNAP and
inhibits it.4,5 Only one gp2 molecule participates in
tight interaction with an RNAPmolecule,6 and point
mutations in, as well as, deletions of the β′ jaw
abolish this binding.5 gp2 was originally thought to
simply switch phage gene transcription from host to
viral RNAP. However, its essential biological role is
to prevent transcription by host RNAP into those
parts of T7 genome that are normally transcribed by
viral RNAP. The slow-moving E. coli RNAP slows
down the fast-moving T7 RNAP, causing the latter
enzyme to pause, which initiates aberrant processing
of T7 replicative intermediates, leading to accumu-
lation of improperly packaged, defective phage
particles.7,8
The RNAP site of gp2 binding, the β′ jaw, is part
of a trough that accepts double-stranded DNA
downstream of the transcription start point.9 An
RNAP mutant lacking the β′ jaw (RNAP-β′Δjaw) is
active but forms unstable transcription initiation
complexes.9 Binding of gp2 to the β′ jaw prevents
formation of detectable promoter complexes by
Eσ70.5,10 gp2 has no effect on (and does not bind to)
preformed open promoter complexes (RPo) or
transcription elongation complexes.5 Thus, the β′
jaw interactions with downstream DNA and gp2
appear to be mutually exclusive, suggesting that the
mechanism of inhibition is based on steric blockade
of the β′ jaw interactions with DNA by bound gp2.
It is commonly accepted that RPo formation is
initiated when Eσ70 contacts with DNA upstream of
the transcription start point are established. Since
gp2 binds the β′ jaw, it is expected to inhibit a late
stage of RPo formation. Thus, gp2 is predicted to
trap an intermediate complex en route to RPo.
10
However, promoter complexes containing gp2, if
they exist, are unstable, and standard methods such
as footprinting failed to reveal the interaction of the
preformed complex of Eσ70 and gp2 (Eσ70–gp2)
with promoter.10 Here, we used an engineered
promoter with optimized sequence to obtain and
partially characterize a specific transcriptionally
inactive promoter complex containing Eσ70 and
gp2. DNase I footprinting and KMnO4 probing of
this complex reveal that gp2 prevents establishment
of downstream DNA contacts and interferes with
DNAmelting near the transcription start site but has
no effect on RNAP interactions with DNA at and
upstream the −10 promoter element. Using a
recently developed fluorescence RNAP beacon
assay,11 we performed quantitative real-time mea-
surements of specific binding of the Eσ70–gp2
complex to promoter DNA and various promoter
fragments. In this way, the effect of gp2 on RNAP
interaction with promoters was dissected. The data
show that gp2 not only greatly decreases RNAP
affinity to downstream promoter duplex but also
reduces RNAP affinity to non-template strand
segment of the transcription bubble located betweenthe −10 element and the transcription start site
(called “discriminator” on some promoters). Fur-
ther, gp2 appears to impede the entry of the
template strand into the active center cavity. The
inhibition of RNAP–discriminator interactions by
gp2 is a novel effect, which may be either direct or
indirect, that is, due to allosteric changes caused by
gp2 binding to the β′ jaw.We propose that promoter
complexes trapped by gp2 correspond to an
intermediate of promoter complex formation. Avail-
ability of such complexes, which are very transient
in the absence of gp2, opens way for their functional
and structural characterization.Results
Experimental setup: Use of the RNAP beacon
assay to monitor the inhibition of E. coli Eσ70
interactions with promoter DNA by T7 gp2
T7 gp2 binding to the jaw domain of the E. coli
RNAP β′ subunit decreases Eσ70 affinity to pro-
moter DNA and prevents formation of catalytically
competent RPo.5,10 Eσ
70 binding to promoter DNA
and various promoter fragments can be measured
using fluorescence protein beacon assay.11 The
beacon assay relies on the detection of fluorescence
signal from RNAP holoenzyme containing the σ70
subunit with fluorescent label site-specifically in-
corporated in proximity to region 2.3, the part of σ
that recognizes the −10 promoter element. The
ground level fluorescence of such RNAP beacon is
low because aromatic σ amino acids quench the
fluorescence of the label. When RNAP beacon binds
promoter DNA or a promoter fragment, specific
interactions between σ region 2.3 and DNA are
established. Since aromatic amino acids that quench
the label participate in interactions with promoter
DNA, the fluorescent probe becomes “unquenched”,
leading to increased fluorescence.
As can be seen from Fig. 2a, the fluorescence
signal generated upon the addition of T5 N25
promoter-containing DNA fragment (shown in Fig.
1) to the RNAP beacon preincubated with excess
gp2 is considerably lower than that observed in
the absence of gp2. The gp2 effect was insignifi-
cant when gp2 was added to preformed complex
of RNAP beacon and T5 N25 promoter DNA (Fig.
2a). The results are consistent with standard abortive
transcript synthesis assay (Fig. 2b): transcription
from T5 N25 was strongly inhibited when gp2 was
added to RNAP before the addition of promoter
DNA (lane 2), but no effect was observed when gp2
was added to preformed open complexes (lane 3).
Thus, the beacon assay allows one to follow the
inhibitory action of T7 gp2 on RNAP interactions
with promoter.
Double-stranded DNA probes 
-65                               -30                 -10           +35 
TCTTTGCTCAAAGAATCATAAAAAATTTATTTGCTTTCAGGAAAATTTTTCTGTATAATAGATTCA----   T5 N25
AGAAACGAGTTTCTTAGTATTTTTTAAATAAACGAAAGTCCTTTTAAAAAGACATATTATCTAAGT---- 
TCTTTGCGCTAAAATTTTTTTTAAAAGTATTTGACATCAGGAAAATTTTTTGGTATAATAGATTCA----   N25cons
AGAAACGCGATTTTAAAAAAAATTTTCATAAACTGTAGTCCTTTTAAAAAACCATATTATCTAAGT---- 
TCTTTGCTCAAAGAATCATAAAAAATTTATCCACTTTCAGGAAAATTTTTCTGCGCGGCAGATTCA---- Non-pro-
AGAAACGAGTTTCTTAGTATTTTTTAAATAGGTGAAAGTCCTTTTAAAAAGACGCGCCGTCTAAGT---- moter DNA
-59                                          -12   
CGCTAAAATTTTTTTTAAAAGTATTTGACATCAGGAAAATTTTTCTGT                      [-59/-12]
GCGATTTTAAAAAAAATTTTCATAAACTGTAGTCCTTTTAAAAAGACA 
-50                                                    * *   *+14 
TCATAAAAAATTTATTTGACATCAGGAAAATTTTTTGGTATAATAGATTCATAAATTTGAGAGA       [-50/+14]
AGTATTTTTTAAATAAACTGTAGTCCTTTTAAAAAACCATATTATCTAAGTATTTAAACTCTCT 
                  Downstream fork junctions 
-12                          +20 
TATAATAGATTCATAAATTTGAGAGAGGAGTT   [-12/+20][+2/+20] (+2)
             ATTTAAACTCTCTCCTCAA                             
TATAATAGATTCATAAATTTGAGAGAGGAGTT   [-12/+20][+3/+20] (+3)
              TTTAAACTCTCTCCTCAA                             
TATAATAGATTCATAAATTTGAGAGAGGAGTT   [-12/+20][+4/+20] (+4)
               TTAAACTCTCTCCTCAA                               Hairpin downstream
fork junctions
TATAATAGATTCATAAATTTGAGAGAGGAGTT   [-12/+20][+5/+20] (+5)
                TAAACTCTCTCCTCAA          
[-12/+9][+4/+9]SP
TATATTAGATTCATAAATTTGAGAGAGGAGTT    NC(+2/+3)
               TTAAACTCTCTCCTCAA                                  -12            +4   +9 
             GC                                                    TATAATAGATTCATAAATTTG
                                                                                  TTAAAC 
TATATTAGATTCATAAATTTGAGAGAGGAGTT    NC(-1/+3)
               TTAAACTCTCTCCTCAA
           TCGC                                                [-12/+9][+4/+9;NC-4/+3]SP
TATATTAGATTCATAAATTTGAGAGAGGAGTT    NC(-4/+3)                    -12             +4   +9
               TTAAACTCTCTCCTCAA                                   TATAATAGATTCATAAATTTG
        CGGTCGC                                                                   TTAAAC
CGGTCGC
Upstream fork junctions                 Single-stranded
probes
-26                        +2                                
 ATGCTTCCGGCTCGTATAATGTGTGGAA  [-26/+2][-26/-12]
 TACGAAGGCCGAGCA                                               -12          +2 
TATATTAGATTCAT [-12/+2}
-26                    -3 
 ATGCTTCCGGCTCGTATAATGTGT      [-26/-3][-26/-12]                TATATTAGAT     [-12/-3]
 TACGAAGGCCGAGCA 
TATATT         [-12/-6]
-26                -7 
 GGAAAATTTTTTGGTATAAT [-26/-7][-26/-12]
 CCTTTTAAAAAACCA 
-38                        -11 
 TATTTGCTTTCAGGAAAATTTTTCTGTA [-38/-11][-38/-12]
 ATAAACGAAAGTCCTTTTAAAAAGACA 
Fig. 1. Structures of DNAprobes used. The probe names used in the text are in red. In fork junction probe names, numbers
in left and right parentheses correspond to borders of upper and bottom strands of fork junctions, with respect to the
transcription start position located at +1 (underlined).“SP” stands for the SP18 linker that joins non-template strandoligoswith
template strand oligos in short hairpin fork junctions (shown as a vertical line in corresponding probe structures). Asterisks
above the [−50/+14] probe indicate positions where the fragments used in experiment shown in Fig. 8 were truncated.
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1019Transcription Inhibition by Phage T7 gp2 ProteinA stable ternary complex containing Eσ70, gp2,
and promoter DNA can form when RNAP
interactions with promoter are optimized
gp2 also decreased the binding of RNAP beacon
to control non-promoter DNA fragment (Fig. 1)
that contained multiple substitutions in the −35 and
−10 regions and lacked transcription activity in
vitro. Curiously, the signal observed upon the
addition of T5 N25 DNA to Eσ70–gp2 was higher
than that observed upon the addition of non-
promoter DNA (Fig. 2a). We interpreted this result
by hypothesizing that some specific interactions
between Eσ70–gp2 complex and promoter are
established. However, we could not detect specific
binding of T5 N25 DNA to RNAP in the presence of
gp2 using KMnO4 probing or DNase I footprinting
techniques (data not shown). We hypothesized that
this negative result may reflect insufficient stability
of ternary (RNAP–gp2–T5 N25) complexes. To(a) 
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Fig. 2. T7 gp2 inhibits RNAP interaction with the T5
N25 promoter. (a) Time dependence of the change in
fluorescence upon mixing 1 nM [211Cys-TMR] σ70 RNAP
holoenzyme with 2 nM −65/+35 T5 N25 (black) or a non-
promoter DNA fragment (red) in the presence or in the
absence of gp2. The upper curve [labeled as “(RNAP+T5
N25)+gp2”] was obtained in an experiment where gp2
was added to the RNAP beacon preincubated with 2 nM
T5 N25 promoter fragment for 30 min. In other experi-
ments, gp2 was added to preformed RNAP–T5 N25 or
RNAP–non-promoter DNA complexes. (b) Inhibition of
abortive transcript synthesis from T5 N25 promoter
fragment by gp2. Reactions contained Eσ70 alone (lane
1) or Eσ70 with gp2 added before (lane 2) or after (lane 3)
open complex formation. An autoradiograph of denatur-
ing polyacrylamide gel is presented.
Fig. 3. Eσ70 forms complexes on the N25cons promoter
in the presence of gp2. Reactions containing indicated
proteins and N25cons promoter DNA fragment terminally
labeled at the template (“t”) or non-template (“nt”) strands
were footprinted with DNase I or probed with KMnO4 as
described in Materials and Methods. gp2 was added prior
to (lanes 3, 7, 12, and 16) or after (lanes 4, 8, 13, and 17) open
complex formation. Reaction products were resolved by
denaturing PAGE and revealed using PhosphorImager.improve the putative ternary complex stability, we
prepared a derivative of −65 to +35 T5 N25 DNA
fragment containing the consensus −35 element, an
optimized UP element,12 and the extended −10
element (Fig. 1). We expected that RNAP binding to
this promoter, which we call N25cons, would be
strengthened due to improved interactions upstream
of the −10 promoter element. As expected, the DNA
fragment containing N25cons generated significant
fluorescence signal when combined with RNAP
beacon in the presence of gp2 (Fig. S1a), indicating
that specific complex between Eσ 70–gp2 and
N25cons forms on this promoter. In the absence of
gp2, Eσ70 was highly active on N25cons in the
abortive transcription initiation assay (Fig. S1b, lane
1), yet despite the considerable fluorescence signal
observed in the beacon assay, transcription from
N25cons was highly sensitive to the addition of gp2
prior to promoter complex formation (Fig. S1b, lane
2). gp2 had no effect on preformed open complexes
on N25cons (Fig. S1b, lane 3).
Eσ70–gp2 formed complexes with the N25cons
promoter that were readily detectable and clearly
distinct from complexes formed by Eσ70 alone or
1020 Transcription Inhibition by Phage T7 gp2 Proteinwhen gp2 was added after promoter complex
formation (Fig. 3). First, DNase I footprinting
demonstrated that, while Eσ70 strongly protected
DNA up to +18 (with weaker protection extending
approximately up to position +25), no protection
downstream of position +8 was observed in
complexes formed by Eσ70–gp2 on either DNA
strand (Fig. 3, compare lanes 2 and 3 and lanes 11
and 12). In contrast, the upstream portion of the
footprint was identical in all complexes. Second,
ExoIII treatment of promoter complexes revealed
that the downstream boundary of Eσ70 promoter
complex, located at position +18 in the absence of(a) 
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Fig. 4. Binding of downstream fork junction probes to
the Eσ70–gp2 complex. (a) Titration of Eσ70 and Eσ70–gp2
with [−12/+20][+4/+20] downstream fork junction. The
Kd values were determined by fitting the dependence of
relative fluorescence signal amplitude (F/Fo) on probe
concentration to a chemical equilibrium equation.11 (b)
The effect of fork junction point position on Eσ70–gp2
interaction with downstream fork junction probes. Time
dependence of the increase in fluorescence upon mixing
the (RNAP beacon–gp2) complex with 50 nM [−12/+20]
[+2/+20], [−12/+20][+3/+20], [−12/+20][+4/+20],
[−12/+20][+5/+20], and [−12/+20;−7C][+4/+20] probes
abbreviated as +2, +3, +4, +5, and +4;−7C, correspond-
ingly. The upper curve corresponds to RNAP beacon
binding to 50 nM [−12/+20][+4/+20] probe in the
absence of gp2.gp2, was mostly shifted to around position +3 in the
case of Eσ70–gp2 complex (Fig. S2). The upstream
boundary, located approximately at position −42,
was slightly shifted downstream in the presence of
gp2, whether added before or after DNA (Fig. S2,
compare lanes 6, 7, and 8). While this observation
suggests that gp2 may modify RNAP interactions
upstream of the −35 promoter element, this effect is
weak, as experiment shown in Fig. 7 (see below)
demonstrates. KMnO4 probing revealed that, in the
absence of gp2, thymine bases at positions from −11
to +3 on the template strand are highly accessible to
permanganate, with thymine at position +4 and
cytidine at position −14 exhibiting weak sensitivity
to the modifying reagent (Fig. 3). In complexes
formed by Eσ70–gp2, the reactivity of bases located
from the upstream edge of the transcription bubble
up to −6 was altered insignificantly, while intensity
of KMnO4-sensitive bands further downstream was
decreased (Fig. 3, compare lanes 15 and 16). On the
non-template strand, strong reactivity at and around
the transcription start point was observed in the
absence of gp2 (Fig. 3, lane 6). This reactivity was
strongly decreased in Eσ70–gp2 complexes (Fig. 3,
lane 7). We explain the residual KMnO4 reactivity at
and around the transcription start site seen in
reactions containing Eσ70–gp2 complexes by the
presence of a small fraction of Eσ70–promoter
complexes in the reactions. The presence of such
complexes is also evident from ExoIII footprinting (a
minor fraction of exonuclease stops at position +18;
Fig. S2, lane 3) and residual abortive initiation
activity (Fig. S1b, lane 5). We therefore suspect that,
in Eσ70–gp2 complexes per se, the transcription start
site is closed, explaining why these complexes are
transcriptionally inactive. The KMnO4 reactivity
decreased insignificantly upon a 2-min challenge
of the Eσ70–gp2–N25cons complex with 50 μg/ml of
DNA competitor heparin (data not shown).
Overall, the results indicate that when interactions
with the upstream promoter part are strong, RNAP
forms a specific, stable, yet transcriptionally inactive
promoter complex in the presence of gp2. The
complex is only partially open, and formation of
contacts in the downstream portion of the transcrip-
tion bubble, as well as contacts with double-
stranded DNA downstream of the transcription
initiation start point, appears to be compromised. In
the ternary complex, the DNA trajectory down-
stream from the −10 element must differ consider-
ably from that in RPo. A similar complex may form
on the wild-type T5 N25 promoter; however, it is too
transient to be detected by footprinting.
Quantitative dissection of the gp2 inhibitory
effect using model promoter fragments
Eσ70 specifically binds upstream and downstream
fork junctions—partially double-stranded DNA
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Fig. 5. Binding of downstream fork junction probes
with template strand overhangs to the Eσ70–gp2 complex
and Δβ′(1149–1190)Eσ70. (a) Time dependence of the
fluorescence intensity in samples containing 1 nM
[211Cys-TMR] σ70 holoenzyme, 200 nM gp2, and 50 nM
indicated downstream fork junction probes. (b) Time
dependence of the fluorescence intensity upon the
addition of 3 nM indicated downstream fork junction
probes to 1 nM [211Cys-TMR] σ70 holoenzyme bearing
the Δβ′(1149–1190) deletion.
1021Transcription Inhibition by Phage T7 gp2 Proteincontaining short non-template strand overhangs
with the −10 promoter element sequence—and this
interaction can be monitored by the beacon
method.11,13,14 By “upstream” and “downstream”,
we here mean the location of double-stranded
segments relative to the non-template strand over-
hangs. gp2 inhibits Eσ70 binding to downstream fork
junction probes, whereas RNAP binding to up-
stream fork junction probe [−38/−11][−38/−12]
(shown in Fig. 1) containing a short single-stranded
extension corresponding to the −11A base is not
affected.14 These results indicate that downstream
fork junctions contain promoter segments whose
recognition by RNAP is targeted by gp2, and
therefore, these probes can be used to study the
gp2 inhibition mechanism in more detail. We
decided to quantitatively measure Eσ70 binding tovarious downstream fork junctions and some other
probes (shown in Fig. 1) in the presence of gp2. To
reach binding saturation, much higher concentra-
tions of downstream fork junction probes were
required in the presence of gp2 than in its absence
(Fig. 4a; see also Ref. 14). However, the binding
observed in the presence of gp2 was specific, since
control probes bearing a C-to-T substitution at the
highly conserved −7 position did not generate any
noticeable signal (see, e.g., Fig. 4b). The equilibrium
dissociation constant (Kd) for Eσ
70–gp2 binding to
[−12/+20][+4/+20] downstream fork junction
probe (with junction point positioned at +4) was
calculated by fitting the experimental dependence of
the fluorescence signal amplitude on probe concen-
tration to a chemical equilibrium equation (e.g., by
titration assay11) (Fig. 4a). The resulting value was
120 nM. Free Eσ70 bound the same probewith aKd of
less than 0.1 nM (Fig. 4a). Thus, gp2 decreases RNAP
affinity to the downstream fork junction promoter
fragments by more than 1000-fold.
As shown in Fig. 4b, probes with junction points at
+2 and +3 bound the Eσ70–gp2 less efficiently than
the [−12/+20][+4/+20] probe. The apparent depen-
dence of downstream fork junction affinities to
Eσ70–gp2 on the junction position is somewhat
surprising, since negligible difference in affinity of
these probes to Eσ70 was detected.14
The effect of gp2 on RNAP interaction with a
segment of template strand adjacent to the transcrip-
tion start point was estimated by comparing the
binding of [−12/+20][+4/+20] or [−12/+9][+4/+9]
SP, a short hairpin downstream fork junction, and
their derivatives bearing 2- to 7-nt-long noncomple-
mentary extensions of template strand. Fluorescence
signal changes observed upon Eσ70–gp2 interaction
with these probes are shown in Fig. 5a and Fig. S4.
The kinetic curves in Fig. 5a indicate that much
higher fluorescence levels are observed when Eσ70–
gp2 is mixed with parent [−12/+20][+4/+20] probe
than with derivative probes containing template
strand overhangs. We determined the Kd value for
RNAP–gp2 binding to one such probe, NC(−3/+4).
Low signal level made it impossible to determine the
Kd value for this probe by titration assay. Therefore,
an estimate of RNAP–gp2 binding to NC(−3/+4)
(KdN0.6 μM) was obtained from a competition
binding assay11 by measuring RNAP–gp2 binding
to −12/+3 oligo with and without 0.2 μM NC(−3/
+4) (Fig. S3). In contrast, the mutant β′Δjaw RNAP
has higher affinity to downstream fork junction
probes bearing template strand extensions than to
parent probes (Fig. 5b and Table 1). Thus, the
inhibitory effect of single-stranded template strand
extension on binding of the [−12/+20][+4/+20]
derivatives is specifically caused by the gp2 binding
to RNAP.
Upon incubation with Eσ70–gp2, [−12/+9][+4/
+9]SP-based downstream fork junction with
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Fig. 6. Binding of non-template oligos containing the
−10 promoter element consensus sequence to free Eσ70
and the Eσ70–gp2 complex. Titration of [211Cys-TMR] σ70
holoenzyme and the gp2–[211Cys-TMR] σ70 holoenzyme
complex with oligonucleotide probes. Continuous lines
correspond to nonlinear regression fit of the data.
Table 1. Dissociation constants for the binding of
promoter fragments to RNAP beacon, RNAP beacon
complex with gp2, and Δβ′(1149–1190) RNAP beacon
DNA probe
Kd
RNAP
(μM)
Kd
(RNAP–gp2)
(μM)
Kd
(RNAP-β′Δjaw)
(μM)
[−12/+20][+4/+20] b10−4 0.12 3.4×10−3
NC(−4/+3) b10−4 N0.6 1.0×10−3
−12/+2 0.16 4.4 0.46
−12/−3 1.8 17
−12/−6 80 87
The structures of DNA probes are shown in Fig. 1. The Kd values
presented are averages from two to three individual experiments;
the error is ±15%.
1022 Transcription Inhibition by Phage T7 gp2 Proteintemplate strand extension generated saturated
signal similar to that observed with parental [−12/
+9][+4/+9]SP; however, the kinetics of signal
increase was significantly slower with the probe
bearing the extension (Fig. S4). These data are inmarked contrast with the situation observed in the
absence of gp2, when an overhang from +3 to −4
actually improves the affinity of short fork junctions
to Eσ70 by ∼40-fold (Fig. S5). These results indicate
that the interactions of template strand overhangs
with RNAP are affected by gp2 in the Eσ70–gp2
complexes with downstream fork junctions.
If gp2 inhibited transcription solely by targeting
interactions with the double-stranded DNA down-
stream of the transcription start point, then no effects
on the interaction with single-stranded DNA in the
transcription bubble should be expected. To deter-
mine if gp2 effect of transcription bubble formation is
direct or indirect, we studied the effect of gp2 on the
interaction of RNAP with oligonucleotides contain-
ing sequences matching the −10 promoter element
consensus sequence and corresponding to single-
stranded non-template extensions of downstream
fork junction probes. Eσ70 specifically binds such
oligonucleotide probes,15 and the interaction can be
measured by the RNAP beacon assay.11 We found
that gp2 inhibits binding of −12/+2 oligo 27-fold
(Fig. 6a and Table 1). The effect was specific since (i)
only very small decrease in RNAP binding to −12/
+2was observed in the presence of R58E gp2mutant
having impaired affinity to RNAP,10 and (ii) no
inhibition of −12/+2 oligo binding was observed
upon gp2 addition to RNAP beacon containing
RNAP-β′Δjaw14 (data not shown).
Eσ70 binding to −12/−3 oligo was inhibited by
gp2 ∼9-fold; the binding of −12/−6 oligo was not
affected (Fig. 6b and c). The results suggest that gp2
hinders Eσ70 interactions with the −5/+2 segment
of the non-template strand. Consistent with this
conclusion, gp2 also decreased binding of upstream
fork junction probes bearing longer (−11/+2 and
−11/−3) non-template strand overhangs, whereas
the binding of an upstream fork bearing a short
−11/−7 overhang was not affected (Fig. S6).
Comparison of Kd values of Eσ
70–gp2 binding to
−12/+2 oligo and [−12/+20][+4/+20] fork junction
shows that the +3/+20 segment increases affinity 37-
fold. In contrast, the +3/+20 segment increased Eσ70
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Fig. 7. The effect of T7 gp2 and T4 AsiA on Eσ70
binding to [−59/−12] probe. [−59/−12] probe (2 nM) was
combined with RNAP beacon (1 nM) preincubated for
15 min with or without 0.2 μM T7 gp2 or T4 AsiA, and the
increase in fluorescence was monitored.
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Fig. 8. The effect of gp2 on Es70 interaction with double-
stranded promoter fragments truncated at various posi-
tions downstream of the transcription start point. (a) Time
dependence of fluorescence intensity in samples contain-
ing 1 nM [211Cys-TMR] σ70 holoenzyme, 200 nM gp2, and
2 nM either of [−50/+14], [−50/+12], [−50/+8], or [−50/
+6] fragments. Upper curves correspond to experiments
in which gp2 was added to the RNAP beacon preincu-
bated with a DNA probe for 30 min; bottom curves show
fluorescence intensity changes upon addition of the DNA
probes to the RNAP beacon preincubated with gp2. The
addition of gp2 or DNA probe is indicated by vertical
arrows. (b) Inhibition of abortive transcript synthesis from
the [−50/+6] probe by gp2. Reactions contained Eσ70
alone (lane 1) or RNAP with gp2 added before (lane 2) or
after (lane 3) open complex formation.
1023Transcription Inhibition by Phage T7 gp2 Proteinaffinity 9000-fold.14 Thus, gp2 greatly decreased
RNAP affinity to downstream promoter duplex. We
also determined Kd values for binding of RNAP
beacon containing RNAP-β′Δjaw to −12/+2 oligo
and [−12/+20][+4/+20] probe (Table 1). In agree-
ment with previous results, RNAP-β′Δjaw binds the
downstream fork junction probe much weaker than
wild-type RNAP;14 however, the mutant RNAP
affinity is∼30-fold higher than that of Eσ70–gp2. The
data also show that, unlike the addition of gp2,
deletion of the β′jaw has only a slight effect on the
−12/+2 oligo binding (Table 1).
As noted above, the ExoIII footprinting data
suggested that gp2 might affect RNAP–promoter
interactions at around position −42. Moreover, this
effect must be distinct from the “normal” function of
gp2 as it is observed whether gp2 is added before of
after promoter complex formation (Fig. S2). To
determine the significance of this new effect, we
measured the consequences of gp2 addition on
RNAP binding to [−59/−12] probe. A control, T4
AsiA protein, which is known to inhibit RNAP
interaction with the −35 element,16 strongly inhib-
ited RNAP binding to this probe (Fig. 7). In contrast,
gp2 had very little or no effect on the binding of this
probe to Eσ70 (Fig. 7). We conclude that gp2 does
not noticeably affect RNAP–promoter interactions
upstream of the −10 promoter element.
Effect of gp2 on RNAP interaction with
double-stranded promoter fragments
truncated downstream of the transcription
start point
The DNase I footprinting of the ternary Eσ70–gp2–
N25cons complex suggests that gp2 blocks RNAP–promoter contacts downstream from approximately
+8 position. A set of double-stranded probes was
used to assess the influence of promoter segments
downstream of the +6 position on promoter in-
teractions with the RNAP–gp2 complex. The parent
probe was a derivative of the [−50/+14] fragment of
the T5 N25 promoter containing the consensus −35
element and the extended −10 element (Fig. 1). The
binding of [−50/+14] and three other derivative
probes truncated at +6, +8, and +12 was assessed by
measuring RNAP beacon signals upon the addition
of (i) gp2 to preformed Eσ70 complexes with each
probe or (ii) DNA probes to the Eσ70–gp2 complex.
Upon reaching equilibrium binding, signal ampli-
tudes should be the same independent of the order of
DNA and gp2 addition. As can be seen in Fig. 8a, the
binding curves were strikingly different when gp2
was added to preformed Eσ70–DNA complexes. The
fluorescence intensity decrease observed with the
[−50/+14] and [−50/+12] probes was very slow. In
1024 Transcription Inhibition by Phage T7 gp2 Proteincontrast, signal amplitudes rapidly reached equilib-
rium values upon the addition of gp2 to Eσ70
complexed with [−50/+6] or [−50/+8] probes.
Moreover, abortive transcript synthesis from [−50/
+6] was inhibited when gp2 was added either prior
or after this probe (Fig. 8b, compare lanes 2 and 3).
Combined with DNase I footprinting and structural
modeling10 data, these results suggest that Eσ70
interactions with duplex DNA downstream of ca
position +9 and with gp2 are mutually exclusive. On
the other hand, Eσ70–DNA contacts upstream of ca
position +9 are compatible with gp2 binding;
however, the interaction with gp2 leads to formation
of an inactive Eσ70–gp2–promoter complex.Discussion
The T7 gp2 is a powerful inhibitor of promoter
complex formation on most promoters. RNAP
interactions with gp2 and promoter were thought
to be mutually exclusive, and promoters that are
resistant to gp2, such as the galP1 promoter,5 escape
inhibition by displacing gp2 from RNAP via
optimized interactions of downstream DNA with
the enzyme.9 The principal result of this work is the
demonstration that, under conditions when RNAP
contacts with promoter elements are strong, a
complex between RNAP σ70 holoenzyme, T7 gp2,
and promoter can form. This complex is transcrip-
tionally inactive; however, based on DNase I and
ExoIII footprints and KMnO4 probing, it resembles
“normal” RPo at and upstream of the −10 promoter
element. Downstream of the −10 element, the
complex containing gp2 differs from RPo: the
transcription start point is not melted, and contacts
with DNAdownstream of position +8 are lacking (in
RPo, strong downstream protection extends to
position +18). Thus, it appears that, in the presence
of gp2, melting of promoter is initiated normally but
does not proceed to the transcription initiation start
point. The inhibition of promoter melting near the
transcription start site is consistent with a proposal
based on a structural model of the gp2–RNAP
complex.10 While the promoter complex we describe
here was obtained on a specially designed promoter,
we surmise that similar complexesmay be formed on
other promoters. However, these complexes are too
transient to be detected by standard biochemical
assays.
It could have been expected that gp2 prevents
RPo formation simply by sterically blocking loading
of downstream DNA into the enzyme trough
formed by the β′ jaw and several other RNAP
domains.9,10 However, the fact that gp2 inhibits
transcription from open complexes formed on a
model template, which lacks DNA downstream
from the +6 position (Fig. 8b), suggests that the
mechanism of gp2 inhibition is more complex. Infact, the absence of promoter opening at and
immediately upstream of transcription start point
may be caused by gp2 binding per se, rather than by
the absence of downstream DNA loading. Indeed,
gp2 inhibits RNAP binding to various promoter
fragments lacking distal part of the downstream
promoter duplex segment, including oligonucleo-
tides and upstream fork junctions probes that bear
no DNA bases downstream from the transcription
start site. Since these effects occur in the absence of
β′ jaw–DNA contacts, they, therefore, indicate that
gp2 inhibits RNAP interaction with downstream
part of the transcription bubble between positions
−6 and +2. Since the site of the binding of gp2, a
small protein, is located away from RNAP sites
interacting with single-stranded promoter DNA,
we believe that this inhibition may be of allosteric
nature. For example, the binding of gp2 to the β′
jaw may interfere with movements of the RNAP β′
clamp domain that may be required for establish-
ment of interactions with single-stranded DNA
segments. 17,18 In the RNAP holoenzyme, σ70
subunit region 1.1 is positioned inside the RNAP-
active-site channel from where it is displaced by the
downstream promoter segment upon RPo for-
mation.19,20 Recent results suggest that efficient
inhibition of Eσ70 by gp2 requires the σ70 region
1.1.6 Thus, the inhibition of RNAP interactions with
single-stranded DNA by gp2 may also involve the
σ70 region 1.1. Additional biophysical experiments
will be required to test these ideas.
The high affinity for RNAP and the two-pronged
mechanism of inhibition of open promoter complex
formation pathway, first, by affecting promoter
opening, and second, by interfering with the β′
jaw contacts with downstream DNA, make gp2 a
very efficient inhibitor. This is a biologically relevant
property, since any leaky transcription from early
phage promoters, particularly the A3 promoter,8
leads to transcriptional interference between the
slow-moving host RNAP and the fast-moving T7
RNAP, causing abnormal progeny phage genome
processing and packaging.
Melting of the transcription start site is an
obviously critical step during the formation of the
catalytically competent open promoter complex.
Apparently, different factors and/or changes in the
RNAP structure can affect promotermelting near the
start site, without having an effect on the nucleation
of promoter melting further upstream. The complex
formed in the presence of gp2 appears to be similar to
previously described complex formed by RNAP
lacking the β lobe.21 However, the mutant RNAP
complexes establish proper downstream contacts in
the presence of transcription substrates and are
transcriptionally active. The antibiotic myxopyronin
binds to a pocket inside the RNAP β clamp domain
and blocks promoter melting propagation toward
the active site downstream from the −3 position,18,22
1025Transcription Inhibition by Phage T7 gp2 Proteinagain resulting in a complex that may be similar to
the gp2-containing complex. Some promoters hav-
ing GC-rich discriminator sequences are known to
form unstable open complexes, a property that is
relevant for their specific inhibition during amino
acid starvation.2,23,24 It is possible that the stringent
control-dependent destabilization of complexes
formed on these promoters is due to the same
mechanism that is used by gp2. Future work will
have to establish how such partially opened pro-
moter complexes are related to intermediate com-
plexes on the pathway to RPo formation.
25–27
Our work demonstrates that protein beacon assay
is a powerful approach to uncover mechanistic
details of transcription factor action. The high
sensitivity and the ability to probe RNAP interac-
tions with upstream, downstream, and central
(corresponding to the transcription bubble) regions
of a promoter allow the use of the beacon assay to
study even such potent transcription initiation
inhibitors as T7 gp2. In addition, because the beacon
assay signal relies on unquenching of σ70 region 2.3
aromatic residues with promoter DNA, it allows one
to study the local environment of the region 2.3
aromatic cluster in response to different inputs.
Other transcription regulators and inhibitors affect-
ing RNAP–promoter interactions, including numer-
ous factors encoded by bacteriophages, can be
informatively analyzed by this technique.Materials and Methods
Proteins
RNAP holoenzyme containing σ70 derivative labeled
at position 211 with fluorescent label 5-tetramethylrho-
damine (TMR) ([211Cys-TMR] σ70) was prepared as in
Ref. 11. T7 phage gp2 wild type and R58E mutant, E. coli
core RNAP containing a deletion (1149–1190) in the β′
subunit, and T4 phage AsiA protein were prepared as
described previously.5,10,16DNA probes
DNA oligonucleotides and modified oligonucleotides
containing the SP18 spacer were synthesized by Integrated
DNA Technologies. Fork junction and double-stranded
DNAprobes were prepared as in Refs. 11 and 14. A control
non-promoter DNA fragment consisted of mutated −65/
+35 T5 N25 strands in which −10 and −35 promoter
element sequences were changed to CGCGGC and
CCACTT, respectively.Fluorometric assays
Fluorescence measurements were performed using a
QuantaMaster QM4 spectrofluorometer (PTI) in transcrip-
tion buffer [40 mM Tris–HCl (pH 8.0), 100 mM NaCl, 5%glycerol, 1 mM DTT, and 10 mMMgCl2] containing 0.02%
Tween 20 at 25 °C. Final assay mixtures (800 μl) contained
1 nM labeled RNAP holoenzyme and DNA probes at
various concentrations. The TMR fluorescence intensities
were recorded with an excitation wavelength of 550 nm
and an emission wavelength of 578 nm. Time-dependent
fluorescence changes were monitored after manual mixing
of RNAP beacon (800 μl) and a DNA probe (b20 μl) in a
cuvette; the mixing dead-time was 15 s.
To obtain equilibrium dissociation constants (Kd) of the
RNAP beacon with oligonucleotides and fork junctions,
we fitted the experimental dependence of the fluorescent
signal amplitude on DNA probe concentration to a
chemical equilibrium equation (i.e., titration assay) as
described in Ref. 11, unless otherwise noted.
The complex of Eσ70 with gp2 (Eσ70–gp2) was prepared
bymixing 1 nM Eσ70 beacon with 200 nM gp2 followed by
10-min incubation at room temperature. Increasing gp2
concentration up to 600 nM did not influence binding of
DNA probes to Eσ70–gp2 under conditions of the
measurements.
In vitro abortive initiation assay
Abortive transcription reactions were performed in a
final volume of 10 μl and contained 200 nM E. coli σ70
holoenzyme (Epicentre), 500 nM gp2 (where indicated),
and 50 nM various DNA templates prepared as described
above in transcription buffer. Reactions were mixed as
indicated and incubated for 10 min at 37 °C, followed by
the addition of CpA RNA dinucleotide primer (200 μM),
cold UTP (20 μM), and [α-32P]UTP (3000 Ci/mmol). The
reactions were incubated for a further 10 min at 37 °C and
then terminated by the addition of an equal volume of
urea-formamide loading buffer. The reaction products
were resolved on a 20% (w/v) polyacrylamide denaturing
gel and visualized using a PhosphorImager.
Footprints
For in vitro footprinting experiments, the double-
stranded DNA promoter fragments were prepared as in
Ref. 11 using radioactively 5′ end-labeled with [32P]γATP
oligonucleotides corresponding to either non-template or
template strand. Next, the labeled promoter fragments
were purified on Micro Bio-Spin 6 Columns (Bio-Rad) and
used for the assays.
DNase I footprinting
Promoter complexes were formed in a final volume of
10 μl and contained 200 nM E. coli σ70 holoenzyme
(Epicentre), 2 μM gp2 (where indicated), and 50 nM DNA
template in transcription buffer. Reactions were mixed
with the order of addition of particular components as
indicated, incubated for 10 min at 37 °C, followed by the
addition of 0.2 units of DNase I (New England Biolabs).
The reactions were proceeded for 30 s at 37 °C and were
terminated by the addition of 20 μl of stop buffer (10 μg of
calf thymus DNA and water) followed by ethanol
precipitation. Samples were dissolved in 8 μl of urea-
formamide loading buffer and resolved in 7% polyacryl-
amide denaturing gel.
1026 Transcription Inhibition by Phage T7 gp2 ProteinKMnO4 probing
Reactions were set up as described for DNase I
footprinting. Promoter complexes were treated with
1 mM KMnO4 at room temperature for 30 s. Reactions
were terminated by the addition of 300 mM β-mercap-
toethanol followed by ethanol precipitation and 20-min
treatment with 10% piperidine at 95 °C. Reaction products
were next treated with chloroform to remove piperidine,
ethanol precipitated, dissolved in 8 μl of urea-formamide
loading buffer, and resolved in 7% polyacrylamide
denaturing gel.
ExoIII footprinting
Reactions were set up as described above. Promoter
complexes were treated with 0.5 units of ExoIII (New
England Biolabs) for 2 min at 37 °C. Reactions were
terminated by the addition of 20 μl of stop buffer (10 μg of
calf thymus DNA and water) and precipitated with
ethanol. Samples were dissolved in 8 μl of urea-formam-
ide loading buffer and resolved in 7% polyacrylamide
denaturing gel.
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The T7 phage-encoded small protein Gp2 is a non-
DNA-binding transcription factor that interacts with
the jaw domain of the Escherichia coli (Ec) RNA poly-
merase (RNAp) b0 subunit and inhibits transcription-
ally proficient promoter-complex (RPo) formation.
Here, we describe the high-resolution solution struc-
ture of the Gp2-Ec b0 jaw domain complex and show
that Gp2 and DNA compete for binding to the b0 jaw
domain. We reveal that efficient inhibition of RPo
formation by Gp2 requires the amino-terminal s70
domain region 1.1 (R1.1), and that Gp2 antagonizes
the obligatory movement of R1.1 during RPo forma-
tion. We demonstrate that Gp2 inhibits RPo forma-
tion not just by steric occlusion of the RNAp-DNA
interaction but also through long-range antagonistic
effects on RNAp-promoter interactions around the
RNAp active center that likely occur due to reposi-
tioning of R1.1 by Gp2. The inhibition of Ec RNAp
by Gp2 thus defines a previously uncharacterized
mechanism by which bacterial transcription is regu-
lated by a viral factor.
INTRODUCTION
Transcription of DNA is a major focal point of regulation of gene
expression in all organisms. In bacteria, transcription is cata-
lyzed by a multisubunit RNA polymerase (RNAp) with subunit
composition a2bb
0us (abbreviated as Es). The catalytic determi-
nants of the bacterial RNAp are contained in the largest and
second-largest subunits (b0 and b, respectively). The overall
architecture of RNAp is reminiscent of a crab claw (Murakami
et al., 2002b). The two pincers of the claw form a positively
charged DNA binding channel (DBC). The active center whereMolecuRNAsynthesis occurs is located deepwithin theDBC (Figure 1A).
A number of flexible domains from the b0 and b subunits (b0 jaw,
b0 insertion 6, b0 downstream clamp, and b downstream and
upstream lobe domains) surround the DBC and contribute to
stable binding of DNA (Opalka et al., 2010).
A dissociable RNAp binding factor called the sigma (s) subunit
confers promoter specificity upon the RNAp by recognizing the
35 and 10 (with respect to the transcription start site at +1,
hereafter called the +1 site) elements present in most bacterial
promoters. Of the seven s factors encoded by the Escherichia
coli (Ec) genome, s70 is responsible for transcription of house-
keeping genes and is therefore a major s factor essential for
growth of the cell (Haugen et al., 2008). The six remaining ‘‘alter-
native’’ s factors contribute to transcription of genes under
specific stress conditions, growth transitions, and/or morpho-
logical changes (Gruber and Gross, 2003). Other bacteria also
have one s70-like major s factor that is responsible for transcrip-
tion of housekeeping genes, and a variable number of alternative
s factors. All alternative s factors, with the exception of s54, are
related to s70.
In Ec, transcription at most s70-dependent promoters begins
with s70-directed reversible binding of Es70 to the promoter,
which results in the formation of the initial closed promoter
complex (RPc). At most promoters, the RPc is unstable and
either dissociates or isomerizes via several intermediates to
the transcription-initiation-competent open promoter complex
(RPo). In the RPo, the promoter DNA strands are locally melted
and form a transcription bubble spanning positions 12 to +3
of the promoter and the +1 position of the template strand placed
at the RNAp active center (Figure 1A) (Murakami et al., 2002a;
Saecker et al., 2011). The double-stranded DNA (dsDNA) imme-
diately downstream of the active center (dwDNA) interacts with
a segment of the DBC called the downstream DBC (dwDBC),
and this interaction is essential for the formation and stability
of the RPo (Murakami et al., 2002a; Saecker et al., 2011).
The b0 jaw, b0 insertion 6, and b0 downstream clamp domains
contribute to the dwDBC (Murakami et al., 2002a). The
dwDNA interaction with the dwDBC can be divided into activelar Cell 47, 755–766, September 14, 2012 ª2012 Elsevier Inc. 755
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Inhibition of Ec RNAp by T7 Gp2center-proximal (+5 to +8) and -distal (+10 to +20) sets of inter-
actions. The active center-distal interactions mainly involve the
b0 jaw, b0 insertion 6, and b clamp domains. In the structural
model of the RPo, the b0 jaw domain aligns with the path of the
dwDNA and is located closest to the dwDNA. The deletion of
the b0 jaw domain (amino acid residues 1149–1190) in the Ec
RNAp dramatically reduces the stability of the RPo (Ederth
et al., 2002). Thus, it is very likely, but as yet experimentally
unproven, that the b0 jaw domain makes sequence-nonspecific
contacts with the dwDNA during RPo formation.
Within the s70 family, only proteins that function as major s
factors contain an extended (100 amino-acid-long) amino-
terminal domain, called region 1.1 (R1.1). Sequences of R1.1
from major s factors from various sources are variable but
tend to be acidic. At s70-dependent promoters, R1.1 plays an
important regulatory role during transcription initiation (see
below). Although the solution structure of the isolated domain
of R1.1 (amino acid residues 1–100) of Thermotoga maritima
sA (a counterpart of Ec s70) is available (Schwartz et al., 2008),
the R1.1 domain is not resolved in the crystal structures of
the sA-containing RNAp from Thermus aquaticus and
T. thermophilus (Murakami et al., 2002a, 2002b; Vassylyev
et al., 2002), implying that it is disordered and/or can adopt
multiple conformations. Fluorescence resonance energy trans-
fer (FRET) analyses indicate that in the absence of promoter
DNA, the position of R1.1 in Es70 corresponds to that of the
dwDNA in the RPo (Mekler et al., 2002). In other words, in
Es70, R1.1 is located deep within the active-center cleft, just
above the floor of the dwDBC channel, and is positioned to
interact with the floor and walls of the dwDBC (Figure 1A) (Mekler
et al., 2002). In the RPo, R1.1 is displaced to the tip of the
b-subunit pincer (Mekler et al., 2002). Hence, it has been
proposed that in free Es70, R1.1 acts as a mimic of dwDNA
andmust be displaced for dwDNA to enter the dwDBC and allow
the RNAp active center to access the DNA (Mekler et al., 2002).
Gp2 is a 7 kDa, T7 bacteriophage-encoded, non-DNA-binding
transcription factor. The essential biological function of Gp2 is to
coordinate transcription of the phage genome by the host and
viral RNAps (Savalia et al., 2010). Gp2 binds tightly to the b0 jaw
domain of Ec RNAp (Ca´mara et al., 2010; Nechaev and Severi-
nov, 1999) and strongly inhibits transcription from s70-depen-
dent bacterial promoters (Ca´mara et al., 2010; Nechaev and
Severinov, 1999). Gp2 inhibits RPo formation but does not
bind to (and therefore has no effect on) preformed RPo (Nechaev
and Severinov, 1999). Recently, using an optimized variant of the
s70-dependent T5 N25 promoter (hereafter called N25cons), we
trapped and characterized a ternary Es70-Gp2-promoter
complex that had normal contacts with promoter DNA upstream
of the +1 site and a partially open transcription bubble, but was
transcriptionally inactive and lacked the interaction with the
dwDNA (Mekler et al., 2011b). Here, we describe the near-
atomic resolution solution structure of Gp2 bound to a fragmentFigure 1. RPc and RPo Formation and the Structure of the Gp2-b0 Jaw
(A) Cartoon depiction of RPc and RPo formation ats70-dependent bacterial promo
(B) Ribbon representation of the Gp2-b0 jaw fragment complex.
(C) The same as (B) but rotated by 90 along the horizontal plane. In (B) and (C)
interaction interface are shown as sticks and labeled correspondingly. See also
Molecuof the b0 jaw domain (Ec b0 subunit residues 1153–1213). We
show by nuclear magnetic resonance (NMR) chemical shift
perturbation analyses that the b0 jaw domain interacts directly
with dsDNA, and that the interaction surface for dsDNA overlaps
with the Gp2 binding surface. By using RNAp containing mutant
s70 lacking R1.1 (amino acid residues 1–100) and determining
the effect of the in trans addition of the isolated R1.1 domain
on the mutant RNAp activity in the presence of Gp2, we demon-
strate that Gp2 inhibits RPo formation by Es70 not only by
sterically preventing dwDNA binding to the dwDBC but also by
exerting R1.1-dependent and long-range antagonistic effects
on RNAp-promoter DNA interactions near the RNAp active
center. Results from biophysical analyses demonstrate that
Gp2 changes the microenvironment of R1.1 in Es70 and restricts
the obligatory displacement of R1.1 from the dwDBC during RPo
formation. A combination of direct (by competing for dwDNA
binding) and indirect (mediated by R1.1) effects makes Gp2
a highly efficient inhibitor of RPo formation by Es70.
RESULTS
Structure of the Complex between Gp2 and the b0 Jaw
Domain
A lysine substitution at residue E1158 or E1188 in the b0 jaw
domain prevents Gp2 from binding to the Ec RNAp (Figure S1A
available online) (Ca´mara et al., 2010; Nechaev and Severinov,
2003). Therefore, the major Gp2 interacting surface on the b0 jaw
domain probably includes residues 1158–1188. In agreement
with this view, deletion of residues 1149–1190 in the Ec RNAp
confers resistance to inhibition by Gp2 (Nechaev and Severinov,
1999). We determined the solution structure of the complex
between Gp2 and a fragment of the b0 jaw domain (representing
Ec b0 jaw domain residues 1153–1213; hereafter referred to as
the b0 jaw fragment) using multidimensional NMR spectroscopy
applied to hybrid-labeled complexes. Backbone Ca, Cb, C0, N,
and HN assignments for each of the labeled binding partner
were obtained from HNCACB/CBCA(CO)NH and HN(CA)CO/
HNCO spectra, and side-chain assignments were completed
with the use of HCCH total correlation spectroscopy spectra.
Broadening of some residues in the binding interface indicates
the presence of conformational exchange in the isolated
complex, perhaps due to the b0 jaw fragment not fully represent-
ing the complete RNAp interaction. Despite this, the interface
was initially characterized based on the manual unambiguous
assignment of a few intermolecular nuclear Overhauser effect
(NOEs) from 13C/15N-filtered NOE spectroscopy–heteronuclear
single quantum coherence (HSQC) spectra. Automated NOE
assignment methods using the ARIA program were used to
complete the NOE assignment of the complex and calculate
a family of 10 structures (Figure S1B and Table 1). The solution
structure of the Ec b0 jaw fragment consists primarily of a four-
stranded antiparallel b sheet (Figures 1B and 1C) and showsFragment Complex
ters (the inspiration for the cartoon was taken fromMurakami and Darst [2003]).
, the interface region is enlarged in the insets, and the residues located at the
Figure S1.
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Table 1. Gp2-Jaw Complex
Number of experimental restraints 1,700
Total NOE-derived 1,532
Ambiguous 476
Unambiguous 1,056
Intraresidue 468
Sequential 200
Medium-range (ji  jj% 4) 73
Long-range (ji  jj > 4) 265
Intermolecular 50
TALOS, 4/c 168
RMSD from experimental restraints
Distance, A˚ 0.023 ± 0.002
Dihedral angle, degrees 0.6 ± 0.1
RMSD from idealized covalent geometry
Bonds, A˚ 0.0036 ± 0.0001
Improper angles, degrees 1.35 ± 0.06
Angles, degrees 0.54 ± 0.01
Coordinate RMSD, A˚
Backbone atoms in secondary structure 1.21 ± 0.15
Heavy atoms in secondary structure 1.47 ± 0.15
Ramachandran plot
Residues in most favored regions, % 75.7
Residues in allowed regions, % 24.2
Residues in disallowed regions, % 0.1
RMSD, root mean-squared deviation.
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b0 subunit in the crystal structures of T. aquaticus and T. thermo-
philusRNAp (Figure S1C). In the complex with Gp2, the b sheet is
extended to a seven-stranded b sheet in an antiparallel arrange-
ment (Figure 1B). The primary interface region is localized to b3
and b2 of the b0 jaw fragment and b3 and a1 of Gp2. The two
invariant arginine residues in Gp2 that are important for binding
to the RNAp, R56 and R58 (Ca´mara et al., 2010), are located in
the interface region in close proximity to E1188, providing
a significant ionic interaction across the interface (Figure 1B,
inset). Additional interfacial residues include L36, L40, T55, and
V57 from Gp2, and V1176, Y1186, E1187, E1188, and M1189
from the b0 jaw domain (Figures 1A and 1B, insets). Residues
L36, L40, and V57 of Gp2 form the major hydrophobic contacts
with V1176 and M1189 of the b0 jaw domain at the binding inter-
face (Figures 1A and 1B, insets). Gp2 contains a contiguous strip
of seven negatively charged amino acids (E21, E34, D37, E38,
E41, E44, and E53; hereafter referred to as the negatively
charged strip [NCS]) on the side of the molecule opposing R56
and R58 (Sheppard et al., 2011). Analyses of the role of the
NCS by mutagenesis reveal that the NCS is not important for
the binding of Gp2 to RNAp, but the disruption of the NCS signif-
icantly attenuates the ability of Gp2 to inhibit RPo formation
(Sheppard et al., 2011). An examination of the surface electro-
static properties of the Gp2-b0 jaw fragment complex reveals
that the NCS in Gp2 is extended by residues E1158, D1181,
D1184, E1187, and E1188 of the b0 jaw domain (Figure S1D).758 Molecular Cell 47, 755–766, September 14, 2012 ª2012 ElsevierInteraction of the b0 Jaw Domain with dsDNA
To better understand how Gp2 inhibits RPo formation by Es70,
we derived a composite structural model of the Gp2-RNAp
complex using our solution structure of the Gp2-b0 jaw fragment
complex together with structural models of the Ec core RNAp
(Opalka et al., 2010) and RPo based on the structure of the
T. aquaticus RNAp (Murakami et al., 2002a). In the composite
structural model, the Gp2-binding surface of the b0 jaw domain
is facing the dwDBC and toward where the dwDNA would likely
lie in the RPo (Figure 2A, insets i and ii). Because Gp2 antago-
nizes the interaction between the dwDNA and dwDBC during
RPo formation (Mekler et al., 2011a, 2011b), we hypothesized
that this region of the b0 jaw domain would make sequence-
nonspecific direct contacts with dsDNA, and the binding of
Gp2 could block or modulate its interaction with dsDNA. To
test whether an interaction exists between the b0 jaw domain
and dsDNA during RPo formation, we conducted an NMR titra-
tion experiment with a randomly generated 14 bp dsDNA frag-
ment and 15N-labeled b0 jaw fragment. We recorded 2D 1H-15N
HSQC spectra to monitor the backbone amide chemical shift
changes in the b0 jaw fragment in the presence of DNA. The
NMR spectrum exhibited several specific chemical shift
changes, which were in fast exchange on the NMR timescale
indicative of a binding constant in the micromolar to millimolar
range (Figure 2B). The major perturbed residues (T1169,
R1174, and M1189) map to the exposed surface of the b3 sheet
of the b0 jaw fragment (Figure 2A, inset ii, and Figure S1A), sug-
gesting that these residues are involved in interaction with
dsDNA. Consistent with this view, results from formaldehyde
crosslinking experiments showed that whereas the wild-type
b0 jaw fragment could be crosslinked to the 32P-labeled 14 bp
dsDNA, a mutant b0 jaw fragment containing an alanine substitu-
tion at R1174 could not be detectably crosslinked to the dsDNA
(Figure S1E, compare lanes 2 and 4). Further, the R1174A muta-
tion in the context of Es70 formed a significantly reduced number
of RPo compared with the wild-type Es70 (Figure S1F). However,
once the RPo were formed, the stabilities of themutant and wild-
type RPo upon challenge with heparin were indistinguishable
(Figure S1F), which is not surprising considering that the inter-
face between Es70 and DNA is extensive in the RPo, and the
effect of a single point mutation in the b0 jaw domain on overall
DNA binding by Es70 would be difficult to detect. Thus, in the
composite model, we redefined the potential path of the dsDNA
in the RPo with respect to the b0 jaw domain (Figure 2A, inset iii).
A comparison of the DNA-interacting surface in the b0 jaw frag-
ment with the Gp2-binding interface from our solution structure
of the Gp2-b0-fragment complex reveals significant overlap
and suggests that Gp2 and dsDNAmay compete for overlapping
interaction surfaces on the b0 jaw domain in the RNAp (Figure 2A,
inset iii and iv). To test this hypothesis, we performed a competi-
tion NMR experiment by titrating Gp2 into a saturated complex
of the b0 jaw-fragment-dsDNA complex and recorded the
changes in the NMR spectrum. As shown in Figure 2C, the char-
acteristic NMR spectrum of the Gp2-b0 jaw-fragment complex
was regained after the addition of Gp2, thus confirming that in
the context of the isolated b0 jaw fragment, Gp2 is able to
displace dsDNA efficiently. Consistent with this view, results
from formaldehyde crosslinking experiments showed that inInc.
Figure 2. Interaction of the b0 Jaw Domain with dsDNA
(A) Surface representation of the Ec core RNAp model (Opalka et al., 2010) color-coded as in Figure 1A. The boxed region is enlarged and looks at the DNA-
binding surface (shown in ribbon representation in insets i–iv). The b0 jaw domain is shown in green as a surface representation and forms part of the DNA-binding
face (i). Inset (ii) is as in (i), but showing the path of the dwDNA from the current model of the RPo (Opalka et al., 2010). Highlighted in red are residues T1169,
R1174, andM1189, which undergo significant chemical shift changes in b0 jaw fragment in the presence of dsDNA (B) andGp2 (C). Inset (iii) is as in (ii), but showing
the redefined path of the dwDNA in the dwDBC. Inset (iv) is as in (iii), but with the surface representation of Gp2 shown in cyan. Note the lack of steric clash
between Gp2 and the b0 insertion 6 domain, which provides further support for our composite model.
(B) Overlay of 2D 1H-15N HSQC spectra of the b0 jaw fragment with and without dsDNA recorded at pH 6.5, 303 K (see key for details). Peaks with significant
chemical shift differences are indicated in red with their residue numbers (T1169, R1174, and M1189).
(C) As in B, but showing the 2D 1H-15NHSQC spectra of the b0 jaw fragment with dsDNA (i.e., the b0 jaw fragment is 15N labeled) with or without unlabeledGp2 (see
key for details).
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Figure 3. Gp2 Requires R1.1 to Efficiently Inhibit RPo Formation
by Es70
(A) Autoradiograph of 20% (v/v) denaturing urea gels showing the synthesis of
the ApApUpU transcript (underlined nucleotides are a32P labeled) from the
lacUV5 promoter by Es70 (lanes 1 and 2) and Es70DR1.1 (lanes 3 and 4) in the
absence and presence of Gp2. The percentage of ApApUpU transcript
synthesized (% A) in the reactions with Gp2 with respect to reactions with no
Gp2 is given at the bottom of the gel for each reaction.
(B) As above, but showing the synthesis of the ApApUpU transcript in the
absence (lane 1) and presence (lanes 2–5) of Gp2 under conditions in which
Es70DR1.1 was preincubated with increasing amounts of isolated R1.1 domain
added in trans to the reaction (shown as the ratio of s70DR1.1 to R1.1). For (A)
and (B), all data obtained in at least three independent experiments fell within
5% of the % A value shown. See also Figure S2.
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crosslinked to the 32P-labeled 14 bp dsDNA (Figure S1E,
compare lanes 2 and 3). Overall, the results strongly suggest
that Gp2 and DNA compete for overlapping binding sites on
the b0 jaw domain in the RNAp, and provide a structural basis
for and further insights (see below) into the mechanism by which
Gp2 inhibits RPo formation by Es70.
Gp2 Requires R1.1 to Efficiently Inhibit RPo Formation
by Es70
The location of Gp2 in our composite structural model of the
Gp2-RNAp complex places Gp2 proximal to the location of
R1.1 of s70 in Es70 inferred from biophysical studies (Mekler
et al., 2002). Thus, it is possible that Gp2 could affect R1.1 func-
tion during RPo formation, and therefore Gp2 could inhibit RPo
formation by a mechanism involving R1.1 of s70. To test this
hypothesis, we explored the role of R1.1 in the mechanism by
which Gp2 inhibits RPo formation by Es70. Initially, we deter-
mined the ability of Gp2 to inhibit Es70 reconstituted with either
wild-type s70 or s70DR1.1 using an in vitro transcription assay.
Incubation of an 2-fold molar excess of Gp2 with Es70 before
the addition of a DNA fragment containing the lacUV5 promoter
abolished the synthesis of lacUV5-specific ApApUpU transcript
(Figure 3A, lanes 1 and 2) (Ca´mara et al., 2010). In contrast, under
identical conditions, Es70DR1.1 was inhibited far less efficiently760 Molecular Cell 47, 755–766, September 14, 2012 ª2012 Elsevier(55% inhibition; Figure 3A, lanes 3 and 4) even though the
affinity of Gp2 for Es70DR1.1 and Es
70 did not differ detectably
among the conditions under which the in vitro transcription
assays were performed (Figures S2A and S2B). Therefore, it
seems that full inhibition of Es70 RPo formation by Gp2 requires
R1.1 of s70. Consistent with this view, the in trans addition of the
isolated domain of s70 R1.1 (encompassing s70 amino acids
1–100) to Es70DR1.1 increased the efficiency of Es
70
DR1.1 tran-
scription inhibition by Gp2, bringing it to the same level as in
the case of Es70 (Figure 3B, lanes 2–5). Thus, the presence of
the isolated R1.1 domain in trans in Es70DR1.1 allows Gp2 to
efficiently inhibit RNAp. Full inhibition of Es70DR1.1 by Gp2
occurred when the isolated R1.1 domain was added in trans to
the Es70DR1.1 either before or after Gp2 binding (Figure S2C).
Control reactions established that the in trans presence of the
isolated R1.1 domain in Es70DR1.1 (in the absence of Gp2) did
not antagonize the ability of Es70DR1.1 to synthesize the
ApApApU transcript (Figure S2D).
An alternative Ec s factor, s38, does not contain R1.1 but is
able to recognize some s70-dependent promoters (Gruber and
Gross, 2003). We compared the ability of Gp2 to inhibit RPo
formation by Es38 and Es70 on one such promoter, the Ec
osmE promoter (Bordes et al., 2000). Although the affinity of
Gp2 for Es38 and Es70 did not differ detectably among the condi-
tions under which the in vitro transcription assays were per-
formed (Figures S2A and S2B), Gp2 inhibited Es38-dependent
synthesis of the ApApCpA osmE transcript by only 80% even
under conditions in which the amount of Gp2 exceeded that of
Es38 by 4-fold (Figure S2E). In contrast, transcription initiation
by Es70 from this promoter was barely detectable under the
same conditions (Figure S2E). As expected, full inhibition of
RPo formation by Es70 on the osmE promoter was R1.1 depen-
dent (Figure S2F, lanes 3–6). Moreover, in the presence of the
R1.1 domain ofs70 added in trans, Gp2 fully inhibited RPo forma-
tion by Es38 on the osmE promoter (Figure S2F, lanes 7–10). In
summary, even though no detectable differences in the affinity
of Gp2 for Es70, Es70DR1.1, and Es
38 were observed in two inde-
pendent experiments (Figures S2A and S2B), we cannot exclude
the possibility that the absence of R1.1 (as in the case of
Es70DR1.1 and Es
38) can affect the affinity of Gp2 for RNAp.
However, the results strongly suggest that R1.1 of s70 is part
of the mechanism by which Gp2 inhibits RPo formation by
Es70: Gp2 alone antagonizes dwDNA binding to the dwDBC,
leading to partial inhibition of RPo formation, and full inhibition
requires R1.1 of s70.
Gp2 Requires R1.1 of s70, but Not the Consensus
Promoter DNA Sequences, to Fully Inhibit RPo
Formation by Es70
The s70 factor makes extensive contacts with the consensus
promoter DNA sequences (i.e., the 35 and 10 promoter
elements) in the RPc and during RPo formation. Because full
inhibition of Es70 RPo formation by Gp2 depends on R1.1 of
s70, we considered whether interactions between Es70 and the
consensus promoter DNA sequences play any role in the mech-
anism bywhich inhibition of RPo formation byGp2 at s70-depen-
dent promoters occurs. To address this issue experimentally, we
determined whether Gp2 could inhibit the catalytic activity ofInc.
Figure 4. Gp2Requires R1.1 ofs70, but Not the Consensus Promoter
DNA Sequences, to Fully Inhibit RPo Formation by Es70
(A) Autoradiograph of a 20% (v/v) denaturing urea gel showing the synthesis of
RNA-U from the MS probe by Es70 and Es70DR1.1 in the absence (condition I)
and presence (conditions II and III) of Gp2. The percentage of RNA-U
synthesized (% A) in the reactions with Gp2 with respect to reactions with no
Gp2 is given at the bottom of the gel for each reaction.
(B) As in (A), except that the reaction was conducted with Es70DR1.1 in the
absence and presence (at8-fold molar excess over s70DR1.1) of isolated R1.1
domain added in trans. For (A) and (B), all data obtained in at least three
independent experiments fell within 5% of the % A value shown. See also
Figure S3.
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(hereafter called the minimal scaffold [MS] probe). TheMS probe
consists of an 18-nucleotide-long DNA duplex and an 8-nucleo-
tide-long RNA-DNA heteroduplex separated by two unpaired
DNA bases (Kulbachinskiy et al., 2004) (Figure S3A). Thus, the
MSprobe lacks the consensus promoter DNA sequences recog-
nized by s70. The addition of a32P-UTP to the Es70-MS probe
complex results in the synthesis of a nine-nucleotide-long a32P-
UTP-labeled RNA product, hereafter called RNA-U (Kulbachin-
skiy et al., 2004). As shown in Figure 4A, lanes 1 and 2, Gp2
inhibits the synthesis of RNA-U from the Es70-MSprobe complex
by preventing Es70 from binding to the MS probe (see also Fig-
ure S3B, lanes 1–4). In contrast, and as expected, the addition
of Gp2 to the preformed Es70-MS probe complex had relatively
little effect on the amount of RNA-U synthesized (Figure 4A,
lane 3). Under identical conditions, when Es70DR1.1 was used,
no inhibitionofRNA-UsynthesisbyGp2wasobserved (Figure4A,
lanes 4–6). The in trans addition of the isolated R1.1 domain to
Es70DR1.1 conferred a significant degree of Gp2 sensitivity upon
the Es70DR1.1-dependent transcription from the MS probe (Fig-
ure 4B, lane 4). Further, in the absenceofs70, the catalytic activity
of core RNAp on the MS probe was unaffected by Gp2 (Fig-Molecuure S3C). In summary, the results obtained with the MS probe
corroborate the view that full inhibition of Es70 RPo formation
by Gp2 depends on s70 (specifically the R1.1 domain) but occurs
independently of the consensus promoter DNA elements.
Inhibition of RPo Formation by Gp2 Involves a
Long-Range, R1.1-Dependent, Antagonistic Effect
on Es70-Promoter Interactions
In the RPc, the promoter DNA does not interact with the dwDBC,
and consistent with previous results, RPc formation is not
inhibited by Gp2 (Ca´mara et al., 2010; Mekler et al., 2011b). We
next conducted experiments to investigate whether the binding
of Gp2 to the b0 jaw domain influences RNAp-promoter interac-
tion outside of the dwDBC during RPo formation, and determine
what role (if any) R1.1 plays in this process. We conducted elec-
trophoretic gel mobility shift assays (EMSAs) to determine
whether Es70 binding to shortened versions of the s70-depen-
dent lacUV5, lPR3, and T7A1 promoter probes truncated at
position 7 of both strands (the 7/7 probes) is inhibited by
Gp2. Note that the 7/7 probes contain the 35 and 10
consensus promoter DNA elements recognized by s70 regions
4.2 and 2.4, respectively, and lack the dwDNA segment. The
results reveal that the binding of Es70 to the 7/7 probes is
not inhibited by Gp2 (Figure 5A, lanes 3 and 4, and Figure S4A),
and are thus consistent with the view that interactions between
the RNAp and the promoter in the RPc are not affected by Gp2.
In contrast, under identical conditions, the binding of Es70 to
the corresponding +20/+20 probes is abolished by Gp2, as
expected (Figure 5A, lanes 1 and 2, and Figure S4A).
We next determined the minimum length of the promoter
template at which inhibition by Gp2 starts to occur. To that
end, we extended the lacUV5 7/7 probe in one-basepair
increments and monitored the Gp2 sensitivity of complex forma-
tion with these probes by EMSA. The results show that binding of
Es70 to the 2/2 probe is reduced by 50% in the presence of
Gp2, and binding of Es70 to the 1/1 and +1/+1 probes is
inhibited by 85% and 100%, respectively (Figure 5B and Fig-
ure S4B). Because the site of Gp2 binding, the b0 jaw, is located
downstream of the +1 position, the inhibitory effect of Gp2
evidently extends beyond the inhibition of dwDNA interactions
with the b0 jaw during RPo formation (see above). In support of
the above view, whereas inhibition of Es70 binding to
the +20/+20 DNA depends on the order of addition, Gp2 in-
hibited the binding of Es70 to the +1/+1 probe independently
of the order of addition (Figure 5C; compare lanes 1–3 and
4–6). The order of addition-independent inhibitory effect of
Gp2 on the binding of Es70 to the +1/+1 probe is specific,
because the binding of Es70 to the +1/+1 probe is not inhibited
by an RNAp-binding mutant of Gp2 (R56E) (Ca´mara et al.,
2010) (Figure S4C). The binding of Gp2 to the b0 jaw per se
was not the cause of inhibition of Es70 binding to the +1/+1
probe, because Es70 bound the +1/+1 probe in the presence
of a Gp2mutant (Mut7) that binds RNAp normally but is function-
ally attenuated (Sheppard et al., 2011) (Figure S4C). Further-
more, the inhibitory effect of Gp2 was markedly reduced when
RNAp containing s70 lacking R1.1 was used to bind the +1/+1
probe (Figure 5D, lanes 3 and 4) and, as expected, was partially
restored when the isolated R1.1 domain was added in trans tolar Cell 47, 755–766, September 14, 2012 ª2012 Elsevier Inc. 761
Figure 5. Inhibition of RPo Formation by Gp2 Involves Long-Range
Antagonistic Effects on Es70-Promoter Interactions
(A) Autoradiograph of a 4% (v/v) native polyacrylamide gel comparing binding
of Es70 to the +20/+20 (lanes 1 and 2) and 7/7 (lanes 3 and 4) probes in the
presence (lanes 2 and 4) and absence (lanes 1 and 3) of Gp2.
(B) Graph showing the percentage of DNA bound by Es70 in the presence of
Gp2 compared with reactions with no Gp2. The dsDNA probes with different
downstream end points are indicated in the x axis of the graph.
(C) Autoradiograph of 4% (v/v) native polyacrylamide gels comparing binding
of Es70 with the +20/+20 (lanes 1–3) and +1/+1 (lanes 4–6) probes in the
absence (condition I) and presence (conditions II and III) of Gp2.
(D) Autoradiograph of a 4% (v/v) native polyacrylamide gel comparing binding
of Es70 (lanes 1 and 2) and Es70DR1.1 (lanes 3–6) in the presence (lanes 2, 4,
and 6) and absence (lanes 1, 3, and 5) of Gp2 to the +1/+1 probe. In lanes 5
and 6, the isolated R1.1 domain is present in trans.
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762 Molecular Cell 47, 755–766, September 14, 2012 ª2012 Elsevierthis reaction (Figure 5D, lanes 5 and 6). Overall, we conclude that
inhibition of the RPo formation by Gp2 also involves a long-
range, R1.1-dependent antagonistic effect on Es70 interactions
with DNA around the RNAp active center.
Gp2 Interferes with the Promoter DNA Template Strand
Accessing the RNAp Active Center
We next wanted to determine the effect of Gp2 on Es70 binding
to variants of the 7/7 lacUV5 probe with either template or
nontemplate single-strand downstream extensions to
position +20 (7/+20 or +20/7 promoter probes, respectively;
recall that RPo formation on the +20/+20 probe is efficiently
inhibited by Gp2). The EMSA results reveal that Gp2 had no
detectable effect on the binding of Es70 to either of these probes
(Figure 5E). To determine whether the RNAp active site can
access the +1 position on the template strand of the 7/+20
probe in the presence of Gp2, we performed transcription-initia-
tion assays. The results, shown in Figure 5F, indicate that even
though Gp2 does not inhibit the binding of Es70 to this probe
(Figure 5E, lanes 1–3), the synthesis of the ApApUpU transcript
is effectively abolished in the presence of Gp2. The inhibitory
effect of Gp2 on transcription from the 7/+20 probe is R1.1
dependent: ApApUpU transcript synthesis by Es70DR1.1 is not
inhibited by Gp2 (Figure 5G, lanes 3 and 4), whereas the in trans
addition of the isolated R1.1 domain to Es70DR1.1-containing
reactions abolishes ApApUpU synthesis (Figure 5G, lane 5).
Therefore, we conclude that the RNAp active center cannot
productively access the template strand of the7/+20 promoter
probe when Gp2 is bound to the b0 jaw domain. This conclusion
is consistent with the view that the binding of Gp2 to the b0 jaw
has a long-range, R1.1.-mediated antagonistic effect on Es70-
promoter interactions near the RNAp active center. In other
words, it seems that the binding of Gp2 to the b0 jaw in Es70
restricts single-stranded DNA from accessing the RNAp active
center in an R1.1-dependent manner.
Gp2 Appropriates R1.1 to Efficiently Inhibit RPo
Formation by Es70
Previously, Mekler et al. (2002) showed that FRET can be used to
monitor the displacement of R1.1 from near the dwDBC in free(E) Autoradiograph of 4% (v/v) native polyacrylamide gels comparing binding
of Es70 to promoter probes with either the nontemplate or template strand
ending at the 7 position (7/+20 and +20/7) in the absence (lane 2 and 5)
and presence (lanes 3 and 6) of Gp2. In (A–E), the percentage of DNA bound by
Es70 or Es70DR1.1 (%C) in the reactions with Gp2 with respect to reactions with
no Gp2 is given at the bottom of the gels. The data obtained in at least two
independent experiments fell within 3% of the % C value shown.
(F) Autoradiographs of 20% (v/v) denaturing urea gels showing the synthesis of
the ApApUpU transcript (underlined nucleotides are a32P labeled) from the
lacUV5 promoter +20/+20 and7/+20 probes by Es70 in the absence (lanes 1
and 3) and presence (lanes 2 and 4) of Gp2.
(G) As in F, but using the 7/+20 probe comparing the activity of Es70 and
Es70DR1.1 in the absence (lanes 1 and 3) and presence (lanes 2, 4, and 5) of
Gp2. In lane 5, the isolated R1.1 domain is present in trans (at 8-fold molar
excess over s70DR1.1). In (F) and (G), the percentage of ApApUpU transcript
synthesized (% A) in the reactions with Gp2 with respect to reactions with no
Gp2 is given at the bottom of the gel for each reaction. The data obtained in at
least two independent experiments fell within 5% of the% A value shown. See
also Figure S4.
Inc.
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Because Gp2 efficiently inhibits transcription initiation in an
R1.1-dependent manner, we wanted to determine whether
Gp2 antagonizes the obligatory displacement of R1.1 during
RPo formation. Initially, we calculated the distance between
R1.1 and the RNAp active center by measuring FRET between
a fluorescein probe incorporated at amino acid position 36 in
s70 R1.1 (hereafter called s70*) and rifampicin (Rif), an antibiotic
that binds RNAp between the upstream and downstream lobes
of the b subunit and effectively quenches the fluorescence in
Es70* (Figure S5A and Figure 6A; compare lines labeled Es70*
and [Es70*-Rif]). As expected, the quenching efficiency is much
lower in the RPo formed on the N25cons promoter than with
Es70* (Figure 6A; compare lines labeled Es70* and [Es70*+Rif]
with lines labeled Es70*+N25cons and [Es70*-Rif]+N25cons,
respectively), thus indicating displacement of R1.1 from near
the dwDBC upon RPo formation. In control experiments in which
Rif was replaced with the colorless RNAp inhibitor sorangicin-A
(Sor), which binds RNAp in the Rif-binding site (Campbell et al.,
2005), no influence on the fluorescence of the fluorescein probe
attached to position 36 in R1.1 was detected (Figure S5B;
compare lines Es70* and [Es70*-Sor]). Further, the addition of
Rif to the preformed Es70*+Sor complex also resulted in a negli-
gible decrease in fluorescence intensity (Figure S5B; compare
lines [Es70*-Sor] and [Es70*-Sor]+Rif). Thus, the Rif-mediated
decrease in fluorescence intensity of the fluorescein probe
attached to amino acid position 36 in R1.1 is specific to the
binding of Rif and is a consequence of quenching via the FRET
mechanism. The addition of Gp2 caused an 13% decrease in
the fluorescence intensity of Es70* (Figure 6B; compare lines
labeled Es70* and Es70*+Gp2), suggesting that the binding of
Gp2 to the b0 jaw domain changes the microenvironment of
R1.1 and/or its positions with respect to the RNAp active center.
These effects result from specific Gp2 binding to the b0 jaw
domain, because no change in fluorescence spectra was
observed in the presence of the R56E Gp2 mutant (Sheppard
et al., 2011), which does not bind to the RNAp (compare Fig-
ure S5C and Figure 6B). The calculated distances between the
fluorescein probe attached to amino acid position 36 in R1.1
and Rif are 41 A˚ and 65 A˚ in Es70* and RPo, respectively (Fig-
ure 6C). However, in the [Es70*-Rif]+Gp2 complex, this distance
is longer than in the [Es70*-Rif] complex by 9 A˚ (Figure 6C). When
the N25cons probe is added to the [Es70*-Rif]+Gp2 complex, the
calculated distance between fluorescein at amino acid position
36 in R1.1 and Rif is 53 A˚ (Figure 6B, compare lines labeled
[Es70*-Rif]+Gp2 and [Es70*-Rif]+Gp2+N25cons, and Figure 6C).
In contrast, as mentioned above, when the N25cons probe is
added to the [Es70*-Rif] complex (i.e., in the absence of Gp2),
the corresponding calculated distance is 65 A˚ (Figure 6A,
compare lines labeled [Es70*-Rif] and [Es70*-Rif]+N25cons,
and Figure 6C). Thus, Gp2 reduces the distance of R1.1
displacement during RPo formation by 12 A˚. This effect is
specific, because no change in fluorescence spectra was
observed in control experiments with R56E Gp2 mutant
(compare Figure S5C and Figure 6B). Because Es70 forms
a complex with the N25cons promoter, which contains Gp2
and bears some hallmarks of the RPo formed in the absence
of Gp2 (see Introduction), our results indicate that ternaryMolecu(Es70-Gp2-N25cons promoter) complex formation is not accom-
panied by the characteristic long-distance displacement of R1.1
that normally occurs during RPo formation (Figures 6A and 6C).
To avoid a possible error related to uncertainty of the Rif-fluores-
cein distance determination (Knight et al., 2005), we performed
control experiments conducted with fluorescein probe attached
to a different position in R1.1 (amino acid 59), which further
corroborated our conclusion (Figure 6C and Figure S5E). When
the N25cons probe is added to the [Es7059*-Rif]+Gp2 complex,
the calculated distance between the fluorescein at amino acid
position 59 in R1.1 and Rif is 40 A˚ (Figure S5F, compare lines
labeled [Es7059*-Rif]+Gp2 and [Es7059*-Rif]+Gp2+N25cons,
and Figure 6C). In contrast, when the N25cons probe is added
to the [Es7059*-Rif] complex (i.e., in the absence of Gp2), the
corresponding calculated distance is 61 A˚ (Figure S5E, compare
lines labeled [Es7059*-Rif] and [Es7059*-Rif]+N25cons, and
Figure 6C). Thus, Gp2 appropriates R1.1 to efficiently inhibit
RPo formation by Es70.
DISCUSSION
The interaction between dwDNA and dwDBC in the RNAp is
important for establishing the RPo for transcription initiation at
bacterial promoters. The Ec RNAp b0 jaw domain, a pivotal
feature of the dwDBC, is a multifunctional domain whose role
in transcription extends beyond RPo formation (Ederth et al.,
2006). In previous studies, Ederth et al., (2006) and our group
(Wigneshweraraj et al., 2006) showed that the b0 jaw domain is
involved in regulatory interplay with other parts of the RNAp
that extend to the distally located nascent RNA-binding site.
In vitro, deletion of the b0 jaw domain in the Ec RNAp destabilizes
RPo, suppresses transcriptional pausing, increases the overall
elongation rate, and decreases intrinsic termination (Ederth
et al., 2002, 2006). Here, we have demonstrated that the b0 jaw
domain makes sequence-nonspecific contacts with dsDNA. Ec
RNAp mutants with the G1161R mutation or the deletion of resi-
dues 1149–1190 in the b0 jaw domain form RPo with significantly
reduced half-lives compared with RPo formed by the wild-type
RNAp. Our data provide an explanation for the observed pheno-
types of the mutant RNAp in a structural context: (1) the b0 jaw
domain residues that undergo significant chemical shift changes
upon interaction with dsDNA (T1169, R1174, and M1180) are all
located within the deleted region (i.e., 1149–1190), and (2) the
invariant G1161 residue (Figure S1A) is located in the b1 sheet
of the b0 jaw domain structure and is facing away from the
DNA-binding surface toward the b0 insertion 6 domain; thus, an
arginine side chain at this position could compromise the overall
structural integrity of the dwDBC. During T7 phage infection of
Ec, the sequence-nonspecific interaction between the b0 jaw
domain and dsDNA is subject to regulation by the small, non-
DNA-binding T7 transcription factor Gp2, which inhibits RPo
formation by the host RNAp. One strategy used by Gp2 to inhibit
RPo formation by the host RNAp is to sterically occlude dsDNA
from binding to the b0 jaw domain by competing with dsDNA for
overlapping interaction surfaces on the b0 jaw domain.
The narrow width of the dwDBC observed in structures of the
bacterial RNAp is thought to constrain the entry of DNA into the
catalytic cleft of RNAp for RPo formation. An obligatory steplar Cell 47, 755–766, September 14, 2012 ª2012 Elsevier Inc. 763
Figure 6. Gp2 Appropriates R1.1 to Efficiently Inhibit RPo Formation by Es70
(A and B) Measurement of FRET between fluorescein incorporated into s70 at position 36 (s70*) and Rif during RPo formation in the absence (A) and presence (B)
of Gp2. The fluorescence emission spectra are recorded with 482 nm excitation.
(C) The FRET efficiency values and distance calculations are tabulated (see also Figure S5) and the values presented are averages obtained from two to three
individual experiments; the estimated error in R0 is 10%.
(D) Cartoon (as in Figure 1A) depicting the mechanism by which RPo formation is inhibited by Gp2 at s70-dependent promoters.
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displacement of the R1.1 domain of s70 from near the dwDBC
to the tip of the b pincer, which occurs concomitantly with the
loading of DNA in the DBC/dwDBC. The negatively charged
R1.1 domain is believed to act as a molecular placeholder for
dsDNA in Es70; therefore, the displacement of R1.1 would facil-
itate the loading of dwDNA into the dwDBC and subsequently
stabilize the formation of RPo (Mekler et al., 2002). Thus, it was
proposed that R1.1 can facilitate DNA entry into the dwDBC by
holding the b and b0 pincers open so that the promoter DNA
can enter the dwDBC and the template promoter strand can
access the RNAp active center (Saecker et al., 2011). Our results
demonstrate that R1.1 of s70 has an important functional role in
the mechanism by which Gp2 inhibits RPo formation at s70-
dependent promoters. Consistent with this view, Gp2 inhibits
RPo formation by RNAp containing alternative s factors such
as s38 or s54 less efficiently or not detectably, respectively (see
above) (Wigneshweraraj et al., 2004). We envisage a model in
which Gp2 repositions R1.1 (see below) and/or stabilizes R1.1
so that it can no longer be displaced to the tip of the b pincer.
This would allow RPo to form and thus stall the Es70-promoter
complex in an intermediate state (intermediate promoter
complex [RPi] in Figure 6D) at s70-dependent promoters.
Furthermore, the extended negatively charged patch in the
dwDBC that results upon binding of Gp2 to the b0 jaw domain
could thus help electrostatically reposition R1.1 and/or mimic
the presence of R1.1 in the dwDBC. In support of the former
view, the removal of the negatively charged side chains of the
amino acids in Gp2 that contribute to the NCS does not affect
the affinity of Gp2 to the RNAp or its overall structural integrity,
but it does severely decrease its ability to inhibit RPo formation
(Sheppard et al., 2011). Intriguingly, the R1.1-dependent inhibi-
tory effect of Gp2 on the binding of dwDNA to the b0 jaw domain
extends beyond the dwDBC and has long-range antagonistic
effects on Es70-promoter interactions that extend up to the
RNAp active center. As a consequence, Es70-promoter DNA
interactions become stalled en route to the RPo (Figure 6D).
Because not even single-stranded DNA can access the active
center of the RNAp in the presence of Gp2, it seems that Gp2
when bound to the b0 jaw domain restricts the conformational
flexibility and changes in the RNAp that normally accompany
RPo formation. Because the interaction between Gp2 and the
isolated b0 jaw domain fragment is several orders of magnitude
weaker than that between Gp2 and the whole enzyme, we
cannot exclude the possibility that Gp2 undergoes positional re-
arrangements and makes additional contacts with the other
domains of the RNAp that surround the dwDBC, notably the
b0 insertion 6 and/or the b downstream lobe domains. It is there-
fore likely that the solution structure of the Gp2-b0 jaw fragment
likely reports on an early encounter complex between Gp2 and
RNAp.
The biological role of Gp2 is to inhibit the transcription of early
T7 genes from strong s70-dependent promoters present on the
T7 genome by the host RNAp (Savalia et al., 2010). The absence
of Gp2 results in unsuccessful infection because the antitermi-
nated host RNAp moves into regions of the T7 genome that
are normally transcribed by the T7 RNAp. The interference of
the fast-moving T7 RNAp, which is responsible for the transcrip-Molecution of middle and late T7 genes, by the slow-moving host RNAp
results in aberrant packaging of concatemeric viral DNA into
virion heads, and thus unsuccessful infection. The two-pronged
strategy used byGp2 to inhibit the host RNAp, through occlusion
of dwDNA from binding to the dwDBC and appropriation of a
s70-specific domain, leads to highly efficient inhibition of Es70-
dependent transcription from very strong early T7 promoters
to ensure successful infection. The inhibition of host RNAp by
Gp2 thus defines an as yet uncharacterized mechanism by
which bacterial transcription is regulated by a nonbacterial
factor.
EXPERIMENTAL PROCEDURES
Proteins and Promoter Templates
Details of the proteins and promoter templates used in this study are provided
in the Supplemental Experimental Procedures.
NMR Spectroscopy and Structure Calculation
Details about the NMR solution structure calculation of the Gp2-b0 jaw frag-
ment complex are provided in the Supplemental Experimental Procedures.
In Vitro Transcription Assays
In vitro transcription assays were conducted essentially as previously
described (Ca´mara et al., 2010). Reactions (10 ml) were conducted using final
concentrations of 100 nM Es70, 20 nM unlabeled promoter DNA probes,
0.5 mM dinucleotide primer ApA, 100 mg/ml heparin, and 3 mCi of [a-32P]-
UTP (for lacUV5) or [a-32P]-ATP and 0.5 mM CTP (for osmE). Unless otherwise
indicated, Gp2 and Es70 (at a 2:1 molar ratio) were always preincubated before
the promoter DNA was added to the reaction. When present, R1.1 was always
preincubated with Es70DR1.1 (at the indicated amounts) before addition of Gp2
and/or promoter DNA to the reaction. The reactions were resolved on a 20%
(w/v) urea-denaturing polyacrylamide gel. The dried gel was visualized and
quantified with the use of an FLA-5000 PhosphorImager.
Native Gel Mobility Assays
All native mobility shift assays were conducted essentially as described previ-
ously (Ca´mara et al., 2010). Binding reactions (10 ml) were set up as described
above.
FRET Assays
Fluorescence emission spectra of Es70 reconstituted with s70 subunit labeled
at position 36 or 59 with fluorescein (s70*) were recorded with 482 excitation as
previously described (Knight et al., 2005). When present, Rif and Sor (at 1 mM)
were incubated with Es70* for 10 min at 37C. The Es70-Gp2 complex was
obtained by incubation of 1 nM Es70 and 200 nM Gp2 for 10 min at 37C.
Promoter complexes were obtained by incubation of 1 nM Es70 or Es70-Gp2
with 5 nM N25cons for 15 min at 37C. The FRET efficiency, critical FRET
radius (R0), and distance between fluorescein and Rif were determined as
previously described (Knight et al., 2005). A previous analysis of the accuracy
of similar FRET-based measurements of distances between Es70-bound Rif
and fluorescein incorporated at different positions in s70 indicated that the
uncertainty of such a distance determination is 11%–25%, with a mean of
15% (Knight et al., 2005).
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The Escherichia coli-infecting bacteriophage T7 encodes a 7 kDa protein, called Gp2, which is a
potent inhibitor of the host RNA polymerase (RNAp). Gp2 is essential for T7 phage development.
The interaction site for Gp2 on the E. coli RNAp is the b9 jaw domain, which is part of the DNA
binding channel. The binding of Gp2 to the b9 jaw antagonizes several steps associated with
interactions between the RNAp and promoter DNA, leading to inhibition of transcription at the
open promoter complex formation step. In the structure of the complex formed between Gp2 and
a fragment of the b9 jaw, amino acid residues in the b3 strand of Gp2 contribute to the primary
interaction interface with the b9 jaw. The 7009 E. coli strain is resistant to T7 because it carries a
charge reversal point mutation in the b9 jaw that prevents Gp2 binding. However, a T7 phage
encoding a mutant form of Gp2, called Gp2b, which carries triple amino acid substitutions E24K,
F27Y and R56C, can productively infect this strain. By studying the molecular basis of inhibition of
RNAp from the 7009 strain by Gp2b, we provide several lines of evidence that the E24K and
F27Y substitutions facilitate an interaction with RNAp when the primary interaction interface with
the b9 jaw is compromised. The proposed additional interaction interface between RNAp and Gp2
may contribute to the multipronged mechanism of transcription inhibition by Gp2.
INTRODUCTION
Central to the regulation of bacterial transcription is the
RNA polymerase (RNAp), the enzyme responsible for the
synthesis of all RNA in bacteria. The bacterial RNAp
is composed of a multisubunit catalytic core (subunit
composition a2bb9v; abbreviated E) and a sigma (s) factor
subunit that determines the specificity of the RNAp-
promoter interaction. In Escherichia coli, the s70-contain-
ing RNAp (Es70) is responsible for the transcription of
most genes during exponential growth (Haugen et al.,
2008). Transcription by Es70 begins with the formation of
the initial Es70–promoter complex known as the closed
promoter complex (RPc). The RPc is often very unstable
and isomerizes, via several intermediates, to the transcrip-
tionally proficient open promoter complex (RPo). In the
RPo, ~15 base pairs of promoter DNA around the
transcription start site are melted to form the ‘transcription
bubble’ and the template DNA strand is positioned at the
active centre of the RNAp. The catalytic b and b9 subunits
of the RNAp define the main DNA binding channel (DBC),
and the active centre where RNA synthesis takes place is
located deep within the DBC. The double-stranded DNA
immediately downstream of the active centre (dwDNA)
interacts with a segment of the DBC called the downstream
DBC (dwDBC), and this interaction is essential for the
formation and stability of the RPo (Saecker et al., 2011).
Abbreviations: DBC, DNA binding channel; Dt, doubling time; dwDBC,
downstream DBC; dwDNA, DNA immediately downstream of the active
centre; HRP, horseradish peroxidase; RNAp, RNA polymerase; RPo,
open promoter complex.
A supplementary table is available with the online version of this paper.
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The RPo formation also represents an important regulatory
step during transcription initiation, and thus the activity of
the bacterial RNAp is controlled by an array of trans-
cription regulatory factors, which repress, stimulate or
modulate its ability to form the RPo (Browning & Busby,
2004). Most bacteriophages (phages) rely on the RNAp of
their host bacteria for expression of their genes during the
infection process. Therefore, RPo formation by the
bacterial RNAp is also subjected to regulation by phage-
encoded proteins through covalent RNAp modifications
and modulation by RNAp-binding proteins (Nechaev &
Severinov, 2003). T7 phage encodes a 7 kDa protein, called
Gp2, which binds to a domain in the b9 subunit, called the
‘jaw’ domain, and potently inhibits RPo formation by the
E. coli RNAp (Nechaev & Severinov, 1999). The b9 jaw
domain is an integral component of the dwDBC and plays
a major role during RPo formation and stable maintenance
of the RPo (Ederth et al., 2002, 2006). The biological role of
T7 Gp2 is to ensure efficient and coordinated transcription
of phage genes by the T7 RNAp without interference from
bacterial RNAp (Savalia et al., 2010). In the solution
structure of the complex of Gp2 with a fragment of the b9
jaw domain (E. coli RNAp b9 residues 1153–1213), two
invariant arginine residues (R56 and R58; R56 and R58 are
invariant in 25 and 23, respectively, out of 25 Gp2-like
proteins in the EBI database at the time of writing) located in
the b3 strand of Gp2 are in close proximity to E1158 and
E1188 in the b9 jaw, and thereby contribute to significant
ionic interactions across the interface (Fig. 1a, b) (James
et al., 2012). Alanine or charge reversal substitutions at
either R56 or R58 prevent Gp2 from binding to the RNAp
(Ca´mara et al., 2010). Conversely, RNAp containing a lysine
substitution at either E1158 (BR3 E. coli) or E1188 (7009 E.
coli) is resistant to inhibition by Gp2 (Nechaev & Severinov,
1999). Thus, the primary interaction interface between Gp2
and the RNAp involves R56 and R58 in the b3 strand of Gp2
and E1158 and E1188 in the b9 jaw domain of the RNAp.
Wild-type T7 is unable to productively infect E. coli 7009
(Chamberlin, 1974; Nechaev & Severinov, 1999; Schmitt et al.,
1987). Amutant phage, called T7b, that successfully infects the
7009 E. coli strain (which has a mutant RNAp containing the
E1188K substitution in the b9 jaw domain), encodes a triple
mutant form of Gp2 (harbouring substitutions E24K, F27Y
and R56C; hereafter called Gp2b) (Chamberlin, 1974; Schmitt
et al., 1987). The molecular basis by which E24K, F27Y and
R56C substitutions in Gp2 suppress the E1188K mutation in
the b9 jaw domain, which prevents wild-type Gp2 from
binding to the RNAp, is not known. In the context of the
Gp2–b9 jaw domain fragment structure, the E24K and F27Y
substitutions are located in the middle and close to the end,
respectively, of the loop connecting the b1 and b2 strands in
Gp2, i.e. at the opposite side to the b3 strand, which forms the
interface with the b9 jaw domain and carries R56 (Fig. 1a). In
this study, we established a simple in vivo bacterial growth
attenuation assay to assess the activity of recombinant Gp2 on
E. coli RNAp in the absence of T7 infection, to study the
molecular basis by which Gp2b inhibits wild-type, 7009 and
BR3 E. coli RNAp. The results strongly suggest that the E24K
and F27Y mutations facilitate the interaction between Gp2b
and RNAp when the primary interaction interface between
Gp2 and RNAp is compromised. Experiments addressing
the loop interconnecting b1 and b2 strands in Gp2
homologues from two T7-like phages that infect Citro-
bacter rodentium further corroborate our results.
METHODS
Bacterial strains and plasmids. Table S1 (available with the online
version of this paper) lists the bacterial strains and plasmids used in
this study. Plasmid pCS1 : Gp2 and derivatives were constructed by
digesting pSW33 : Gp2 (and derivatives) with XbaI and HindIII, and
the 0.3 kb fragment containing gene 2 was cloned into the same sites
in pBAD18 (Invitrogen). The coding sequences of Gp2 homologues
CR44b protein 13 (CR44b_13) and CR8 protein 16 (CR8_16) were
PCR-amplified from phage genomic DNA (kindly provided by Ana
Louisa Toribio and Gordan Dougan, The Wellcome Trust Sanger
Institute, Cambridge, UK) with primers containing restriction
sites for NdeI and BamHI and cloned into the same sites in
plasmid pET33b+ (Novagen) to generate pAS33 : CR44b_13 and
pAS33 : CR8_16, respectively. Similarly, plasmids pAS1 : CR44b_13
and pAS1 : CR8_16 were constructed using the procedure described
for pCS1 : Gp2. Mutant forms of T7 Gp2 and CR44b_13 were
constructed using the QuikChange Site-Directed PCR Mutagenesis kit
(Stratagene) using pCS1 : Gp2, pSW33 : Gp2 or pAS1 : CR44b_13 as a
template. T7 Gp2 was overexpressed and purified as described
previously; CR44b_13 and CR8_16 were overexpressed and purified
Fig. 1. Sequence alignment analysis of T7 Gp2-like proteins. (a) Ribbon representation of the T7 Gp2–E. coli RNAp b9 jaw
domain fragment (residues 1153–1213) complex. Gp2 is shown in cyan and the b9 jaw domain fragment is shown in green. The
positions of the amino acids E24, F27 and R56 in T7 Gp2 are indicated along with the E1158 and E1188 residues in the b9 jaw
domain. (b) Alignment of amino acid sequences from known Gp2-like proteins. The sequences are displayed in single-letter
amino acid code, with the length of the sequence indicated on the far right. The localization of the b-strands and a-helix based
on the structure of T7 Gp2 is indicated. The highly conserved R56 and R58 residues are highlighted in blue. The positions of
amino acids residues E24 and F27 in T7 Gp2 are underlined and in bold type. The arginine residue, corresponding to T7 Gp2
amino acid residue S23 in Gp2-like proteins in phages CR8, CR44b, K1F and EcoDS1, is also underlined in bold type. (c)
Alignment of the b9 jaw domain amino acid residues 1153–1213 from a representative set of host RNAps, with those infected
by T7-like phages encoding Gp2-like proteins indicated by asterisks. Amino acid residues corresponding to E1158 and E1188
of the E. coli RNAp are shown in bold type. (d) As in (a), except that the structural models of Gp2-like proteins CR44b_13
(orange) and CR8_16 (pink) are superimposed and amino acid residue R15 is indicated. The structural models of the Gp2
homologues were calculated with SWISS-MODEL using NMR structures of T7 Gp2 as a template (Arnold et al., 2006; Ca´mara
et al., 2010).
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exactly as T7 Gp2 (Ca´mara et al., 2010). Wild-type and mutant forms
of the E. coli core RNAp were overexpressed from pVS10 and purified
by affinity chromatography exactly as described previously (Ca´mara
et al., 2010). The E1188K and E1158K mutant E. coli RNAps were
constructed by using the QuikChange Site-Directed PCR Mutagenesis
kit using pVS10 as the template (Belogurov et al., 2007). Purified
proteins were then dialysed into storage buffer [10 mM Tris/HCl
(pH 8.0), 50 mM NaCl, 0.1 mM EDTA, 1 mM DTT, 50% (v/v)
glycerol] and aliquots were stored at220 uC (short-term) and280 uC
(long-term). The sequences of primers used for the cloning and
mutagenesis in this study are available from the authors upon request.
Bacterial growth attenuation assays. Seed cultures were grown at
37 uC, shaking at 700 r.p.m. for 6–7 h in a THERMOstar (BMG
Labtech) plate incubator by directly inoculating a colony from a freshly
transformed Luria agar plate into 200 ml of Luria broth (LB) medium
(Difco) containing 100 mg ampicillin ml21 and 0.5% (w/v) glucose (to
prevent leaky expression of Gp2 from the PBAD promoter) into a 96-
well microtitre plate (Sterilin). The experimental growth curves were
also performed in 96-well microtitre plates in a POLARstar Omega
multiwell plate reader (BMG Labtech). The seed cultures were diluted
1 : 100 in a final volume of 200 ml of fresh LB medium containing
100 mg ampicillin ml21 and incubated at 30 uC, shaking at 500 r.p.m.
The expression of Gp2 was induced at OD600 of ~0.2–0.25 by adding
0.04% (w/v) arabinose for MG1655, JE1134 and BR3 cultures, and
0.4% (w/v) arabinose for 7009 cultures. The doubling time (Dt) was
calculated from the gradient of the growth curve typically between the
OD600 corresponding to induction time and OD600 0.7–0.8. The R
2
values in each case were .0.98. At least three biological and technical
replicates were performed for each growth curve.
Quantitative Western blotting. E. coli MG1655 cultures were grown
in conditions as described above. At 2 h post induction (see text for
details), cell samples were taken and the total amount of Gp2 molecules
per cell was determined by Western blotting using standard protocols. E.
coli whole-cell extract (corresponding to 2.56107 cells) was analysed by
SDS-PAGE on gels that were calibrated with known amounts of purified
Gp2. Proteins were transferred to a Hybond-ECL nitrocellulose
membrane using a Trans-Blot Semi-Dry transfer cell (Bio-Rad). To
detect Gp2, anti-His monoclonal antibodies conjugated with horseradish
peroxidase (HRP) (Sigma) in combination with the ECL SuperSignal
West Femto Chemiluminescent Substrate kit (Pierce) were used. Digital
images of the blots were obtained using an LAS-3000 Fuji Imager, and
signal quantification and calculations were performed exactly as described
by Piper et al. (2009). Briefly, the amount of Gp2 (ng) (Fig. 2d, table,
column 2) at each time point post induction was estimated from the
calibration curve. The number of molecules of Gp2 per cell (Fig. 2d,
table, column 3) was determined by first calculating the total number of
moles of Gp2 [mass (g)/Mr (10 000 Da)], multiplying by Avogadro’s
constant (6.02261023 mol21) and then by dividing the total number of
Gp2 molecules by the number of cells in the sample (i.e. 2.56107 cells).
In vitro transcription assays. These were performed exactly as
previously described (Ca´mara et al., 2010).
Efficiency of plaque formation assays. These were performed
exactly as previously described (Ca´mara et al., 2010; Rokyta et al., 2002).
RESULTS
Insights from multiple protein sequence
alignment of T7 Gp2 homologues
To determine how amino acids at positions corresponding
to T7 Gp2 E24, F27 and R56 compare with corresponding
residues in homologous proteins encoded by related
phages, we conducted a BLAST search using standard search
parameters and T7 Gp2 as a query sequence. The multiple
protein sequence alignment of known Gp2 homologues (in
the EBI database, July 2012) was done using COBAT (Fig.
1b) (Papadopoulos & Agarwala, 2007). We also built an
alignment of the T7 Gp2 target (the b9 jaw fragment
region, E. coli b9 amino acids 1153–1213) with corres-
ponding sequences from several bacterial species (Fig. 1c).
As expected, the amino acid residues R56 and R58 in T7
Gp2 that are essential for the binding to the E. coli b9 jaw
are identical in 25 and 23, respectively, out of 25 known
Gp2 homologues (Fig. 1b). Similarly, amino acid residues
E1158 and E1188 display a high degree of conservation
only in bacteria infected by phages encoding Gp2
homologues (Fig. 1c). Overall, this observation is consist-
ent with previous structural and biochemical analyses
which show that the primary interaction interface between
T7 Gp2 and the E. coli RNAp involves R56 and R58 in
strand b3 of Gp2 and E1158 and E1188 in the b9 jaw
domain.
A phenylalanine residue at a position corresponding to F27
of T7 Gp2 is conserved in 18 out of 24 Gp2 homologues,
whereas amino acids at a position corresponding to E24 in
T7 Gp2 display a significant degree of variation (Fig. 1b).
Interestingly, we note that phages CR8, CR44b, K1F and
EcoDS1 encode Gp2-like proteins that contain a positively
charged amino acid (R15) at the position that corresponds
to T7 Gp2 S23, a residue immediately adjacent to E24 that
is changed for lysine in Gp2b (Fig. 1b, underlined). From
structural models generated for Gp2 homologues from
phages CR8 and CR44b and based on the solution
structure of the T7 Gp2–b9 jaw domain fragment complex,
it is evident that R15 in CR44b_13 and CR8_16 (and by
extension also in Gp2 homologues encoded by K1F and
EcoDS1) is located in the loop interconnecting b1 and b2
strands of the proteins (Fig. 1d). Thus, it is possible that
Gp2 homologues from CR8, CR44b, K1F and EcoDS1
phages, like T7 Gp2b, can also inhibit 7009 and/or BR3
RNAp. If true, this would indicate that Gp2 homologues
encoded by wild-type CR8, CR44b, K1F and EcoDS1
phages interact with RNAp like the mutant Gp2 encoded
by T7b.
A simple in vivo assay measures the activity of
Gp2 in the absence of T7 phage infection
To experimentally address the observations derived from
multiple sequence alignment and to understand the
molecular basis by which the triple amino acid substitu-
tions in Gp2b suppress the E1188K mutation in the b9 jaw
domain, we developed a simple in vivo assay to determine
and compare the ability of wild-type and mutant Gp2
proteins to inhibit E. coli RNAp in the absence of T7
infection. In this assay, gene 2 (which encodes Gp2) is
placed under the control of an arabinose-inducible araBAD
promoter (PBAD) in plasmid pCS1 : Gp2 and introduced
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Fig. 2. Establishing a simple in vivo assay to measure the activity of Gp2 in the absence of T7 phage infection. Growth curves of
(a) E. coli MG1655 and (b) 7009 cells expressing Gp2 upon induction with arabinose at t50. The solid red, dotted and solid
black lines represent cells harbouring pCS1 :Gp2WT, pBAD18 (empty vector) and pCS1 :Gp2R56E, respectively; the dashed
line represents cells harbouring pCS1 :Gp2WT to which ampicillin was not added to the growth medium. (c) As in (a), except
that at t52 h, the cells were pelleted and resuspended in fresh LB to remove inducer (arabinose) prior to continuation of growth.
The dashed red line represents cells that were induced for the second time (see text for details) at t56 h. (d) Quantification of
Gp2 molecules per E. coli MG1655 cell at t50.5, 1 and 2 h post induction of Gp2. Top panel: digitalized image of the Western
blot probed with HRP-conjugated anti-His monoclonal antibodies containing purified Gp2 (as a reference standard) and whole-
cell protein extracts corresponding to 2.5107 cells. Bottom-left panel: calibration curve relating signal intensity to the amount
of purified Gp2 (in ng). Bottom-right panel: table showing the calculated number of molecules of Gp2 per cell for each time
point sampled post induction.
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into E. coli strain MG1655. As shown in Fig. 2(a),
induction of Gp2 expression upon addition of 0.04% (w/
v) arabinose (at t50) results in efficient attenuation
of bacterial growth. The attenuation of bacterial growth
is specific, since it is not observed in wild-type cells
transformed with the pCS1 : Gp2R56E plasmid, which
encodes a functionally defective Gp2 mutant (Ca´mara
et al., 2010) (Fig. 2a), or in E. coli strain 7009 transformed
with pCS1 : Gp2 (Fig. 2b). Control experiments established
that attenuation of bacterial growth was not caused by a
loss of selection due to the inhibition of transcription of
the b-lactamase gene from pCS1, since attenuation of
bacterial growth upon arabinose induction was observed in
the absence of ampicillin (Fig. 2a, b). Additional control
experiments, shown in Fig. 2(c), established that recom-
binant Gp2, when expressed in E. coli, acts like a
bacteriostatic agent: growth-attenuated E. coli MG1655
cells obtained 2 h (i.e. at t52) after Gp2 induction
resumed growth when inoculated into fresh growth
medium after removal of the inducer, and stopped growing
upon reinduction with arabinose at t56 h (Fig. 2c).
Further analysis of whole-cell extracts from cells obtained
at t52 h after Gp2 induction revealed that the total
number of Gp2 molecules per E. coli cell is ~5000
molecules (Fig. 2d). Since the total number of RNAp
molecules in an exponentially growing E. coli cell is
estimated to be ~2000–2500 molecules (Ishihama, 1999), it
seems that the total number of Gp2 molecules per E. coli
cell exceeds that of the total number of RNAp molecules
per E. coli cell by at least twofold under conditions where
attenuation of bacterial growth is observed. In summary,
the in vivo bacterial growth attenuation assay established
here can be used to determine and compare the activity of
Gp2 mutants to inhibit the E. coli RNAp in vivo in the
absence of T7 phage infection.
E24K and F27Y substitutions facilitate Gp2
interaction with RNAp when the primary
interaction interface is compromised
It is not known which one of the three changes (or a
combination thereof) restores the binding of Gp2b to the
7009 RNAp. Therefore, we constructed single, double and
triple mutant versions of Gp2 based on Gp2b and tested
their ability to inhibit the wild-type, 7009 and BR3 E. coli
RNAp using appropriate strains and the in vivo bacterial
growth attenuation assay described above (Fig. 2). Con-
sistent with previous results from alanine-scanning muta-
genesis (Ca´mara et al., 2010), single or double amino acid
substitutions at E24 (to K) and/or F27 (to Y) attenuated
the growth of E. coli MG1655 to the same degree, as did the
wild-type Gp2. On the other hand, expression of Gp2R56C
did not significantly affect the growth rate (expressed as Dt
in Table 1) as compared with cells harbouring the empty
plasmid vector (pBAD18), indicating that the R56C
substitution strongly affected the interaction with the
wild-type RNAp. However, the Dt of cells expressing
double mutant Gp2 variants containing the R56C mutation
in combination with either the E24K or the F27Y mutation
(i.e. Gp2E24K/R56C and Gp2F27Y/R56C) was detectably
increased (by ~4.1- and ~1.8-fold, respectively) compared
with the growth rate of cells harbouring the empty plasmid
vector (Fig. 3a, Table 1). Although compared with wild-
type Gp2, Gp2E24K, Gp2F27Y and Gp2E24K/F27Y mutants, the
Gp2E24K/R56C and Gp2F27Y/R56C mutants attenuated the
growth of MG1655 E. coli cells relatively weakly (Fig. 3a,
Table 1. Dt values for E. coli MG1655, 7009 and BR3 cells expressing wild-type Gp2 and mutant Gp2 containing different
combinations of point mutations based on Gp2b
ND, Not determined.
Gp2 Ec MG1655 Dt*
(min)±SDD
FId Ec 7009 Dt (min)±SD FI§ Ec BR3 Dt (min)±SD FI||
Empty vector 53±5 1.0 54±3 ND 66±1 ND
Wild-type ND ND 58±1 1.0 117±6 1.0
E24K ND ND 57±4 1.0 179±6 1.5
F27Y ND ND 54±3 1.0 176±10 1.5
E24K/F27Y ND ND 57±2 1.0 249±7 2.1
R56C 64±1 1.2 65±2 1.2 102±4 0.9
E24K/R56C 221±8 4.1 85±3 1.6 166±9 1.4
F27Y/R56C 93±11 1.8 83±5 1.6 151±2 1.3
E24K/F27Y/R56C 280±48 5.3 142±5 2.6 262±1 2.2
Gp2b+R58E 52±1 1.0 59±8 1.1 73±5 0.6
*Dt (doubling time) in LB at 30 uC in microtitre plates.
DSD is based on at least three independent measurements for each strain/plasmid combination.
dFold increase in Dt with respect to MG1655 E. coli cells containing the empty vector.
§Fold increase in Dt with respect to 7009 E. coli cells expressing wild-type Gp2.
||Fold increase in Dt with respect to BR3 E. coli cells expressing wild-type Gp2.
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Fig. 3. Ability of single, double and triple
mutant versions of Gp2 based on Gp2b to
attenuate bacterial growth upon induction.
Growth curves of (a) E. coli MG1655, (b)
7009 and (c) BR3 expressing wild-type Gp2
and Gp2 mutants containing various combina-
tions of mutations based on Gp2b. Gp2
expression was induced with arabinose at
t50. In each graph, the solid red, dotted and
dashed black lines represent cells harbouring
pCS1 :Gp2WT, pBAD18 (empty vector) and
pCS1 :Gp2 encoding the indicated mutant
form of Gp2, respectively. In panels (a–c), the
same relevant traces for cells harbouring
pCS1 :Gp2WT and pBAD18 (empty vector)
were used.
Inhibition of E. coli RNA polymerase by T7 Gp2
http://mic.sgmjournals.org 2759
Table 1), the effect was highly reproducible. When present
together, the E24K and F27Y mutations further improved
the ability of Gp2R56C (i.e. Gp2b) to attenuate wild-type E.
coli growth (Fig. 3a), and the Dt of cells expressing Gp2b
was increased ~5.3-fold compared with that of cells
harbouring the empty plasmid vector (Table 1). In
summary, it appears that mutations in amino acids
residues in and surrounding the loop interconnecting b1
and b2 strands in Gp2 (i.e. E24K and F27Y) can
compensate for mutations in Gp2 (i.e. R56C) that
compromise (but not abolish; see below) the interaction
interface between Gp2 and the b9 jaw domain. Based on Dt
values calculated for MG1655 E. coli cells after induction of
Gp2E24K/R56C, Gp2F27Y/R56C and Gp2b (Table 1), it seems
that the charge reversal substitution at E24 (i.e. E24K) in
the loop interconnecting the b1 and b2 strands in Gp2
rather than the F27Y mutation at the beginning of the b2
strand is more important in enabling the interaction
between Gp2 and the RNAp when the primary interaction
interface with the b9 jaw is compromised by the R56C
substitution. However, since a glutamate substitution at
position R58 in the context of Gp2b effectively abolishes
the ability of Gp2b to attenuate the growth of wild-type E.
coli, it would seem that an interaction interface between the
b3 strand and b9 jaw domain still persists in the Gp2b–
RNAp complex (Fig. 3a). Experiments with the 7009 and
BR3 E. coli strains, which encode Gp2-resistant forms of
RNAp (see Introduction), further corroborated this view:
even though the Dt of 7009 and BR3 E. coli cells, when
compared with the MG1655 E. coli cells, is relatively
unaffected by overproduction of wild-type Gp2, Gp2b
increases the Dt of 7009 and BR3 E. coli cells by ~2.6-
and 2.2-fold, respectively, compared with corresponding
cells expressing wild-type Gp2 (Fig. 3b, c, Table 1).
Interestingly, in the context of the BR3 E. coli cells,
expression of Gp2E24K/F27Y attenuates growth as efficiently
as that of Gp2b (Fig. 3c, Table 1). In both cases, the R58E
substitution abolishes the ability of Gp2b to attenuate cell
growth (Fig. 3b, c). Overall, the results strongly suggest that
the E24K and F27Y substitutions facilitate an interaction
between Gp2 and RNAp when the primary interaction
interface in the b3 strand is compromised.
T7 Gp2 amino acids 14–59 are sufficient to inhibit
the E. coli RNAp
It is evident from the alignment (Fig. 1b) that the highest
degree of sequence conservation occurs between residues
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Fig. 4. Amino acids 14–59 of Gp2 are sufficient to inhibit the E. coli RNAp. Growth curves of E. coli MG1655 cells in which the
expression of (a) Gp214–59, (b) Gp214–59/R56C and (c) Gp214–59/E24K/F27Y was induced at t50 (dashed lines). In each graph,
the solid red and dotted lines represent cells harbouring pCS1 :Gp2WT and pBAD18 (empty vector), respectively.
Table 2. Dt values for E. coli strain MG1655 expressing wild-
type and mutant versions of Gp214–59
ND, Not determined.
Gp2 Ec MG1655 Dt*
(min)±SDD
FId
Empty vector 49±1 1.0
Wild-type ND ND
Gp214–59 239±16 4.9
Gp214–59 (R56C) 57±2 1.2
Gp214–59 (E24K/F27Y) 338±25 6.9
*Dt (doubling time) in LB at 30 uC in microtitre plates.
DSD is based on at least three independent measurements for each
strain/plasmid combination.
dFold increase in Dt with respect to MG1655 E. coli cells containing
the empty vector.
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corresponding to T7 Gp2 amino acids 14–59. Therefore, it
is possible that amino acids outside this region are
dispensable for activity. We used the in vivo bacterial
growth attenuation assay to determine whether the
truncated form of Gp2 (Gp214–59) is functionally active.
Results shown in Fig. 4(a) and Table 2 reveal that
expression of Gp214–59 detectably attenuates MG1655 E.
coli cell growth, though not as efficiently as full-length Gp2
expression. The Dt of MG1655 cells expressing Gp214–59 is
increased ~4.9-fold when compared with MG1655 E. coli
cells harbouring the empty plasmid vector (Table 2). Since
further N- and C-terminal truncations (e.g. Gp216–59,
Gp214–58 and Gp214–55) resulted in proteins unable to affect
cell growth rate (data not shown), the results suggest that a
minimal functional region of T7 Gp2 comprises amino acids
14–59. The attenuation of cell growth by Gp214–59 is specific,
since no growth attenuation is detected in the context of the
R56C mutation (Fig. 4b). However, the E24K and F27Y
mutations clearly improve the efficiency by which Gp214–59
attenuates MG1655 cell growth (Fig. 4c). The Dt of MG1655
E. coli cells expressing Gp214–59 carrying the E24K/F27Y
double substitution is increased ~6.9-fold compared with
that of cells harbouring an empty plasmid vector (Table 2).
This result indicates that E24K and F27Y substitutions
improve the binding of Gp2 to the RNAp even if the primary
interaction interface with the b9 jaw domain is intact but the
binding affinity is attenuated by N- and C-terminal deletion
of evolutionarily variable segments.
Gp2 homologues from phages that infect C.
rodentium inhibit E. coli RNAp even if the
interaction with the b§ jaw is compromised
To obtain further experimental evidence that E24K and
F27Y substitutions in Gp2 facilitate the interaction of Gp2
with RNAp when the primary interaction interface with the
b9 jaw domain is compromised, we conducted experiments
with Gp2 homologues, proteins 13 and 16 from phages
CR44b and CR8 (CR44b_13 and CR8_16), which infect C.
rodentium, a model animal bacterial pathogen used to
study human infections by enteropathogenic and entero-
haemorrhagic E. coli. Initially, we wanted to determine
whether recombinant CR44b_13 and CR8_16 can com-
plement a T7 mutant phage (T72am64) harbouring a
mutation in gene 2 (Burck & Miller, 1978). T72am64
infections of wild-type E. coli BL21 cells are not productive,
since Gp2 function is essential for phage development.
However, E. coli BL21 cells containing pSW33 :Gp2WT
(which allows expression of Gp2 from a T7 RNAp-de-
pendent promoter) are successfully infected by T72am64, as
judged by the efficiency of plaque formation, which gave an
efficiency of plating (EOP) value of 1.0±0.18. EOP was
measured using the following equation: EOP5(number of
T72am64 plaques on strain+test plasmid)/(number of
T72am64 plaques on strain+pSW33 :Gp2WT). In contrast,
the EOP was significantly reduced (to 0±0.01) on lawns of E.
coli BL21 cells containing pSW33 :Gp2R56E, which encodes a
functionally defective Gp2 mutant. When plasmids encoding
recombinant CR44b_13 (pAS33 : CR44b_13) were trans-
formed into E. coli BL21, T72am64 formed plaques, albeit
at 40% reduced efficiency compared with E. coli BL21 cells
harbouring pSW33 :Gp2WT (EOP of 0.61±0.02). However,
T72am64 was able to form plaques equally well on E.
coli BL21 cells harbouring a plasmid encoding CR8_16
(pAS33 : CR8_16) (EOP of 1.01±0.21) and wild-type Gp2
(pSW33 :Gp2WT). Thus, we conclude that CR44b protein 13
and CR8 protein 16 can partially and fully, respectively,
substitute for T7 Gp2 during T7 infection.
Next, we conducted a growth attenuation assay to establish
whether CR44b_13 and CR8_ 16, like T7 Gp2, bind to the b9
jaw domain of the E. coli RNAp. As shown in Fig. 5(a),
induction of CR44b_13 and CR8_16 expression with 0.04%
(w/v) arabinose from pAS1 : CR44b_13 and pAS1 : CR8_16,
respectively, in wild-type E. coli MG1655, resulted in
efficient growth attenuation. However, no growth attenu-
ation of E. coli strain JE1134, which encodes a b9 subunit
with residues 1149–1190 deleted (Fig. 5b), was observed. We
next determined whether CR44b_13 and CR8_16 can inhibit
E. coli RNAp harbouring either the E1158K (i.e. found in
BR3 E. coli strain) or E1188K (i.e. found in 7009 E. coli
strain) mutations, as suggested by sequence analysis (above).
As shown in Fig. 5(c), whereas the growth of E. coli strain
7009 was not detectably attenuated by either CR44b_13 or
CR8_16, the growth of E. coli strain BR3 was efficiently
attenuated by both phage proteins (Fig. 5d). In vitro
transcription assays, which report the ability of T7 Gp2
CR44b_13 and CR8_16 proteins to inhibit the synthesis of
the tetranucleotide RNA product (ApApUpU) from the
lacUV5 promoter by the RNAp containing s70, with purified
wild-type, BR3 and 7009 RNAp and T7 Gp2, confirmed the
in vivo results (Fig. 5e).
If a charge reversal substitution (E24K) in T7 Gp2b indeed
facilitates binding to the RNAp when the primary contact
with the b9 jaw domain is weakened (Fig. 3), then R15 of
CR44b_13 should be important for attenuation of BR3 E.
coli growth. Results shown in Fig. 5(f) confirm that this
is indeed the case: the mutant variant of CR44b_13
harbouring the R15E mutation fails to attenuate the
growth of E. coli strain BR3 upon induction. However,
the R15E mutation has no detectable effect on the ability of
CR44b_13 Gp2 to attenuate the growth of wild-type E. coli.
Overall, results with Gp2-like proteins encoded by C.
rodentium phages provide further support for the view that
the molecular basis by which Gp2b is able to inhibit the
7009 RNAp is that E24K and F27Y substitutions facilitate
an interaction between Gp2 and RNAp when the primary
interaction interface is compromised.
DISCUSSION
T7 Gp2 binds tightly to and potently inhibits E. coli RNAp.
Previous biochemical and structural studies have shown
that amino acid residues in the b3 strand of Gp2 contribute
to the primary interaction interface with the b9 jaw domain
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of the RNAp. Results from the current study show that
substitutions in amino acid residues of Gp2 located in the
region surrounding and including the loop interconnecting
the b1 and b2 strands, and, therefore, located on the
opposite side to the b3 strand, can compensate for amino
acid substitutions in Gp2 and/or the b9 jaw domain that
compromise the primary interaction interface between Gp2
and the RNAp. This seems to constitute the molecular basis
by which T7b (encoding Gp2b harbouring the E24K, F27Y
and R56C substitutions) can successfully infect the 7009 E.
coli strain (harbouring the E1188K mutation) that is
resistant to infection by wild-type T7 phage.
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Fig. 5. Experiments with Gp2-like proteins from C. rodentium phages CR44b and CR8. Growth curves of (a) E. coli MG1655,
(b) JE1134, (c) 7009 and (d) BR3 cells in which the expression of T7 Gp2 and Gp2-like proteins CR44b_13 and CR8_16 was
induced at t50 (solid red lines). In each graph, the dotted line represents cells harbouring pBAD18 (empty vector). (e)
Autoradiograph of a 20% (w/v) denaturing gel showing synthesis of the transcript ApApUpU (the 32P-labelled nucleotides
underlined) from the lacUV5 promoter by the s70-containing RNAp in the presence of Gp2, CR44b_13 and CR8_16. The molar
ratio of RNAP to Gp2/Gp2-like proteins is indicated above each lane. The percentage of ApApUpU transcript synthesized (%A)
by the RNAp is calculated relative to the reaction without Gp2 and is indicated at the bottom of each lane. (f) Growth curves of
E. coli MG1655 (left) and BR3 (right) cells expressing CR44b_13 and harbouring the R15E amino acid substitution. Induction
with arabinose was performed at t50.
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Since the E24K and F27Y substitutions allow (1) the
functionally defective Gp2 mutant with the R56C substi-
tution effectively to attenuate wild-type E. coli growth
(Fig. 3a, Table 1) and (2) detectably improve the ability of
the truncated Gp2 form, Gp214–59, to attenuate wild-type E.
coli growth (Fig. 4, Table 2), it is possible that the region of
Gp2 surrounding and including the loop interconnecting
the b1 and b2 strands contributes to an ‘auxiliary’ inter-
action interface between Gp2 and RNAp and contributes to
the mechanism by which Gp2 efficiently inhibits RPo
formation by the RNAp: the overall architecture of RNAp
is reminiscent of a ‘crab claw’. The b and b9 subunits form
the two ‘pincers’ of the claw and define the DBC and
dwDBC (see Introduction). During RPo formation access
to the DBC and dwDBC is controlled by large-scale
movements of the b9 subunit (Mekler et al., 2002). Thus,
with respect to accessibility of the DBC, RNAp can exist in
a so-called ‘closed state’ (in which the width of the DBC is
insufficient to allow access of double-stranded DNA) or in
an ‘open state’ (in which the DBC is sufficiently wide to
allow access of double-stranded DNA) (Chakraborty et al.,
2012). The open state is required for RPo formation, and
after loading and unwinding of DNA to form the
transcription bubble, the RNAp converts into the closed
state. Furthermore, the binding of dwDNA to the dwDBC
and the concomitant displacement of the s70 domain,
known as region 1.1, from the catalytic cleft are the
minimal pre-requisites for efficient and stable RPo
formation at promoters utilized by the RNAp containing
the s70 factor (Mekler et al., 2002). Gp2 seems to employ a
three-pronged strategy to inhibit RPo formation by (i)
sterically antagonizing the interaction between dwDNA
and the b9 jaw domain, (ii) preventing obligatory
displacement of s70 region 1.1, and (iii) inducing RNAp
to adopt the closed state, thereby restricting DNA access to
the DBC and dwDBC (Ca´mara et al., 2010; Chakraborty
et al., 2012; James et al., 2012; Mekler et al., 2011). Thus,
the interface between Gp2 and the RNAp could consist of
at least two interaction interfaces: a primary one with the
b9 jaw and one or more auxiliary interaction interfaces. We
hypothesize that these interfaces collectively contribute to
the high affinity between Gp2 and the RNAp and
orchestrate the multipronged mechanism of transcription
inhibition by Gp2. Specifically, we envisage a model in
which, when Gp2 is bound to the jaw domain on the b9
pincer, the region surrounding and including the loop
interconnecting the b1 and b2 of Gp2 interacts with the b
pincer (which is located directly across from the b9 jaw on
other side of the DBC) and thereby ‘locks’ the RNAp in the
closed state, leading to very efficient inhibition of RPo
formation (Fig. 6). This mechanism of inhibition of RPo
formation by Gp2 is analogous to how some antibiotics
(such as myxopyronin, corallopyronin and ripostatin) and
the non-DNA-binding transcription factor DksA inhibit
RPo formation by allosterically inducing RNAp to adopt
the closed state (Chakraborty et al., 2012; Rutherford et al.,
2009). However, in terms of interaction with the RNAp,
Gp2 seems to be analogous to the transcription anti-
termination factor RfaH, which binds to b9 clamp helices
and a b gate loop, which are located directly across from
each other on the two sides of the DBC and thereby lock
the RNAp in the closed state to ensure transcription pro-
cessivity, reducing pausing and termination (Sevostyanova
et al., 2011). Experiments to verify the model in which Gp2
simultaneously interacts with the b and b9 pincers to in-
hibit RPo formation are currently in progress.
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ABSTRACT: Diﬀerences in kinetics of transcription initiation by RNA
polymerase (RNAP) at diﬀerent promoters tailor the pattern of gene
expression to cellular needs. After initial binding, large conformational
changes occur in promoter DNA and RNAP to form initiation-capable
complexes. To understand the mechanism and regulation of tran-
scription initiation, the nature and sequence of these conformational
changes must be determined. Escherichia coli RNAP uses binding free
energy to unwind and separate 13 base pairs of λPR promoter DNA to
form the unstable open intermediate I2, which rapidly converts to much
more stable open complexes (I3, RPo). Conversion of I2 to RPo involves folding/assembly of several mobile RNAP domains on
downstream duplex DNA. Here, we investigate eﬀects of a 42-residue deletion in the mobile β′ jaw (ΔJAW) and truncation of
promoter DNA beyond +12 (DT+12) on the steps of initiation. We ﬁnd that in stable ΔJAW open complexes the downstream
boundary of hydroxyl radical protection shortens by 5−10 base pairs, as compared to wild-type (WT) complexes. Dissociation
kinetics of open complexes formed with ΔJAW RNAP and/or DT+12 DNA resemble those deduced for the structurally
uncharacterized intermediate I3. Overall rate constants (ka) for promoter binding and DNA opening by ΔJAW RNAP are much
smaller than for WT RNAP. Values of ka for WT RNAP with DT+12 and full-length λPR are similar, though contributions of
binding and isomerization steps diﬀer. Hence, the jaw plays major roles both early and late in RPo formation, while downstream
DNA functions primarily as the assembly platform after DNA opening.
Escherichia coli RNA polymerase (RNAP) is a molecular
catalytic machine that synthesizes RNA from a DNA template.
Kinetic-mechanistic studies with the WT RNAP and the λPR
promoter as a function of RNAP concentration, upstream DNA
length, and solution variables (temperature, salt and solute
concentrations), together with footprinting of key intermedi-
ates, provide strong evidence that RNAP is also a molecular
“isomerization” machine, opening and stabilizing the initiation
bubble of promoter DNA in the active site cleft to form a series
of open complexes of increasing stability (I2, I3, and RPo; see
Figure 1A).1−4 Early in the mechanism, RNAP bends the
upstream ends of both the −35 and −10 regions of the
promoter to wrap upstream DNA on the back side of RNAP
and to put the downstream duplex in contact with the cleft in
the ﬁrst kinetically signiﬁcant intermediate I1.
5,6 Subsequently
RNAP actively opens the initiation bubble (−11 to +2) in the
cleft to form the initial open complex I2, in which the start site
region of the template strand may be positioned as in RPo, but
the discriminator region of the nontemplate strand is not.1
The initial, unstable open complex I2 is greatly stabilized in
the steps converting it to I3 and RPo (Figure 1B).
2,3 Analysis of
large eﬀects of urea and other solutes on the composite
dissociation rate constant kd reveals that ∼120 amino acid
residues fold or are buried in interfaces in the large scale
conformational changes that convert I2 to RPo, including ∼80
residues in converting I2 to the subsequent (I2−I3)‡ transition
state and ∼40 residues in converting this transition state to RPo
via I3.
3,7 We proposed that conversion of I2 to RPo involves
rearrangement of the nontemplate strand in the cleft1 and
assembly of the β′ jaw (E. coli β′ 1150−1208) and other mobile
domains of RNAP (called downstream mobile elements, or
DMEs; deﬁned in Figure 2A) on downstream duplex DNA.2,3
Although structural studies of RNAP suggest that the DMEs are
rigid bodies, crystallization conditions may select for certain
ordered conformations of the DMEs,7 and PONDR8
calculations suggest that extensive regions of E. coli DMEs
are not stably folded in apo-holoenzyme (see Figure 2B and
Discussion).7
In the present study, we focus on the role of the jaw in the
steps of open complex formation at the λPR promoter. Deletion
Received: September 14, 2012
Revised: October 31, 2012
Published: November 1, 2012
Article
pubs.acs.org/biochemistry
© 2012 American Chemical Society 9447 dx.doi.org/10.1021/bi301260u | Biochemistry 2012, 51, 9447−9459
of the jaw (ΔJAW = β′Δ1149−1190) is known to reduce the
lifetimes of open complexes at several promoters,9 but its
eﬀects on the steps that form and stabilize open complexes have
not been previously characterized. The far downstream region
of the promoter (+10 to +20), engulfed10 by interactions with
DMEs (Figure 2) in stable open complexes (RPo), corresponds
to the region that has been proposed to interact with the jaw in
elongation complexes and heteroduplex promoter com-
plexes.9,11,12 Importantly, although deletion of the jaw has
pleiotropic eﬀects on transcription initiation, elongation, and
termination, it does not compromise E. coli viability,9 indicating
the lack of gross structural changes in ΔJAW transcription
complexes.
Recent studies by James et al. are consistent with a direct
interaction between the jaw and the promoter DNA.13 What is
the role of these interactions? Do they participate in promoter
opening,12 or are they responsible for stabilization of the initial
unstable open complex (I2)?
2,3,7 On the basis of comparison of
properties of open complexes formed by ΔJAW RNAP and/or
a λPR promoter variant truncated at +12 (DT+12), we
conclude that interactions of the jaw, and/or of neighboring
DMEs that become repositioned when the jaw is removed, with
the far downstream duplex DNA occur primarily in the late
conversion of I3 to RPo, while interactions of the jaw with in-
cleft elements of RNAP, including other DMEs and/or region
1.1 of σ70,14 are responsible for its eﬀects on the early steps of
open complex formation.
■ EXPERIMENTAL PROCEDURES
Buﬀers. RNAP storage buﬀer contains 50% glycerol (v/v),
0.01 M Tris (pH 7.5 at 4 °C), 0.1 M NaCl, 0.1 mM DTT, and
0.1 mM Na2EDTA. Wash buﬀer for nitrocellulose ﬁlter binding
experiments contains 0.01 M Tris (pH 8.0 at room temper-
ature), 0.1 M NaCl, and 0.1 mM Na2EDTA. Phosphate buﬀer
(PB) for dissociation kinetic experiments in the absence of
Mg2+ is 0.01 M Na2HPO4
−, 0.16 M NaCl (0.14−0.30 M NaCl
in salt dependence experiments), 1 mM dithiothreitol (DTT),
and 100 μg/mL BSA. Tris buﬀer (TB), a common transcription
buﬀer used here for kinetics experiments in the presence of
Mg2+, is 0.04 M Tris (adjusted to pH 8.0 at the experimental
temperature with HCl), 0.12 M KCl, 0.01 M MgCl2, 1 mM
DTT, and 100 μg/mL BSA. Low salt Tris buﬀer (LSTB) is the
same as TB, but with 0.06 M KCl and 0.005 M MgCl2. RNAP
storage buﬀer was added to keep the glycerol concentration
constant in a series of association experiments (where the
RNAP concentration was varied) and in dissociation experi-
ments (6% total RNAP storage buﬀer in TB and LSTB; 13% in
PB). For MnO4
− footprinting experiments, DTT was omitted;
for HO• footprinting experiments, the Tris concentration was
reduced to 0.01 M.
RNAP Preparation. E. coli ΔJAW RNAP core was prepared
as described previously.15 E. coli WT RNAP core, σ70, and
holoenzyme were endogenously expressed and puriﬁed from E.
coli MG165516 as described previously.1 ΔJAW holoenzyme
was reconstituted by incubating ΔJAW RNAP core (500 nM)
and WT σ70 (2 μM) for 90 min at 37 °C.
λPR Promoter DNA Preparation. Full-length (FL) λPR
DNA duplex fragments (∼180 bp long; approximately −120 to
+60) were PCR-ampliﬁed from plasmid pPR59 (λPR −59 to
+34, a gift from Dr. Wilma Ross)17 using downstream primer
5′-CAGGACCCGGGGCGCGCTTAATTAACACTCTTA-
TACATTATTCC-3′ and upstream primer 5′-GTAC-
GAATTCGATATCCAGCTATGACCATGATTACGC-
CAGC...3′. Fragments were isolated using the Qiagen
QIAquick PCR Puriﬁcation Kit (Valencia, CA). To end label
the template strand downstream, duplex fragments were
cleaved with BssHII, and the 5′ phosphates were removed
with Antarctic Phosphatase and replaced with [γ-32P] ATP
using T4 polynucleotide kinase. The 3′ ends were ﬁlled in using
Sequenase with 1 mM dGTP + dCTP, and the upstream end
was cut with EcoRV to remove the upstream label. For
nontemplate strand downstream ﬁll-in label, duplex fragments
were cleaved with EcoRV and BssHII, and ﬁlled in with [α-32P]
dCTP (along with 1 mM cold dGTP + dCTP) using
Sequenase.
Downstream-truncated (at +12; DT+12) λPR DNA duplex
fragments (∼140 bp long; approximately −120 to +12) were
obtained by PCR as above, using the same upstream primer as
for full-length λPR (see above) and downstream primer 5′-
GAGGACCCGGGTTACTACATGCAACCATTAT-
CACCGCCAGAG-3′. To ﬁll-in label the upstream end of the
template strand, the PCR product was cleaved with EcoRI and
SmaI, and labeled with [α-32P] dATP (added with 1 mM cold
dATP + dTTP) using Sequenase.
Enzymes used in λPR promoter DNA preparation and
labeling were obtained from New England Biolabs (Ipswitch,
MA), except for Sequenase, which was obtained from
Aﬀymetrix (Santa Clara, CA). All labeled fragments were
puriﬁed on a 5% acrylamide gel and isolated using an Elutip-d
Figure 1. Proposed mechanism of forming and stabilizing the open
complex between E. coli RNAP and λPR promoter DNA. (A)
Investigation of the kinetics of association of free RNAP (R) with λPR
promoter DNA (P) to form open complexes provides information
about the ﬁrst half of this mechanism, including the equilibrium
constant K1 for binding, bending, and wrapping the DNA duplex to
form the advanced closed complex I1, and the rate constant k2 for the
rate-determining isomerization step (converting I1 to I2) in which the
DNA duplex is opened in the cleft by RNAP.1,4,6 Investigation of the
dissociation of open complexes provides information about the late
steps of the DNA opening mechanism: k3 is the rate constant for
conversion of I2 to I3; and k−3 is the composite rate constant for
conversion of RPo (or an initial I3/RPo mixed population) to I2. The
ratio k3/k−3 is deﬁned as K3, the equilibrium constant for conversion of
I2 to the equilibrium mixture of I3 and RPo.
3 The rate-determining step
in dissociation is DNA closing (rate constant k−2). (B) A cartoon
model describing the molecular transitions of this mechanism. The
active site Mg2+ ion is shown as a red ball. The β′ mobile jaw is a
downstream mobile element (DME) located in the vicinity of the
downstream duplex. Here, we propose that the jaw and other DMEs
assemble and tighten around the downstream duplex in the late steps
of the mechanism to stabilize the late open complexes.
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Puriﬁcation Minicolumn (Whatman (GE Healthcare, Pitts-
burgh, PA)).
Dissociation Assays. For dissociation kinetic assays, an
initial population of 90 ± 10% open complexes was obtained by
incubation of excess WT or ΔJAW RNAP holoenzyme (5−20
nM active) with 32P-labeled λPR promoter (∼150 pM) at 25 or
37 °C. Irreversible dissociation was initiated by addition of 50−
100 μg/mL heparin, a nondisplacing competitor for both WT18
and ΔJAW RNAP (Figure S2, Supporting Information). For
studies of eﬀects of urea on dissociation, urea was added at the
same time as heparin. As a function of time, 100 μL aliquots
(∼3000 cpm) were removed and applied to nitrocellulose ﬁlters
on a vacuum manifold.4 Filters were dried under heat lamps
and counted with a Hewlett-Packard Tri-Carb 2100 TR
scintillation counter. In TB, about 20% of open complexes
formed by ΔJAW RNAP are found to be nondissociating.
Addition of urea reduces the initial population of ΔJAW open
complexes, making it diﬃcult to quantify the dissociation rate
constant kd accurately as a function of urea in TB. Experiments
with WT and ΔJAW RNAP to determine eﬀects of urea on kd
were therefore performed at a convenient NaCl concentration
(0.16 M) in PB, the buﬀer used to determine the eﬀects of
univalent salt concentration on kd.
Analysis of Dissociation Data. Filter-retained counts were
corrected by subtracting background counts (determined by
ﬁltering solutions in the absence of RNAP) to determine cpmt,
the ﬁlter-retained counts due to open complexes. For each data
set, the dissociation rate constant kd was determined by ﬁtting
cpmt vs time to the ﬁrst order rate equation
= + −A B k tcpm exp( )t d (1)
where A = cpmt=∞ (which can diﬀer from background because
of a subpopulation of nondissociating complexes) and B =
cpmt=0 − cpmt=∞ . The fraction of promoter DNA in the form
of open complexes at time t (θt) is calculated as θt = (1/
E)(cpmt=0/cpmtot) where cpmtot is the total cpm in the aliquot
ﬁltered and E is the eﬃciency of retention of open complexes
on the nitrocellulose ﬁlter membrane, typically in the range
0.6−0.9 (see below) depending on the details of how the ﬁlters
are prepared and how the ﬁlter bound complexes are treated
with wash buﬀer.3 In Figures 5 and 6, the quantity plotted is Δθ
= θt − θt=∞, where θt=∞ = (1/E)(cpmt=∞/cpmtot). All data
ﬁtting, analysis and normalization were performed using Igor
Pro Version 5.03.
Determination of the Equilibrium Constant K3 for
Stabilization of the Initial Open Complex by Assembly
of Downstream Mobile Elements. Values of K3 (deﬁned in
Figure 1) were determined from experimental values of
dissociation rate constants kd using the relationship
3
= − ≅ < <− − −K k k k k k k/ 1 / for3 2 d 2 d d 2 (2)
The value of the DNA closing rate constant k−2 for WT RNAP
and FL λPR promoter DNA at 25 °C was interpolated from
results at 10 and 37 °C,3 using the experimentally determined
Figure 2. DMEs and their proposed stepwise assembly on downstream DNA to stabilize the initial open complex (I2) in transcription initiation. (A)
DMEs of the β and β′ subunits (surface representation) surrounding the downstream DNA duplex (black, to +15) are deﬁned on a model of the E.
coli RNAP transcription elongation complex.22 DMEs include the β lobe (red, β 184−224, 344−438); the β sequence insertion (SI)1 (yellow, β
225−343); the β′ clamp (green, β′ 131−347, 1260−1368); the β′ upstream clamp (pink, β′ 808−912); β′ SI3 (orange, β′ 943−1130); and the β′
jaw (blue, β′ 1149−1208). All residue numbers refer to E. coli RNAP. (B) Regions of β and β′ in E. coli RNAP22 that are predicted to be
unstructured (primarily DMEs) by the PONDR (Predictor of Natural Disordered Regions) VL-XT program are represented by brightly shaded
ribbons (see Supporting Information). (C) In the conversion of I2 to I3 (or the preceding transition state), a step in which approximately 80 RNAP
residues are buried by folding/assembly/binding,3 we propose that the β′ clamp and/or β lobe assemble on the proximal DNA duplex (+3 to +10).
(D) In the conversion of I3 (or the previous transition state; see text) to RPo, a step in which approximately 40 RNAP residues are buried by folding/
assembly/binding,3 we deduce that the β′ jaw and neighboring DMEs assemble on the distal downstream DNA (+10 to +20).
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activation energy (9.9 kcal/mol). This DNA closing rate for
WT RNAP and FL λPR is independent of urea concentration;
the entire eﬀect of urea on kd is on K3.
3 A preliminary
dissection of the dissociation kinetics for ΔJAW RNAP−FL
λPR complexes (E. Ruﬀ, unpublished) indicates that the
diﬀerence in kd between ΔJAW and WT RNAP is largely in
K3, and that the eﬀect of urea in both cases is primarily on K3.
We assume that this situation also applies for DT+12 λPR. For
the dissociation of WT RNAP from FL λPR the uncertainty in
k−2 is approximately 20%,
3 and that in K3 is approximately 30%.
Association Assays. To initiate association, excess WT or
ΔJAW RNAP (1−50 nM active) was added to 32P-labeled λPR
promoter (∼150 pM) in TB at 37 °C. At selected times after
mixing, 100 μL aliquots (∼3000 counts) were withdrawn.
Heparin (50 μg/mL ﬁnal) was added for 10 s and each aliquot
was ﬁltered and counted as described above.
Analysis of Association Data. Association experiments for
ΔJAW RNAP at low concentrations (e.g., in Figure 8 in
Results) do not go to completion under the conditions
investigated, and kinetic data were therefore analyzed as
reversible associations4 according to eq 3:
β= + − − −= = tcpm cpm (cpm cpm )(1 exp( ))t t t0 eq 0
(3)
where β is the decay to equilibrium rate constant, cpmt is the
background-corrected counts retained on the ﬁlter at time t,
and cpmeq and cpmt=0 are the values of cpmt at equilibrium and
extrapolated to t = 0, respectively. The decay rate constant β is
related to the rate constants kd and α of dissociation and
association, respectively, by
β α α θ= + =k /d eq (4)
where θeq is the fraction of promoter DNA in the form of
competitor-resistant (open) complexes at equilibrium, and
α = +K k K[RNAP]/(1 [RNAP])1 2 1 (5)
where K1 is the equilibrium constant for forming the I1
intermediate closed complex and k2 is the isomerization
(DNA opening) rate constant.4 The composite association
rate constant ka (Table 1) is given by
4
=k K ka 1 2 (6)
If association is irreversible, then θeq = 1, kd = 0, and β = α.
More generally, determination of α from β requires knowledge
of either θeq or kd. Determination of θeq from the experimental
quantities cpmeq and cpmtot (the background-corrected total
cpm in each ﬁltered aliquot) requires knowledge of the ﬁlter
eﬃciency E, the fraction of competitor resistant (open)
complexes in solution that are retained on the ﬁlter:4
θ θ= = Ecpm /cpmeq tot eq
obs
eq (7)
Therefore, from eqs 4 and 7,
βθ β= −E k( )eqobs d (8)
Analysis of the variation in experimental values of βθeq
obs vs β
for a series of experiments at diﬀerent [RNAP] yields best-ﬁt
values of E and kd, allowing calculation of θeq and α from each
determination of β using eq 4. For the sets of experiments
analyzed here, eﬃciencies E of 0.62, 0.77, and 0.81 were
obtained for WT-DT+12 complexes, ΔJAW-FL complexes, and
ΔJAW-DT+12 complexes, respectively. Values of E and θeq
were used to calculate θt for Figure 8. For WT RNAP and DT
+12 promoter DNA, values of α obtained from eq 4 were
analyzed as a hyperbolic function of [RNAP] using eq 5 to
obtain ka, K1, and k2. For ΔJAW RNAP, where α is observed to
be proportional to [RNAP] over the accessible concentration
range, only ka is obtained from the analysis. Igor Pro Version
5.03 was used for data ﬁtting and analysis.
KMnO4 Footprinting. Open complexes (5 nM active
RNAP + ∼1 nM 32P-λPR promoter DNA) were formed in TB
(-DTT) or LSTB (-DTT) by incubation for 30 min at 37 °C.
After incubation, heparin (100 μg/mL) was added to some
samples for 10 s before addition of KMnO4 to eliminate short-
lived complexes. KMnO4 (1.25 mM ﬁnal concentration) was
added for 10 s (determined to be a single-hit dose) and
reactions were quenched with 1 M β-mercaptoethanol. Samples
were then cleaved with 1 M piperidine, puriﬁed, and run on an
8% acrylamide gel together with control (-RNAP) lanes.19,20
HO• Footprinting. Open complexes were formed in LSTB
at 37 °C as described for KMnO4 footprinting, except that
buﬀers contained DTT and were prepared with a reduced Tris
concentration (10 mM) because Tris scavenges HO•.21 After a
brief (10 s) challenge with 100 μg/mL heparin, [Fe-EDTA]−2
(1.8 mM Fe2+, 4.2 mM EDTA) and sodium ascorbate (1.2
mM) were added, followed by addition of H2O2 (0.1%) to
generate HO•. After 10 s, a short enough exposure time to be
in the single-hit regime, reactions were quenched (11.7 mM
thiourea + 2.0 μM EDTA) and worked up by phenol extraction
and ethanol precipitation. Samples were run on an 8%
acrylamide gel.6,10
Gel Imaging and Analysis. Footprinting and transcription
gels were imaged using either a Typhoon 9410 Variable Mode
Imager or a Typhoon FLA-9000 (both from GE Healthcare)
and analyzed using Image Quant TL. HO• line scans were
normalized to a short region of the footprint upstream of −60.
This upstream normalization provides a better match of
downstream as well as upstream baselines for the diﬀerent
line scans on each gel than is achieved by normalization to any
group of downstream bands or to total cpm. While small drifts
Table 1. Dissociation Rates of ΔJAW and WT RNAP Open Complexes and Their Interpretation: Eﬀects of [Urea]a
RNAP λPR relative dissociation rateb 10−3 K3 (M
−1)c ΔG30c (kcal/mol) urea dependence of kd (d ln kd/d[urea]) (M-1)d
WT FL 1 ∼63 −6.5 ± 0.3 3.1 ± 0.1
WT DT+12 23 ± 3 ∼2.7 −4.7 ± 0.3 1.9 ± 0.2
ΔJAW FL 67 ± 7 ∼0.9 −4.1 ± 0.3 2.1 ± 0.1
ΔJAW DT+12 52 ± 11 ∼1.2 −4.2 ± 0.4 2.1 ± 0.1
aConditions: PB (0.16 M NaCl), 25 °C. bCalculated for WT/FL dissociation rate constant kd = (2.7 ± 0.2) × 10
−5 s−1 for these conditions (Figure
5). cK3 and ΔG30 deﬁned as in Figure 1. K3 is the composite equilibrium constant and ΔG30 is the corresponding standard free energy change for the
process of converting the initial open complex I2 to the equilibrium population of stable open complexes (RPo, I3) for λPR at 25 °C. K3 calculated
from eq 2 using a DNA closing rate constant k−2 = 1.7 ± 0.4 s
−1 at 25 °C, obtained by interpolation of WT/FL results.3 Uncertainty in K3 ∼ 30−
45%. dSlopes of plots (Figure 6D) of ln kd vs [urea].
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in the downstream baselines are observed with this normal-
ization (visible in the diﬀerence line scans in Figure 4E,F), they
are not large enough to aﬀect the semiquantitative conclusions
of our analysis. To reduce noise, a moving average of 10
positions (approximately 0.7% of the length of the gel) was
applied to each line scan (Excel). Diﬀerence line scans for each
DNA strand were determined by measuring the distance
between the free DNA backbone and RNAP-complexed DNA
backbone for each DNA base position +1 to +22. For each
strand, distances were normalized to the maximum distance,
averaged with the independent (duplicate) experiment, and
plotted in a bar graph to more explicitly portray the relative
protection of WT and ΔJAW RNAP open complexes.
Prediction of RNAP Disordered Regions. The E. coli
RNAP β and β′ subunits22 were analyzed using VL-XT, the
most stringent program in PONDR8 (Predictions of Naturally
Disordered Regions). Only sequences in which at least 15
sequential residues are predicted to be disordered were
considered, and predicted disordered sequences known to be
in subunit−subunit interfaces were excluded.
■ RESULTS AND ANALYSIS
KMnO4 Footprints of λPR Promoter DNA in ΔJAW
Complexes. How does the highly conserved bacterial jaw
domain aﬀect the distribution and structure of RNAP-promoter
complexes? Ederth et al. observed that ΔJAW RNAP forms
unstable complexes at the λPR promoter at 30 °C at moderate
salt concentration (0.01 M MgCl2, 0.15 M KCl).
9 To eliminate
the possibility that a mixed population of complexes and free
promoter DNA exists under these conditions, we sought
conditions to increase the stability and lifetime of ΔJAW RNAP
complexes at the λPR promoter (Figure 3A) for footprinting
experiments. At 37 °C in lower-[salt] buﬀer (LSTB: 0.005 M
MgCl2, 0.06 M KCl), ΔJAW RNAP-λPR open complexes are
long-lived (Figure 3B,C; LSTB lanes), suggesting that all bound
DNA is in the form of an open complex.
To compare extents of DNA opening, we exposed ΔJAW
and WT RNAP complexes to KMnO4 in either LSTB or TB
(0.01 M MgCl2, 0.12 M KCl). KMnO4 preferentially oxidizes
unstacked thymines, providing a method of detecting and
quantifying DNA opening in RNAP-promoter complexes.1,20,23
We ﬁnd that ΔJAW-λPR complexes are open: thymines at −11,
−9, −8 and +1 on the template strand (Figure 3B) and −4, −3
and +2 (but not −7 and −10) on the nontemplate strand
(Figure 3C)) exhibit the same KMnO4 reactivity, and therefore
are exposed to the same extents in the open regions of WT-λPR
and ΔJAW-λPR open complexes. In TB, detected thymines on
both strands in ΔJAW open complexes are signiﬁcantly less
KMnO4-reactive than in WT open complexes (Figure 3B,C; TB
lanes). Though ΔJAW open complexes are less stable and
shorter-lived in TB than in LSTB, this cannot explain the large
reductions in KMnO4 reactivity (see below). For both WT and
ΔJAW RNAP, λPR promoter DNA opening and closing rate
constants are only weakly (if at all) dependent on salt
concentration3 (E. Ruﬀ, unpublished), so this is not a salt
eﬀect on DNA opening. Nor can it be a salt eﬀect on KMnO4
reactivity, since the KMnO4 reactivities of these thymines in
WT open complexes are the same in TB as in LSTB.
HO• Footprints of λPR Promoter DNA in ΔJAW Open
Complexes. The jaw domain is located near the downstream
DNA (Figure 2A), and can interact with DNA nonspeciﬁ-
cally.13,24,25 Furthermore, a large β′ region that includes the jaw
cross-links to the DNA backbone.26 However, direct evidence
demonstrating jaw contacts to DNA in any RNAP−DNA
complex (e.g., closed, open, initiation, or elongation states) is
lacking. Here, we ask whether the jaw deletion alters protection
of the DNA backbone in open promoter complexes. Figure 4
compares normalized line scans from quantitative single-hit
HO• footprints of both template (panels A and C) and
nontemplate (panels B and D) strands of FL λPR in stable open
complexes formed by either WT or ΔJAW RNAP in LSTB at
37 °C. (Sequencing gels for the experiments in panels A and B
are shown in Figure S1, Supporting Information.) Bar graphs of
average diﬀerences in HO• protection between open
complexes and free promoter DNA at each downstream
position from +1 to +22 are shown in Figure 4E,F.
Two very signiﬁcant diﬀerences are observed in HO•
footprints of ΔJAW and WT open complexes. First, the
downstream boundaries of HO• protection of both strands in
the ΔJAW RNAP open complex are shorter than for WT
RNAP. The boundary on the template strand (Figure 4E) is
approximately 1 helical turn shorter for the ΔJAW open
complex than for that formed by WT RNAP, ending near +10
instead of +20. For the nontemplate strand (Figure 4F), the
downstream boundary of the ΔJAW RNAP open complex is
near +15, about 0.5 helical turn shorter than that observed for
WT RNAP (+20). (The diﬃculty in quantitatively normalizing
the entire length of these >100 nucleotide line scans is revealed
in the drift in the region downstream of the boundary of the
WT footprint at +20, observed in the diﬀerence plots in Figure
4E,F. This drift is not large enough to aﬀect the semi-
quantitative results presented above, though it does increase the
uncertainty in assignment of the downstream boundary of the
ΔJAW footprints (sequence position +10 ± 2 bases on the
template strand and position +15 ± 3 bases on the nontemplate
Figure 3. MnO4
− cleavage of unstacked (single-stranded) thymine
residues of λPR promoter DNA−RNAP open complexes. (A)
Sequence of λPR promoter DNA positions −35 to +20. The −35
and −10 elements of the promoter, which interact with σ regions 4.2
and 2.3/2.4, respectively,5 are boxed. MnO4-reactive thymines in WT
RNAP open complexes are denoted by bullets above and below the
template (t) and nontemplate (nt) strands, respectively. (B, C)
Comparison of KMnO4 footprints of λPR promoter DNA in ΔJAW
and WT RNAP open complexes in TB (0.01 M Mg2+, 0.12 M K+) and
in LSTB (0.005 M Mg2+, 0.06 M K+) at 37 °C: (B) template strand;
(C) nontemplate strand. Positions of reactive thymine residues are
indicated; nontemplate strand thymines at positions −7 and −10 are
not reactive to MnO4
− because they are protected by interactions with
σ.37
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strand).) The reduction in HO• protection of the ΔJAW
RNAP open complex provides direct evidence that the jaw,
and/or neighboring regions of RNAP perturbed by deleting the
jaw, likely contacts one side of the duplex DNA from +10 to
+20 in WT RPo. Direct contact between the jaw and the distal
downstream duplex (+10 to +20) was proposed previ-
ously.9,24,26 However, structural studies of bacterial RNAP
suggested that the interaction between the jaw and the DNA
downstream duplex is proximal to the transcription start site,
forming an interface only to about +12.22,25 In this case, the
presence of the jaw might act indirectly by inﬂuencing the
concurrent folding/assembly of one or more additional DMEs
onto the distal downstream duplex. At this time, we are not able
to distinguish between these two possibilities.
A second very striking diﬀerence between HO• footprints of
ΔJAW and WT open complexes, shown for the downstream
region of the promoter DNA analyzed in Figure 4E,F (but also
clearly observable in the upstream promoter regions in Figure
4A−D), is that all regions of both DNA strands in the ΔJAW
open complex are signiﬁcantly less protected from HO• than is
the case for WT RPo. This eﬀect extends at least from −45 to
the downstream boundary of the footprint and is especially
pronounced in the open region of the promoter (initiation
bubble; −11 to +2) in the active site cleft. This global reduction
in protection cannot be attributed simply to the shorter lifetime
of the ΔJAW open complex, which is more than 1 h in LSTB
and therefore much longer than the time scale of the
footprinting experiments (10 s). In TB, the ΔJAW open
complex exhibits no signiﬁcant HO• protection of either
template or nontemplate strand (data not shown), even though
the lifetime of the ΔJAW complex in TB (30 min) is much
greater than the time required to footprint (10 s; see below),
and KMnO4 footprints (Figure 2) reveal that this complex is an
open complex.
A plausible explanation of the reduced protection observed
for the ΔJAW RNAP open complex in both buﬀers is that more
water remains in the ΔJAW RNAP−promoter interface than in
the WT RNAP−promoter interface, and that HO• gains access
to the DNA in the interface by facilitated diﬀusion on a
network of residual water of hydration. Alternatively, or in
addition, the ΔJAW RNAP−promoter interface may be more
dynamic than that of the WT enzyme, exhibiting normal modes
of vibration that result in local separations of RNAP and
promoter DNA that allow HO• access to all portions of the
interface in a 10 s footprinting experiment without any global
dissociation.
Large Eﬀects of Deletion of the Jaw or of Down-
stream Promoter DNA on the Rate of Dissociation of
Open Complexes. To investigate when, where, and how
strongly the jaw and neighboring DMEs assemble on the
downstream duplex in the process of forming the stable open
complex at λPR, we compared the kinetics of dissociation of
open complexes formed by WT and ΔJAW RNAP on FL and
truncated (at +12) λPR promoter DNA (DT+12). Dissociation
Figure 4. Line scans of lanes in single-hit HO• footprinting experiments (Figure S1) performed in duplicate for the template (A,C) and nontemplate
(B, D) strands of λPR promoter DNA in open complexes with ΔJAW RNAP (blue) or WT RNAP (gray) and free λPR DNA (gold) in LSTB at 37
°C. The regions of the DNA initiation bubble (−11 to +2) and the downstream DNA duplex (+3 to +20) are indicated by brackets below a model of
these DNA regions. Bar graphs in panels E and F display the relative protection of individual downstream positions of template (E) and nontemplate
(F) strands in ΔJAW and WT open complexes, calculated as the average of diﬀerence line scans for each strand (see Experimental Procedures). Each
panel is normalized so the maximum diﬀerence in protection in this interval is set equal to 1.0.
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time courses in PB (0.16 M NaCl) at 25 °C are shown in
Figure 5A. Dissociation rate constants kd calculated from these
data (see Table 1) are compared with one another, and with
the corresponding quantities determined at 37 °C in TB (0.12
M KCl, 0.01 Mg2+), in Figure 5B. Values of kd in TB, obtained
by analysis of reversible association kinetic experiments (shown
in Figure 8 below) are listed in Table 2. In both PB (25 °C)
and TB (at 37 °C), WT-FL open complexes are long-lived.
Dissociation rate constants kd for WT-FL open complexes are
small and of comparable magnitude (kd = 2.7 × 10
−5 s−1 in PB
at 25 °C; kd = 2.2 × 10
−5 s−1 in TB at 37 °C18), permitting
convenient study of the destabilizing eﬀects of urea on kd of the
less stable variant complexes.
For both sets of solution conditions, eﬀects of deletion of the
jaw or of the downstream DNA on kd are large (∼20−60-fold
increase in kd from that observed for dissociation of WT RNAP
from FL λPR). Details diﬀer somewhat in the two conditions
investigated. In TB, each single variant increases kd
approximately 25-fold; in PB, deleting the jaw increases kd
even more dramatically (67-fold), while the eﬀect of deleting
the downstream duplex is similar to that observed in TB. The
additional eﬀect of the second deletion (comparing kd for
ΔJAW-DT+12 with kd for ΔJAW-FL or WT-DT+12) is small
in PB at 25 °C, but larger in TB at 37 °C. In PB at 25 °C,
deletion of the downstream DNA in ΔJAW open complexes
does not aﬀect the dissociation rate, and deletion of the jaw in
open complexes formed with DT+12 DNA increases the
dissociation rate by only a small amount (∼2-fold) compared to
WT RNAP. In TB at 37 °C, however, deletion of the
downstream DNA in ΔJAW open complexes increases the
dissociation rate by approximately 8-fold. These diﬀerences
between the variants in PB and TB probably result from speciﬁc
eﬀects of Mg2+; previous dissociation studies with WT RNAP
and FL λPR as a function of Mg
2+ concentration provided
evidence for binding of 2−3 Mg2+ ions in the conversion of I2
to RPo.
27
Because kd = k−2/(1 + K3), where k−2 is the DNA closing rate
constant (the bottleneck step in dissociation) and K3 is the
composite equilibrium constant for forming the stable open
complex (RPo, I3, or an equilibrium mixture of the two) from I2
(Figure 1), these large eﬀects on kd of deleting either the jaw or
the downstream DNA could result from a combination of
increases in k−2 and/or reductions in K3. For WT RNAP, the
large eﬀect of urea on kd arises from K3, while k−2 is
independent of urea concentration.3 Because deletion of either
the jaw or the downstream duplex signiﬁcantly reduces the urea
dependence of kd (as shown in Figure 6D below), we infer that
the primary eﬀect of these deletions must be on K3. Consistent
with this deduction, preliminary measurements of k−2 for
dissociation of ΔJAW RNAP from FL λPR promoter DNA (E.
Ruﬀ, unpublished) reveal that it is similar to (indeed somewhat
smaller than) k−2 for WT RNAP.
Values of the equilibrium constant K3 and the standard free
energy change ΔG30 for conversion of I2 to the stable open
complex obtained from these data using eq 2 are listed in
Tables 1 and 2 for the two conditions investigated. For WT
RNAP and FL λPR, the full stabilization of the open complex is
∼ −7 kcal/mol (K3 of order 105), as determined previously.
3 A
similar conclusion was obtained from dissociation kinetic
studies with DT heteroduplexes.12 Tables 1 and 2 show that
deletion of either the far downstream duplex (at +12) or of the
jaw eliminates approximately one-third of the stabilization
provided by the DME assembly. In PB, deletion of both the
downstream duplex (at +12) and the jaw has no additional
eﬀect, as expected if the main eﬀect of deleting the jaw is to
eliminate interactions of DMEs with region +12 to +20 of the
Figure 5. Kinetics of dissociation of WT and variant open complexes
in PB (0.16 M Na+) at 25 °C (panel A), as compared to results in TB
(0.01 M Mg2+, 0.12 M K+) at 37 °C (panel B). (A) Fraction of
dissociable open complexes remaining at time t (Δθ; see Experimental
Procedures), determined using the nitrocellulose ﬁlter assay in PB with
excess heparin as competitor (Table 1). Complexes investigated
include WT RNAP at FL (gray) or DT+12 (green) λPR promoter
DNA and ΔJAW RNAP at FL (blue) and DT+12 (orange) λPR
promoter DNA. (B) Relative dissociation rate constants of variant
complexes expressed relative to WT-FL complexes. Results in PB
(green, blue, and orange bars, as determined by studies shown in panel
A) are compared with those in TB (gray bars, as determined by the
nitrocellulose dissociation assay (WT complexes) or decay to
equilibrium data (ΔJAW complexes; see Table 2)).
Table 2. Rate and Equilibrium Constants for the Steps of Transcription Initiation at the λPR Promoter at 37 °C
a
RNAP λPR relative dissociation rate
b 10−3 K3 (M
−1)c ΔG30c (kcal/mol) 10−6 kad (M−1 s−1) 10−6 K1d (M−1) k2 (s−1)d
WT FL 1 ∼150 −6.7 ± 0.3 3.8 ± 0.7e 6.6 ± 2.7e 0.66 ± 0.27e
DT+12 25 ± 3 ∼5.9 −5.4 ± 0.3 5 ± 2 40 ± 20 0.14 ± 0.09
ΔJAW FL 23 ± 3 ∼6.6 −5.5 ± 0.3 0.33 ± 0.05f ndg ndg
DT+12 180 ± 80 ∼0.8 −4.2 ± 0.8 0.33 ± 0.05f ndg ndg
WT UT-47h 0.9 ± 0.3 ∼170 −7.4 ± 0.5 0.5 ± 0.1 26 ± 2 0.02 ± 0.003
aConditions: TB (0.01 M MgCl2, 0.12 M KCl), 37 °C.
bCalculated for WT/FL dissociation rate constant kd = 2.2 (±0.3) × 10
−5 s−1 for these
conditions.18 Values of kd for variants were determined from reversible association kinetic data of Figure 8 using eq 8 (see Experimental Procedures).
cK3 and ΔG30 are deﬁned in Figure 1 and Table 1 footnote c; at 37 °C for λPR, these quantities presumably refer to the process of converting I2 to
RPo. K3 is calculated from eq 2 using a DNA closing rate constant k−2 = 3.3 (±0.7) s
−1 at 37 °C.3 Uncertainty in K3 is ∼30% except for ΔJAW-DT
+12 and WT-UT-47 where it is ∼75% and ∼60%, respectively. dValues of ka, K1, and k2 obtained from eqs 5 and 6; ka is the composite second-order
association rate constant for open complex formation, K1 is the composite equilibrium constant for forming the I1 closed complex, and k2 is the
isomerization rate constant for converting closed intermediate I1 to open intermediate I2.
eRef 4. fAssociation results for ΔJAW RNAP at FL and DT
+12 λPR promoters were ﬁt together.
gNot able to be determined from these data. hDissociation and association rate constants for WT RNAP at
upstream-truncated (at −47; UT-47) λPR.19
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downstream duplex. Eﬀects observed in both buﬀers indicate
that removal of the jaw disrupts a salt- and Mg2+-dependent
network of contacts of DMEs with each other and with the
distal downstream duplex, greatly reducing K3 and the lifetime
of the open complex and greatly increasing its HO• reactivity.
Eﬀects of Urea on Dissociation Rate Constants kd for
WT vs Variant Open Complexes. The eﬀect of urea on
dissociation rate constants for WT RNAP-FL λPR open
complexes in PB is as large as that observed for unfolding a
small globular protein (100−150 residues),28 which we
interpreted in terms of the folding and assembly of DMEs on
the downstream duplex DNA (+3 to +20) in the process of
converting I2 to RPo.
3,7 If deletion of the jaw and/or the
downstream duplex reduces the folding and assembly of DME
on the downstream DNA in these late steps, then dissociation
of these variant open complexes should exhibit a smaller
dependence on urea concentration than for the WT-FL RPo.
Panels A−C of Figure 6 compare the kinetics of dissociation of
WT-FL and variant open complexes in 0.94 M urea with that
observed in the absence of urea (from Figure 5A). These panels
illustrate the general observation that the eﬀect of urea on the
rate of dissociation of WT-FL RPo is much larger than the eﬀect
of urea on the rates of dissociation of the ΔJAW RNAP and DT
+12 downstream deletion variants. Dissociation rate constants
kd obtained from these data and analogous experiments at
intermediate urea concentrations are plotted on a log scale (ln
kd) vs urea concentration for these four situations in Figure 6D.
Linear ﬁts represent the data well in all cases, with intercepts
(compared with WT RNAP-FL λPR in Table 1) that agree
within uncertainty with the experimentally determined
dissociation rate constants in the absence of urea (Figure 5A).
Slopes obtained from linear ﬁts (d ln kd/d[urea]) are listed in
Table 1. For dissociation of WT-FL RPo in PB, d ln kd/d[urea]
= 3.1 M−1, the same within uncertainty as that reported
previously in TB at 17 °C (3.0 M−1).7 For the three single and
double variant open complexes formed with ΔJAW RNAP
and/or DT+12 λPR, d ln kd/d[urea] is only 2/3 as large (d ln
kd/d[urea] = 1.9−2.1 M−1). From eq 2, these urea derivatives
of kd are equal in magnitude and opposite in sign to the
corresponding urea derivatives of K3, because the DNA closing
rate constants k−2 are independent of urea concentration for
WT3 and ΔJAW (E, Ruﬀ, unpublished) RNAP. Deletion of the
jaw, of the downstream duplex at +12, or of both, eliminates
one-third of this urea eﬀect.
Dissection of urea eﬀects on the dissociation rate constant kd
for WT RNAP-FL λPR open complexes reveals that two-thirds
of it is in conversion of I2 to the (I2 − I3)‡ transition state, with
the other one-third in the conversion of this transition state to
I3 and then to RPo.
3 Both the urea results and the reductions in
open complex lifetime observed for the jaw deletion and/or
downstream DNA truncation indicate that by these criteria the
ΔJAW-FL λPR ﬁnal open complex is more similar to (I2 − I3)‡
or I3 than to RPo. Comparison of the eﬀects of urea on
dissociation of open complexes formed by WT and ΔJAW
RNAP at FL and DT+12 λPR with these kinetic-mechanistic
results argues strongly that the jaw assembles with other DMEs
on the downstream duplex promoter DNA late in the
mechanism of RPo formation, most likely in the conversion
of I3 to RPo, and that the ﬁnal open complex formed by ΔJAW
RNAP is a plausible model of the intermediate I3 formed by
WT RNAP at FL λPR. Relative dissociation rate constants
(Tables 1 and 2) are consistent with this conclusion, as are the
diﬀerent eﬀects of salt concentration on dissociation rate
constants of WT and ΔJAW open complexes, presented next.
Eﬀects of Salt Concentration on Dissociation Kinetics
of the ΔJAW RNAP−FL λPR Open Complex are
Consistent with an I3-like Open Complex. Figure 7
compares the eﬀects of NaCl concentration on dissociation
Figure 6. Eﬀects of urea on the dissociation rate constant kd, used as a probe of coupled folding and assembly of DMEs (Figure 2), including the jaw,
on downstream DNA. Experiments were performed using the nitrocellulose ﬁlter assay in PB at 25 °C. Panels A−C compare dissociation time
courses in 0.94 M urea (triangles), plotted as in Figure 5A, with those in the absence of urea (ﬁts reproduced from Figure 5A). (A) WT-FL λPR
(gray). (B) WT-DT+12 λPR (green). (C) ΔJAW-FL (blue) or -DT+12 λPR (orange). (D) Plot of ln kd vs urea molarity, comparing dissociation of
WT and ΔJAW RNAP from FL and DT+12 λPR promoter DNA. Colors are coded to panels A−C. The ﬁtted line for the combined ΔJAW-FL and
ΔJAW-DT+12 data set is blue. Slopes (d ln kd/d[urea]) are listed in Table 1.
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rate constants for WT-FL open complexes at 25 °C2 and
ΔJAW-FL open complexes at 25 °C in PB. Paralleling the
reduced eﬀect of urea on kd for ΔJAW open complex
dissociation (33% reduction compared to WT RNAP),
dissociation of the ΔJAW open complex in PB is much less
salt concentration dependent (50% reduction in d ln kd/d
ln[Na+]; see Table 3) than dissociation of RPo formed by WT
RNAP at FL λPR. While the previous kinetic data for WT
RNAP did not allow the salt eﬀect on kd to be uniquely
dissected into contributions from the individual steps of
dissociation, as was done for the urea eﬀect,3 the greatly
reduced salt eﬀect on dissociation of the ΔJAW open complex
is completely consistent with the proposal that this complex is
I3-like, with a salt dependence which is halfway between that of
RPo (d ln kd/d ln[Na
+] = 9) and that of the initial open
complex I2 (d ln kd/d ln[Na
+] = 0).
Early Steps of ΔJAW−λPR Open Complex Formation.
We previously proposed that DMEs have large eﬀects on early
as well as late steps of open complex formation.5,6 Here, we use
association kinetic studies to test our hypothesis that the jaw
participates in the steps leading up to and/or including opening
(R + P ⇄ I1→ I2; Figure 1). For a series of concentrations of
ΔJAW RNAP, all in excess over promoter DNA, time courses
of open complex formation at FL and DT+12 λPR at 37 °C in
TB are plotted in Figure 8A,C. Analogous results for association
of WT RNAP at DT+12 λPR are plotted in Figure 8B. In all
cases the kinetics are single-exponential, demonstrating that the
initial binding step(s) (R + P⇄ I1) are in rapid equilibrium on
the time scale of the subsequent slow step (I1→ I2) involving
DNA opening.29
At all but the highest RNAP concentrations investigated, the
kinetics of association of ΔJAW RNAP with both FL and DT
+12 (Figure 8A,C) are reversible, forming equilibrium mixtures
of open complexes and unbound promoter DNA. By contrast,
time courses of association of WT RNAP with FL λPR
4 and
with DT+12 λPR (Figure 8B) are irreversible. Values of RNAP-
concentration-dependent composite association rate constants
α (eq 5) for ΔJAW RNAP at FL and DT+12 λPR, obtained as
described in Experimental Procedures from the decay-to-
equilibrium data in Figure 8A,C, are plotted vs concentration of
ΔJAW RNAP in Figure 8D. Also plotted in Figure 8D are
values of α for the association of WT RNAP with DT+12 λPR
(Figure 8B), and ﬁtted curves summarizing the RNAP-
concentration-dependences of α previously reported for
association of WT RNAP with FL λPR
4 and with upstream-
truncated (UT-47) λPR.
19
From Figure 8D, rates of open complex formation from free
reactants at all but the lowest RNAP concentrations are slower
for all variants than for the WT-FL case. In particular, values of
the rate constant α for the ΔJAW variant and either FL or DT
+12 λPR are as small as those observed previously for
association of WT RNAP with UT-47 λPR.
19 Removing either
the jaw or the upstream DNA reduces the rate of open complex
formation to a similarly large extent. This ﬁnding supports our
previous proposal that the upstream clamp, jaw, and other
DMEs function as a relay system, in which the upstream clamp
interacts with the far upstream DNA in the wrapped I1
intermediate, and this interaction shifts the positions of the
jaw and other DMEs to open a gate in the downstream cleft
and allow entry of the downstream duplex prior to opening.5,6
Removing only the downstream DNA (i.e., open complex
formation by WT RNAP with DT+12 λPR) reduces α to a
much smaller though still signiﬁcant extent at higher RNAP
concentrations.
Initial slopes of plots of α vs RNAP concentration (Figure
8D) are overall second-order rate constant for open complex
formation ka (eq 6). Values of ka for WT RNAP and either FL
or DT+12 λPR are similar, and are approximately 10-fold larger
than those for ΔJAW RNAP and either FL or DT+12 λPR, or
for WT RNAP and UT-47 λPR. This large eﬀect on ka of
deleting the jaw cannot be explained entirely by an interaction
of RNAP with the downstream duplex in I1 or the subsequent
transition state, since the same behavior is observed with both
FL and DT+12 λPR. This is consistent with the deduction from
the kd data that the jaw deletion has large eﬀects on the
interaction of DMEs with the downstream duplex late in RPo
formation, in the conversion of I3 to RPo.
From eq 6, ka is the product of the equilibrium constant K1
for formation of the I1 closed complex and the rate constant k2
for the isomerization step, including DNA opening, that
converts I1 to I2. For situations where K1 and the range of
RNAP concentrations investigated are large enough, individual
values of K1 and k2 are obtained from analysis of the
dependence of α on [RNAP] using eq 5. For open complex
formation by WT RNAP, truncation of the downstream duplex
(DT+12), like upstream truncation (UT-47), increases K1 and
reduces k2. For DT+12, these eﬀects compensate, so the overall
ka is unaﬀected by downstream truncation; for UT-47, Davis et
al. found that the reduction in k2 was the dominant eﬀect,
greatly reducing ka even though K1 increased.
19 For open
complex formation by ΔJAW RNAP with either FL or DT+12
λPR, the data do not permit dissection of ka into K1 and k2.
The ﬁnding that association rate constants ka are the same for
open complex formation by ΔJAW RNAP and FL or DT+12
λPR promoter (Table 2) appears to contradict what is observed
in Figure 8, where decay to equilibrium rates at a speciﬁed
[RNAP] are faster for ΔJAW-DT+12 complexes (Figure 8C)
Figure 7. Comparison of eﬀects of [Na+] on dissociation rate
constants kd of open complexes formed by ΔJAW (blue squares) and
WT RNAP (black triangles)2 at FL λPR in PB, 25 °C. Slopes of these
plots (d ln kd/d ln[Na
+]) are listed in Table 3.
Table 3. Salt Eﬀects on Dissociation Kinetics of ΔJAW and
WT RNAP Open Complexesa
RNAP λPR
relative
dissociation
rateb
10−3 K3
(M−1)b,c
ΔG30
(kcal/mol)d
d ln kd/
d ln[Na+]e
WT FL 1 6.0 ± 1.0 −5.2 ± 0.3 9.5 ± 1.0
ΔJAW FL 28 ± 3 0.21 ± 0.05 −3.2 ± 0.2 4.7 ± 0.7
aConditions: PB, 25 °C. bAt 0.23 M Na+ where, for WT RNAP, kd =
(2.8 ± 0.1) × 10−4 s−1, interpolated from Figure 7. cCalculated using
k−2 = 1.7 ± 0.4 s
−1 at 25 °C, interpolated from results at 10 and 37
°C.3 dCalculated from K3.
eDetermined from Figure 7.
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than for ΔJAW-FL complexes (Figure 8A). This is not a
contradiction; the faster decay to equilibrium is entirely because
kd for dissociation of ΔJAW-DT+12 open complexes is larger
than for ΔJAW-FL open complexes in TB (Table 2).
■ DISCUSSION
In fundamental and signiﬁcant ways, the mechanism of forming
and stabilizing the open RNAP-λPR promoter complex
resembles the mechanism of an enzyme-catalyzed reaction.1,5
First, in a series of steps that are rapidly reversible, like those
that form a precatalytic complex between enzyme and
substrates, RNAP binds the start-site region of duplex promoter
DNA, bends it, and inserts it into the active site cleft.3,6,19 Then,
in a slow (rate-determining) step occurring in the active site
cleft, like the catalytic step of an enzyme-catalyzed reaction,
RNAP opens the initiation bubble (−11 to +2) and appears to
place the +1 template strand base in the active site.1
Subsequent to opening, the downstream half of the melted
nontemplate strand appears to be repositioned, and RNAP
DMEs assemble and fold on the distal downstream duplex.1−3,7
For the conditions used to investigate dissociation of open
complexes here, the steps of DME disassembly are rapidly
reversible on the time scale of the rate determining DNA
closing step. For both enzyme catalyzed reactions and
transcription initiation, the early and late reversible steps are
the targets of most regulatory factors and ligands.
In this study, we probed the role of RNAP interactions with
the downstream DNA by removing either the DNA down-
stream beyond +12 or the jaw, which is thought to interact with
the downstream DNA. Footprinting reveals that ΔJAW open
complexes diﬀer structurally from those formed by the WT
RNAP: although the DNA is melted to the same extent, both
DNA strands are globally less protected from HO• attack, and
the downstream boundary of HO• protection shortens by 5−
10 bp. Dissociation kinetics of ΔJAW open complexes are faster
and less dependent on urea concentration, whereas promoter
binding-DNA opening is much slower than for WT RNAP.
These results implicate the jaw role during both early and late
steps in RPo formation. By contrast, the downstream DNA
appears to function primarily after DNA opening: while DT+12
truncation has the same eﬀect on dissociation kinetics as the
removal of the jaw, it does not aﬀect association rate constant ka
for WT RNAP.
Consistent with the reported eﬀects of the jaw deletion on
the lifetime of the open complex,9,14 we deduce that the jaw is
required for RNAP contacts with the distal downstream region
(+10 to +20) of the promoter established in the last step of
stabilization of the open complex (conversion of I3 to RPo).
Strikingly, however, we also ﬁnd that deletion of the jaw greatly
reduces the rate of the early steps of initiation. We deduce that
this eﬀect is not simply due to loss of interactions with the
downstream DNA; a loss of interactions of the jaw with in-cleft
elements such as other DMEs and/or with region 1.1 of σ70
must also be involved.14 This interpretation is consistent with
observations of Mekler et al. that gp2, a phage inhibitor that
binds to the jaw, destabilizes RNAP/scaﬀold complexes even in
the absence of downstream DNA.24 In addition, results of HO•
footprinting suggest that the jaw is required to seal the
downstream end of the cleft in RPo, eliminating water and
forming a tight interface of RNAP-DNA backbone interactions
that is highly protected from HO• attack. By contrast, the open
DNA strands and surrounding duplex in the I3-like ΔJAW open
complex appear to be more hydrated, as judged by their
increased HO• reactivity. Expulsion of water during RPo
Figure 8. Comparison of association kinetics of ΔJAW and WT RNAP with FL and DT+12 λPR promoter DNA in TB at 37 °C. Panels A−C display
time courses of the fraction of λPR promoter DNA in the form of heparin-resistant open complexes (θ) for diﬀerent RNAP concentrations for (A)
ΔJAW RNAP and FL λPR promoter (blue), (B) WT RNAP and DT+12 λPR promoter (green), and (C) ΔJAW RNAP and DT+12 λPR promoter
(orange). Curves are single exponential ﬁts to eq 3, yielding decay to equilibrium rate constants β, from which the association rate constant α is
obtained (eq 4). (D) Plots of α vs [RNAP] for the data of panels A−C, compared with published ﬁts for association of WT RNAP with FL (gray)4
and UT-47 λPR (purple).
19 The axes of the inset ﬁgure are the same as in the main panel. A hyperbolic ﬁt (eq 5) to the WT-DT+12 data set (green
curve) and a linear ﬁt to the combined ΔJAW-FL and ΔJAW-DT+12 data set (blue line) are shown. Values obtained from these ﬁts are reported in
Table 2.
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formation presumably contributes signiﬁcantly to the entropic
driving force for the endothermic steps of opening and
conversion of the initial open complex (I2) to RPo, as
previously proposed.2
Our current and previous results indicate that assembly of
DMEs on the downstream duplex stabilizes the initial open
complex I2 in converting it to RPo.
2,3 Analysis of RNAP binding
to heteroduplex downstream junction templates with pro-
gressively shortened downstream DNA duplex revealed that
many interactions contribute to this stabilizing eﬀect.12 The
largest incremental eﬀect was observed when the duplex was
extended from +8 to +9. Structural studies suggest that DNA
near +9 contacts the jaw directly.25 This interaction likely plays
a role in formation and stabilization of RPo and is subject to
control by gp213 and likely other regulators.
However, structural analysis of RNAP shows that the jaw
does not extend beyond +10, raising a question of how the far
downstream protection is established. Collectively, the available
data suggest that contacts between the jaw and promoter DNA
set the trajectory for DNA entry into a trough formed by the
jaw and clamp domains. Single-molecule FRET experiments
demonstrate that the clamp is open in free RNAP but closes
upon the formation of RPo.
30 While the open state of the clamp
permits DNA movement in and out of the cleft, interactions of
DNA with RNAP trigger an inward 16° rotation of the clamp,
eﬀectively sealing the cleft in RPo. The observed protection
from HO• is likely due to a combination of the cleft closure
and direct contacts between DMEs and DNA.
Cross-linking data support the existence of direct interactions
between DNA backbone from +10 to +20 and a large fragment
of the β′ subunit (residues 821−1407), which includes the
clamp, the jaw, and SI3.26 Given the range of motions
demonstrated30 and proposed22 for these DMEs, we cannot
pinpoint speciﬁc interactions of RNAP regions with each
position in the promoter DNA. Furthermore, DMEs are
proposed to function together in several relay systems (Figure
2),5,13 and changes in diﬀerent elements may give rise to similar
eﬀects on transcription, e.g., in the case of the jaw and SI3,
which share an extensive interface.31 Thus, it is diﬃcult to
distinguish between direct (mediated via DNA contacts) and
indirect eﬀects of deletions in individual DMEs. A more reﬁned
mapping of the DME contacts with the promoter DNA awaits
high-resolution structural and cross-linking analysis of RPo.
We propose that in ΔJAW RNAP-promoter complexes, the
downstream DNA may not be properly positioned in the
trough, and clamp closure is subsequently inhibited. The same
eﬀect is observed upon addition of gp2, which blocks DNA
interactions with the jaw30 and locks the clamp in the open
state.13
The Role of the Jaw in Early (Pre-Opening) Steps. The
profound eﬀects of deleting the jaw on the early steps of open
complex formation, observed for both FL and DT+12
promoter DNA, indicate that the jaw and/or neighboring
regions aﬀected by its deletion are a key part of the proposed
relay system5,6 by which the upstream promoter sequence,
transcription factors, ligands and solution variables work
together to regulate the rate of forming the initial open
complex (I2), and thereby regulate the rate of transcription
initiation. The limited evidence available to date suggests that
much of this regulation occurs in the steps that put the
downstream DNA duplex in the cleft. The subsequent opening
step is relatively independent of solute concentration2,7
suggesting that, like catalytic steps of enzymes, it occurs within
a somewhat sealed cleft that is not readily accessible to solutes
and regulatory ligands.
We have proposed that these early acting upstream
regulatory factors have a common basis of action: together
they set or modify the trajectory of far-upstream DNA in early,
relatively unstable closed intermediate complexes (designated
RPc) in which the promoter DNA lies outside the cleft.
5 The
trajectory of far-upstream DNA determines its ability to interact
with the upstream clamp, which in turn aﬀects the positioning
of the jaw and other DMEs.6 More speciﬁcally, we proposed
that when −35 and UP elements are recognized by σ70 region 4
and the αCTDs (respectively), far-upstream DNA is bent and
wrapped around the back of RNAP, in close proximity to the
downstream end of the active site cleft and the upstream clamp.
These interactions trigger release of DMEs from their blocking
positions, opening the downstream gate to allow entry of the
downstream duplex.
Interestingly, yeast RNAP II may also use a molecular relay
to mediate loading of the duplex DNA into the active site cleft,
which is obstructed in the free enzyme in all multisubunit
RNAPs. The Pol II subunit Rpb4/7 (absent in bacterial RNAP)
binds to the RNAP core, facilitating clamp closure.32 Recent
studies postulate that subsequent binding of the multisubunit
mediator complex attracts Rpb4/7, resulting in formation of the
open clamp state and thus allowing for the entry of duplex
DNA into the RNAP active site cleft.33
The Role of the Jaw in Late (Post-Opening) Steps. The
observed dissociation rate constant kd of stable open complexes
(mainly RPo) to free promoter and RNAP provides information
about the steps that convert RPo back to I2 and the rate of DNA
closing (I2→ I1) (Figure 1). The DNA closing rate (k−2) is not
a function of salt or urea concentration.3 Therefore, solute and
salt eﬀects on kd arise from their eﬀect on the equilibrium
constant for conversion of I2 to RPo (K3). For the conditions of
our experiments, steps by which RPo converts to I2 rapidly
equilibrate on the time scale of DNA closing (I2 → I1).
29 We
proposed that the conversion of I2 to RPo involves assembly of
DMEs on the downstream duplex, and movement of the
downstream portion of the nontemplate strand in the cleft.1−3
Our current studies test these proposals by deleting the jaw
and/or the downstream duplex (DT+12).
Kontur et al. concluded from the urea eﬀect on kd that
approximately 100−150 residues of RNAP are buried by
folding/assembly in the steps converting the initial open
complex I2 to the ﬁnal open complex RPo (Figure 2).
3 Roughly
two-thirds of this urea eﬀect occurs in the conversion of I2 to
the subsequent (I2−I3)‡ transition state, and the remaining 40
residues are buried in the conversion of this transition state to
RPo. In the current study, we ﬁnd that, in contrast to WT
enzyme, the ΔJAW variant does not protect the distal
downstream DNA from HO• attack. The eﬀect of urea on
dissociation of ΔJAW RNAP from either FL or DT+12 λPR and
of WT from DT+12 λPR indicates that ∼40 fewer residues are
buried in the open complex formed by these variants. PONDR
predicts that 33 residues near the jaw are unstructured in
RNAP (Figure 2B). The simplest explanation of these
observations is that the jaw folds and assembles with other
DMEs on the distal promoter DNA in the ﬁnal step of open
complex formation (Figure 2D), and that the open complex
formed by ΔJAW may therefore be a stable mimic of the
relatively unstable I3 intermediate open complex formed by WT
RNAP on the path to RPo at λPR.
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What events (involving burial of approximately 80 residues
by folding/assembly) occur in the conversion of I2 to I3? We
propose that folding and assembly of regions of the β′ clamp
and/or the β lobe, DMEs proposed to interact with the
proximal downstream DNA duplex (+3 to +9),9 occur in this
step (Figure 2C). PONDR predicts that 99 residues of the β′
clamp and 57 residues of the β lobe are unstructured in RNAP.
Formation of the proximal downstream contacts would
logically precede assembly of the jaw and/or other DMEs to
the distal downstream duplex, as stability increases in the
conversion of I2 to RPo. Experiments are in progress to test
these predictions for interactions of the DMEs with down-
stream DNA in I2 and I3, and to determine the eﬀect of
promoter sequence and interactions in the cleft on the extent of
assembly and tightening of the jaw and other DMEs.
Our studies reveal the existence of three types of “open”
promoter complexes that diﬀer in interactions between the
downstream duplex DNA with DMEs. We hypothesize that the
distribution among these complexes diﬀers at diﬀerent cellular
promoters, underlying their regulation by transcription factors
such as DksA, which allosterically alters RNAP contacts with
DNA downstream from the active site.34 We propose that this
mode of regulation may be utilized by eukaryotic RNAPs,
which have structural elements that are homologous (β′ clamp,
β lobe) or functionally analogous (β′ jaw) to bacterial DMEs.35
Furthermore, similar to our footprinting results obtained at
λPR, recent single-molecule studies of yeast RNAP II open
complexes revealed very diﬀerent positions of the downstream
DNA,36 supporting our idea that promoter DNA/RNAP
interactions in this region are highly dynamic and suggesting
that they may contribute to regulation of eukaryotic gene
expression.
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Successful infection of Escherichia coli by bacteriophage T7 relies upon the transcription of the
T7 genome by two different RNA polymerases (RNAps). The bacterial RNAp transcribes early T7
promoters, whereas middle and late T7 genes are transcribed by the T7 RNAp. Gp2, a T7-
encoded transcription factor, is a 7 kDa product of an essential middle T7 gene, 2, and is a potent
inhibitor of the host RNAp. The essential biological role of Gp2 is to inhibit transcription of early T7
genes that fail to efficiently terminate in order to facilitate the coordinated usage of the T7 genome
by both host and phage RNAps. Overexpression of the E. coli udk gene, which encodes a uridine/
cytidine kinase, interferes with T7 infection. We demonstrate that overexpression of udk
antagonizes Gp2 function in E. coli in the absence of T7 infection and thus independently of T7-
encoded factors. It seems that overexpression of udk reduces Gp2 stability and functionality
during T7 infection which consequently results in inadequate inhibition of host RNAp and in the
accumulation of early T7 transcripts. In other words, overexpression of udk mimics the absence of
Gp2 during T7 infection. Our study suggests that the transcriptional regulation of the T7 genome
is surprisingly complex and might potentially be affected at many levels by phage- and host-
encoded factors.
INTRODUCTION
The Escherichia coli bacteriophage T7 relies upon the
multisubunit RNA polymerase (RNAp) of its host and a
single subunit RNAp encoded by its own genome for
transcription of its genes. During the infection process, the
host RNAp transcribes early T7 phage genes from the
genetic left end of the viral genome, whereas the T7 RNAp
transcribes the middle and late T7 phage genes. Whilst
activities of both the host and T7 RNAp on the T7 phage
genome are likely to be regulated and co-ordinated at
multiple levels involving host and phage factors, it is
generally accepted that the products of T7 phage early gene
0.7 and middle gene 2 are responsible for inhibition of host
RNAp at later stages of infection such that host resources
are shifted towards the production of viral transcripts
synthesized by the T7 RNAp. T7 Gp0.7 is a serine/
threonine kinase that phosphorylates a specific threonine
residue (T1068) in the evolutionarily variable region (b9
GNCD/I6 domain) of the host RNAp, which results in
increased r-independent termination during transcription
of host genes (Severinova & Severinov, 2006). T7 Gp2 is a
7 kDa protein that binds to the structurally conserved b9
jaw domain of the host RNAp that is adjacent to the b9
GNCD/I6 domain. Gp2 is a potent inhibitor of the E. coli
RNAp and antagonizes conformational changes in the
RNAp and interactions between the RNAp and the
promoter DNA that are necessary for the engagement of
the RNAp with the promoter DNA for transcription
initiation (James et al., 2012; Mekler et al., 2011).
Unlike Gp0.7, Gp2 is essential for T7 phage growth in E.
coli. Recently, it was demonstrated that the essential
function of Gp2 during T7 phage infection is to abolish
transcription from the strong host RNAp-dependent early
T7 phage promoters A0-A3 (Savalia et al., 2010). Down-
mutations in the T7 A3 promoter compensate for the
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absence of Gp2 (Savalia et al., 2010). Likewise, mutations
in boxA anti-termination element located downstream of
early T7 phage promoters also make Gp2 dispensable
(Savalia et al., 2010). It therefore follows that, in the
absence of Gp2, T7 A0-A3 promoter-initiated and boxA
anti-terminated transcription by host RNAp interferes with
T7 phage infection. The exact mechanism of this
interference remains unknown.
Qimron et al. (2006) showed that mutant T7D0.7 phage,
and to a relatively lesser extent wild-type T7 phage, is
unable to grow on wild-type E. coli cells overexpressing
udk, a uridine/cytidine kinase, which converts uridine and
cytidine into the ribonucleoside monophosphates UMP
and CMP, respectively. More recently, Qimron et al. (2008)
identified missense mutations in gene 2 and gene 3.5
(which encodes T7 lysozyme – an inhibitor of the T7
RNAp) that enable T7D0.7 mutant and wild-type T7 phage
growth on E. coli overexpressing udk. Overproduction of
Gp2 was sufficient to suppress the growth defect of T7D0.7
mutant and wild-type T7 phage in udk overexpressing E.
coli cells (Qimron et al., 2008). Thus, it appears that during
T7 phage infection of udk overexpressing E. coli cells, Gp2
is not able to adequately inhibit the host RNAp (Qimron et
al., 2008). However, whether udk overexpression directly
affects Gp2 function or is mediated via an unidentified T7
phage and/or host factor(s) during T7 phage infection
remains unknown. In addition, the consequence of udk
overexpression on the biological role of Gp2 during T7
phage infection remains uncharacterized. Here, we present
results from experiments in which we have addressed these
issues.
METHODS
Plasmids. Plasmid pAS2:Gp2 and pAS2:CR44b_13 was constructed
by digesting pSW33:Gp2 (Ca´mara et al., 2010) and pAS33:CR44b_13
(Shadrin et al., 2012) with XbaI and HindIII restriction endonucleases
and the resulting 0.3 kb fragment containing T7 gene 2 and
CR44b_13 was cloned into the same sites in pBAD33 (ATCC).
pAS3 was constructed from pQE30 (Qiagen) by digesting with BsmI
and further circularization of the largest fragment. The resulting pAS3
plasmid is distinct from pQE30 only by 407 bp (BsmI–BsmI deletion)
in the coding region of the chloramphenicol acetyltransferase gene.
To make pAS3:udk, E. coli udk gene was amplified by PCR using
primers 59-TTTGGATCCATGACTGATCAGTCTCACCAGTG-39 and
59- ATCAAGCTTATTCAAAGAACTGACTTATTTTCGCT-39 (italic
; underlined type indicates restriction enzyme sites), digested with
BamHI and HindIII and cloned into the same sites of pAS3 vector.
Bacterial growth attenuation assays. These assays were conducted
in 250 ml flasks in a water bath at 37 uC with agitation at 180 r.p.m.
Each flask contained 25 ml Luria broth (LB) growth medium
supplemented with 30 mg chloramphenicol l21 (to select for plasmids
pAS2:Gp2 and pAS2:CR44b_13) and 100 mg ampicillin l21 (to select
for plasmids pAS3 and pAS3:udk), which was inoculated with 0.25 ml
overnight culture grown in the same medium additionally supple-
mented with 0.5% glucose to prevent leaky expression of proteins.
The overexpression of udk was induced by adding IPTG to 1 mM
final concentration when the culture reached OD600~0.15. Thirty-five
minutes after induction with IPTG the cells were pelleted and
resuspended in the same volume of the medium containing
antibiotics. At this point a sample corresponding to t50 was taken
and Gp2 synthesis was induced by adding L+-arabinose solution to a
final concentration of 0.1% (w/v). For the calculation of Gp2
stability, a second washing step (as above) was performed at t51.5 h
to remove arabinose. At least three biological replicates were
performed for each growth curve shown in Figs 1, 2 and S1 <, available
with the online version of this paper.
Western blotting.Western blots were conducted exactly as described
by Shadrin et al. (2012) but using polyclonal antibodies against Gp2
(Eurogentec) and using anti-rabbit–horseradish peroxidase-conju-
gated antibodies (Dakocytomation) as secondary antibodies. Western
blots were conducted for two samples obtained from two of the three
biological replicates from the growth curve experiments (see above)
and the best representative blot is shown. The Gp2 half-life was
calculated by measuring the relative intensities of the Gp2 signal from
the Western blots assuming that the Gp2 degradation begins
immediately after removing arabinose.
Primer extension analysis of early T7 transcripts. The reactions
were conducted essentially as described by Savalia et al. (2010) but in
E. coli strain BL21 containing the udk overexpression ASKA plasmid
pCA24N:udk (Kitagawa et al., 2005) in the presence of 0.5 mM IPTG.
RESULTS
Overexpression of udk antagonizes Gp2 activity in
E. coli in the absence of T7 phage infection
We recently described a simple bacterial growth attenu-
ation assay to study the activity of wild-type and mutant
Gp2 forms in vivo in the absence of a T7 phage infection
(Shadrin et al., 2012). In this assay, plasmid-borne Gp2 is
expressed from the arabinose-inducible araBAD promoter
in E. coli strain MG1655. The induction of Gp2 expression
with arabinose results in efficient attenuation of bacterial
growth. We adapted this assay to find out if overexpression
of udk can antagonize Gp2 activity in the absence of a T7
phage infection. In our experimental setup, E. coli strain
MG1655 contained two compatible plasmids: pAS2:Gp2 in
which gene 2 is placed under the control of the arabinose-
inducible araBAD promoter and either pAS3:empty or
pAS3:udk in which udk is placed under the control of the
IPTG-inducible T5 promoter. The E. coli cells were grown
for 1 h in LB at 37 uC to OD600~0.15 and udk over-
expression was induced with 1 mM IPTG for 45 min. The
cells were then washed with fresh LB media and
resuspended in LB containing 0.1% w/v L+-arabinose to
induce Gp2 expression and allowed to grow at 37 uC. As
shown in Fig. 1(a), the expected attenuation of bacterial
growth upon induction of Gp2 in the absence of udk
overexpression was detected under our experimental
conditions (compare solid and dotted red lines).
Overexpression of udk, in the absence of Gp2 expression
did not lead to attenuation of bacterial growth (Fig. 1a,
dotted blue line). However, we failed to detect the expected
attenuation of bacterial growth upon Gp2 induction in
cells overexpressing udk (Fig. 1a, solid blue line). Similar
results were obtained when experiments were repeated in
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the context of the Gp2-like protein from Citrobacter
rodentium (CR44b_13) which shares 47% identity with
Gp2 that also binds to the b9 jaw domain of the E. coli
RNAp and inhibits transcription initiation (Fig. 1b, c)=
(Shadrin et al., 2012). Overall, we conclude that the
overexpression of udk antagonizes Gp2 function in E. coli
in the absence of any other T7 phage encoded factor(s). In
other words, it seems that the antagonistic effect of udk
overexpression on Gp2 activity in E. coli during T7 phage
infection occurs independently of any other T7 phage-
encoded factors.
Overexpression of udk in E. coli reduces Gp2
stability and functionality in the absence of T7
phage infection
We extended the Gp2-mediated growth attenuation assay
to monitor accumulation and stability of Gp2 in the
absence and presence of overexpressed Udk. The experi-
ment shown in Fig. 2 was setup exactly as in Fig. 1, but the
E. coli cells were subjected to additional washing step in
fresh LB to remove arabinose that is used to induce Gp2
expression. Samples were taken at t50, 0.5, 1 and 1.5 h to
monitor Gp2 accumulation post-induction and at t51.8,
2.3 and 2.8 h to monitor Gp2 stability after removal of
arabinose (note that all time points are relative to t50
when Gp2 expression was induced). Whole-cell extract
from ~108 E. coli cells from each sample was prepared and
analysed by Western blotting using polyclonal antibodies
against Gp2. As shown in Fig. 2, increased (by ~four- to
fivefold) accumulation of Gp2 was observed in whole-cell
extracts prepared from udk overexpressing E. coli cells
when compared with whole-cell extracts prepared from
udk non-overexpressing E. coli cells. This is as expected
because induction of Gp2 expression will eventually lead to
inhibition of transcription of gene 2 from the pAS2:Gp2 by
the E. coli RNAp, which, in the presence of udk over-
expression will not occur (see above). However, the relative
stability of Gp2 in whole-cell extracts prepared from udk
overexpressing E. coli cells appears to be significantly
reduced upon removal of the inducer (arabinose) when
compared with the stability of Gp2 in whole-cell extracts
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Fig. 1. Overexpression of udk antagonizes Gp2 activity in E. coli in the absence of T7 phage infection. (a) Growth curves of E.
coli MG1655 containing different plasmid combinations and growth conditions (as indicated). (b) Growth curves of E. coli cells
containing pAS2:CR44b_13 encoding Gp2-like protein CR44b_13 from CR44b phage, and with different plasmid
combinations >.
Overexpression of E. coli udk mimics absence of T7 Gp2
http://mic.sgmjournals.org 3
prepared from udk non-overexpressing E. coli cells (Fig. 2).
Under our experimental conditions, the estimated half-life
of Gp2 in udk overexpressing E. coli cells is ~49 min
whereas it exceeds 3 h in udk non-expressing E. coli cells.
Intriguingly, the relative amount of total Gp2 molecules in
whole-cell extracts from udk overexpressing and non-
expressing cells at t52.8 (i.e. 1 h after removal of the
inducer) is comparable, even though Gp2 is unable to
attenuate E. coli cell growth under udk overexpressing
conditions. Since the binding of Gp2 and the promoter
DNA downstream of the transcription start site to the b9
jaw domain (which is necessary for transcription initiation
to occur) are mutually exclusive events (Mekler et al.,
2011), this observation suggests that Gp2 is somehow
prevented from interacting with the RNAp under udk
overexpressing conditions. Overall, it seems that udk
overexpression is likely to result in a condition that mimics
the absence of Gp2 function in E. coli.
Overexpression of udkmimics the absence of Gp2
function during T7 phage infection
The essential biological role for Gp2 during T7 infection of
E. coli is the prevention of anti-terminated transcription
from the early T7 promoters A0-A3 (Savalia et al., 2010)
into regions of the T7 phage genome normally transcribed
by the T7 RNAp. Inspired by the finding that over-
expression of udk could create a condition that mimics the
absence of Gp2 in E. coli, we set out to determine the effect
of udk overexpression on Gp2 functionality during T7
phage infection. As shown in Fig. 3 (inset) and consistent
with the observation made by Savalia et al. (2010), in the
course of wild-type T7 phage infection of E. coli,
transcription from early T7 promoters A0-A3 by the host
RNAp is eliminated shortly after initiation of transcription
by the T7 RNAp (Savalia et al., 2010). In contrast, when E.
coli is infected by T7 carrying an amber mutation in gene 2,
host RNAp transcription from early phage promoters
continues late in infection (Savalia et al., 2010). A similar
effect is observed when wild-type T7 infects a host
bacterium whose RNAp lacks the b9 jaw domain (Savalia
et al., 2010). In agreement with the results shown in Figs 1
and 2, transcripts from early T7 promoters accumulated
continuously throughout T7 phage infection in cells
overexpressing udk. This result thus clearly indicates that
overexpression of udk effectively prevents Gp2 function in
vivo during T7 phage infection. In other words, over-
expression of udk mimics the absence of Gp2 during T7
phage infection and leads to accumulation of anti-
terminated transcription from early T7 promoters, which
as a consequence abrogates successful T7 phage gene
expression and infection.
DISCUSSION
In this study we demonstrate that overexpression of E. coli
udk allows transcription from early T7 promoters to
continue late in infection, thus mimicking infections that
occur in the absence of Gp2 function i.e. when E. coli cells
are infected by gene 2 mutant T7 phage or cells whose
RNAp carries lesions in the Gp2-binding b9 jaw domain is
infected by the wild-type T7 phage (Savalia et al., 2010). It
therefore follows that udk, when overexpressed, obliterates
the essential in vivo function of Gp2, i.e. inhibition of
transcription from early T7 phage promoters (Savalia et al.,
2010). The mechanism by which overexpression of udk
obliterates Gp2 function remains largely elusive; yet, our
results indicate that it is unlikely to involve any T7 phage-
encoded factors. However, we cannot exclude the possibil-
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Fig. 2. Overexpression of udk in E. coli reduces Gp2 stability and
functionality in the absence of T7 phage infection. As in Fig. 1,
growth curves (top panel) of E. coli MG1655 containing
pAS2:Gp2 and pAS3:empty (grey line) and pAS2:Gp2 and
pAS3:udk (black line). Samples for preparing whole-cell extracts
were taken at the indicated time points and analysed by Western
blotting (middle panel) and signal intensity (relative to Gp2 signal
at t51.8 in whole-cell extracts from cells containing pAS2:Gp2
and pAS3:empty) on the Western blot was quantified and plotted
on a graph (bottom panel).
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ity of the involvement of host factors that could affect Gp2
functionality during T7 phage infection under udk over-
expressing conditions. This view is consistent with the
observation that purified recombinant Udk has no
detectable effect on E. coli RNAp transcription from the
early T7 phage promoter T7 A1 on its own and does not
influence the ability of Gp2 to either bind to or inhibit the
E. coli RNAp in vitro (Fig. S2a, b). Further, since Udk
coverts cytidine and uridine into their respective ribonu-
cleoside monophosphates, CMP and UMP, we considered
whether the significantly increased intracellular concentra-
tion of CMP and GMP under udk overexpressing
conditions could potentially affect the ability of Gp2 to
bind to and inhibit the E. coli RNAp. Thus, we investigated
the ability of Gp2 to inhibit transcription initiation by the
E. coli RNAp in the presence of CMP and GMP. As shown
in Fig. S2(c), Gp2 is able to inhibit transcription initiation
from the lacUV5 promoter equally well in the absence and
presence of CMP and GMP. However, we note that
overexpression of udk appears to significantly reduce the
half-life of Gp2 in E. coli when compared with the half-life
of Gp2 under udk non-overexpressing conditions. This
could indicate that Gp2 is somehow prevented from
interacting with the RNAp under udk overexpressing
conditions. We propose that RNAp-unbound Gp2 is more
susceptible to proteolysis under udk overexpressing condi-
tions than Gp2 that is bound to the RNAp and thus
relatively better protected from proteolysis. In support of
the latter, Gp2 is relatively less stable (estimated half-life of
16 min) in mutant E. coli cells JE1134 (Ederth et al., 2002)
containing mutant RNAp without the b9 jaw domain (this
is the binding site for Gp2) (Fig. S1) than in wild-type E.
coli cells (estimated half-life of .3 h; Fig. 2). Furthermore,
the view that Gp2 is somehow prevented from interacting
with the RNAp under udk overexpressing conditions is
consistent with the observation made by Qimron et al.
(2008) demonstrating that the overexpressed udk-mediated
antagonist effect on Gp2 function during T7 phage
infection can be overcome by supplying excess plasmid-
borne Gp2.
The fact that we detect continuous accumulation of
transcription from early T7 phage promoters under udk
overexpressing conditions during T7 infection is thus
consistent with the view that overexpression of udk creates
a condition that mimics the absence of Gp2 function. This
provides experimental evidence in support of the model
proposed by Qimron et al. (2008), which predicts that
under udk overexpressing conditions, transcription by the
‘slow-elongating’ host RNAp from the early T7 promoters
into regions of the T7 genome normally transcribed by the
‘fast-elongating’ T7 RNAp, causes the latter to pause, which
in turn results in undue recruitment of T7 genome
packaging factors Gp18 and Gp19 and thus the production
of less than unit length phage genomes, which as a
consequence abrogates successful infection of E. coli by T7
phage. We speculate that udk could have been part of a past
mechanism in E. coli that existed to thwart infection by T7-
like phages, but is no longer available as a mechanism for
suppression of T7 infection. We propose that the T7 phage
has evolved a strategy involving the serine/threonine kinase
Gp0.7 to counteract the effect of Udk. Two lines of
evidence support this view. Firstly, Udk is phosphorylated
at a threonine residue in stationary phase E. coli cells
(Macek et al., 2008), suggesting that Udk activity could be
somehow antagonized by phosphorylation. Secondly,
mutant T7D0.7 phage is severely impaired for growth in
E. coli cells overexpressing udk, whereas wild-type T7 is
relatively less impaired compared with T7D0.7 phage. In
other words, we propose that Gp0.7-mediated phosphor-
ylation of Udk could prevent the Udk-mediated antagon-
ism of Gp2 function during T7 phage infection of E. coli.
Global transcriptome and phosphoproteome analysis in E.
coli under udk overexpressing conditions and during wild-
type T7 and T7D0.7 infections might provide further
insights into overexpressed Udk-mediated antagonism of
Gp2 function in E. coli during T7 phage infection. Such
experiments are currently under way in our laboratory.
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